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Unlike the  adult mammal, the chick can successfully regenerate its  spinal  cord until 
embryonic  day  (E)  13.  Multiple  factors  may  contribute  to  the  subsequent  loss  of 
regenerative capacity,  although most research has concentrated on axonal re-growth 
inhibition as a key issue. The number of viable cells remaining in the spinal cord could 
also be  important and may  be affected by cell  survival  and cell replacement.  In this 
thesis  the  early  response  of the  chick  spinal  cord  to  injury  has  been  investigated, 
focusing on cell death and the potential to replace lost cells by neurogenesis.
Pharmacological  reduction  of haemorrhage  after  injury  at  E l5  resulted  in 
reduced apoptosis and cavitation, suggesting that blood-borne factors, such as the serine 
protease thrombin, may cause apoptosis. Endogenous thrombin expression and activity 
after  injury  was  investigated.  Thrombin  was  not  up-regulated  after  injury  at  E l5; 
however, evidence suggests that the activity of other serine proteases was increased. In 
parallel, in organotypic slice cultures, exogenous thrombin treatment did not increase 
apoptosis.  These  results  provide  new  information  about  the  contribution  of serine 
proteases to apoptosis in the chick, suggesting that, although thrombin is not of primary 
importance, other serine proteases could play a greater role.
Next, the contribution of neurogenesis to  regeneration at E ll  was examined. 
Changes  in  the  expression  and  phosphorylation  of  the  early  neuronal  marker, 
doublecortin, in response to injury were observed. Although increased proliferation in 
the grey matter was observed, no  increase in neurogenesis after injury was detected. 
Surprisingly, ongoing neurogenesis was discovered in the normal spinal cord at Ell. 
These results challenge established views about the timing of neurogenesis in the chick 
spinal cord and suggest that ongoing proliferation and neurogenesis may contribute to 
the regenerative capacity at this stage.
This thesis presents insights into factors involved  in the early response of the 
chick  spinal  cord  to  injury,  providing  new  information  about  the  contribution  of 
neurogenesis and cell survival to regenerative capacity.
2I, Katherine Ann Whalley, confirm that the work presented in this thesis is my own. 
Where information has been derived from other sources, I confirm that this has been 
indicated in the thesis.Table of Contents
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1.1.  Structure and function of the spinal cord
The central nervous system (CNS) is composed of two continuous structures, the brain 
and the spinal cord. The spinal cord consists of a small, roughly cylindrical column of 
nervous tissue,  housed within the vertebral  column and  extending  from the medulla 
oblongata at the base of the brain to the level of the first or second lumbar vertebrae 
(Haines  1997a).  Although the  structural  organisation of the  spinal cord is  simple in 
comparison to the brain,  its importance for the function of the  CNS,  and indeed the 
entire body, cannot be underestimated. The spinal cord provides the means by which the 
brain is able to interact with the rest of the body and the environment.
The principle cell types in the CNS are neurons and glia, with sub divisions of each 
providing the morphological and functional diversity which characterises the nervous 
system  (Haines et al.  1997).  In general,  neurons make up the wiring of the nervous 
system, integrating and conveying electrical signals from one part of the CNS to another 
while  glial  cells  have  structural  and  homeostatic  roles,  maintaining  the 
microenvironment of the spinal cord. In reality, however, the roles of different cell types 
are more complex and overlap significantly. Neurons are sub divided according to their 
morphological features, localisation, function, and neurotransmitter type.  Spinal cord 
glia are  divided  into two  main types;  astrocytes,  which have  functions that include 
provision  of  structural  support  and  maintenance  of  neuronal  metabolism,  and 
oligodendrocytes, which produce the myelin sheath that is essential for fast neuronal 
conductance (Jessen 2004).
The  spinal  cord  is  arranged around  the  central  canal,  which  is  continuous  with the 
brain’s ventricular system and through which cerebrospinal fluid passes. Closest to the 
central canal is the grey matter, butterfly shaped in cross section, in which all neuronal 
cell bodies are located. Surrounding the grey matter lies the white matter, which can be 
divided into a number of longitudinal columns, containing ascending and descending 
myelinated neuronal fibre tracts (Fig.  1.1.). The nervous tissue is surrounded by three 
fibrous layers of meninges which provide protection for the delicate structures beneath 
(Haines 1997b).
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Fig. 1.1  Structure  of  the  adult  human  spinal  cord.  Schematic  diagram 
illustrating  the  structural  features  of the  adult  human  spinal  cord.  Adapted 
from Gupta, 1997.
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A  supply  of oxygenated blood reaches the  spinal  cord via three  main  arteries  - the 
anterior and posterior spinal arteries, and the segmental artery - which branch into the 
smaller blood vessels which penetrate the spinal cord (Mautes et al.  2000). Similarly, 
the anterior and posterior spinal veins are responsible for the drainage of blood from the 
spinal cord.  The walls of blood vessels throughout the CNS  consist of a specialised 
endothelial  structure,  the  blood  brain  barrier,  which  strictly  regulates  substances 
entering and leaving the CNS (Huber et al. 2001; Ballabh et al. 2004)
In  the  human,  thirty-one  pairs  of spinal  nerves,  containing  a  mixture  of afferent 
(sensory) and efferent (motor) neurons, branch off from the spinal cord to innervate the 
periphery. Sensory information gathered by receptors in the periphery reaches the dorsal 
part of the grey matter via neurons that have their cell bodies in the dorsal root ganglia, 
situated just outside the spinal cord. In the grey matter information is integrated and 
conducted  to  higher  control  centres  via  white  matter  tracts  which  include  the 
spinocerebellar, spinothalamic and spinoreticular tracts. Likewise, motor information is 
conducted from the motor cortex or brainstem nuclei to the spinal cord via four major 
tracts; the reticulospinal tract, the vestibulospinal tract, the rubrospinal tract and the 
corticospinal  tract.  The  ventral  part  of the  grey  matter  contains  the  cell  bodies  of 
primary effector neurons which exit the spinal cord to convey commands to muscles 
and  glands  in  the  periphery.  Additional  functions  of the  spinal  cord  include  the 
maintenance  of body  homeostasis  and the  generation of rapid responses to  harmful 
external conditions via short neuronal circuits, independent of higher control, termed 
reflex arcs. The spinal cord is therefore a pivotal component of the CNS, without which 
the brain would be isolated and unable to fulfil its functional roles.
1.2.  Development of the spinal cord
At the three  layer stage of embryogenesis,  a midline portion of the dorsal  ectoderm 
becomes specialised towards a neural fate by signals from a region of the underlying 
mesoderm, called the organiser (Stem 2005). The specialised region, termed the neural 
plate, goes on to give rise to the entire CNS. The mechanism by which the neural plate 
arises is still controversial.  Studies in Xenopus embryos suggested that the inductive 
factors are principally inhibitors of bone morphogenetic protein 4 (Bmp4), giving rise to 
the  default model of neural  induction,  whereby the ectoderm automatically adopts a
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neural fate unless prevented from doing so by Bmp4 (Frisen et al.  1998; Stem 2005). 
However, evidence from studies of chick embryo development suggests that positive 
signalling from factors such as fibroblast growth factor (Fgf) and Wnt proteins may also 
be required for neural induction, which may begin at an earlier stage than previously 
thought (Bally-Cuif and Hammerschmidt 2003; Stem 2005).
The neural tube, the basic structure of the developing CNS, forms from the neural plate 
in a process termed neurulation as outlined in Fig  1.2  (Smith and  Schoenwolf 1997; 
Copp et al.  2003). Neurulation also gives rise to the neural crest, a group of ectodermal 
cells which migrate peripherally from the dorsal part of the neural tube and form the 
peripheral and enteric nervous systems as well as a range of other cell types including 
melanocytes, and some skeletal cells (Bums 2005).
The  walls  of the  neural  tube  initially  consist  of a  pseudostratified  layer  of highly 
proliferative  multipotent progenitor cells,  the neuroepithelium,  from which  all CNS 
neurons and glia are ultimately derived. As these cells proliferate, the cell body moves 
backwards and forwards across the width of the neuroepithelium, making contact with 
the inner and outer edges of the tube via long processes (Hollyday 2001). The position 
of the cell body within the epithelium at any given moment corresponds to its current 
cell cycle  stage.  Between mitosis (M) and the DNA synthesis (S) phase, cells move 
away from the lumen of the neural tube before returning for the next round of division. 
Cell division that results in the birth of two daughter cells that are themselves both stem 
cells is termed symmetric division. As proliferation continues, asymmetric division, in 
which one daughter cell exits the cell cycle and migrates away from the lumen of the 
neural tube, also takes place. This generates a second layer of cells, the intermediate 
zone,  in which differentiation into  specific cell types is initiated.  Eventually,  a third 
layer,  the  marginal  zone,  forms,  containing  neuronal  axons  and  glial  cells.  The 
intermediate and marginal  zones later develop into the  grey  and white  matter of the 
adult spinal cord.  The control of symmetric versus asymmetric division may  depend 
upon intrinsic factors such as the distribution of certain proteins in the daughter cells 
and extrinsic regulation by signalling factors such as Notch (Ikeshima-Kataoka et al, 
1997, Shen et al, 1997, Zhong et al,  1996, Lewis, 1996, Frisen et al, 1998).
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Fig.  1.2. Principles of neurulation. A) During neural tube closure, 
a region of the dorsal ectoderm (yellow) lying above the notochord 
(green) thickens to form the neural plate (blue) and elevates to form 
the  neural  folds.  B)  The  neural  plate  begins  to  fold,  forming  the 
neural groove. C) Continued folding causes the neural  folds to be 
brought together at the midline. D) Finally, the neural folds fuse to 
form a continuous neural tube. Adapted from Frisen et al, 1998.
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Techniques for labelling cells as they undergo their final division before exiting the cell 
cycle have been used to investigate relationships between the timing of a cell’s birth and 
its fate. These labels include molecules which are incorporated into DNA such as 3[H]- 
thymidine or bromo-deoxyuridine (Fujita  1964;  Sidman et al.  1959;  Gratzner  1982). 
Studies  have  demonstrated that radial  glia are the  earliest cell  type to  differentiate, 
followed sequentially by neurons, oligodendrocytes and astrocytes (Lee et al.  2000). 
Figure  1.3  illustrates the relative timing of these events in the human and chick spinal 
cord. Radial glia are present transiently during neurogenesis in the spinal cord and have 
a role in the guidance of radially-migrating neurons, while at later stages they can give 
rise to both neurons and astrocytes (Malatesta et al.  2000; Noctor et al.  2002; Hatten 
1990). During the period of neurogenesis more neurons are bom than will ultimately be 
required  and the  final  number of neurons  is refined by  a wave  of programmed cell 
death,  which  takes  place  at  around  7  weeks  gestation  in  the  human  and  around 
embryonic  day  (E)  6-7  in  the  chick  (Wozniak  et al.  1980;  Oppenheim  1991). 
Gliogenesis is initiated around the time that neurogenesis reaches its conclusion with 
oligodendrocytes developing firstly from a restricted ventral region of the CNS and then 
migrating  out  to  cover  all  regions  (Ono  et  al.  1995;  Hajihosseini  et  al.  1996). 
Oligodendrocytes begin to surround neuronal axons with a myelin sheath at a slightly 
later stage. Astrocytes develop towards the end of neurogenesis, with cells expressing 
Fgfr3, a putative astrocytic marker from around E8 in the chick, and the later astrocytic 
marker  GFAP  from  around  E10  (Pringle  et al.  2003;  Sim et al.  2002).  Astrocytic 
development  from  intermediate  glial  precursors  takes  place  in  regions  of  the 
neuroepithelium  distinct  from  those  which  give  rise  to  oligodendrocytes.  Although 
multiple types of glial precursor are thought to exist it is known that some astrocytes 
develop from radial glial cells via transdifferentiation (Pixley and de Vellis 1984; Gray 
and Sanes 1992; Chanas-Sacre et al. 2000; Doetsch et al.  1999; Liu and Rao 2004).
The differentiation of neural progenitor cells into neurons and glia involves a series of 
decision-making steps in which cells first become post-mitotic and then commit to a 
specific  lineage  (Hollyday  2001).  The  mechanisms  underlying  regulation  of these 
decisions  are  complex  and  not  yet  fully  determined.  However,  it  is  known  that 
neurogenesis and gliogenesis are initiated in progenitor domains in a specific temporal 
and spatial pattern and that this pattern is determined early.  Within a progenitor cell, 
neurogenesis is controlled in part by the expression of pro-neural genes, such as the
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Fig  1.3.  Temporal  birth  of  neurons  and  glia  in  the  developing  spinal  cord.  Figure  at  top  shows  the 
approximate  sequential  order of birth of glia and neurons  in the  developing  spinal  cord.  Table  shows  studies 
which have recorded the approximate dates at which each cell type/ event is observed in the human and chick 
spinal cord.
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basic helix-loop-helix (bHLH) transcription factors, while gliogenesis is promoted by 
factors  which  antagonise  bHLH  proteins  (Bally-Cuif and  Hammerschmidt  2003). 
However, the effect of different genes varies with development. Certain factors, such as 
the transcription factor 01ig2, are involved in specification firstly of neurons and then 
later oligodendrocytes (Lu et al.  2002). The neural tube is also patterned spatially into 
specific cellular subtypes by diffusible signals arising from structures in the ventral and 
dorsal midlines and from tissues adjacent to the developing cord (Hollyday 2001; Helms 
and Johnson 2003; Stemple 2005).
1.3.  Spinal cord injury
1.3.1.  The impact of spinal cord injury
Traumatic injury to the spinal cord affects between 11.5 and 53.4 people per million in 
the developed world, with life-shattering consequences for individuals and enormous 
economic  costs  to  society  (Sekhon  and  Fehlings  2001).  The  human  CNS  has  an 
extremely  limited  capacity  for  self-repair and  damage  usually  results  in  permanent 
functional losses. The principle causes of spinal cord injury are road traffic accidents, 
sports accidents, accidents at work, falls in the home and violence (Sekhon and Fehlings 
2001). As a consequence, unlike many neurodegenerative diseases, spinal cord injury 
affects many young, otherwise healthy individuals with a consequent requirement for 
long term care.  During the 20th century, improvements in medical care substantially 
reduced  the  mortality  rates  associated  with  spinal  cord  injury  and  consequently 
increasing numbers of individuals are living with chronic spinal cord injury (Houle and 
Tessler 2003).
Injury to the spinal cord can take several forms, most frequently involving compression 
or blunt impact. Less commonly, a penetrating injury may result in partial or complete 
spinal cord transection. Regardless of injury type, the functional outcome depends upon 
the severity of the injury and the spinal cord level at which it takes place. Spinal cord 
injury results in the disruption of the axonal tracts carrying information between the 
body and brain. Body areas innervated by nerves arising at or below the injury site are 
effectively  isolated,  losing  sensory,  motor and autonomic  function.  The  outcome of 
spinal cord injury may therefore range from paraplegia, in which only the lower half of
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the body is paralysed, to tetraplegia in which assistance for functions such as breathing 
may be necessary (Profyris et al.  2004).  Secondary complications associated with the 
loss of these functions may also arise, including urinary tract infections, pressure sores 
and neurogenic pain.
1.3.2.  Pathophysiology of spinal cord injury
Injury  to  the  central  nervous  system  in  the  adult  mammal  invokes  a  series  of 
pathophysiological events which culminate in the functional impairments experienced 
by the patient. Characteristic features of spinal cord injury include neuronal and glial 
death,  axonal  degeneration  and  demyelination,  the  formation  of large  fluid  filled 
cavities  within  the  spinal  cord  and  the  generation  of a  glial  scar.  Many  of these 
processes also occur, to an equal or lesser extent, in lower vertebrate and avian species.
Primary and secondary injury
Cellular and tissue damage following injury to the mammalian CNS is divided into two 
broad  stages,  termed  the  primary  and  secondary  injury  (Dumont  et al.  2001).  The 
primary injury occurs immediately upon the traumatic disruption of spinal cord tissue, 
resulting in the immediate destruction of tissue and haemorrhage due to rupture of cell 
membranes and blood vessel walls. Damage tends to be focused in the delicate, highly 
vascularised grey matter at the cord centre due to the concentration of shearing forces in 
this  region,  and  is  localised to  the  injury  site  (Profyris  et al.  2004).  Although  the 
primary injury results in significant disruption, overall damage is vastly expanded by a 
series of delayed  injury  processes,  triggered by the  initial  insult,  which collectively 
make up the secondary injury (Fig.  1.4). These processes include vascular alterations, 
biochemical activity and cellular responses and trigger cell death by both necrotic and 
apoptotic mechanisms (Hausmann 2003). The extent of the secondary injury response 
after injury  in species  that demonstrate  a greater regenerative  response,  such as the 
embryonic chick (see section  1.4), is unknown, and a reduction in these mechanisms 
might make a contribution to spinal cord regeneration in these species.
Haemorrhage
In a typical spinal cord injury, mechanical trauma causes damage to the blood vessel 
network resulting in localised haemorrhage within the injured part of the cord. Within
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the  first 24 hours  after injury, this haemorrhage  spreads  extensively within the cord 
(Noble  and  Wrathall  1989b).  Haemorrhage has a number of consequences that may 
contribute to the progression of secondary injury mechanisms, including disruption of 
the regulatory blood brain barrier and exposure of the spinal cord to inflammatory cell 
types and other potential neurotoxins.  In addition, haemorrhage interrupts the blood 
supply to metabolically demanding spinal cord cells and is a primary cause of ischemia 
after  injury  (Tator  and  Fehlings  1991;  Dumont  et  al.  2001).  The  importance  of 
haemorrhage in mediating later tissue damage is reflected by the correlation between the 
extent of haemorrhage in the cord and the eventual appearance of large cavities in the 
same regions (Noble and Wrathall 1989b; Noble and Wrathall 1989a).
Ischemia
After an injury, interruption of the blood supply due to haemorrhage causes spinal cord 
tissue to rapidly become hypoxic.  This is exacerbated by effects such as neurogenic 
shock,  in which a loss of sympathetic nervous control occurs resulting in peripheral 
vasodilatation and reduced blood pressure, thrombosis and vasospasm which further 
reduce blood flow (Dumont et al. 2001). Additionally, the automatic regulatory systems 
that are normally responsible for maintaining a constant blood flow in the CNS become 
dysfunctional and the supply of blood comes under the direct regulation of the systemic 
blood pressure. Neurons in particular have extremely high metabolic requirements and, 
in the event of hypoperfusion,  suffer rapidly from a loss of cellular metabolism and 
ATP depletion. This has a number of downstream effects including loss of membrane 
permeability  and  activation  of calcium-dependent  enzymes  which  attack  cellular 
components and may lead to cell death (Profyris et al. 2004). After a period of hypoxia, 
the return of the blood supply with a sudden influx of oxygen leads to the production of 
reactive  oxygen  species and  free radicals (Piantadosi  and Zhang  1996;  Kwon et al. 
2004).  These  reactive molecules oxidise  lipids, protein and nucleic acids,  leading to 
damage  of cellular membranes  and  degradation of proteins  and  DNA  (Kwon et al, 
2004).
Excitotoxicity
Following spinal cord trauma, membrane depolarisation and cellular lysis contribute to 
the release of large quantities of the excitatory neurotransmitter glutamate from neurons 
and  glia.  Extracellular glutamate  levels  are  further increased by  compromise  of the
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active  mechanisms  by  which  it  is  recovered  by  cells,  due  to  the  loss  of cellular 
metabolism.  Excessive  stimulation  of ionotropic  glutamate  receptors  causes  further 
membrane  depolarisation  and  an  increase  in the  intracellular  levels  of calcium  and 
sodium (Choi  1987). Increased intracellular sodium causes water to enter the cell down 
an osmotic gradient, resulting in oedema and cell lysis. Increased intracellular calcium 
levels  are  associated  with  a  number  of  additional  detrimental  effects  including 
disruption of mitochondrial activity and activation of destructive proteolytic enzymes. 
Additionally,  continued membrane  depolarisation results  in  further neurotransmitter 
release causing an escalation of the excitotoxic effect (Faden and Simon  1988;  Choi 
1988; Choi 1992; Liu et al  1991; Liu et al  1999a).
Inflammation
Although  the  CNS  is  generally  regarded  as  an  immune-privileged  area,  injury  and 
disruption  of the  blood brain barrier initiates an inflammatory  response  (Hausmann
2003).  An influx of neutrophils within the first hours after injury  is followed by the 
recruitment  of macrophages  and  lymphocytes  from  the  periphery  and  activation of 
resident microglial cells (Popovich et al  1997; Popovich and Jones 2003).  Cytokine 
release leads to further inflammatory cell recruitment and the inflammatory response 
escalates  over several  days after the  injury.  The issue  of whether this inflammatory 
response is of harm or benefit to the injured spinal cord has been the subject of much 
controversy; however, a consensus now suggests that it represents a ‘dual-edged sword’ 
(Bethea  and  Dietrich  2002;  Kwon  et  al  2004).  Inflammation  makes  a  significant 
contribution to the expanding secondary injury. Macrophages and microglia cause tissue 
destruction as well as releasing cytokines which can contribute to oxidative stress by 
stimulating the generation of reactive oxygen species and nitric oxide (Leskovar et al 
2000;  Satake et al.  2000).  It has  been  shown that microinjection of an activator of 
macrophages and microglia into the spinal cord without causing physical damage results 
in a persistent inflammatory response that leads to significant secondary damage and 
cavitation (Fitch et al  1999). On the other hand, the inflammatory response can have 
beneficial  effects.  For example,  macrophages  secrete  certain molecules  and  growth 
factors which could contribute to wound healing (DeKosky  et al  1994;  Bethea and 
Dietrich 2002; Nguyen et al  2002).  Macrophages also  contribute to the removal  of 
harmful debris and molecules that are inhibitory to future axonal re-growth. It has even 
been  suggested  that the  diminished  inflammatory  response  observed  in the  CNS  in
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comparison to  other tissues  underlies  the  poor repair  of this  region  and  functional 
improvements have been demonstrated after re-introduction of inflammatory cell types 
(Rapalino et al.  1998; Schwartz et al.  1999; Moalem et al.  1999).
Apoptotic cell death
Cell death can occur as a result of two alternative mechanisms, necrosis or apoptosis, 
characterised by their biochemical pathways and accompanying morphological changes. 
Necrosis is a passive form of cell death in which cell swelling and lysis usually occur 
and  an  inflammatory  response  may  be  initiated  (Kwon  et  al.  2004).  In  contrast, 
apoptosis is a genetically-programmed form of cell death involving protein synthesis 
and a regulated series of biochemical events, which does not stimulate an inflammatory 
response.
Apoptosis has a variety of non-pathological functions during development and in tissue 
homeostasis, and alterations in its regulation are associated with several disease areas 
(Thompson  1995; Henderson  1996; Savitz and Rosenbaum  1998). Apoptosis may be 
triggered by external  stimuli or in response to internal  signalling.  The activation of 
members of the caspase family of cysteine proteases represents a critical convergent 
step for classical apoptotic pathways and results in the cleavage of key survival related 
proteins and, ultimately, cell death (Cohen 1997; Thomberry and Lazebnik 1998; Kuan 
et al.  2000). Although the pathways leading to caspase-dependent cell death have been 
intensively investigated, apoptotic cell death has also been observed in the absence of 
caspase activation, leading to the concept of caspase-independent apoptotic pathways 
(Stefanis  et al.  1999;  Yaginuma et al.  2001;  Oppenheim  et al.  2001;  Abraham  and 
Shaham 2004).  This is a growing field of research, in which release of proapoptotic 
proteins,  such as apoptosis-inducing factor (AIF), from mitochondria, may be of key 
importance  (Lorenzo  and  Susin  2004).  By  either  mechanism,  apoptotic  cell  death 
culminates  in  DNA  fragmentation,  cell  shrinkage  and  phagocytosis  by  surrounding 
cells.
Ischemia  and  excitotoxicity  can  trigger  both  necrotic  and  apoptotic  mechanisms. 
Additionally, exposure of spinal cord cells to neurotoxic molecules and inflammatory 
cells  during haemorrhage may  contribute to  cell  death  (Noble  and  Wrathall  1989b; 
Bethea and Dietrich 2002).  There is evidence for caspase-dependent apoptosis taking
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place in the spinal cord after injury in both experimental models and human patients 
(Crowe  et al.  1997; Liu et al.  1997; Lou et al.  1998; Emery et al.  1998; Yong et al. 
1998;  Springer et al.  1999; Citron et al.  2000a;  Li  et al.  2000).  Apoptosis has been 
shown to take place in two waves after spinal cord injury and lasts 3  weeks after the 
injury in rats and 8  weeks in humans (Liu et al.  1997; Emery et al.  1998). An early 
phase of apoptosis of neurons and glia close to the injury site is followed by the delayed 
apoptosis of oligodendrocytes at a distance from the injury (Liu et al.  1997; Shuman et 
al.  1997; Li et al.  1999).  Delayed apoptosis of microglia in the white matter has also 
been observed (Casha et al 2001, Shuman et al,  1997)
Axonal degeneration
As a result of a traumatic mechanical injury to the spinal cord the axons of surviving 
neurons may be severed or damaged. Additionally, neurons close to the lesion may die, 
leaving behind axonal fragments. Damaged axons degenerate over the course of days to 
years after the injury in a process termed Wallerian degeneration, contributing to the 
ongoing secondary injury process (Profyris et al.  2004). This degeneration involves de­
my elination,  axonal  swelling  and  axonal  lysis.  Ultimately  the  debris  generated  by 
axonal  degeneration  is  cleared  by  the  arrival  of  macrophages  and  microglia. 
Oligodendrocytes that rely on their association with axons for neurotrophic support may 
subsequently die due to the removal of this supply.
Glial scar formation
One of the later events to occur after spinal cord trauma is the formation of the so-called 
glial scar, which forms over several weeks after the injury (Fawcett and Asher 1999). 
The formation of the glial scar is directly related to the inflammatory response and may 
be associated with increased TGFP2 expression after injury (Fitch et al.  1999; Lagord et 
al. 2002). Similarly, other inflammation-related molecules, including interleukin (IL)-l, 
interferon-y (IFNy) and FGF2 have been associated with glial scar formation (Silver and 
Miller 2004). Microglia and macrophages initially invade the injury site, acting to clear 
up  the  debris  from  degenerating  axons  and  oligodendrocytes.  As the  lesion  site  is 
cleared, oligodendrocyte precursors enter the site and begin to differentiate. Following 
this,  astrocytes  migrate  to  the  injury  site  where  they  proliferate  and  become 
hypertrophic, generating large quantities of intermediate filaments (Profyris et al. 2004).
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Eventually these cells fill the cavities left by the injury. During this process a barrier is 
effectively created between the region of injury site and the rest of the spinal cord. In 
cases where the meningeal membranes surrounding the spinal cord have been disrupted 
by the injury this is compounded by the entry of meningeal cell types which, together 
with the astrocytes, form a dense scar matrix. The action of glial cells and the formation 
of the scar after spinal cord injury has both beneficial and harmful consequences. The 
entry of glial cells into the injury site helps to stabilise the spinal cord, repair the blood 
brain barrier and re-establish the microenvironment (Bush et al  1999). The segregation 
of the injured tissue at the lesion site may also help to protect the rest of the spinal cord 
from further damage. In support of this, studies have  shown that removal of reactive 
astrocytes  using a transgenic  approach to  delete  GFAP  expressing cells exacerbates 
tissue damage  after CNS  injury (Faulkner et al  2004;  Bush et  al  1999).  However, 
components  of the  glial  scar  including  oligodendrocyte  precursors  and  reactive 
astrocytes have been demonstrated to be extremely inhibitory to future axonal re-growth 
(Silver and Miller 2004; Properzi and Fawcett 2004).
1.3.3.  Experimental models of spinal cord injury
Much of what is known about the secondary injury mechanisms that take place in the 
injured  mammalian  spinal  cord  has  been  derived  from  animal  models.  A  range  of 
different models has been developed, each designed to mimic aspects of the situation in 
the traumatised human spinal cord. The extent to which they are able to do this dictates 
the usefulness of the model.  Two common rodent models are spinal cord contusion, 
usually involving a controlled weight drop into the dorsal surface of the spinal cord, and 
spinal cord compression in which a weight is placed onto the cord for a set duration 
(Noble  and Wrathall  1989b; Noble  and Wrathall  1989a;  Mautes et al  2000;  Young
2002). These models mimic the most common forms of human spinal cord injury and 
pathophysiological changes observed in these models correspond well to human spinal 
cord  injury  pathology.  However,  the  complex  nature  of these  types  of injury  can 
complicate the interpretation of results designed to examine distinct aspects of spinal 
cord  injury,  such  as  axonal  regeneration.  A  third  commonly  used  model  involves 
transection, or more usually hemisection, of the spinal cord (Rosenzweig and McDonald 
2004). In human spinal cord injury, transection alone is relatively rare; however these 
models are useful for measuring axonal regeneration since they allow researchers to
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ensure that all descending and ascending tracts are completely transected. In addition to 
these models, systems that demonstrate the capacity to regenerate after injury, such as 
the embryonic chick spinal cord,  can be useful in understanding the response of the 
spinal cord to injury and these will be discussed in greater detail in section 1.4.
1.3.4.  Current and prospective treatments
At present, treatment for spinal cord injury cannot provide any anatomical repair and 
most therapies are directed towards rehabilitation, coping with disability and prevention 
of various  associated  consequences  of the  injury.  These  areas  have  shown  great 
progress, resulting in greatly reduced mortality, yet there is clearly great demand for 
therapeutics which can improve long term functional recovery (Blight 2002).
Whilst  complete  repair  of the  injured  spinal  cord  remains  a  distant  goal,  small 
improvements in neuronal circuitry could have enormously beneficial consequences for 
patients.  This  might  extend to  regaining the  control  of bladder  function,  breathing 
without a respirator or small gains in limb movement rather than a complete restoration 
of locomotion.  However, a stumbling block in the development of therapeutic agents 
arises in the translation of treatments that show promise in rodent models to the clinic. 
This may be related to the reliance on locomotor function as the usual outcome measure 
in preclinical studies (Blight 2002). Consequently, only one pharmacological agent, the 
steroid methylprednisolone,  has been licensed for spinal cord injury (Bracken et al
1998). As will be described below, this treatment is the subject of much controversy and 
is not prescribed in the UK, although it is licensed for use in the US. Although the past 
fifteen years have seen a number of other clinical trials launched, most of these have 
demonstrated little positive effects (Blight 2002).  Meanwhile, basic research continues 
to  identify  potential  approaches  for  improving  outcome  and  trials  of  several  of 
promising  agents  are  imminent.  As  our  understanding  of the  pathophysiological 
processes taking place after spinal cord injury continues to improve it is hoped that trials 
of prospective  therapies  will  produce  better  outcomes.  This  may  be  aided  by  a 
consideration of the responses to  trauma that take place  in systems which can more 
successfully repair after injury.
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1.4. Spinal cord regeneration
A  number  of organs  in  the  human  body  are  able  to  self-repair  to  varying  extents 
throughout adult life. These include the liver, skin and the peripheral nervous system 
(PNS).  In  contrast,  the  CNS  does  not  spontaneously  regenerate  once  it  has  been 
damaged,  leading  to  significant  functional  losses  as  outlined  above.  The  lack  of 
regeneration observed in the adult mammalian CNS is in striking contrast to the robust 
regeneration that is observed after injury in a number of other systems (Fig 1.5). These 
include  adult  mammalian  systems  such  as  the  peripheral  nervous  system,  lower 
vertebrates, such as fish and certain amphibian species, and embryonic systems, such as 
the chick spinal cord (Ferretti et al. 2003).
1.4.1.  Regeneration in the peripheral nervous system
Not all adult mammalian neurons are incapable of regeneration. In contrast to the CNS, 
PNS neurons demonstrate a remarkable capacity for repair after injury (Fawcett and 
Keynes 1990). Injury to the PNS results in the activation and proliferation of Schwann 
cells, the myelinating glial cells that are unique to the PNS. These cells are thought to 
represent a key element of the regenerative response of the PNS neurons, aiding axonal 
re-growth  by  clearing  cellular  debris  and  expressing  and  secreting  a  number  of 
molecules  which  support  axon  growth,  contributing  to  a process termed  Wallerian 
degeneration (Fawcett and Keynes  1990; Son et al.  1996). Primary afferent (sensory) 
neurons also  have the unique feature of interacting with both PNS  and CNS tissue, 
crossing the junction between the two at the dorsal root entry zone (DREZ).  Sensory 
neurons  can robustly regenerate their peripheral processes  after an injury,  yet show 
limited capacity to re-enter the CNS by crossing the DREZ after an injury (Chong et al.
1999).  Interestingly,  pre-conditioning  of  sensory  neurons  by  transection  of  the 
peripheral  process  has  been  demonstrated  to  increase  the  regenerative  response 
following a later injury to the central process (Richardson and Issa 1984; Neumann and 
Woolf 1999).  PNS  neurons therefore represent a useful model  for comparison with 
CNS  neurons  within  the  same  species  and  additionally  allow  comparison  of the 
response of peripheral and central parts of the neuron.
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1.4.2.  Regeneration in lower vertebrate species
Certain fish and amphibians demonstrate the capacity to spontaneously regenerate many 
body  parts,  including  the  CNS.  There  is,  however,  a  large  degree  of variation  in 
regenerative  capacity  between  different  species.  The  most dramatic  regeneration is 
observed in tailed amphibians (urodeles) such as salamanders and newts, which are able 
to regenerate their limbs, retina,  lens and spinal  cord throughout adult life.  In these 
species robust spinal cord regeneration, leading to functional recovery, takes place after 
tail transection or amputation (Davis et al  1989; Chernoff 1996; Clarke and Ferretti 
1998; Ferretti et al 2003). Likewise, teleost fish are able to regenerate their spinal cord 
during adulthood (Anderson and Waxman 1983; Zottoli et al  1994).  Spinal cord injury 
(tail  amputation)  in  anuran  amphibians  such  as  Xenopus  results  in  a  variable 
regenerative  response,  with regenerative  capacity  being  lost  around metamorphosis 
(Beattie et al  1990).  Studies  have  also  shown that  a high  regenerative  capacity  is 
observed  in bullfrog  larvae  only  if the  injury  is carried out close to metamorphosis 
(Forehand and Farel  1982).  Furthermore, recent studies have identified a ‘refractory 
period’ of tadpole development which lasts between stages 45 and 48, during which the 
tail does not regenerate and which relates to the downregulation of BMP and Notch 
signalling pathways at this stage (Beck et al, 2003).
Regeneration in the urodele amphibian is known to involve both axonal re-growth and a 
coordinated  reorganisation  of spinal  cord  ependymal  cells,  which  proliferate  and 
migrate to replace lost tissue (O'Hara et al  1992; Clarke and Ferretti  1998). A similar 
ependymal  response has  also  been observed  in other regenerative  lower vertebrates 
including  teleost  fish  (Anderson et al  1986).  Regeneration  of cut  axons  has  been 
confirmed in regenerating bullfrog larvae. Brainstem-spinal neurons were labelled with 
two different retrograde tracers applied to the lumbar cord before and after the injury 
and double-labelled cells were subsequently observed in the brainstem (Forehand and 
Farel 1982). The high regenerative capacity of these species has been attributed by some 
to the retention of developmental properties in the spinal cord but may also be the result 
of other factors including a high intrinsic capacity of neurons to regenerate, reduced 
glial scarring or an ability to recruit progenitor cells in response to injury (Holder and 
Clarke 1988; Chernoff 1996).
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1.4.3.  Regeneration in embryonic higher vertebrates
Higher vertebrates, including avian and mammalian species, demonstrate a high degree 
of regenerative capacity in their spinal cord during embryonic development which is 
lost  as  development  progresses  (Nicholls  and  Saunders  1996).  These  systems  can 
therefore provide information about factors affecting loss of regenerative capacity in a 
model that has greater relevance to the adult mammal than lower vertebrates. The most 
useful systems for experimental manipulation are those that do not have to be accessed 
in utero, allowing complex manipulations to be carried out which would not be tolerated 
by most mammalian embryos. These models include the embryonic chick, which can be 
accessed while in the egg, and marsupials such as the opossum, which are born early 
during development and undergo a significant portion of their spinal cord development 
postnatally, while attached externally to the mother.
The  embryonic  chick  spinal  cord  has  been  demonstrated  to  undergo  complete 
anatomical  and  functional  repair after transection injury  up until  embryonic  day  13 
(El3), after which this faculty is lost (Shimizu et al.  1990; Hasan et al.  1991). Recovery 
has been assessed by examining the re-growth of axonal tracts by retrograde labelling, 
electrophysiological recordings and behavioural measurements such as the capacity to 
hatch unaided (Hasan et al.  1993; Sholomenko and Delaney 1998).  In order to confirm 
that  neurites  that  grow  across  the  injury  site  are  derived  from  the  regeneration  of 
damaged axons, rather than continuing nervous system development, a double labelling 
strategy similar to that used in the anuran amphibian has been employed (Hasan et al.
1993).  The developing opossum, either Didelphis  Virginia or Monodelphi domestica, 
has been shown to have a similar developmentally-regulated capacity for regeneration. 
In organotypic cultures or in vivo the opossum spinal cord has been demonstrated to 
undergo complete anatomical and functional recovery up to  12 days after birth, beyond 
which this capacity  is lost (Treherne et al.  1992;  Saunders et al.  1998;  Martin et al.
2000).  These studies have also demonstrated that axonal re-growth takes place in the 
regenerating cord, and that synaptic connections are made although it has not been fully 
established  whether  the  re-established  connections  are  normal  (Lepre  et al.  1998; 
Saunders  et al.  1998).  The embryonic chick and opossum spinal cord are extremely 
useful  models  for investigating  spinal  cord regeneration.  The  developmental  loss of 
regenerative  capacity  allows  for  direct  comparisons  of  a  regenerating  and  non-
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regenerating system within the same species. In this thesis, the embryonic chick spinal 
cord  was  used  to  investigate  mechanisms  that  contribute  both  to  spinal  cord 
regeneration and to its loss with progressing development.
1.4.4. What can we learn from regenerating systems?
The  ultimate  goal  of  spinal  cord  injury  research  is  to  identify  strategies  to  gain 
successful  regeneration  in  the  mammalian  spinal  cord,  with  a  wide  variety  of 
approaches under consideration. To narrow the field of potential therapeutic strategies it 
would  be  beneficial  to  determine  the  factors  responsible  for  the  marked  lack  of 
regeneration  in  the  mammalian  CNS.  To  this  end,  knowledge  gained  about  the 
regenerative process in other species and systems, such as the embryonic chick spinal 
cord,  will  be  useful.  Although  these  systems  differ  in  many  ways  from  the  adult 
mammal, they provide a supplementary  experimental approach to models that more 
closely mimic the human injury. In particular it is hoped that this approach may lead to 
the identification of factors that are of key importance for successful regeneration
1.4.5. Factors affecting regenerative capacity
As described above, enormous variation in the ability of the CNS to self-repair after an 
injury exists among species and between developmental stages. Determining the factors 
that  govern these  differences  in  spinal  cord regenerative  capacity  will  increase  our 
understanding of why the human spinal cord is unable to regenerate.Unfortunately, no 
single  factor is  likely to be responsible for determining regenerative ability and the 
multitude of different elements that may be involved make this a complex issue. In the 
following  sections, a simplified model for considering the factors involved in spinal 
cord regeneration will be outlined. Next, a number of potential contributory elements 
will be discussed in relation to their role in determining the regenerative capacity in 
different systems and how they might be targeted therapeutically in a non-regenerating 
system.
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1.4.6. Conditions for successful regeneration
The term ‘regeneration’ has been interpreted in a number of different ways; however, 
for the purposes of this thesis, regeneration is defined as the restoration of functional 
connectivity within the spinal cord following an injury. This concept is comparable to 
limb, or whole organ regeneration, and is likely to involve processes such as cellular 
proliferation and migration in addition to the re-growth of axons. It is useful to begin by 
considering what conditions must be met for successful spinal cord regeneration to take 
place. Fig.  1.6 summarises a simplified view of these conditions, which can be divided 
into two broad complementary requirements for regeneration.
First, in order for functional regeneration to occur, there must be enough viable cells 
present within the spinal cord. This includes both neurons that send projections long 
distances up and down the cord, and intemeurons, which make the local connections 
that are responsible for the fine control of neuronal activity  and glial cells.  There is 
evidence that only a fraction of the original neuronal cell count needs to  survive an 
injury  in order for significant functional recovery to take place  (Fehlings and Tator 
1995). The number of viable cells can be influenced both by the degree of cell loss after 
the injury and by the ability of the spinal cord to generate replacement cells to take over 
from those lost.
Second, the neurons must be able to re-grow disrupted axons or grow new axons to 
restore neuronal pathways. This can be controlled both by the intrinsic capacity of the 
cell for axonal re-growth and by the permissiveness of the spinal cord environment to 
axonal re-growth, which is influenced by the presence or absence of growth-promoting 
or inhibitory molecules. Regenerating axons must also be re-myelinated, requiring the 
presence  of surviving  oligodendrocytes.  Furthermore,  limited benefit  is  likely to be 
gained by axon re-growth unless the connections established are functional and do not 
lead to abnormal neuronal activity. Axonal path finding and synapse formation must 
therefore be adequately controlled.
In a robust regenerative response to  injury,  such as that taking place in the pre-El3 
chick, all of these steps must take place. Failure to meet any or all of these conditions 
might result in the loss of regenerative capacity, such as that observed in the post-El 3
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chick or the adult mammal.  However, recent research involving regenerative species 
such  as  the  chick  has  tended  to  concentrate  mainly  on  the  second  of these  two 
conditions  and  studies  on  axonal  regeneration  have  significantly  enhanced  our 
understanding  of the  control of this process and lead to  some promising therapeutic 
avenues.  The results of these studies will be discussed briefly below. The first of the 
conditions outlined above has, in contrast, been relatively neglected in recent studies 
and will form the theme of this thesis. Cell survival and cell replacement after injury, 
which act to ensure the presence of sufficient numbers of viable cells in the spinal cord, 
may be of importance in determining regenerative capacity; however their contribution 
to the regenerative response in the embryonic chick spinal cord has not previously been 
investigated.
1.5.  Axonal regeneration after spinal cord injury
The success of axonal regeneration depends upon both factors intrinsic to the neurons 
and on a number of extrinsic  factors.  Axonal  growth  is  lead by the  growth cone,  a 
specialised neuronal ending containing the cellular machinery necessary to navigate the 
extracellular environment and interpret external guidance cues. Regenerative capacity 
can thus  be  affected  by  changes  in external  signals,  which may  promote  or inhibit 
growth, as well as by the intrinsic ability of the neuron to respond to cues by initiating 
appropriate cellular mechanisms for growth. In this section, the intrinsic regenerative 
capacity of neurons from regenerating and non-regenerating systems will initially be 
considered. Most extrinsic factors that are proposed to promote or inhibit axon growth 
during regeneration are related to axon guidance cues expressed during development. 
Therefore, a brief review of axon guidance cues will be followed by a discussion of 
specific inhibitory and growth promoting factors that are thought to be of importance 
after spinal cord injury.
1.5.1.  Intrinsic ability of neurons to regenerate
The  once  widely  accepted  view  that  CNS  neurons  are  intrinsically  incapable  of 
regeneration has been more or less dismissed by the demonstration that CNS axons can 
grow when transplanted into a non-CNS or embryonic environment (Richardson et al. 
1980). However, studies on the growth of different types of CNS neurons in vitro have
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demonstrated that there can be marked differences in the intrinsic ability of neurons to 
regenerate on the same substrate (Fawcett 1992). For example, neurons that are capable 
of extensive axonal outgrowth include cerebellar deep nuclei neurons, while cerebellar 
Purkinje cells have a limited growth capacity (Properzi and Fawcett 2004). The intrinsic 
capacity of sensory neurons to grow into the CNS following dorsal column lesion can 
be  increased  by  preconditioning  lesions  (Neumann  and  Woolf 1999).  Additionally, 
embryonic neurons have in a number of cases been shown to be able to grow in the 
adult CNS where adult CNS neurons apparently cannot (Wictorin and Bjorklund 1992; 
Li and Raisman 1993; Shewan et al.  1995). Indeed, a number of studies have indicated 
that the intrinsic regenerative capacity of neurons diminishes with age. In some studies 
the environment in which neurons are situated does not affect this loss of regenerative 
capacity with age. However in other studies this developmental transition occurred only 
in an inhibitory  environment suggesting the  onset,  at later developmental  stages,  of 
responsiveness to inhibitory signalling factors (Condic 2001; Li et al.  1995; Shewan et 
al.  1995).
Despite  this  evidence,  the  molecular  changes  underlying  differences  in  intrinsic 
regenerative capacity are poorly understood. A greater understanding of these changes 
should  provide  a  basis  for  enhancing  regeneration  in  neurons  that  show  a  weaker 
intrinsic axonal re-growth capacity.
Several growth-associated molecules have been shown to be upregulated after injury in 
regenerative  neurons,  such  as  growth-associated  protein  (GAP)  43  and  leukocyte 
protein  1   (LI)  (Chaisuksunt et al.  2000).  GAP43  is upregulated after a conditioning 
lesion in DRG neurons  and  is thought to be involved in the  subsequently  improved 
regenerative response (Chong et al.  1994). Axotomy of rubrospinal neurons resulted in 
a  shorter-lasting  up-regulation of growth-associated  genes  to  PNS  neurons  with no 
concurrent regenerative improvement (Tetzlaff et al.  1991). Addition of these factors to 
non-regenerative  neurons  has  produced  only  a  moderately  enhanced  regenerative 
response, suggesting that other key factors remain to be identified (Buffo et al.  1997; 
Bomze et al.  2001). Expression of growth related signalling molecules such as integrins 
has also been demonstrated to be reduced in more mature neurons, providing another 
strategy  for  improving  the  intrinsic  ability  of adult  CNS  neurons  to  regenerate  by
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artificially upregulating integrin expression to levels observed in less mature neurons 
(Condic 2001).
Intracellular  factors  that  alter  the  response  of neurons  to  a  potentially  inhibitory 
environment  might  also  be  of importance.  One  such  factor  might  be  cyclic  AMP 
(cAMP),  which  has  been  shown  to  promote  axonal  growth  even  in  inhibitory 
environments, although in these studies pre-treatment with cAMP before  injury was 
necessary  (Cai  et al.  1999; Neumann et al.  2002).  Reduced cAMP levels have been 
suggested to underlie reduced regenerative capacity in more mature neurons (Cai et al.
2001). cAMP levels may also govern the response of neurons to axonal guidance cues 
(Ming et al.  1997;  Song et al.  1997). Administration of a phophodiesterase inhibitor, 
Rolipram,  which  prevents  cAMP  degradation,  has  been  demonstrated  to  improve 
regeneration in experimental models of spinal cord injury (Nikulina et al. 2004).
1.5.2.  Axonal path finding and synaptic targeting
Although strategies for enhancing the intrinsic regenerative capacity of neurons or for 
removing environmental inhibition may result in greater axonal growth, this does not 
mean that  functionally  relevant connections  will  be  formed.  Axonal  growth during 
development involves the strict direction of growth cones down the correct pathways by 
various secreted or membrane bound guidance cues (Mueller 1999). The growth cone 
contains actin-rich finger-like protrusions called filopodia which probe and interact with 
the environment of the advancing neurite. The filopodia express a wealth of receptors 
which,  via  intracellular  signalling  pathways  that  involve  the  Rho  family  of small 
GTPases, determine the direction of axon growth (Mueller 1999). Rearrangement of the 
actin cytoskeleton, which is regulated by Rho family members including RhoA, Rac and 
Cdc42,  may  result  in  retraction  of filopodia  and  growth  cone  collapse  or  neurite 
advancement  and  filopodia  formation  (Mueller  1999;  Nobes  and  Hall  1995).  The 
response of the growth cone to a given guidance cue has also been shown in some cases 
to be affected by intracellular levels of cAMP (Ming et al.  1997; Song et al.  1997).  It is 
likely  that  a  similarly  strict regulation  of axonal  re-growth will  be  required during 
regeneration to  ensure that appropriate connectivity  is restored.  Importantly,  axonal 
guidance involves inhibitory as well as growth-promoting cues, which has relevance for 
strategies that aim to universally reduce growth inhibition or augment growth promotion
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in the CNS environment. Table 1.1 summarises some of the principle guidance cues that 
are  involved  in  axonal  growth  during  development.  Growth  cone  receptors  and 
environmental  guidance  cues may  need to  be  restored  to  a  developmental  state  for 
regeneration to take place.  However, little is known about the re-expression of these 
molecules in the injured spinal cord and most of the work investigating the potential 
role of these molecules in CNS regeneration has been carried out on the projection from 
retinal ganglion cells (RGC) in the eye to the superior colliculus in the brain.
Overall, it is apparent that axon guidance during development is subject to a complex 
array of cues and signalling pathways. To recapitulate such signalling from scratch in 
the regenerating nervous system is therefore a daunting task. Nevertheless, in systems 
that do regenerate,  sufficient guidance  cues  could be presumed to  be either already 
present  or  up-regulated  in  response  to  injury.  Encouragingly,  studies  on  RGC 
regeneration have indicated that some of these molecular cues continue to be expressed 
in the adult mammalian CNS long after development is complete. On the other hand, the 
continuing presence or even up-regulation of some chemorepellant molecules might 
contribute to the inhibition of axonal growth.
1.5.3.  Growth-promoting factors
As described above, axonal regeneration involves the interaction of receptors present on 
the growth cone surface with factors present in the environment that may support and 
encourage growth. It can therefore be presumed that the presence or absence of such 
growth  promoting  factors  might  contribute  significantly  to  the  overall  success  of 
regeneration.  Potentially  growth-promoting  factors  include molecules  located  in the 
extracellular  matrix  (ECM),  such  as  laminin,  fibronectin  and  some  of  the 
chemoattractive  molecules  described  above.  In  addition  neurotrophic  and  growth 
factors, secreted by neighbouring cells, can influence the intrinsic activity of the growth 
cone.  There  is  some evidence for differences in the expression of growth promoting 
factors in regenerative and non-regenerative systems.  For example, heparan sulphate 
proteoglycan (HSPG) and laminin, both of which are known to enhance neurite growth, 
have  been demonstrated to  be  down-regulated with development of the  optic  nerve, 
which corresponds to a reduction in regenerative capacity (Cohen et al.  1987; Hantaz- 
Ambroise et al.  1987). The expression of molecules such as laminin and HSPG in
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Guidance cue Growth cone receptor Details Chemoattractive or chemorepulsive? Role in axon guidance after 
injury?
Semaphorins
•Secreted
•Membrane bound
•Neuropilin receptors 
(He & Tessier-Lavigne,
1997)
•Plexins (Winberg et al,
1998)
•More than 30 members 
identified so far (Chen 
1997).
•May be secreted or 
membrane bound 
•All possess 500aa 
extracellular SEMA 
domain
Chemorepellants but may act under 
some circumstances as chemoattractants 
(Mueller, 1999, Wong et al, 1997)
•Changes in semaphorin expression 
(including up-regulation of type-3 
semaphorins) have been reported 
after injury (DeWinter et al, 2002, 
Pasterkamp et al 1998)
•May guide regenerating neurons or 
inhibit regeneration as part of glial 
scar
Ephrins •Eph receptors 
•Two classes Eph-A and 
Eph-B, according to their 
preferred ligand
•Ephrin-A class are GPI- 
linked to cell membrane 
•Ephrin-B class are 
transmembrane proteins
Mediate growth cone collapse but 
chemoattractive properties have also 
been described (Holmberg & Frisen, 
2002)
•Ephrins and Eph receptors (Ephrin 
B2 and Eph B2) up-regulated by 
reactive astrocytes after injury 
(Bundesen et al, 2003)
Netrins •Deleted in colorectal 
cancer (DCC) receptors 
•UNC5H receptor
•4 family members Either, depending on receptor:
•DCC receptors promote attraction 
•UNC5H receptor mediates inhibition 
(Hong et al, 1999, Keino-Masu et al, 
1996, Mueller, 1999)
Netrins and receptors down- 
regulated in some injury models but 
other studies have questioned their 
role. (Ellezam et al, 2001, Deiner et 
al, 1997, Petrausch et al, 2000),
Slits Roundabout (Robo) 
receptors
•3 family members 
•Secreted ligands
Both chemorepellant and 
chemoattractive
Others:
•Neurotrophins 
•Myelin proteins 
•CSPGs/Tenascin
•See later sectionsIntroduction
regenerative  species such as  lower vertebrates or the  embryonic  chick has  not been 
documented. However, further support for the importance of such factors comes from 
studies,  mainly  involving  neurotrophic  factors,  in which  exogenous  application  of 
growth-promoting factors has been shown to enhance regeneration.
The neurotrophins are a group of polypeptides, including BDNF, NGF, GDNF and NT- 
4/5, which play a number of roles during development of the nervous system including 
promoting  neuronal  survival  and  regulating  axon  guidance.  These  factors  could 
therefore  have  the  dual  benefit of reducing  cell  death as  well  as  encouraging  axon 
growth after injury (Cheng et al.  2002).  Neurotrophins have been applied singly or in 
combination at the injury site, via injection or by transplantation of cells expressing the 
protein, with some limited success (Schnell et al.  1994; Menei et al.  1998; Grill et al. 
1997; Liu et al.  1999b; Namiki et al. 2000; Coumans et al. 2001; Shumsky et al. 2003). 
In an alternative approach, neurotrophins have been applied directly to the neuronal cell 
body  in  the  brain.  Application  of  BDNF  or  NT-4/5  in  the  brainstem  has  been 
demonstrated to result in an up-regulation of growth-associated genes and improved 
regeneration of axotomised neurons (Kobayashi et al.  1997). Using a similar approach it 
was  shown that  CNS  axons  could be  stimulated to  re-grow a  full year after injury 
(Kwon  et al.  2002).  However,  neurotrophin  treatment  alone  has  only  rarely  been 
demonstrated to  induce regeneration in the  CNS  and  it is  likely that such treatment 
would  need  to  be  combined  with  other  treatments  that  might  improve  the 
permissiveness of the environment in which the axons must grow (Bradbury et al.  1999)
1.5.4.  The inhibitory environment
The concept of permissive and non-permissive environments for axonal extension after 
injury was prompted by the discovery that damaged mammalian CNS axons are able to 
grow into peripheral nervous system grafts but do not behave in the same way in the 
damaged CNS environment (David and Aguayo  1981). Since this discovery, intensive 
research into potential  inhibitory molecules has resulted in the  identification of two 
main sources of inhibitory signalling molecules in the injured spinal cord: myelin and 
the glial scar.
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Myelin-derived inhibitory molecules
Degenerating myelin deposited at the injury site has been suggested to form the main 
inhibition to axonal re-growth in the immediate aftermath of the injury, a proposition 
which is supported by several lines of enquiry. In vitro studies have demonstrated that 
axonal  outgrowth  is  inhibited  on  substrates  containing  myelin  (Schwab  and  Caroni 
1988). Immunisation against myelin or suppression of myelin formation by x-irradiation 
during development has been shown to promote regeneration in the injured spinal cord 
(Savio and Schwab 1990; Huang et al.  1999; Bregman et al.  1995; Caroni and Schwab 
1988; Schnell and Schwab 1990). Chemically-induced lesions of non-myelinated axons 
in the CNS that avoid damage to neighbouring myelinated tracts result in regeneration 
which does not occur when myelinated axons are also damaged (Berry  1982). On the 
other hand, some researchers have cast doubt on the concept of myelin as an inhibitory 
factor for regeneration, questioning the evolutionary basis for such inhibition (Raisman
2004). Furthermore, studies have demonstrated that PNS axons are able to regenerate 
within both intact and degenerating spinal cord white matter (Davies et al  1997; Davies 
et al  1999). Additionally, it has been suggested that in some cases CNS myelin may 
actually benefit axon regeneration by  inhibiting erroneous branching and promoting 
directed growth down myelin-lined channels (Raisman 2004). Despite this controversy, 
several  different molecular components  of myelin have  been  identified  as potential 
contributors to the inhibition of axonal re-growth.  These  include the Nogo proteins, 
myelin-associated  glycoprotein  (MAG)  and  oligodendrocyte-myelin  glycoprotein 
(OMgp), as summarised in Figure 1.7.
The most prominent of the inhibitory myelin proteins over recent years has been Nogo- 
A. The Nogo gene was cloned in 2000, followed by the identification of three isoforms, 
Nogo-A, Nogo-B and Nogo-C, of which Nogo-A appears to have the greatest role in 
the nervous system. In addition to inhibiting axon re-growth via the Nogo-66 receptor 
(NgR, Fig  1.7) Nogo proteins also interact with mitochondrial proteins such as Nogo- 
interacting  mitochondria protein  (NIMP),  anti-apoptotic  proteins  such as  Bcl-2  and 
axonal  proteins  such  as  Caspr,  suggesting  a  variety  of endogenous  roles  for these 
proteins (Teng et al 2004). Nogo-A is expressed on CNS oligodendrocytes, while NgR 
is expressed on axons, consistent with a role in axonal outgrowth inhibition by Nogo-A 
(Huber et al 2002; Wang et al 2002b). Furthermore, NgR is not expressed in the
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•Member of the reticulon family 
•At least 2 inhibitory domains:
•Nogo-66 region (Chen et 
al. 2000b; Fournier et al. 
2001; GrandPre et al. 
2000; Prinjha et al. 2000) 
•N-terminal ‘Nogo-A’ 
region (Oertle et al.2003) 
•Expressed in CNS 
oligodendrocytes but also axons 
•Nogo-A'7 ' mice display 
inconsistent regeneration 
phenotype (Kim et al. 2003; 
Simonen et al. 2003, Zheng et al.
2003)
Myelin-associated 
glycoprotein (MAG)
•Expressed by
oligodendrocytes and Schwann 
cells (DeBellard et al. 1996; 
McKerracher et al. 1994; 
Mukhopadhyay et al.  1994) 
•Promotes DRG growth during 
development (Johnson et al. 
1989)
•Inhibits axonal growth in 
adult (Mukhopadhyay et al. 
1994)
•MAG dominant negative mice 
idisplay inconsistent phenotype 
(Bartsch et al. 1995, Li et al.
1996)
Oligodend rocyte- 
myelin 
glycoprotein 
(OMgp)
•GPI anchored 
protein
•Expressed by 
oligodendrocytes 
and neurons
“  Nogo-66
■ir-
umm u SMfflSsmss iSSSSiSSSf
NgR (Nogo-66 receptor)
•Mediates inhibitory 
signalling from Nogo-66, 
MAG and OMgP (Fournier 
et al. 2001, Liu et al. 2002, 
Wang et al, 2002a) 
•Expressed on embryonic 
and post-natal neurons 
(O’Neill et al. 2004, Wang et 
al. 2002b)
•GPI linked
•NgR-7 "  mice show improved 
recovery (Kim et al. 2004)
$ 15*™
•Neurotrophin receptor 
•Co-receptor for NgR, 
mediates down-stream 
signalling (Wang et al. 
2002a)
•p75N T R ‘/show 
improved PNS but not 
CNS regeneration 
(Boyd and Gordon,
2001; Song et al. 2004)
LINGO
•Second, recently 
identified co-receptor 
for NgR (Mi et al.
2004)
Down stream signalling processes:
•RhoA (Fournier et al. 2003; Yamashita et al. 2002)
•RhoA-associated kinase (ROCK)
Growth cone collapse
Fig 1.7. Properties of the principal myelin-derived inhibitory molecules.
Illustration adapted from Sandvig et al, 2004.
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regeneration-competent  PNS  and  Schwann  cells  do  not  express  Nogo-A  (He  and 
Koprivica 2004). However, Nogo-A is also expressed by CNS neurons and both Nogo 
and NgR are expressed in the CNS during development, when extensive axon growth 
takes  place,  suggesting that the presence  of these  factors  in the  spinal  cord  does not 
always prevent neurite extension (O'Neill et al.  2004;  Huber et al.  2002;  Wang et al. 
2002b). Understanding of the role of Nogo proteins in axonal outgrowth inhibition was 
further  complicated  by  the  inconsistent  regenerative  phenotypes  of knockout  mice 
investigated in three separate studies (Zheng et al.  2003; Kim et al. 2003; Simonen et al. 
2003). Overall, although targeting of the Nogo proteins has yielded therapeutic benefit 
in experimental models, our understanding of the role of Nogo-A in the injured spinal 
cord is far from complete.
Glial-scar derived inhibitory molecules
The glial scar, made up principally of astrocytes and meningeal cells, has been proposed 
to form a major physical barrier to axonal re-growth. In addition to laying down a dense 
matrix that may be difficult for axons to cross, cells in the glial scar express molecules 
that are  inhibitory  to  axonal  re-growth (Fig  1.8).  These  include  chondroitin  sulphate 
proteoglycans (CSPGs), such as NG2, neurocan, versican, and brevican, and tenascins 
(Silver and Miller 2004; Morgenstem et al.  2002). These are summarised in Figure  1.8. 
Like the myelin-derived inhibitory molecules, both CSPGs and tenascins play important 
roles in axonal pathfinding during nervous system development (Faissner 1997; Snow et 
al.  1990).  Recent evidence suggests that not all proteoglycans are inhibitory to axonal 
growth and  some,  in particular the  small  CSPG  decorin,  may  actually  be  capable of 
promoting  neurite  growth  in  the  injured  spinal  cord  (Davies  et  al.  2004).  The 
mechanism  by  which this  occurs  is  not  fully  understood,  however  it  is  thought that 
decorin can suppress levels of transforming-growth factor |3 (TGF|3) which is involved 
in deposition of the glial  scar.  The extracellular matrix of the glial  scar is also a rich 
source  of molecules  associated  with  axonal  guidance  during  development  such  as 
ephrins,  semaphorins  and netrins, many  of which are upregulated  after injury  (Table 
1.1). The disrupted expression of these guidance molecules within the scar region might 
therefore contribute to the inhibitory environment.
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•Includes NG2, neurocan, versican and 
brevican
•Consist of core protein with 
chondroitin sulphate (CS) and 
glycosaminoglycan (GAG) side chains, 
both of which inhibit axon growth 
(Fawcett and Asher, 1999)
•Involved in axon guidance during 
development
•Secreted and membrane bound forms 
found in glial scar
•Expressed by activated astrocytes after 
spinal cord injury (Fitch and Silver
1997)
Protein core
\
s  s
S
S
Tenascins
•Family of glycoproteins 
•Include tenascin-R (TR), tenascin-C 
and tenascin-Y
•Secreted by oligodendrocytes 
•TR is up-regulated in glial scar after 
injury (Probstmeier et al. 2000)
I
Chondroitin 
sulphate side 
groups
Downstream actions
•Linked to Rho/ ROCK pathway but do 
not cause growth cone collapse in vitro 
(Monnier et al. 2003)
•May bind to laminin, preventing 
interaction with growth cone integrins 
(McKeon et al.  1995)
i
Downstream actions
•Contain binding sites for integrins 
through which they regulate adhesion 
of growth cone to ECM
Fig 1.8. Properties of the principal glial-scar derived inhibitory molecules.
Illustrations adapted from Properzi and Fawcett and Faissner, 1997.
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The importance of the inhibitory environment for regenerative capacity
Axonal  regeneration  is  an  essential  component  of  spinal  cord  repair  in  many 
regenerative species, from lower vertebrates to the chick and opossum spinal cord. A 
number of studies indicate that there may be important differences in the environment 
encountered  by  regenerating  neurons  in  regeneration-competent  and  incompetent 
species.  For example, the onset of myelination in the developing opossum coincides 
with the loss of regenerative capacity (Ghooray and Martin  1993).  Certain inhibitory 
components  of myelin have also been shown to be differentially  expressed between 
regenerating and non-regenerating systems. For example, evolutionary divergence has 
led to the N-terminal inhibitory sequence present in mammalian Nogo-A being absent in 
the equivalent reticulon protein in fish, and myelin from these species does not result in 
axonal inhibition in in vitro co-cultures with mammalian CNS neurons (Diekman et al,
2005).  On the other hand it has been shown that amphibians do express the Nogo-A 
sequence and also that fish do express the Nogo-66 region of the protein (Klinger et al. 
2004; Diekmann et al.  2005; Bahr and Bonhoeffer 1994). Furthermore, zebrafish have 
been reported to express MAG (Lehmann et al. 2004). The composition of the glial scar 
has also been demonstrated to be different in embryonic animals in which regenerative 
capacity is higher. In some lower vertebrate species that can regenerate, CSPGs are not 
upregulated by reactive astrocytes, although a glial scar is formed (Silver and Miller 
2004; Reier et al.  1992).  Similarly, the up-regulation of SEMA3 which is observed in 
the  glial scar after CNS  injury contrasts with a down-regulation of this molecule in 
peripheral sensory and motor neurons and in the normally non-permissive dorsal spinal 
cord  following  PNS  injury  (Pasterkamp et al.  1998a;  Pasterkamp  et  al.  1998b). 
However, exceptions to these rules exist, making the role of the inhibitory environment 
less  clear  cut.  For  example,  the  optic  nerve  loses  the  capacity  to  support  neurite 
outgrowth prior to myelination (Shewan et al.  1993). The peripheral nervous system has 
also been reported to up-regulate many postulated inhibitory  factors such as  CSPGs 
after injury,  although it is thought that the rapid clearance of these molecules might 
explain the apparent lack of axonal re-growth inhibition (Pasterkamp et al.  1998a).
The contribution of some of these factors to regeneration has been investigated in the 
embryonic chick. For example, it has been shown that the chick spinal cord is capable 
of  regeneration  only  at  stages  prior  to  myelination  and  experimental  delay  in 
myelination  has  been  demonstrated  to  extend  the  permissive  period  for  axonal
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regeneration  (Keirstead  et  al.  1992;  Keirstead  et  al.  1995).  Additionally,  the 
regeneration-competent period is associated with a low ratio of CSPG expression to 
expression of the growth promoting HSPG; this ratio was demonstrated to increase after 
El3 (Dow etal.  1994).
Strategies for overcoming the inhibitory environment
The multitude of inhibitory factors that has been identified in the injured spinal cord 
suggests that removal or inhibition of any single factor is unlikely to result in significant 
improvements  in regeneration.  However,  a number of different strategies have been 
pursued in experimental models, and these are summarised in Fig  1.9. Interestingly, it 
has also been shown that neurons can grow in an inhibitory environment if provided 
with  certain  growth  factors  prior  to  exposure  to  the  inhibitor)  signalling,  via  a 
mechanism involving cAMP (Cai et al.  1999). Downstream signalling involves protein 
kinase  A  (PKA)  and  genes  including  Arginase  I,  which  catalyses  the  synthesis  of 
polyamines, possibly  leading to rearrangement of the  cytoskeleton (Cai  et al.  2002; 
Spencer and Filbin 2004).  Similarly, enhancing retinoid signalling by transduction of 
sensory neurons with the retinoic acid receptor RAR(3 can promote regeneration across 
inhibitory substrates via mechanisms which probably involve cAMP signalling (Wong 
et  al.  2006)  These  mechanisms  might  also  explain  the  higher  innate  regenerative 
capacity of immature neurons because prenatal DRG neurons have been shown to have 
higher cAMP and Arginase  1   levels than more postnatal neurons, and PKA inhibitors 
blocked spontaneous regeneration in the embryonic rat spinal cord (Cai et al. 2001; Cai 
et al.  2002).  Thus  an alternative  strategy  to  aid  axonal  re-growth would be to treat 
neurons  to  render  them  unresponsive  to  inhibitory  signals.  A  drawback  is  the 
requirement for cAMP elevation prior to contact between the axon and the inhibitory 
substrate.  The  inhibitory  environment might also be  overcome by transplantation of 
synthetic or biological bridges permissive to axon growth. Transplantation of peripheral 
or embryonic  nerves  enhances  regeneration  in  animal  models  but  has  a  number of 
ethical and practical drawbacks for clinical use (David and Aguayo 1981; Iwashita et al.
1994). A range of different synthetic and biodegradable materials have been developed 
including collagen based gels, fibronectin mats or tubes made of polycarbonates (Geller 
and Fawcett 2002; Montgomery et al.  1996; Plant et al.  1997; Steuer et al.  1999). These 
may  be  implanted  in  conjunction with cell  transplantation  strategies,  which will  be 
outlined in greater detail below.
53Neutralising antibodies or 
peptides/ vaccination 
(Bregman et al, 1995, Merkler 
et al, 2001, Huang et al, 1999)
Myelin degeneration
TGF
Glial scar formation
Antibodies, decorin (Davies et al, 
2004, Logan et al 1999)
Nogo-A
MAG
Receptor blocking peptides (NEP1-40), soluble 
NgR (Fournier et al 2002, GrandPre et al, 2002, 
Li & Strittmatter, 2003)
NgR
p75
CSPGs
RhoA ROCK
Target downstream signalling 
(Dergham et al, 2002, 
Fournier et al 2003, 
Lwhmann et al,  1999, 
Niederost et al, 2002)
Digestion of side chains with chondroitinase 
ABC (Bradbury ey al, 2002, Moon et al, 2001)
Fig  1.9.  Strategies  to  overcome  the  inhibitory  environment.  Schematic  diagram,  illustrating  the  components  of the  signalling 
pathways which inhibit axonal growth which have been targeted experimentally to improve spinal cord regenerationIntroduction
Overall, a number of promising strategies to overcome the inhibitory environment of the 
injured CNS have been identified. The wide range of potentially inhibitory molecules 
suggests that any successful treatment will need to act on a number of different targets, 
perhaps via common downstream signalling pathways.  However, the magnitude of the 
regeneration observed when these strategies have been tested in experimental models 
has been modest. It is also unclear to what extent re-growing axons are able re-establish 
the correct synaptic connections.  It therefore remains to be determined whether these 
positive effects will translate to clinical effect in the human spinal cord and lead to long­
distance axonal regeneration.  These approaches will probably  be most successful  in 
combination  with other therapeutic  approaches  such  as  neurotrophin treatment  and 
cellular transplantation (Fouad et al.  2005). Furthermore, it seems clear that strategies 
that reduce the formation of the inhibitory environment, for example by reducing the 
extent of secondary injury and cell death, might significantly contribute to improved 
regeneration.
1.6.  Cell death and survival after spinal cord injury
1.6.1. The importance of cell survival for regenerative capacity
It is apparent that the likelihood of successful spinal cord regeneration will be vastly 
enhanced in situations in which a larger number of cells survive the injury. Cell death 
reduces the number of viable cells available to regenerate their axons and results in the 
formation of cavities within the spinal cord which can act as a physical barrier to axonal 
re-growth.  Changes  in  cell  death  or  survival  responses  to  injury  might  therefore 
contribute to differences in regenerative capacity.  This possibility has, however, not 
been examined extensively across regenerative species. Previous studies in the chick 
spinal  cord  have  demonstrated  a  relationship  between  the  developmental  loss  of 
regenerative  capacity  and  a  dramatic  increase  in  the  apoptotic  response  to  injury 
(O’Neill,  2002,  PhD  thesis,  Whalley  et al,  2006).  The  mechanisms  underlying  this 
change in the apoptotic response have not been determined. Another recent study in the 
chick  highlighted  the  correlation  between  increased  sensitivity  of  developing 
oligodendrocytes to apoptosis after injury and the peak of myelination which occurs 
between E l3 and E l8, but did not examine neuronal apoptosis in detail (McBride et al.
2003).
55Table  1.2.  Neuroprotective  strategies  targeting  secondary  injury 
mechanisms.  Table  shows  major  strategies  which  have  been  tested  in  pre- 
clinical animal models and clinical trials.
Strategy- Process(es)
targeted
Pre-clinical studies Clinical success?
Glutamate
antagonists
excitotoxicity Showed significant 
effects in SCI models 
(Gaviria et al. 2000)
No significant 
improvement 
(gacyclidine) in phase 
2 trials (unpublished)
Calcium
channel
blockers
Ischaemia Mixed results with 
nimodipine (Fehlings 
etal. 1989; Haghighi 
etal  1993)
No benefit shown in 
prospective trial 
(Pointillart et al. 
2000)
Interleukin-10 Inflammation Protective in 
experimental models 
(Brewer et al.  1999, 
Plunkett et al. 2001)
Not yet tested
Steroids (e.g.
methylprednis
olone)
•Free radical 
formation
•Lipid
peroxidation 
•Cytokine 
production 
•iNOS activity 
(Carlson and 
Gordon, 2002)
Mixed results in 
animal experiments 
(Young etal.  1988; 
Koyanagi and Tator, 
1997)
•Clinical trials results 
showed effect at 8h 
after injuiy, but are 
controversial 
(Bracken et al.  1992, 
Bracken et al, 1997, 
Hurlbert  2001) 
•Approved for SCI 
treatment in the US, 
but rarely elsewhere.
GM-1
gangliosides
•excitotoxicity Provided
neuroprotection in 
experimental models 
(Ferrari and Greene, 
1998)
•Clinical trials did not 
show evidence of 
improved outcome 
(Geisler et al. 2001)
Minocycline •Caspase activity
•Microglial
activation
•iNOS activity
Improves outcome in 
experimental models 
(Lee et al. 2003b, 
Stirling et al. 2004, 
Wells etal. 2003)
Not yet tested
Neurotrophins •Trophic support Reduce apoptosis in 
experimental models 
(Koda et al. 2002)
Not yet tested
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Evidence for the pathological effects of haemorrhage in the spinal cord also comes from 
two studies in which treatment with recombinant thrombomodulin reduced haemorrhage 
at 24 hours after injury and also resulted in neuroprotection and reduced cavitation after 
a compression or contusion injury (Taoka et al.  1998; Festoff et al.  2004). However, 
treatment with thrombomodulin did slightly increase haemorrhage within the first three 
hours after injury and the authors have attributed the effects of the drug to the effects of 
thrombomodulin on thrombin signalling, which will be discussed further below (Festoff 
et al.  2004). Furthermore, changes in the haemorrhagic response may contribute to the 
regenerative capacity of the spinal cord. In the developing chick spinal cord, the age- 
related increase in apoptosis in the spinal cord after injury corresponds to a dramatic 
increase  in the  extent of haemorrhage within the cord (Whalley et al.  2006;  O'Neill
2002). This developmental increase in haemorrhage reflects the rapid development of 
the spinal cord vascular system which occurs at around the time that the chick loses its 
ability  to  regenerate  its  spinal  cord (O'Neill 2002;  Whalley  et al.  2006).  Moreover, 
pharmacologically increasing the amount of haemorrhage in the chick spinal cord at 
normally  regenerative  stages  was  shown  to  result  in  an  increase  in  cavitation  and 
apoptosis to levels equivalent to those normally seen only at non-regenerative stages 
(O'Neill  2002;  Whalley et al.  2006).  It is therefore  of interest to  consider potential 
factors  which might be responsible  for the  link between apoptosis and haemorrhage 
after injury.
1.6.4.  Serine Proteases
The correlation between haemorrhage and apoptosis after spinal cord injury points to 
the potential involvement of blood-borne factors in triggering apoptosis in the injured 
CNS.  Blood  contains  a  multitude  of  different  factors  that  could  be  considered 
contenders for this role, not least the inflammatory molecules and cells that are known 
to contribute to secondary injury. However, evidence suggests that the serine pro  teases, 
more usually associated with their roles in haemostasis, also make excellent candidates 
for linking haemorrhage with apoptosis in the nervous system.
Introduction to serine proteases
The serine proteases are a large family of proteolytic enzymes with serine residue at 
their  catalytic  site  (Stone  and  Maraganore,  1992).  Members  of the  family  include
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thrombin,  activated  protein  C  (APC),  plasminogen,  plasmin  and  the  plasminogen 
activators,  tissue-type  plasminogen  activator  (tPA)  and  urokinase  (Turgeon  and 
Houenou 1997). These molecules are all key players in a series of complex interacting 
pathways  which  regulate  the  formation  and  breakdown  of fibrin-based  blood  clots 
(Fig. 1.10).  Most  serine  pro teases  are  expressed  as  inactive  precursors  which  are 
subsequently activated by the proteolytic action of an enzyme higher in the cascade. 
Serine protease activity is further regulated by a protein superfamily called ‘serpins’, 
including protease nexin-1  (PN-1), a potent thrombin inhibitor and neuroserpin, a tPA 
inhibitor  (Osterwalder  et al.  1996;  Sommer  et al.  1987).  Serpins  act  primarily  by 
forming complexes with serine proteases that are subsequently internalised by nearby 
cells (Pike et al.  2005).  Additionally, the activity of serine proteases may be regulated 
by  other  inhibitors  which  include  the  thrombin  inhibitor  thrombomodulin. 
Thrombomodulin is a chondroitin sulphate proteoglycan that combines with thrombin to 
activate protein C, which has opposing actions to thrombin (Pindon et al.  1997).
In addition to their well-characterised roles in the circulatory system the serine proteases 
may have important roles in many other parts of the body. They have been associated 
with inflammation, tissue remodelling, cell migration and tumour formation (Turgeon 
and Houenou 1997). One area in which they are believed to have an important function 
is the nervous system.  In particular, the action of thrombin in the nervous system has 
been extensively investigated, due to the early identification of its receptor and elements 
of its signalling pathway (Vu et al.  1991). Additionally, the plasminogen activator, tPA, 
has been known to have a role in CNS  development for many years (Krystosek and 
Seeds  1981; Sumi et al.  1992) Although much of the original work concentrated on the 
role of these molecules in the peripheral nervous system, recent focus has moved to the 
central nervous system, with emerging evidence for crucial roles in the brain and spinal 
cord (Gingrich and Traynelis 2000).
The  discovery  of a  specific  thrombin  receptor  and  the  identification  of its  novel 
‘tethered ligand’ mechanism of action, whereby cleavage of the N-terminal domain by 
thrombin or another serine protease, exposes a new amino terminus that can bind and 
activate  the  receptor,  was  of key  importance  in  uncovering  the  function  of serine 
proteases in the CNS (Rasmussen et al.  1991; Vu et al.  1991; Coughlin 2000). Protease
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Fig.  1.10.  Components  of  the  coagulation  cascade.  Schematic 
diagram illustrating the principle interactions (simplified) underlying 
coagulation/  fibrinolysis.  Inactive  serine  protease  precursors  are 
shown  in  blue  boxes,  the  activated  proteases  are  shown  in  green 
boxes.  Serine protease inhibitors (serpins) are shown in red boxes. 
Abbreviations:  a=  activated  APC  =  activated  protein  C,  F  = 
coagulation  factor,  ,  PAI-1  =  plasminogen  activator  inhibitor  -1, 
PAR = proteinase activated receptor, PN-1 =  protease nexin -1, tPA 
=  tissue  plasminogen  activator,,  TM  =  thrombomodulin.  Adapted 
from  Gingrich  and Traynelis,  2000  and  the  Chromogenix  website 
(  ).
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activated  receptor-1   (PAR-1)  is  a  G  protein  coupled  receptor which  is  linked to  a 
number of different signalling molecules including mitogen-activated protein kinase 
(MAPK),  Rho  GTPase,  inositol  1,4,5,-triphosphate and adenylate cyclase (Coughlin
2000).  Three further PAR receptors have subsequently been cloned and demonstrated 
to be activated by different serine proteases to varying degrees (Coughlin 2000). Many 
studies which have demonstrated the involvement of the PAR-1 receptor in downstream 
cellular effects have done so using short peptide agonists which mimic the sequence of 
the  cleaved amino-terminal region, or specific PAR-1  antagonists  (Macfarlane et al.
2001).
Serine proteases in the normal CNS
The first indication that serine proteases might have a functional role in the CNS came 
from  studies  demonstrating  that  genes  for  many  of  these  enzymes,  including 
prothrombin, Factor X, urokinase and tPA are expressed in the rodent brain and spinal 
cord (Dihanich et al.  1991; Deschepper et al.  1991; Sumi et al.  1992; Weinstein et al. 
1995; Shikamoto and Morita 1999).
Prothrombin  is  expressed  in the  rat  brain  by  embryonic  day  (E)  13  and  its  levels 
decrease just before birth and then increase during the early post-natal period (Dihanich 
et al.  1991).  Further studies demonstrated the presence of the PAR-1 receptor in the rat 
brain and its localisation in a number of CNS regions including the cortex, thalamus, 
hypothalamus,  hippocampus and basal  ganglia and the  spinal  cord  (Weinstein et al. 
1995; Niclou et al.  1994). Crucially, the expression of thrombin and its receptor were 
shown to co-localise in a number of brain regions, although, in contrast to prothrombin 
expression patterns, PAR-1  becomes more restricted in the adult brain (Weinstein et al. 
1995). In the rat spinal cord, PAR-1  is expressed exclusively in the grey matter and in 
ependymal cells, with no expression observed in the white matter (Niclou et al.  1994). 
Although thrombin  and  PAR-1  are  known to  be  expressed  in the  developing  chick 
spinal cord, a detailed analysis of their pattern of expression has not been carried out.
The expression of urokinase and tPA has also been examined in the developing rat CNS 
(Sumi et al.  1992).  Urokinase was shown to be expressed early during development 
(from El2.5) in developing neurons in the spinal cord and continued to be expressed 
into adulthood, while tPA was found to be concentrated in floor plate cells (Sumi et al.
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1992).  The expression of plasminogen activators has not been examined in the chick 
spinal cord in detail; however studies in the cerebellum, cerebral hemispheres and optic 
lobe have  demonstrated that only urokinase  is expressed in the  chick CNS  and that 
expression  levels  are  elevated  during  periods  of neuronal  migration  and  synapse 
formation (Scicolone et al.  1997; Pereyra-Alfonso et al.  1997; Scicolone et al.  1998).
Accompanying the serine proteases in the brain, a range of different serpins have also 
been demonstrated to be expressed by neural cells (Wagner et al.  1991; Niclou et al. 
1994; Krueger et al.  1997). PN-1 is thought to be the predominant thrombin inhibitor in 
the brain, produced by both astrocytes and neurons and localised around blood vessels 
in the brain (Choi et al.  1990). In the rat spinal cord PN-1  is expressed from El8 and is 
predominantly located in the small glial cells in the grey and white matter as well as in 
motomeurons (Niclou et al.  1994). Thrombomodulin is expressed by endothelial cells 
and astrocytes (Pindon et al.  1997; Pindon et al. 2000). Again, little is known about the 
expression patterns of these serpins in the developing chick spinal cord.
The function of serine proteases in the normal CNS is not fully understood. However 
these molecules are believed to have important roles in nervous system development, 
plasticity and homeostasis (Turgeon et al.  2000). A number of in vitro studies point to 
an involvement for serine proteases in morphogenesis and differentiation of neurons and 
glia.  Activation  of PAR-1  causes  cell  rounding  and  neurite  retraction  in  cultured 
neuroblastoma cell lines and motomeurons via activation of Rho GTPase (Gurwitz and 
Cunningham 1988; Suidan et al.  1992; Jalink and Moolenaar 1992; Jalink et al.  1994; 
Brewer 1995; Turgeon et al.  1998). Likewise, inhibitors of thrombin such as PN-1  and 
hirudin promote  neurite  outgrowth  (Monard et al.  1983;  Gurwitz  and  Cunningham 
1990).  In contrast plasminogen and plasmin  have  been reported to  promote  neurite 
outgrowth in explant cultures (Nagata et al.  1993; Pittman and DiBenedetto  1995). In 
astrocyte cultures, thrombin has a mitogenic effect and can affect astrocyte morphology 
and stellation (Perraud et al.  1987; Cavanaugh et al.  1990; Nelson and Siman  1990). 
Thrombin  also  plays  a  role  in  programmed  cell  death  during  nervous  system 
development. It has been demonstrated that inhibition of thrombin by PN-1  results in a 
reduction  in  programmed  cell  death  in  motomeurons  in  vivo  in the  chick embryo 
whereas activation of PAR-1  with peptide ligands can stimulate apoptosis in vivo in the 
chick embryo and in purified motomeuron cultures (Turgeon et al.  1999; Houenou et al.
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1995).  Thus,  many  of the  in  vitro  effects  of serine  proteases  are  indicative  of an 
important role during nervous system development. The continuing expression of these 
molecules in the adult CNS may contribute to functions such as synaptic plasticity and 
long-term potentiation, and the maintenance of tissue homeostasis and tPA has been 
suggested to participate in several related processes including synaptic remodelling in 
long term potentiation (Monard 1988; Baranes et al.  1998; Qian et al  1993).
Serine proteases and CNS injury
Many  studies  have  suggested that  serine proteases  play  a role  in  maintaining  CNS 
homeostasis.  As  such,  disruption of the  balance  of expression  and  activity  of these 
molecules following injury might be expected to contribute to CNS pathology. It has 
been suggested that serpins in the CNS may act to neutralise potential harmful increases 
in  serine  protease  levels,  but that their  capacity  to  maintain  this  balance  might be 
reduced in injury situations which result in sudden high levels of serine protease activity 
(Choi et al.  1990; Vaughan and Cunningham  1993).There could be multiple causes of 
such disruption, including excessive extravasation of serine proteases, their activators or 
inhibitors, from the blood, or increased endogenous expression of these molecules in 
response to injury. In support of this suggestion, endogenous levels of serine proteases 
have been demonstrated to be altered after injury and in some neuropathological disease 
states (Wagner et al.  1989; Rao et al.  1993; Vaughan et al.  1994; Turgeon et al.  2000; 
Riek-Burchardt et al.  2002;  Masos and Miskin  1997). mRNA levels of prothrombin, 
PAR-1  and plasminogen activators have all been demonstrated to be up-regulated after 
controlled contusion spinal cord injury in the rat (Citron et al.  2000b). There have also 
been reports of altered serpin expression after injury, while thrombomodulin expression 
has also been demonstrated to increase  in astrocytes after injury (Nitsch et al.  1993; 
Pindon  et al.  2000).  The  plasminogen  activators  and thrombin have  been the  most 
prominent of the serine proteases in studies into CNS injury responses.
Plasminogen activators and CNS injury
The plasminogen activators tPA and urokinase have been suggested to have a number of 
deleterious  effects  in the  CNS  (Fig  1.11).  This  is  of particular  importance  in brain 
injuries such as stroke, in which tPA is often used as therapeutic agent to promote the 
dissolution of blood clots (del Zoppo  1998).  The mechanisms by which these factors 
cause damage are not fully determined but may involve the conversion of plasminogen
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to plasmin and the initiation of a proteolytic cascade which results in cell death (Chen 
and Strickland 1997; Tsirka et al.  1997; Melchor et al.  2003). In addition, tPA has been 
linked to both activation of NMDA receptors, providing a mechanism by which this 
factor might exacerbate excitotoxicity, and to microglial activation, suggesting that it 
may also modulate the inflammatory response (Tsirka et al.  1995; Nicole et al.  2001). 
In support of this, mice in which the tPA gene has been removed have been shown to be 
resistant to excitotoxicity and to have reduced damage in models of stroke (Tsirka et al. 
1997; Wang et al.  1998).  Similarly, urokinase-/- mice demonstrated less damage in a 
brain stab wound model (Kataoka et al. 2000). Furthermore, administration of tPA itself 
can exacerbate damage in models of ischaemia or stroke and inhibition of tPA using 
antibodies or the tPA inhibitor, tPA STOP reduces the induction of neuronal apoptosis 
by activated microglia (Wang et al.  1998; Flavin et al.  2000). Importantly, tPA knock 
out mice have also been demonstrated to have reduced neuronal damage after spinal 
cord injury (Abe et al. 2003). Co-injection of tPA with thrombin into the brain has been 
demonstrated to increase injury beyond levels seen with either serine protease alone, 
suggesting that these two  factors may potentiate  each others  action (Figueroa et al.
1998).  On the  other hand,  up-regulation of urokinase  and tPA in the PNS has been 
suggested  to  contribute  to  axonal  re-growth  and  mice  lacking  these  proteins  have 
reduced recovery after PNS  injury (Siconolfi and  Seeds 2001a;  Siconolfi and  Seeds 
2001b).
Thrombin in CNS injury
Several studies have highlighted potentially damaging effects of thrombin on neurons 
and  glia while  others  suggest that thrombin might promote regeneration (Fig  1.11). 
Some of the effects of thrombin associated with nervous system development, such as 
changes in neurite outgrowth, might have potentially detrimental influences on CNS 
repair after injury, by preventing axonal regeneration. Importantly, thrombin might also 
have significant effects on neuronal cell survival and apoptosis.
In vitro,  thrombin appears to have a bi-phasic effect on cell death, providing protection 
for neurons and glia against metabolic insults at lower concentrations but promoting 
apoptosis at higher concentrations (Vaughan et al.  1995; Smith-Swintosky et al.  1995; 
Pike et al.  1996). Pre-treatment with low doses of thrombin even seems to protect cells 
against subsequent larger doses of thrombin, via a receptor-mediated mechanism (Jiang
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et al.  2002).  Similarly  in  vivo,  the  effects  of thrombin  on  cell  death  in  models  of 
ischemia are dose-dependent and low doses of thrombin have been shown to produce a 
‘pre-conditioning’  protective  effect  against  subsequent  injury  or  larger  doses  of 
thrombin  (Xi  et al  1999;  Striggow et al.  2000;  Masada et al.  2000).  Inhibition of 
thrombin by PN-1 protects sciatic neurones from cell death after axotomy (Houenou et 
al.  1995).  Injection  of thrombin  into  the  brain  has  been  demonstrated  to  result  in 
oedema,  cell  death  and  inflammation,  although  it  is  debatable  whether  the  large 
quantities of thrombin injected were comparable with likely amounts of thrombin which 
would enter the brain during an injury (Nishino et al.  1993; Lee et al.  1997; Xue and 
Del Bigio 2001).
Some effects of thrombin on neuronal cells may be a direct result of proteolytic action 
of this enzyme on cell components. Thrombin can also cause apoptosis directly via its 
interaction with the PAR-1 receptor and downstream caspase-dependent mechanisms, as 
demonstrated  in  cultures  of  hippocampal  neurons  and  embryonic  chick  spinal 
motomeurons  (Donovan  et al.  1997;  Turgeon  et al.  1998;  Turgeon  et al.  1999; 
Smirnova et al.  1998). Similarly, many of the neuroprotective effects of thrombin have 
been demonstrated to involve PAR-1 signalling (Pike et al.  1996). Interestingly both the 
neuroprotective  and  apoptosis-promoting  effects  of thrombin  appear to  involve  the 
activation of Rho GTPase (Donovan et al.  1997; Donovan and Cunningham 1998). The 
mechanisms underlying the ‘pre-conditioning’ effect of low dose thrombin treatment are 
not well understood, although activation of thrombin receptors has been reported to be 
important, as has up-regulation of thrombin inhibitors such as PAI-1  and heat shock 
proteins (Jiang et al.  2002; Xi et al.  2003a; Xi et al.  2003b).  Thrombin may promote 
cell survival through its effects on the synthesis and secretion of survival related factors 
such as endothelin-1 and NGF (Neveu et al.  1993; Ehrenreich et al.  1993).
In addition to its direct effects in apoptotic pathways, thrombin may also act as a pro- 
inflammatory factor in the CNS and may contribute to the formation of the glial scar, 
primarily through effects on the activation of microglia and astrocytes (Cavanaugh et al. 
1990; Pindon et al.  2000; Suo et al.  2003; Suo et al.  2002). However, one recent paper 
has suggested that the reported effects of thrombin on microglial cytokine secretion are 
not mediated via thrombin activity but by the action of an associated higher molecular 
weight protein in the preparations used (Hanisch et al.  2004).  As outlined in an earlier
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section, the effects of inflammation after CNS injury may have both a beneficial and a 
harmful component.
One way in which thrombin might benefit regeneration is demonstrated by its actions 
after  peripheral  nervous  system  injury.  Both  prothrombin  and  pN-1  have  been 
demonstrated to be up-regulated by Schwann cells after injury (Smirnova et al.  1996). It 
is  believed  that  the  balance  between these  two  factors  may  help  to  control  neurite 
outgrowth to ensure correct axonal targeting and synapse formation by the regenerating 
neurons.
Overall, the complexity of the effects of thrombin on CNS cells suggests a number of 
different,  possibly  interacting  roles  after  injury.  Physiological  concentrations  of 
thrombin in the CNS remain to be determined and it is therefore not established whether 
the effects of thrombin after injury are likely to be primarily beneficial or harmful. It 
should be noted that the concentrations of thrombin required to produce cell death may 
be  significantly  reduced  in  cells  which  are  undergoing  metabolic  stress  (Xi  et al. 
2003a). Therefore, from these previous findings it is certainly possible that increased 
concentration of CNS thrombin might contribute to increased cell death after injury.  .
Thrombin and regenerative capacity
In light of the complex roles of thrombin which have been suggested by previous in 
vitro and in vivo studies it would be of interest therefore to establish whether changes in 
thrombin expression or activity might contribute to differences in regenerative capacity 
in different systems or species. Although increased expression of components of the 
thrombin  signalling  pathway  are  a  feature  of non-regenerative  spinal  cord  injury 
models, very few such studies have been carried out in regenerative systems.
The  correlation between increased apoptotic  response  in the  non-regenerating chick 
spinal cord and increased haemorrhage provides the framework for the hypothesis that 
increased thrombin activity in the post-El3 chick might be responsible for the lack of 
regeneration. In support of this suggestion, a study was conducted in which thrombin 
activity was compared between two regenerating systems, the fish optic nerve and the 
rat sciatic nerve, and a non-regenerating system, the rat optic nerve. This study showed 
that a large (40-fold) increase in thrombin activity in the rat optic nerve at one day after
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injury was not matched by the smaller increase observed in either of the regenerative 
systems  (Friedmann  et  al.  1999).  The  authors  suggest that  the  smaller  increase  in 
thrombin activity  in the  sciatic  nerve or in the  fish  optic  nerve,  in which thrombin 
activity was up-regulated later and for a longer duration, might actually be beneficial for 
regeneration while the larger increase results in toxicity, although this proposal was not 
tested.
Although much of what is known about thrombin suggests potentially deleterious roles 
in the injured nervous system,  some other studies carried out in regenerative species 
suggest  that  thrombin  might  also  have  a  directly  positive  effect  in  promoting 
regeneration. Thrombin has been highlighted as a key influence in the regeneration of 
both the newt limb and lens. Thrombin has been shown to regulate the cell-cycle re­
entry  which  occurs  in  cultured  newt  myotubes  following  stimulation  with  serum, 
mimicking a key process which takes place during  limb regeneration (Tanaka et al.
1999).  Furthermore,  in  vivo  studies  of lens and  limb  regeneration in the newt have 
demonstrated an increase in thrombin activity specifically in regions corresponding to 
the  location  of  cells  which  contribute  to  regeneration  via  dedifferentiation  and 
proliferation (Imokawa and Brockes 2003). Lens regeneration was inhibited by injection 
of thrombin inhibitors. This thrombin activity was not observed in cell types that do not 
contribute  to  the  regenerating  lens  or  in  non-regenerative  species  such  anuran 
amphibians.  The effects of thrombin on newt myotubes are not mediated via direct 
activation  of PAR-1  but  seem  to  involve  cleavage  of a  serum  protein,  which  has 
recently been partially characterised and demonstrated to be a glycoprotein (Straube et 
al.  2004). The authors of these papers suggest that the specific effects of thrombin in 
these regenerating  systems may be  due to the presence of a membrane tissue factor 
found on newt myotubes or dorsal iris cells which activates thrombin (Imokawa and 
Brockes 2003; Maden 2003).
1.7.  Cell replacement after spinal cord injury
1.7.1.  The contribution of cell replacement to regenerative capacity
One factor, which remains constant in all systems and species, is that, regardless of the 
success of neuroprotective or axonal regeneration strategies, there will inevitably be a
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degree of cell loss after spinal cord injury. For this reason, the ability to replace lost and 
damaged  cells  by  recapitulating  the  developmental  process  of neurogenesis  could 
represent a key factor in determining regenerative success. A number of studies have 
investigated whether populations of progenitor cells exist in the spinal cord of different 
species  and  the  response  of  these  populations  to  injury.  These  studies  have 
demonstrated an apparent correlation between the capacity for endogenous progenitor 
cells to generate new neurons and the regenerative capacity of the spinal cord.
In lower vertebrates,  such as the  urodele amphibians,  cellular replacement is  a key 
element of the regenerative response.  Spinal cord regeneration is associated with the 
proliferation of progenitor cells in the ependyma, and their subsequent differentiation 
into neurons and glia (Benraiss et al.  1999). This is particularly evident in the case of 
urodele tail amputation, in which the entire missing section of spinal cord is completely 
rebuilt, but also plays an important role after transection injury. One major issue which 
remains  unresolved  is  the  relative  contribution  of such  undifferentiated  progenitor 
populations versus the dedifferentiation or transdifferentiation of already differentiated 
cell types.  This has been addressed in cell-lineage tracing experiments with varying 
results (Echeverri and Tanaka 2002; Gargioli and Slack 2004). Both transdifferentiation 
and dedifferentiation have been demonstrated to occur during the regeneration of organs 
including the limb and the eye (Brockes  1998). However, in a number of regenerative 
systems it has not yet been fully established whether these mechanisms predominate 
over stem cell recruitment and it is likely that each individual  situation may rely on 
different processes for regeneration (Ferretti 2004).  One  unique feature of the  lower 
vertebrate spinal cord that differs from that of less regenerative species is the persistent 
presence in the adult spinal cord of a type of ependymal cell that has a radial glia like 
morphology and long processes which extend to the pial surface (Holder et al.  1990). 
These  ependymal  cells  express  the  astrocytic  marker  GFAP  together  with  other 
intermediate filaments such as nestin and vimentin and up-regulate expression of these 
molecules after injury (O'Hara et al.  1992; Walder et al.  2003). These cells are thought 
to play a major role in regeneration by proliferating and differentiating into neurons 
(Nordlander and Singer 1978; Benraiss et al.  1999).
Very  little  is known about the relative contribution of cell replacement strategies to 
repair in higher regeneration-competent species such as the opossum or chick.  Most
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studies in these species have focused exclusively on axonal regeneration. It would be of 
particular interest to determine whether axon re-growth alone is sufficient to provide 
these  systems  with  regenerative  ability  or  whether  there  is  also  a  role  for  cell 
replacement,  as  this may  have  implications  for the treatment of human  spinal  cord 
injury. In the developing opossum, a proliferative response to injury has been observed. 
However subsequent generation of neurons has not been demonstrated (Terman et al.
2000). In the chick spinal cord no studies so far have investigated this issue. As these 
models represent a midpoint between the highly regenerative lower vertebrates and the 
non-regenerative adult mammal it is of particular interest to determine the importance of 
cell replacement for regeneration in these species.
For many years it was commonly believed that adult mammalian CNS neurons were 
post-mitotic  and  that,  once  lost due  to  injury  or disease,  there  was  no  endogenous 
population of cells available for replacement. More recently, this has been challenged 
by a number of in vitro studies which have demonstrated that neuronal precursors, both 
stem  cells  and  more  restricted  progenitors,  exist  in  multiple  regions  of the  adult 
mammalian CNS  including the  spinal  cord (Gage 2000;  Reynolds and Weiss  1992; 
Weiss et al.  1996; Morshead et al.  1994; Nunes et al. 2003). Furthermore, neurogenesis 
has been demonstrated to be an ongoing process in at least two regions of the brain. 
Neural  progenitors  arising  in the  subventricular  zone  close  to  the  lateral  ventricle 
migrate  to  the  olfactory  bulb  via the  rostral  medullary  stream  (RMS)  and undergo 
neuronal differentiation in a continuous process (Lois and Alvarez-Buylla 1993; Luskin 
1993).  Secondly, the subgranular zone in the hippocampus contains neural stem cells 
which give rise to neurons that migrate to the granular layer of the dentate gyrus (van 
Praag et al. 2002).
In the adult mammalian spinal cord, neural stem cells have been suggested to be present 
in  the  ependymal  region  surrounding  the  central  canal  and  in  the  parenchyma 
(Johansson et al.  1999; Horner et al.  2000; Yamamoto et al.  2001). However, although 
these  cells  have  been  reported  to  proliferate  in response  to  injury,  and  up-regulate 
markers such as nestin, neurogenesis has not been observed and in most cases only glial 
cell types are generated (Frisen et al.  1995; Johansson et al.  1999; Namiki and Tator 
1999; Homer et al.  2000; Yamamoto et al.  2001; Shibuya et al.  2002; Takahashi et al.
2003).
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This comparison of different species illustrates that a fundamental difference between 
the adult mammalian nervous system and that of regenerative lower vertebrate species is 
that endogenous progenitor cells are not recruited in response to injury to generate new 
neurons.  The  reasons  for  this  difference  are  unknown  but  may  include  intrinsic 
differences  in the  size or properties  of progenitor populations,  or differences  in the 
environmental cues that might be responsible for recruitment. It is also clear that, with 
the exception of clear-cut examples such as urodele spinal cord amputation, the actual 
contribution  of such  newly  generated  neurons  to  spinal  cord  repair  has  not  been 
examined  fully  in  all  regenerative  species.  One  interesting  proposition,  outlined by 
Holder and Clarke, 1988, is that, in systems in which endogenous neurogenesis persists 
into adulthood it may be the case that the molecular cues necessary for axonal growth 
and cellular migration are retained, allowing axonal regeneration to take place. Whether 
this has a greater impact than cell replacement is unknown; however in regeneration 
following  tail  amputation  it  is  apparent  that  proliferation  must  make  a  major 
contribution to repair. The importance of the endogenous progenitor cell response for 
regenerative  capacity  therefore  remains  to  be  determined.  This  issue  is  of great 
importance  when  considering  whether therapeutic  strategies  aimed  at restoring this 
function  are  likely  to  bring  functional  benefit.  These  questions  may  ultimately  be 
answered  by  future  studies in which  such processes  may  be  stimulated in the adult 
mammalian spinal cord; however, it my be possible to gauge the likely outcome of such 
treatment by establishing whether endogenous progenitor cell recruitment does indeed 
correspond to regenerative capacity in species such as the chick.
1.7.2.  Strategies for identifying progenitors and measuring neurogenesis
As  described  above,  a  number  of  studies  have  attempted  to  assess  the  relative 
contribution of progenitor cells and neurogenesis to regenerative capacity. However this 
type of study is complicated by difficulties associated with the identification of neural 
stem cells and in measuring neurogenesis.
Several different types of neural progenitor cells are present in the embryonic CNS. 
These can be defined in terms of their developmental potential and include true neural 
stem cells which can both self renew by dividing to produce at least one new stem cell 
and differentiate into every cell type present in the CNS (McKay 1997). More restricted
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progenitor  cell  populations  also  exist.  With  the  growing  realisation  that  neural 
progenitor cell populations are also active in the adult CNS there has been increasing 
interest in the  study of these cells and their response to  injury.  Protocols have been 
developed to allow these cells to be studied extensively in vitro, where it is possible to 
examine factors such as the potential of a cell to self-renew and the types of cells it 
generates. However, in vivo investigations into the role of endogenous progenitor cells 
in the  central  nervous  system are hampered by the  lack of suitable markers  for the 
various stages of progenitor cell development.
Dividing cells can be identified in vivo by a number of different strategies (Ming and 
Song 2005). These include methods for labelling cells undergoing DNA synthesis by 
incorporation  of labelled  nucleotides  such  as  3[H]-thymidine  or  BrdU,  a  synthetic 
thymidine analogue.  3[H]-thymidine is detected by autoradiography, whereas BrdU can 
be detected using a specific monoclonal antibody (Gratzner 1982; Sidman et al.  1959). 
Both labels are retained and passed down to subsequent generations during rounds of 
cell  division,  allowing the  fate  of dividing  cells to  be traced,  although the  label  is 
gradually diluted with each division. It is important to note that incorporation of BrdU 
or 3  [H]-thymidine is an indication of DNA synthesis rather than cell division, and there 
is therefore a theoretical possibility that mechanisms such as DNA repair, or abortive 
cell  cycle  re-entry  might  make  little  contribution to  the  overall  labelling  which  is 
observed using these techniques (Ming and Song 2005; Kuan et al.  2004; Selden et al.
1993). Alternative methods include labelling dividing cells using retroviruses, which, 
when incorporated into the host genome, express detectable proteins such as Lac Z or 
green fluorescent protein (GFP).  In order to determine whether the labelled dividing 
cells go on to  adopt a neuronal fate it is necessary to couple this labelling with cell 
specific markers. Using BrdU this is achievable by double immunostaining techniques. 
However, these methods have a number of caveats and restrictions; these include the 
fact that they cannot generally be used to study neurogenesis in the human in vivo, due 
to  the  requirement to  administer BrdU,  which  is  potentially  carcinogenic,  to  living 
humans, although in rare circumstances this has been carried out (Eriksson et al, 1998). 
For human studies the only real option to identify newly bom neurons is to examine 
tissue  post-mortem  for  proteins  which  are  expressed  during  various  stages  of 
neurogenesis. To this end, a number of different markers have been proposed. However
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to  date  there  is  no  available  unequivocal  marker that  labels  dividing  cells  that  are 
destined to become neurons.
The intermediate filament (IF) protein family has provided a number of useful markers 
that are commonly used to label different cell types in the CNS. As shown in Fig.  1.12, 
several different IF proteins including vimentin, nestin, peripherin, neurofilaments and 
GFAP are sequentially expressed as a cell progresses from a stem cell to a differentiated 
neuron or glial cell  (Lendahl et al.  1990).  One of the most widely used markers for 
neural stem cells is nestin, yet this protein is also expressed by a number of other cell 
types including reactive astrocytes and radial glia (Lendahl et al.  1990; Dahlstrand et al. 
1995). In the chick, a nestin-like protein, transitin, has been identified which is thought 
to be similarly expressed in progenitor cells and radial glia (McCabe and Cole  1992; 
McCabe et al.  1992; Cole and Lee  1997; Lee and Cole 2000). Thus, so far, no single 
protein has been identified which is uniquely expressed by a neural stem cell, which 
means that unequivocal identification of these cells is impossible and most studies rely 
on a combination of imperfect markers.
The  identity of neural  stem cells has been complicated further by recent revelations 
about the  role  of radial  glial cells and astrocytes  in neurogenesis.  Radial  glial  cells 
develop from the neuroepithelium during embryogenesis and are present in the CNS 
transiently during periods of neurogenesis, where they have been suggested to have a 
role in the guidance of migrating neurons (Flatten  1999). They were classified as glial 
cell types due to the expression of molecules typically found in astrocytes such as glial 
fibrillary acid protein (GFAP) or an astrocytic glutamate transporter (GLAST) and it 
was  believed  previously  that,  after  the  completion  of  neurogenesis,  these  cells 
differentiated  solely  into  astrocytes  (Levitt  and  Rakic  1980;  Hartfuss  et al.  2001). 
However, recent in vitro studies have demonstrated that radial glia can generate neurons 
and may be a major source of neuronal progenitors in the embryo (Malatesta et al. 2000; 
Noctor  et  al.  2002).  Furthermore,  studies  suggest  that  radial  glial  cells  are  a 
heterogeneous  population  of cells  within  which  specific  sub-populations  may  be 
destined to differentiate into different cell types (Hartfuss et al.  2001; Kriegstein and 
Gotz 2003).  Recent  studies  have  suggested that  GFAP-positive  cells present in the 
embryonic and early postnatal subventricular zone and the dentate gyrus can also act as
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neuronal precursors although the identity of these cells is unclear (Doetsch et al.  1999; 
Seri et al. 2001).
Once a progenitor cell becomes committed to a neuronal fate, a number of different 
neuron-specific proteins are expressed and are commonly used to identify neurons by 
immunohistochemistry. These include (33-tubulin, poly-sialylated-neural cell adhesion 
molecule (PSA-NCAM), collaspin response-mediated protein 4 (CRMP) and HuC/D, 
which are expressed in relatively immature neurons, and NeuN, which is expressed at a 
slightly  later stage after cell cycle exit (Fig  1.12).  However,  many  of these proteins 
continue to be expressed throughout the life of a neuron and are therefore unsuitable for 
studies of neurogenesis, except in conjunction with a mitotic marker such as BrdU. The 
ideal marker of a newly born neuron would need to be only transiently expressed in 
order to identify a newly bom neuron. A protein that has been reported to have these 
properties, at least in the adult CNS, is the microtubule associated protein doublecortin.
1.7.3.  Doublecortin
In  the  quest  for  a  unique  marker  of neurogenesis,  doublecortin  appears  to  be  a 
promising candidate. Several studies have demonstrated that, in neurogenic regions of 
the  adult  brain,  doublecortin  is  expressed  early  and  transiently  during  neuronal 
development, with expression levels which correlate well with neurogenesis assessed by 
other methods (Brown et al.  2003; Couillard-Despres et al.  2005; Gleeson et al.  1999; 
Hannan et al.  1999; Nacher et al. 2001; Rao M.S. and Shetty A.K. 2004). Doublecortin 
is  a  microtubule  associated  protein  which  has  come  to  attention  mainly  due  to  its 
essential role in cortical development (Bai et al.  2003). Mutations in doublecortin are 
associated with x-linked lissencephaly, a condition in which correct lamination of the 
cortex fails to occur, presumably due to abnormal neuronal migration (Francis et al. 
1999; Gleeson et al.  1999; Sossey-Alaoui et al.  1998; Gleeson et al.  1998; des Portes et 
al.  1998). In addition to its potential as a specific neurogenic marker, doublecortin itself 
has been demonstrated to have a number of properties that suggest that this protein 
might actually have an interesting role in spinal cord regeneration. It is apparent that a 
number of the responses of spinal cord cells to injury involve substantial rearrangements 
of the cytoskeleton. Doublecortin has been demonstrated to have a role in regulating the
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Fig  1.12  Sequential  expression  of  markers  during  nervous  system  development.
Figure  illustrates  the  principal  pathways  of  development  of  neurons,  astrocytes  and 
oligodendrocytes from neuroepithelial cells. Some of the many specific antigenic markers 
present  at  each  stage  are  indicated.  Illustrations  adapted  from 
http://wwwO.gsf.de/idg/groups/adult  neurogenesis/start.html.
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stability  of  microtubules,  a  function  which  could  be  of  importance  for  cell 
differentiation,  migration,  synaptic  plasticity  and  even  cell  death (Bai  et al.  2003; 
Gleeson et al.  1999; Horesh et al.  1999; Nacher et al.  2001; Shmueli et al.  2001). The 
binding  of doublecortin  to,  and  hence  the  stabilisation  of,  microtubules  is  strictly 
regulated by the phosphorylation of doublecortin which can be governed by a number of 
different kinases including Cdk5, JNK, protein kinase A (PKA) and MAP/microtubule 
affinity associated kinases (MARK) (Tanaka et al.  2004; Gdalyahu et al.  2004; Schaar 
et al. 2004). From what is already known about the properties of doublecortin it is likely 
that further investigation of its role in the injured  spinal  cord may not only provide 
information about neurogenesis but also may suggest a potentially important role for 
this protein.
1.7.4.  Therapeutic strategies for cellular replacement after spinal cord injury
In the adult mammal it is apparent that under normal circumstances endogenous cell 
replacement either does not take place or is insufficient to result in significant functional 
improvement.  Studies  investigating the therapeutic potential  of cellular replacement 
strategies  have  therefore  taken  two  different  approaches;  either  replacing  lost  and 
damaged cells directly by transplantation of exogenously derived cells or attempting to 
enhance the response of endogenous populations of progenitor cells.
Studies  involving  exogenous  cell  replacement  strategies  are  probably  the  more 
advanced strategy and in a number of cases have demonstrated that cellular replacement 
can lead to increased regeneration. Transplanted cells may restore function to areas of 
the spinal cord from which cells have been lost and may also support the regeneration of 
axons  by  providing  structural  and  neurotrophic  support  (Enomoto  et  al.  2003).  A 
number of studies have involved transplantation of various types of neuronal precursor 
cell into the rodent spinal cord and have monitored the subsequent differentiation of 
these cells using labelling with markers such as GFP or BrdU (Reier et al.  1992; Cao et 
al. 2001; Enomoto et al. 2003; Mothe et al. 2005; Blits et al. 2005). These studies have 
so far demonstrated little evidence of neuronal differentiation within the spinal cord. 
One  of  the  most  important  factors  to  consider  when  contemplating  stem  cell 
transplantation is the source of the cells. A number of studies have indicated that region 
specific stem cells exist, while other studies have suggested that the environment of the
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transplant  is  sufficient  to  re-direct  cells  from  an  alternative  region  towards  the 
appropriate fate (Shihabuddin et al. 2000).
In addition to the transplantation of neural stem or progenitor cells, a number of studies 
have  suggested  that  transplantation  of alternative  cell  types,  including  fibroblasts, 
olfactory ensheathing cells and Schwann cells, may enhance regeneration, mainly by 
improving the permissiveness of the spinal cord environment for regenerating axons 
(Bunge  1994; Li et al.  1998; Xu et al.  1999; Liu et al. 2000; Ramon-Cueto et al. 2000; 
Raisman 2001). Cells may be transplanted by direct injection into the injury site or by 
seeding the cells onto a bio-engineered scaffold,  which may be designed to provide 
structural  support  and to  provide,  via  slow-release  mechanisms,  factors  which will 
enhance cell survival, proliferation or differentiation (Geller and Fawcett 2002). These 
scaffolds may also be of great benefit in providing a mechanism for bridging regions of 
the spinal cord that are difficult for axons to cross, either due to the presence of a large 
cavity or the formation of a glial scar. As technological advances continue to improve 
these scaffolds they are likely to become a key part of transplantation strategies.
At present,  transplantation  appears  to  be  one  of the  most  advanced  and  promising 
therapeutic avenues under investigation and clinical trials of some of these transplants 
have been initiated (Tsai and Tator 2005). However, there are a number of caveats to 
this approach that do need to be considered. An exogenous source of cells raises ethical 
issues  to  regarding  the  use  of embryonic  stem  cells  and  may  also  have  practical 
difficulties associated with immune rejection of transplants.  Finally, due to a lack of 
long-term studies it has not been established fully that cells transplanted in this way will 
not result in the formation of tumours.
As an alternative approach, therapeutic strategies might be developed to enhance the 
endogenous  capability  for  repair,  which  would  alleviate  many  of the  ethical  and 
practical complications of using exogenous sources of cells for replacement, although 
safety issues may remain.  Despite these advantages and in contrast to the number of 
studies  involving  transplantation  of  exogenously-derived  cells,  there  have  been 
relatively few studies investigating the therapeutic potential of stimulating endogenous 
precursors. As outlined above, although proliferation and migration of precursor cells 
has been demonstrated in the mammalian spinal cord in response to injury, this does not
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result in neurogenesis (Mothe and Tator 2005; Namiki and Tator 1999; Yamamoto et al.
2001). An understanding of the factors, lacking in the adult mammal, responsible for 
‘switching on’ neurogenesis is essential if endogenous progenitor cell stimulation is to 
be achieved.  It is known that neurogenesis in the hippocampus can be affected by a 
number of different stimuli, including stress, physical activity and certain growth factors 
(Gould et al.  1997; Jin et al.  2002; Kempermann et al.  1997).  Similarly, a number of 
different neurotrophic and growth factors including EGF, FGF, NGF and VEGF have 
been demonstrated to influence proliferation and differentiation of neural stem cells in 
vitro (Reynolds and Weiss  1992; Cattaneo and McKay 1990; Ray et al.  1993; Jin et al.
2002).  This has  prompted  a limited  selection of studies to  attempt treatment  of the 
spinal cord with neurotrophic factors. Administration of EGF and FGF2 has been shown 
to increase the proliferation and migration of spinal cord ependymal cells (Kojima and 
Tator 2002; Martens et al. 2002). It is also notable that FGF2 upregulation is associated 
with the urodele spinal cord regeneration, although its role in this process is not fully 
understood (Zhang et al. 2000). Expression of Notch-1  may also be important since this 
molecule  is associated with tail regeneration in Xenopus  larvae  (Beck et al.  2003). 
Supposing that the correct signals to stimulate proliferation are identified, it may also be 
necessary to recapitulate some of the  signalling associated with embryonic neuronal 
development  to  stimulate  differentiation  and  correctly  pattern  newly  born  cells. 
Unfortunately, the factors which might be responsible for these processes are even less 
well understood.
To  a large  extent,  the potential  for stimulation of endogenous progenitors has been 
under-exploited due to our limited understanding about the factors necessary to achieve 
such  stimulation.  These  strategies  would  therefore  benefit  greatly  from  a  better 
understanding  of the  mechanisms  underlying  stimulation of endogenous progenitor 
populations  in  regenerative  species.  To  date,  the  contribution  of proliferation  and 
neurogenesis  to  the  regenerative  capacity  of the  chick  spinal  cord  has  not  been 
examined.  Establishing the  extent to  which these  processes  are  important in  higher 
regenerative species such as the chick might be the key to determining whether such 
stimulation is likely to be effective in the adult mammal.
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1.8.  Objectives of this study
From this overview of the literature it is apparent that an enormous variation in spinal 
cord  regenerative  capacity  exists  between  different  species  and that a multitude  of 
different factors might contribute to this variability. It is also clear that many of these 
factors  are  likely  to  be  interrelated  and  that  a  full  understanding  of their  relative 
contributions to the determination of regenerative capacity would be of benefit when 
trying to identify factors which can be translated to the therapeutic treatment of the non- 
regenerative spinal cord. In this thesis the embryonic chick spinal cord will be used as a 
model to investigate the potential contribution of some of these factors. The chick spinal 
cord has a number of advantages over other available models of spinal cord injury and 
regeneration.  The window of time during which regenerative  capacity  is lost in this 
model is well defined and relatively rapid, allowing this model to be used to examine 
both  regeneration  competent  and  incompetent  states.  The  similarities  between  the 
pathological  features observed in the post-El5  chick and those in adult mammalian 
species are striking, and suggest that findings in this model are likely to be of greater 
relevance to the human spinal cord than those in lower vertebrates. Finally, access to the 
chick embryo while in ovo improves ease of experimental manipulations in comparison 
to mammalian embryonic models such as the opossum.
Research using this model has in the past largely concentrated on factors affecting the 
permissiveness of the spinal cord environment for axonal re-growth. While this issue is 
of key importance, it is evident that a number of other factors may make an equal and 
complementary contribution to regenerative capacity in this model. In particular early 
responses to injury, including those which lead to cell death and those which promote 
cell proliferation and replacement may affect the number of viable cells which remain in 
the  spinal  cord  after  injury.  Fig  1.13  summarises  current  knowledge  about  the 
differences in the early response of the chick spinal cord to injury at regenerating and 
non-regenerating  stages  and  illustrates  some  of the  questions  that  remain  to  be 
answered.
Changes  in  cell  death  and  survival  responses  to  injury  have  been  demonstrated  to 
correlate with the loss of regenerative capacity in the chick spinal cord (O’Neill, 2002, 
PhD thesis). In this thesis these findings will be investigated further, with a particular
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concentration on the potential role of haemorrhage and factors brought into the spinal 
cord by blood. The potential for endogenous or exogenous serine proteases, particularly 
thrombin, to contribute to the apoptotic response after injury will be investigated.
Endogenous cell replacement strategies are currently the subject of a number of studies 
in the adult mammal. In order to understand whether such strategies are likely to be of 
benefit, it is of interest to determine the contribution of such mechanisms to recovery in 
regeneration  competent  systems.  In  this  thesis  the  extent  to  which  neurogenesis 
contributes to the success of regeneration in the El 1  spinal cord will be examined.
80Key:
*  /   -Factors suggested to be important 
by previous studies 
Cnj  - Factors whose significance has 
□  not been tested
Q)
Proliferation  g 
Neurogenesis El 1  spinal cord ■>  regeneration
Neuroprotection ion 9
Developmental increase 
in vascularisation El 1- 
E15
$
haemorrhage  □
Apoptotic stimuli
thrombin
apoptosis
El 5 spinal cord
No
regeneration
Fig.  1.13 Summary of current understanding about the early  response 
to  injury  in  the  chick  spinal  cord.  Figure  illustrates  a  number  factors 
which might contribute to the loss of regenerative capacity between El 1  and 
El5, which will be investigated in this thesis.
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1.6.2. Neuroprotective strategies after spinal cord injury
Neuroprotective  strategies  could  take  the  approach  of  directly  inhibiting  cell  death 
pathways.  The delayed nature  of the  apoptotic response to  injury  provides  scope for 
inhibition of caspase activity or of protein synthesis, strategies which have had varying 
effectiveness  in experimental  models  of spinal cord injury  (Liu et al.  1997;  Li et al. 
2000;  McBride  et al.  2003;  Ozawa  et al.  2002;  Nottingham  et  al.  2002).  However, 
caspase activation represents a relatively late stage event in the apoptotic process and it 
would be preferential to act further upstream to prevent the initiation of such pathways. 
Much of the cell death, both apoptotic and necrotic, occurring after spinal cord injury is 
a result of secondary injury processes that vastly expand the extent of tissue damage 
over a period of seconds to days after the injury (Dumont et al. 2001). One of the most 
effective ways in which cell survival might be improved in the aftermath of spinal cord 
injury would therefore be to reduce these secondary injury events. Fortunately, many of 
these processes occur within a timeframe that might allow for therapeutic intervention 
to slow or halt their progress. Table 1.2 summarises the outcomes of various strategies 
that  have  been  followed  to  target  secondary  injury-induced  cell  death.  Although 
neuroprotective strategies have demonstrated success in in vivo models, little progress 
has  been  made  in  transferring  these  ideas  to  the  clinic,  with  the  exception  of  the 
controversial  steroid methylprednisolone.  In  part,  this  may  be  a result of differences 
between a controlled situation in animal studies and the highly complex and variable 
human injury, together with inter-species differences in the control of functions such as 
locomotor activity.  Over recent years, much attention has switched towards  strategies 
aimed at achieving axonal regeneration. However, neuroprotective strategies still have 
much to offer, not least with the potential to significantly reduce the degree of axonal 
damage requiring repair.
1.6.3. Relationship between haemorrhage and apoptosis
There is evidence to suggest that one of the earliest pathophysiological events to occur 
after spinal cord injury, haemorrhage,  makes an important contribution to  subsequent 
tissue  damage  and  cell  death.  This  hypothesis  is  supported  by  the  observation  that 
regions  of haemorrhage found early  after injury  correspond to the  later formation  of 
large cavities.
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2.1. General Reagents
All general laboratory reagents were obtained from Sigma-Aldrich (Poole, UK) unless 
otherwise stated.
2.2. Preparation of Solutions
2.2.1.  General Solutions 
EDTA
186.1 g of disodiumethylenediametetracetate.2 H2O was dissolved in 800ml of distilled 
H2O  (dfhO). The pH was adjusted to 8.0 by adding sodium hydroxide pellets until the 
powder dissolved. The pH was then adjusted to 7.4 with concentrated HC1 if required, 
before making the volume up to 11 with dH20. The solution was autoclaved before use.
Phosphate Buffered Saline (PBS)
1   PBS  tablet  (Oxoid,  Basingstoke,  UK)  was  dissolved  in  100ml  of dH20  to  give  a 
solution containing 0.16M NaCl, 0.003M KC1, 0.008M Na2HP04 and 0.001M KH2P04. 
Where required, the solution was autoclaved before use.
Tris (1M)
121.lg of Trizma base was dissolved in 800ml dH20. The pH was adjusted as required 
by adding concentrated HC1. After cooling to room temperature final adjustments to the 
pH  were  made.  The  volume  was  made  up  to  11  with  dH20  and  the  solution  was 
autoclaved before use.
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2.2.2. Solutions for histology 
Paraformaldehyde (PFA)
4% PFA was prepared by dissolving 16g of PFA in 400ml PBS and heating at 70°C in a 
water bath until dissolved. After cooling, aliquots were stored at -20°C until required.
Cryoprotectant solution
A  cryoprotectant  solution  for  the  preservation  of frozen  floating  cryosections  was 
prepared  by  mixing  150ml  ethylene  glycol,  100ml  glycerol  and  250ml  PBS.  The 
mixture was stored at +4°C until required.
Acid Alcohol
An acid alcohol solution was prepared by mixing 70ml EtOH,  1ml concentrated HC1 
and 29ml dFEO.
2.2.3. Solutions for immunohistochemistry 
Citric Acid buffer
2.1g of citric acid monohydrate was dissolved in 800ml dFbO. The pH of the solution 
was adjusted to 6.0 by adding sodium hydroxide pellets. The solution was made up to 11 
with dH20. The solution was prepared fresh for each use.
Sodium Borate (0.1M)
19g sodium borate was dissolved in 500ml dH20. The pH of the solution was adjusted 
to 8.5 by adding concentrated HC1. The solution was stored at room temperature
2.2.4. Solutions for TUNEL 
Proteinase K permeabilisation solution
A permeabilisation solution was prepared by combining 915pl dH20, 50pl Tris (1M), 
25pl EDTA (200mM) and lOpl proteinase K (lmg/ml). The solution was prepared fresh 
each time it was used and was pre-heated for 30 minutes at 37°C before use.
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2.2.5.  Solutions for RT-PCR
For all procedures involving  RNA manipulation reagents were prepared with water 
treated with 1ml diethylpyrocarbonate (DEPC) per litre overnight at 37°C followed by 
autoclaving to inactivate the DEPC.
lOx MOPS buffer
41.85g of MOPS, 6.8lg sodium acetate trihydrate and 3.76g EDTA were dissolved in 
DEPC-treated dF^O to give a total volume of 11. The buffer was stored in the dark at 
room temperature.
RNA denaturing buffer
An RNA denaturing buffer was prepared by combining 24mg orange G, 300pl glycerol, 
450pl 10x MOPS buffer, 720pl formaldehyde and 2.25ml formamide. The solution was 
aliquoted and stored at -20 °C
5 x Tris Borate-EDTA (TBE) buffer
54g Trizma base, 27.5g boric acid and  10ml 0.5M EDTA (pH 8.0) were dissolved in 
dH20 to give a total volume of 11. The solution was diluted  lOx before use to give a 
0.5x working solution.
TE Buffer
TE Buffer contained lOmM Tris and ImM EDTA. The solution was adjusted to pH 8.0 
by adding concentrated HC1.
2x PCR buffer for semi-quantitative PCR
A 2x PCR buffer was prepared, containing the reagents listed in Table 2.1. Aliquots 
were stored at -20°C.
Orange G loading buffer
A 5x DNA loading buffer was prepared by combining  lOg sucrose, 50mg orange G, 
5mg sodium azide and 20ml DEPC-treated dHiO.
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Table 2.1. 2x PCR buffer preparation
Reagent Supplier Stock
concentration
Final concentration 
in PCR reaction
Volume (in 
|xl) for 1ml
PCR Buffer Invitrogen lOx lx 200
MgCl2 Invitrogen 50mM 2.5mM 100
dNTPs Amersham lOmM each 0.2mM each 40
W-l Invitrogen 1% 0.05% 100
Distilled H20 - - - 560
2.2.6.  Solutions for Western blotting
10% Sodium dodecyl sulphate (SDS)
5g of SDS was dissolved in dH20  to give a total volume of 50ml.
Protein extraction buffer
Protein extraction buffer was prepared by combining the following reagents:
3M NaCl  5 ml
NonidetP-40  1ml
10% SDS  1ml
1M Tris pH 8.0  5ml
Distilled H2O  88ml
The buffer was stored at +4°C. Immediately prior to use, proteinase inhibitor cocktail 
was added from a 25x stock solution.
Protein Loading buffer
A 2x loading buffer was prepared from the following reagents: 
1M Tris pH 6.8  0.5ml
Glycerol  1ml
2-mercaptoethanol  0.05ml
10% SDS  0.5ml
H20   2.9ml
Bromophenol blue  a few crystals
The buffer was stored at 4°C until used.
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lOx Running buffer
30g Trizma base,  144g glycine and  lOg SDS were dissolved in dH20 to give a final 
volume of 11.
Transfer buffer
Transfer  buffer  was  prepared  by  combining  100ml  lOx  Running  Buffer,  400ml 
methanol and 1500ml dH2 0 .
lOx Tris Buffered Saline (TBS)
80g NaCl, 2g KC1 and 30g Trizma base were dissolved in 800ml distilled H2O. The pH 
was adjusted to 8.0 by adding concentrated HC1. The solution was made up to a final 
volume of 11 and autoclaved.
Blocking buffer
Blocking buffer was prepared fresh before each use by dissolving 5% non-fat milk in 
TBS with 0.05% Tween 20.
Wash buffer
Wash buffer was prepared by adding Tween 20 to TBS to a concentration of 0.5%.
2.2.7.  Solutions for thrombin activity assay 
Thrombin activity assay buffer
Activity assays buffer contained 0.05M Tris and 0.15M sodium chloride. The pH of the 
solution was adjusted to 8.3 by adding concentrated HC1.
2.3.  Source of tissues
2.3.1.  Chicken tissues
Fertilised White Leghorn chicken eggs were obtained from Henry Stewart & Co. Ltd., 
(Lincolnshire, UK).  Humidified force flow incubators were supplied by Curfew Ltd. 
(Essex, UK).
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2.3.2. Mouse tissues
Tissue  sections  from  129/Sv mice were donated by members of the Developmental 
Biology Unit, ICH.
2.3.3. Human tissues
Pre-embedded paraformaldehyde fixed tissue sections of human material were obtained 
from the MRC and Wellcome Trust funded Human Developmental Biology Resource.
2.4. Drugs 
Tricaine
A 0.75g/l solution of ethyl 3-aminobenzoate methanesulfonate (tricaine) was prepared 
fresh on each occasion by dissolving 0.15g tricaine in 20 ml PBS.
Desmopressin
[deamino-Cys^D-Arg8]-Vasopressin  (desmopressin)  was  dissolved  in  PBS  to  a 
concentration of 150pg/ ml.
Caspase inhibitor II
Biotin-X-Asp(Ome)-Glu(Ome)-V  al-Asp(Ome)-CH2F  (Biotin-DEVD-FMK)  was 
obtained from Calbiochem (San Diego, CA). A lOmM stock solution was prepared in 
dimethyl sulphoxide (DMSO). The solution was aliquoted and stored at -20°C.
Bromodeoxyuridine (BrdU)
A  lOmg/ml solution of 5-Bromo-2’-deoxyuridine was prepared in PBS and stored at 
+4°C for up to 1  week.
2.5. Tissue culture media and equipment
Tissue  culture  plates,  flasks  and  dishes  were  supplied  by  TPP  (Trasadingen, 
Switzerland). Sterile strippettes were supplied by Coming (Coming, NY). Cultures were 
maintained  in  incubators  supplied  by  Sanyo  for  cell  culture  (Bensenville,  IL)  and
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Heraeus for slice cultures (Brentwood, UK). Gases were supplied by Cryoservice Ltd. 
(Worcester, UK). Low melting point agarose was supplied by Invitrogen (Paisley, UK).
2.5.1. Culture medium
Dulbecco’s modified essential medium (D-MEM), containing 4500mg/l glucose, 4mM 
1-glutamine and 110mg/l sodium pyruvate, and Leibovitz’s L-15 medium were supplied 
by  Gibco  (Paisley,  UK) and stored at +4°C.  L-glutamine (200mM),  lOOx antibiotic- 
antimycotic solution containing  10,000U/ml penicillin,  10,000^ig/ml streptomycin and 
25p,g/ml amphotericin B, and Trypsin-EDTA were supplied by Gibco. Heat-inactivated 
fetal  calf serum was obtained from sigma.  All reagents were  aliquoted under sterile 
conditions and stored at -20°C.
2.5.2. Thrombin and thrombin inhibitors
A 2000U/ml (~10pM) solution of bovine thrombin was prepared in 0.1% bovine serum 
albumin (BSA) and aliquots were stored at -20°C until required. Hirudin was dissolved 
to a concentration of 2000U/ml in 0.1% BSA and stored in aliquots at -20°C. D-Phe- 
Pro-Arg-chloromethylketone  (PPACK)  was  obtained  from  Calbiochem  (San Diego, 
CA). A lOmM solution of PPACK was prepared in distilled water and stored at +4°C.
2.5.3. Apoptotic Agents
A stock solution of 5mg/ml nocodazole was prepared in DMSO. A stock solution of 
0.5mg/ml rotenone was prepared in DMSO. Roscovitine was obtained from Calbiochem 
(San Diego,  CA)  and was dissolved to  20mM in  DMSO.  All  apoptotic agents were 
stored in aliquots at -20°C.
2.5.4. Reagents for detecting apoptosis in cell culture
5,5’,6,6’-tetrachloro-1,1 ’,3,3’-tetraethylbenzimidazolylcarbocyanine  (JC-1),  was 
obtained from Molecular Probes (Paisley, UK). A 5mg/ml stock of JC-1  was preparedMaterials
in DMSO and aliquots were stored at -20°C. Stock solutions of ethidium bromide and 
acridine orange (1 mg/ml) were prepared in dH20 and stored at +4°C.
2.5.5.  Antisense oligonucleotides
Unmodified antisense oligonucleotides against doublecortin were custom synthesized 
by Sigma-Genosys. Sequences for antisense and sense controls are shown in Table 2.2.
Table 2.2. Doublecortin antisense oligonucleotide sequences
Oligonucleotide sequence
Doublecortin antisense 5’ CCAAAATCAAGTTCCAT 3’
Doublecortin sense 5’ ATGGAACTTGATTTTGG 3'
2.6. Histology equipment and reagents
Histoclear  was  supplied  by  National  Diagnostics  (Atlanta,  GA).  Paraffin  wax  and 
plastic moulds for wax embedding were obtained from Raymond Lamb (Eastbourne, 
UK).  A Microm HM330 microtome was used to  section wax blocks (Bicester, UK). 
OCT compound was obtained from BDH (Poole, UK).  A Bright 5040 cryostat was 
used  to  cut  frozen  sections  (Huntington,  UK).  Dispase  was  obtained  from  Gibco 
(Paisley, UK). The cytospin, filter cards and funnels were supplied by Thermo Shandon 
(Hemel Hempstead, UK). Ehrlich’s Haemotoxylin was obtained from BDH and Eosin 
was supplied by Raymond Lamb.  Glass slides were supplied by BDH. Poly-L-lysine 
and  TESPA  were  obtained  from  Sigma.  Glass  coverslips  in a variety  of sizes were 
obtained from Raymond Lamb.
2.7. Immunohistochemistry Reagents
2.7.1.  Primary Antibodies
For details of primary antibodies used in this study see Table 2.3.
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2.1.2.  Secondary Antibodies
All secondary antibodies were obtained from Jackson ImmunoResearch (West Grove, 
PA, USA) and are summarised in Table 2.4. Secondary antibodies were reconstituted in 
dPhO, diluted 50% in glycerol and stored in aliquots at -20°C
Table 2.3. Primary Antibodies used in this study
Antibody Description of Antigen Supplier Dilution Species Antigen
retrieval
RM-270
C-terminal domain of 
160kDa neurofilament-M
Molecular
Probes 1: 2000 Mouse
Yes
BrdU
Bromo-deoxyuridine, 
incorporated into nuclei of 
proliferating cells
Oxford
Biotechnology 1:100 Rat Yes
NeuN
Uncharacterised antigen 
found in nuclei of most 
post mitotic neuronal cell 
types
Chemicon 1:100 Mouse Yes
($3 Tubulin
Labels cell bodies, axons 
and dendrites of post­
mitotic neurons
Promega 1:2000 Mouse Yes
HuC/D
Neuron specific RNA- 
binding proteins HuC, 
HuD and He-Nl. Labels 
the cell body of neurons 
shortly after exit from 
mitotic cycle
Molecular
Probes
1:  100 Mouse Yes
Doublecortin
(DCX)
Microtubule associated 
phosphoprotein located in 
migrating neurons and 
neuroblasts
Santa Cruz 1:200
(IHC)
1:500
(WB)
Goat No
EAP3
Transitin, a intermediate 
filament protein, with 
some similarity to nestin
Developmental 
Studies 
Hybridoma 
Bank, Iowa
1:10 —  
1:100
Mouse Yes
3CB2 Radial glia DSHB, Iowa 1:10 Mouse Yes
GFAP
Intermediate filament 
protein specific for 
astrocytes
DAKO 1:100 Rabbit Yes
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Table 2.4. Secondary antibodies used in this study
Secondary Antibody Dilution
Fluorescein (FITC)-conjugated affmipure goat anti-rat IgG 1:50
Fluorescein (FITC)-conjugated affmipure goat anti-mouse IgG 1:50
Cy  3-conjugated affmipure goat anti-mouse IgG 1:50
Cy  3-conjugated affmipure rabbit anti-goat IgG 1:50
Rhodamine conjugated affmipure donkey anti-rabbit IgG 1:50
HRP-conjugated affmipure rabbit anti-goat IgG 1:2000 (ELISA) 
1:20,000 (WB)
2.7.3.  Other reagents
Declere™ antigen retrieval solution was obtained from Cell Marque (Hot Springs, AR, 
USA).  Hydrophobic pens for isolating sections were obtained from Sigma.  Citifluor 
mounting medium was supplied by Citifluor products (London, UK).  Hoechst 33258 
was  diluted to  1.2mg/ml  in dH20.  Aliquots were  stored at -20°C  and diluted  1:500 
before use. Propidium Iodide was diluted to  1  mg/ml in dHiO and stored at +4°C. To- 
Pro-3-isomerase  was  supplied  by  Molecular  Probes  at  a  concentration  of  ImM  in 
DMSO. The solution was aliquoted and stored at -20°C.
2.8. TUNEL
TUNEL  staining  was  carried  out  using  the  In-Situ  Cell  Death  Detection  Kit  - 
Fluorescein from Roche (Mannheim, Germany).
2.9. Microscopes
For dissections,  a Zeiss  Stemi  SV6  microscope  was used  (Carl Zeiss,  Oberkochen, 
Germany).  For light and fluorescent microscopy a Zeiss Axioplan 2 microscope was 
used.  Cell cultures were observed on a Zeiss Axiovert  135M.  Images were captured 
using  a  ProgRes  C14  digital  camera  from  Jenoptik  (Jena,  Germany).  Confocal 
microscopy was carried out using a Leica TCS  SP2 laser scanning spectral confocal 
microscope (Leica Microsystems, Wetzlar, Germany).
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2.10. Imaging software
Images were captured using Openlab software (Improvision, Coventry, UK). Further 
image preparation and analysis was carried out using Volocity software (Improvision) 
and Adobe Photoshop Elements 3.0 (Adobe, Edinburgh, UK).  Confocal images were 
obtained and manipulated using Leica Confocal Software (LCS) and LCS lite software 
(Leica Microsystems, Wetzlar, Germany).
2.11. Molecular biology reagents and equipment
2.11.1. RNA extraction and reverse transcription
TRI  reagent  was  obtained  from  Sigma.  RNA  was  quantified  using  a  GeneQuant 
spectrophotometer (Amersham  Biosciences,  Little  Chalfont,  UK).  Moloney  Murine 
Leukemia Virus  (MuLV)  Reverse  Transcriptase  (2.5U/pl),  lOx  PCR  Buffer  II  and 
MgCL  (25mM)  were  obtained  from Applied Biosystems  (Foster City,  CA).  Pn(N)6 
random hexamers were obtained from Amersham Biosciences and were diluted to 1  (iM 
in TE buffer.  The  stock solution was  further diluted  in dFLO to  50jaM  for reverse 
transcription.  dATP,  dCTP,  dGTP  and  dTTP  were  obtained  from  Amersham 
Biosciences at a concentration of lOOmM each. These were combined and diluted with 
dFLO  to  give  a final  concentration  of lOmM  each.  The  stock  solution was  further 
diluted to 2.5mM each for reverse transcription. RNaseOUT recombinant ribonuclease 
inhibitor  (40U/^il) was supplied by Invitrogen and was diluted to 20U/pl for reverse 
transcription.
2.11.2. Semi-quantitative RT-PCR
Taq DNA Polymerase (5U/p,l), MgCh  (50mM),  lOx PCR Buffer and  1%  W-l  were 
obtained from Invitrogen.  Primers were designed using Primer 3  software (Rosen & 
Skaletsky, 2000) and were obtained from Sigma-Genosys (Table 2.5).  Primers were 
reconstituted to  lOO^M in sterile dFLO. Aliquots were stored at -20°C. Before use, the 
primers were further diluted to 50pmole/pl PCR was carried out on a programmable
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thermal cycler (MJ Research Inc, Boston, MA). Thin walled PCR tubes were obtained 
from Elkay Ltd (Basingstoke, UK).
Table 2.5. Oligonucleotide sequences used for semi-quantitative PCR
Gene Forward Primer 
Sequence
Reverse Primer Sequence product size
Chick GAPDH 5 ’ CAGTGAGAAAGTCG 
GAGTCA 3’
5 ’ G AC ACCC ATC AC AAAC 
ATGG3’
400 bp
Chick Doublecortin 5’GAACGTCAATCCCA 
ACTGGT 3’
5 ’ CCTGT  GC AT  AGCGG A  AT 
TTT 3’
364 bp
2.11.3. Nucleic acid gel electrophoresis reagents and equipment
Agarose was obtained from BDH (Poole UK). RNA and DNA Gels were prepared and 
run using equipment supplied by Gibco. A 0.24-9.5kB RNA ladder was obtained from 
Invitrogen. DNA ladders were supplied by Bioline (London, UK).  Ethidium bromide 
was diluted to  1  mg/ml and stored at room temperature in the dark.  Gel Imaging was 
performed using a UVdoc system (Topac, Hingham, MA) and Lablmage software was 
used to investigate the density of bands (Halle, Germany)
2.11.4. Real time PCR
Primers and probes for chick thrombin, urokinase and GAPDH were custom designed 
and synthesised by Applied Biosystems from supplied sequences (Table 2.6).  These 
were provided as a 20x assay mix, containing primers at  18pM and probes at 5pM. 
TaqMan Universal PCR master mix was obtained from Applied Biosystems. Optical 
plates and lids were obtained from Applied Biosystems.  PCR was carried out on an 
Applied Biosystems 7000 real time PCR machine.
Table 2.6. Primers and probes used for real-time PCR
Gene Forward primer 
sequence
Reverse primer 
sequence
Probe sequence
Chick
GAPDH
5 ’GGGCACGCCATCAC 
TATCTTC 3’
5 ’ ACCTGCATCTGCCC 
ATTTGAT 3’
5’CAGGAGCGTGACC 
CC 3’
Chick
Thrombin
5’CCTCCTTGTGTTCA 
TGCTAAGCT 3’
5’TGGTGCTGCTAGCT 
ATTGTGATG 3’
5’AACAGCACCTGAAT 
CCA 3’
Chick
Urokinase
5’GCCCTGCAGCACCA
TAGA3’
5 ’ GTTTTGG AAG ATGC 
CAGCTATCC 3’
5’CATGTACGCTCACA
CTTC3’
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2.11.5.  Western Blotting
Protein concentrations were determined using the BCA™ Protein Assay Kit from Pierce 
(Rockford, IL).  A microplate reader was supplied by Dynex technologies (Worthing, 
UK) Proteinase inhibitors were supplied by Roche and dissolved to a 25x stock in dfhO 
(Mannheim, Germany). Calf intestinal alkaline phosphatase (20U/pl) and  lOx alkaline 
phosphatase reaction buffer were obtained from Promega (Southampton, UK).  SDS- 
PAGE and Western transfer were performed using a BioRad electrophoresis system and 
tank transfer system (Hercules, CA). Hybond C Nitrocellulose membranes, enhanced
T \  / ___  T X /f
chemoluminescent  (ECL)  reagents  and  Hyperfilm  ECL  were  supplied  by 
Amersham Biosciences.
2.12. Centrifuges
To  centrifuge  samples  of up  to  1.5ml  volume  at  +4°C,  a  Heraeus  Biofuge  13R 
refrigerated centrifuge was used. For tissue culture, a Heraeus Labofuge 400 was used 
to  centrifuge  tubes  up  to  a volume  of 50ml.  For  all  other  experiments,  a Heraeus 
Biofuge pico, capable of spinning volumes up to 1.5ml was used.
2.13. Activity assay reagents
The thrombin-specific chromogenic substrate CS-01(38) was obtained from Quadratech 
(Epsom, UK). The substrate was diluted fresh each time it was used to a concentration 
of  1  mg/ml  in  assay  buffer.  A  stock  solution  of bovine  thrombin  was  prepared  at 
lOOU/ml  in assay buffer.  Aliquots were  stored at -20°C.  Recombinant hirudin from 
yeast was dissolved to 2492U/ml in activity assay buffer and aliquots were stored at - 
20°C.
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3.1. Animals
All  procedures  involving  animals  were  carried  out  under  Home  Office  Licensing 
approval  and  in  accordance  with  the  Animals  (Scientific  Procedures)  Act  1986. 
Fertilised White Leghorn chicken eggs were incubated on their sides in a humidified 
forced flow  incubator at 37°C, taking the first day of incubation as embryonic day 0 
(EO). For surgical and other manipulations, a window, approximately 2cm , was opened 
on the upper side of the egg on or before E7,  taking care not disturb the underlying 
membranes and vessels. This procedure was aided by piercing a hole in the wide end of 
the egg two or three days before windowing to encourage the membranes to drop away 
from the egg surface. The window was covered and sealed with clear tape and the eggs 
re-incubated until the required stage.
3.2. Surgery
Spinal cord transection was carried out under a dissecting microscope at E ll  or E15. 
The protocol used was an adaptation of that described by Shimuzu et al,  1990. At E15 
the embryos were anaesthetised by administration of 0.5ml of 0.75g/l tricaine in PBS 
prior  to  surgery.  A  pair  of  fine  forceps  was  used  to  break  a  small  hole  in  the 
chorioallantoic  membrane,  carefully  avoiding  major  blood  vessels.  A  glass  hook, 
prepared by heating and bending a glass pipette, was pushed through the hole and used 
to lift the embryo gently towards the window, with the dorsal side facing upwards (Fig
3.1.). Fine forceps were placed on either side of the spinal column in the cervical region 
and closed for a few  seconds,  to perform the transection,  before  gently  lowering  the 
embryo.  Following  surgery,  the  window  was  re-sealed  with  tape  and  the  eggs  re­
incubated for up to 4 days.
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Fig.  3.1.  Spinal  cord  injury  in  the  chick  embryo.  Schematic  diagram 
illustrating the process used to injure the chick embryo spinal cord. A) A small 
hole was made in the chorioallantoic membrane and a glass hook was used to 
bring the embryo close to a window made in the shell and stabilise the embryo 
during  the  injury.  B)  Fine  forceps  were  inserted  either  side  of the  dorsal 
column  and  were  closed  to  produce  a  transection/  crush  injury.  C) 
Haemotoxylin and Eosin stained section showing the typical morphology after 
the injury.
96Methods
3.3.  Drug and BrdU treatment.
3.3.1. Desmopressin
Initially,  a range  of doses  of desmopressin was  tested  initially  for their  effects  on 
embryo survival and reduction of haemorrhage, in order to determine an appropriate 
dose for the following studies. 0.5ml of 7.5, 75 or 150p,g/ml desmopressin in PBS were 
administered  to  6  embryos  at  the  time  of injury  directly  onto  the  chorioallantoic 
membrane  and  was  found  not  to  affect  survival  rates  at  24  hours  after  injury. 
Subsequently, the highest dose,  150p,g/l was used. Control embryos were treated with 
PBS alone.
3.3.2. Caspase Inhibitor II
Two different concentrations (0.5mM and 2mM) of Biotin-DEVD-FMK were prepared 
in dimethylsulphoxide (DMSO). 0.5ml was administered to each embryo at the time of 
injury by injecting through the chorioallantoic membrane. As a control some embryos 
received treatment with DMSO alone.
3.3.3. Bromodeoxyuridine (BrdU)
A range  of concentrations of BrdU  and different administration methods,  including 
injecting onto and under the chorioallantoic membrane and sub-cutaneous injections 
were evaluated. For the final experiments,  100p4 of lOmg/ml BrdU was administered 
directly onto the chorioallantoic membrane.  In the  experiments  in which injury was 
carried out, BrdU was administered at the time of injury and this dose was repeated at 
24-hour intervals throughout the incubation period following surgery.
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3.4.  Organotypic spinal cord slice culture
3.4.1. Preparation and maintenance of slice cultures
A  protocol  for the  preparation  of organotypic  slice  cultures  was  adapted  from  one 
kindly provided Dr. Laurent Nguyen (MRC-NIMR, London, UK). In the preparation of 
slice cultures as many steps as possible were carried out in a tissue culture hood. 3% 
low melting point agarose was prepared in L-15 medium and maintained at 40°C until 
required.  The  cervical  spinal cord was dissected out from E ll  or E l5  embryos and 
embedded in the agarose, using a 6-well tissue culture plate as a mould (Fig. 3.2.). The 
agarose  was  placed  on  ice  to  set,  and then blocks  containing the  spinal  cord were 
trimmed  and  attached to  the  vibratome  plate.  500pm  slices  were  using  autoclaved 
blades and collected in chilled L-15. The slices were transferred to the lid of a small 
tissue culture dish, allowing two slices per lid. A 50pl drop of medium was placed on 
top of each slice and then the dish was inverted to produce a ‘hanging drop’ in which 
the slice was suspended. Slices were cultured in humidified trays in at 37°C in 5%C02 
for 24 hours. Slices were then collected, rinsed in PBS and fixed immediately with 4% 
PFA  overnight  at +4°C.  They were then dehydrated through  an ascending  series  of 
alcohol concentrations (50%, 70%, 85% and 95% EtOH) and stored in 100% EtOH at 
-20°C until required.
3.4.2. Treatment of slice cultures with low serum conditions
In order to test the effect of low serum conditions on apoptosis in slice cultures, slices 
were maintained for 24 hours in medium containing either 1% or 10% fetal calf serum.
3.4.3. Treatment of slice cultures with thrombin and thrombin inhibitors
To test the effects of thrombin on apoptosis in the slice cultures, bovine thrombin, at a 
final concentration of lOOnM or lpM, was added to the culture medium for 24 hours. In 
some cases, slices were incubated in medium containing 1  % serum and 1  pM thrombin. 
In others, the thrombin inhibitors hirudin (final concentration 40U/ml) or PPACK (final 
concentration 40nM) were added.
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Fig. 3.2. Organotypic spinal cord slice culture. Schematic diagram illustrating the methods used to culture spinlal  cord slices. A) 
Dissected spinal cords were embedded in agarose blocks.  B) 500pm slices were cut using the vibratome C) Slices were cultured in 
50pl hanging drops of medium. D) Slices were subsequently fixed and stained to detect apoptosis.Methods
3.5.  Cell culture
3.5.1. Culturing SH-SY5Y cells
SH-SY5Y  human  neuroblastoma  cells  were  kindly  donated  by  Dr.  Arturo  Sala 
(Molecular Haematology and Cancer Biology Unit, ICH). The cells were grown as a 
mixed  adherent  and  suspension  culture  in  75cm  flasks  in  DMEM  with  added  1- 
glutamine, 10% FCS and antibiotics/ antimycotics. Cultures were maintained in a 37°C, 
humidified tissue culture incubator in 5% CO2. Every 2-3  days, when the cells were 
close to confluence, they were re-plated after splitting by 50%. In order to do this, the 
medium containing suspended cells was transferred from the flask to a centrifuge tube 
and centrifuged at lOOOrpm (~194xg) for 5 minutes to pellet the cells before removing 
the  supernatant.  The  adherent  cells  in the  flask were  washed  with  10ml  PBS,  then 
incubated with 1ml trypsin/EDTA for 3 minutes at 37°C to detach the cells. The trypsin 
was  neutralised  by  addition  of 4ml  DMEM  with  10%  serum  and  the  cells  were 
transferred  to  the  tube  containing  the  pelleted  suspension  cells.  The  tube  was 
centrifuged at  1  OOOrpm for 5 minutes to collect the cells at the bottom of the tube and 
the supernatant was removed. The cells were re-suspended in 5ml fresh medium. 2.5ml 
of the cells in solution was added to approximately 8 ml fresh medium in a clean flask.
3.5.2. Treatment of SH-SY5Y cells with apoptotic agents
In order to test the effects of various apoptotic agents on SH-SY5Y cells, the cells were 
plated in 24 well plates on glass coverslips. This was achieved by trypsinising the cells 
as  described  above.  Once  re-suspended,  an  aliquot  of the  cells  was  removed  for 
counting.  1  OOpil of the cell solution was mixed with 200pl tryphan blue solution, to 
label dead cells, and 200p,l PBS and approximately 18pl of the mixture was loaded into 
a haemocytometer for counting. The number of live cells was counted within 8 large 
squares, the volume of which was 10'4ml each, using an inverted microscope. The mean 
cell count per square was multiplied by  5x104 to give the number of cells/ ml in the 
original suspension. The cells were then plated at approximately 3xl04 cells per cm2, 
giving a total of 6xl04 cells per well  in a 24 well plate.  The cells were cultured in 
normal medium for at least 24 hours to allow adherence. A range of different doses of
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thrombin,  rotenone or nocodazole was added to the  cultures  for up to 24 hours.  An 
inverted microscope was used to monitor the progress of apoptosis and images were 
captured at various time intervals.
3.5.3. Treatment of SH-SY5Y cells with roscovitine
In order to determine the effect of inhibition of Cdk5 on cell death, SH-SY5Y cells were 
treated with the Cdk5 selective inhibitor, roscovitine. Cells were plated at a density of 3 
x  104 cells per cm2 in  1  Omm diameter tissue culture plates and grown for 48 hours to 
allow the cells to adhere. Roscovitine was added to the medium at a final concentration 
of lOfiM or 20pM. The cells were incubated for a further 24 hours before observation 
using an inverted microscope.
3.5.4. Detection of apoptotic cells with Ethidium Bromide and Acridine Orange
In  order  to  identify  apoptotic  cells  after  treatment  with  thrombin,  rotenone  or 
nocodazole, cells were stained simultaneously with two different nuclear dyes, ethidium 
bromide and acridine orange (Duke 2004). Ethidium bromide is only taken up by dying 
or dead cells, and stains DNA orange.  In contrast, acridine orange is taken up by all 
cells  and  stains  DNA  green.  Apoptotic  cells  can  be  identified  by  their  condensed, 
abnormal chromatin. This assay therefore allows for the detection of four different cell 
states:  1) living, healthy cells (green, normal nucleus), 2) live, apoptotic cells (green, 
abnormal  nucleus),  3)  dead,  necrotic  cells  (orange,  normal  nucleus)  and  4)  dead, 
apoptotic cells (orange, abnormal nucleus).
A working  solution was  prepared by  combining 200pl  each  of acridine  orange  and 
ethidium bromide stock solutions (lOOpg/ ml) and  1600pl PBS. 40pl of this solution 
was  added  to  the  cells  in  500pl  medium  in  a  24  well  plate  and  the  samples  were 
incubated at 37°C for  10 minutes before being observed using an inverted fluorescent 
microscope.
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3.5.5. Detection of apoptotic cells with JC-1 dye
As an early indicator of apoptosis in SH-SY5Y cells the mitochondrial dye JC-1  was 
used.  JC-1  accumulates in mitochondria in a membrane potential  dependent manner 
(Reers  et al.  1991).  In  healthy  cells,  JC-1  enters  the  mitochondria where,  at  high 
concentrations, it precipitates to form a red fluorescent stain. However, in cells in which 
mitochondrial membrane potential has been lost, an early indicator of apoptosis, JC-1 
remains in the cytoplasm where, at low concentrations it stains the cells green. JC-1 dye 
was diluted in medium to a final concentration of 20pg/ ml. The dye does not dissolve 
well  in  aqueous  solutions  and the  mixture  was  therefore  vortexed  vigorously  for  5 
minutes before being filtered to remove aggregates of dye.  500jxl of the mixture was 
incubated with cells in a 24 well plate for up to 1  hour before observation on an inverted 
fluorescent microscope.
3.5.6. Antisense treatment of SH-SY5Y cells
To knockdown doublecortin mRNA expression, the cells were treated with antisense 
oligodeoxynucleotides, using sequences reported by Bai et al, 2003 (Section 2.5.5). SH- 
SY5Y cells were plated at a density of 104 cells per well in a 96 well plate. The cells 
were  grown for 24 hours to allow them to  adhere to the plastic.  Antisense or sense 
oligodeoxynucleotides were added to the cells at concentrations ranging from  1  pM to 
20pM.  In control cultures,  an equivalent volume of sterile distilled H2O was  added. 
Since  the  oligodeoxynucleotides  used  in  this  study  were  unprotected  and  would 
therefore be degraded relatively quickly  in culture,  antisense was added to the cells 
every 12 hours for 3 days.
3.6. Tissue collection and processing for histology and immunohistochemistry
3.6.1.  Dissection and fixation
At the appropriate time points following surgery the embryos were sacrificed and the 
entire thoracic/ cervical region of the spinal column dissected out on ice and rinsed in 
cold PBS. To prevent tissue degradation and stabilise cellular morphology, fixation was
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carried out immediately by immersion in 4% paraformaldehyde (PFA) overnight at 4°C. 
After fixation, PFA was removed by rinsing for at least 1  hour in PBS at 4°C.
3.6.2. Decalcification
In order to  permit sectioning through the  vertebrae  in embryos  older than E l3,  the 
vertebrae were decalcified by immersion in 0.5M EDTA pH 7.4 at 4°C for 3-4 days, 
replacing the solution every 1  -2 days.
3.6.3. Wax Embedding
For most immunohistochemistry experiments, samples were embedded in paraffin wax 
to support the tissue during sectioning and to preserve cellular morphology. As wax will 
not readily enter the tissue due to its high water content, the fixed samples were first 
passed through an ascending series of ethanol (EtOH) solutions to gradually dehydrate 
the tissue. The samples were passed through changes of 50% EtOH, 70% EtOH, 85% 
EtOH,  95%  EtOH  and 2  changes  of 100% EtOH.  The  duration of each step varied 
according  to  the  tissue  size,  but  was  typically  1   hour.  The  tissue  was then passed 
through 3  changes of a synthetic  solvent, Histoclear,  at room temperature.  This was 
followed by immersion in a mixture of 50% Histoclear: 50% wax in a 70°C oven, and, 
finally, 3  changes of 100% wax at 70°C. The tissue was carefully oriented in labelled 
plastic moulds for either longitudinal or transverse sectioning and embedded in clean 
wax. The blocks were cooled before removal from the moulds and sectioning.
3.6.4. Cryo Embedding
For a number of experiments samples were frozen before sectioning. Following fixation 
and rinsing as outlined above, tissues were immersed in 20% sucrose solution overnight 
at 4°C to preserve tissue morphology during freezing. After rinsing in PBS for 1  hour at 
4°C, the tissue was then immersed in OCT compound in foil moulds for 30 minutes at 
4°C to promote penetration of the OCT. The tissue was oriented within the mould using 
a fine needle and the  blocks were rapidly frozen in isopentane chilled with dry  ice. 
Blocks were  stored at -80°C and then brought up to the cryostat temperature before 
sectioning.
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3.6.5. Coating slides
Clean glass slides were coated with either poly-L-lysine or 3-aminopropyltriethoxy- 
silane (TESPA), to ensure adhesion of tissue sections to the slides. Although poly-L- 
lysine coating was sufficient for all wax sectioning it was noted that TESPA-coated 
slides provided better adhesion of cryosections.
For poly-L-lysine coating, clean glass slides were arranged in slide racks and immersed 
in a 10% solution of poly-L-lysine for 5 minutes before drying overnight at 37°C.
For TESPA-coating the slides were arranged in glass slide racks and cleaned by dipping 
in successive troughs containing 10% hydrochloric acid/ 70% ethanol, distilled H2O and 
95% ethanol for a minimum of 30 seconds each and then drying overnight at 60°C. The 
slides were then dipped for 30 seconds in a trough containing 2% TESPA in acetone, 
followed by dipping for 30 seconds each in two troughs containing acetone and finally 
they were rinsed in distilled H2O. The slides were then dried overnight at 37°C.
3.6.6. Wax Sectioning
7 pm  sections  of wax  embedded  tissue  were  cut  using  a  Microm  HM330  rotary 
microtome and floated on pools of distilled H2O on labelled slides.  The  slides were 
gently warmed at approximately 37°C on a horizontal slide heater to flatten the sections. 
Excess water was removed using a plastic pipette and the slides were dried horizontally 
for at least 30 minutes before arranging in slide racks and drying in a 30°C oven for 24- 
48 hours.
3.6.7  Cryostat sectioning
10 or 30pm  sections  of frozen tissue were  cut  using  a Bright  5040  cryostat.  10pm 
sections were transferred to TESPA-coated slides, air dried for 1-2 hours and stored at 
-80°C until required. 30pm sections were transferred, using a fine tipped paintbrush, to 
24 well tissue culture plates containing PBS. These were stored at 4°C before staining,
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or for longer term storage the  sections were placed in a cryoprotectant solution and 
stored at -20°C.
3.6.8  Cytospin preparation
In  order  to  produce  slides  for  immunostaining  with  clear  single-cell  resolution,  a 
cytospin  preparation  of dissociated  spinal  cord  cells  was  used.  Spinal  cord  tissue 
(approximately 6mm in length taken from the cervical spinal cord region) was diced and 
collected in L-15.  The samples were centrifuged in  1.5ml eppendorf tubes briefly at 
8000rpm (~6080xg) to collect the tissue in the bottom of the tube and the L-15 was 
removed.  The  tissue  was  dissociated  by  adding  approximately  0.5ml  of dispase 
(20U/ml) and incubating at 37°C for at least 20 minutes.  During the incubation, the 
tissue was gently fragmented by pipetting up and down with a 1ml Gilson pipette. Once 
no visible tissue fragments could be seen the samples were centrifuged at 8000rpm for 2 
minutes to collect the cells in a pellet. The dispase was removed and the cells were re­
suspended  in  0.5ml  DMEM-F-12.  The  cells  were  diluted  a  further  10  times  with 
DMEM-F-12. The cytospin was set up by fitting a TESPA coated slide, filter card and a 
clean cytospin funnel in each clip and loading these into the machine. 200|il of the cell 
suspension was added to each funnel and the cells were spun at 500rpm for 5 minutes 
onto the slides. The cell preparations were air-dried for 15 minutes to ensure adherence 
of the cells, dipped briefly in PBS to rinse and fixed with 4% PFA for 10 minutes before 
continuing with the staining procedure.
3.7.  Haemotoxylin and Eosin Staining
To  examine tissue morphology,  sections were stained with Haemotoxylin and Eosin 
(H&E).  Haemotoxylin is a basic dye which has a high affinity for nucleic acids and 
which stains cell nuclei a dark blue colour. Eosin, an acidic dye, provides an effective 
counterstain by staining all cytoplasm and connective tissue pink.
Both  dyes  are  water-soluble;  wax  sections  therefore  must  be  deparaffinised  and 
rehydrated for staining to be successful. This was achieved by immersing the slides in 
Histoclear in a coplin jar for 2 changes of 5  minutes duration to remove the wax and 
then passing the sections through a descending series of alcohol solutions as follows; 2
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x 5 minutes in 100% EtOH, 1x5 minutes in each of 95%, 85%, 70% EtOH and finally 
1   x 5 minutes in dH20. The sections were immersed in Ehrlich’s Haemotoxylin for 10 
minutes, rinsed in dH20  for 1   minute and transferred to a running tap water bath for 5 
minutes.  This procedure produces  ‘over-staining’  of the  sections with Haemotoxylin 
which was then corrected by dipping  in an acid alcohol  solution for 3-6  seconds to 
remove some of the stain.  The sections were returned to the tap water bath and then 
immersed in  1  % Eosin for  10 minutes before a final rinse for 5 minutes in tap water. 
Finally, the sections were dehydrated by immersing in 95% EtOH for 1  minute,  100% 
EtOH  for  3  minutes  and  Histoclear  for  5  minutes.  Sections  were  mounted  and 
coverslipped using DPX.
3.8.  Immunostaining
In order to investigate the localisation of various antigens and cell type markers in tissue 
sections and dissociated cell cytospin preparations a two-step indirect immunostaining 
procedure was used. Using this method a primary antibody directed against the antigen 
of interest first binds to the antigen. A secondary antibody, conjugated to a fluorescent 
label  and directed against the  species  in which the primary  antibody  is raised, then 
reacts  with the  primary  antibody.  This  step  provides  amplification of the  signal  as 
several secondary antibodies may react with a single primary antibody. The localisation 
of the antigen can then be visualised using a fluorescent microscope.  The localisation 
of two different antigens can be visualised in a single tissue section by using secondary 
antibodies labelled with different fluorescent molecules (Fig 3.3).
3.8.1.  Basic immunostaining protocol
Preparation of sections
In order to allow penetration and activity of the various water-soluble reagents used for 
immunostaining,  wax  sections  were  deparaffinised  and  rehydrated  as  described 
previously (Section 3.7.).  Frozen sections were warmed up to room temperature and 
then immersed in PBS for 10 minutes to remove OCT compound.
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Fig. 3.3. Detection of co-localisation of two antigens by immunohistochemistry. Schematic diagram illustrating the steps taken to 
detect two independent antigens (A) by double immunostaining. B) Incubation with an excess of the primary antibody against the 
first antigen of interest is followed by incubation with a fluorescently-conjugated secondary antibody against the species in which the 
first  primary  was  raised  (C).  D)  Incubation  with  a  second  primary  antibody,  raised  in  an  unrelated  species  is  the  followed  by 
incubation with a second secondary, conjugated to a different fluorescent dye (E).Methods
Antigen retrieval
Fixation with PFA  causes cross-linking  of basic  amino  acids  in proteins which can 
cause ‘masking’ of some antigens, preventing antibody binding. The degree of masking 
will depend on whether the antigen reacts with formaldehyde and is also affected by 
whether the antibody to be used is polyclonal, containing an immunoglobulin mixture 
which binds to many different epitopes on the antigen, or monoclonal, raised against a 
single epitope. For most antibodies it was therefore necessary to carry out an antigen 
retrieval step prior to staining in order to ‘un-mask’ the antigen (Table 2.3, page 90).
Two different methods of antigen retrieval were used in this study. In some cases the 
slides were immersed in 0.5M citric acid buffer, pH 6.0, and heated at 60% power in a 
microwave for 8 minutes. Slides were then cooled to room temperature and rinsed for 5 
minutes in dH20 before continuing. More frequently, simultaneous deparaffinisation, 
rehydration and antigen retrieval was carried out using Declere solution, diluted 1:20 in 
dH20. Slides were immersed in the solution and heated for approximately 4 minutes at 
80% power, until the solution began to boil and then a further 20 minutes at 30% power. 
Slides were then placed in a trough of fresh boiling Declere, cooled to room temperature 
and rinsed for 5 minutes in dH20 before continuing.
Acid treatment for BrdU staining
For BrdU immunostaining only, the sections were incubated in a solution of 0.1 M HC1 
for 30 minutes at room temperature, followed by 2M HC1 for 30 minutes at 37°C to 
denature double stranded DNA (Zhang et al.  2003). The sections were neutralised in a 
solution of 0.1M Sodium borate pH 8.5 for 15 minutes at room temperature, then rinsed 
in PBS before continuing.
Serum blocking
Non-specific background staining may occur due to hydrophobic interactions between 
immunoglobulins, particularly those present in the secondary antibody, and proteins in 
the tissue. This can be reduced by the use of detergents and therefore Tween 20 was 
routinely added to all immunostaining reagents at a concentration of 5ml/l. Non-specific 
binding can be blocked most effectively by pre-incubation with a solution containing 
proteins, such as serum which will compete for hydrophobic binding sites in the tissue.
108Methods
The sections were isolated by drawing a ring using a hydrophobic PAP pen to prevent 
reagents  from running  off the  slide,  and  approximately  200pl  serum per  slide  was 
added, covering the sections. In most cases a solution of 10% Fetal Calf Serum (FCS)/ 
1% Bovine Serum Albumin (BSA) in PBS was used; for others a 10% solution of serum 
from  the  species  donating  the  secondary  antibody  was  prepared.  These  treatments 
appear to be interchangeable as no difference in the degree of non-specific background 
was observed. The sections were incubated in serum for 1  hour at room temperature in a 
humidity chamber.
Primary Antibodies
Following blocking, the serum was tipped off and replaced with the primary antibody 
made up to the required dilution (see Table 2.3, page 90, for dilutions and suppliers) in 
the blocking serum. For all new antibodies the optimum dilution was first established by 
carrying out a titration experiment in which staining intensity and background staining 
with different dilutions were compared.  Sections were usually incubated overnight in 
primary antibody at 4°C in a humidity chamber.
Secondary Antibodies
Following  incubation  with  the  primary  antibody,  the  sections  were  rinsed  with  3 
changes of PBS, before application of a secondary antibody, directed against the species 
in which the primary antibody was raised and conjugated to a fluorescent dye (Table
2.4,  page  91).  All  secondary  antibodies  were  used  at  a  1:50  dilution.  Usually,  the 
secondary  antibody  solution also  contained  Hoechst 33258  dye  at a  1:500  dilution, 
which stains all cell nuclei, although this staining was found not to be effective after 
acid-treatment for BrdU-staining. In other cases, propidium iodide at a 1:1000 dilution 
was used to stain cell nuclei. The sections were incubated with the secondary antibody 
for 45 minutes at room temperature, before further rinsing with PBS and were mounted 
using  a  PBS/Glycerol  mounting  medium,  Citifluor,  to  preserved  fluorescence. 
Coverslips were applied and sealed with nail varnish to prevent the slides from drying.
Controls
A  number  of  different  controls  were  carried  out  to  ensure  the  validity  of  the 
immunostaining procedure with each antibody.  These included negative controls,  in 
which no primary antibody was used, which gives an indication of the specificity of the
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secondary antibody. In other cases, the primary antibody was replaced by non-immune 
serum of the same subclass and species as that of the primary antibody. This gives an 
indication of the non-specific binding of that antibody type in the tissue.  In cases in 
which  the  peptide  antigen  was  available  this  was  used  to  pre-absorb  the  primary 
antibody by incubating the primary antibody in an excess of the peptide for 30 minutes 
before staining. These controls helped to ensure the specificity of the primary antibody.
3.8.2.  Double immunostaining
In  order  to  visualise  more  than  one  antigen  in  a  tissue  section  at  a time,  double- 
immunostaining with two different primary antibodies was  carried out.  Since cross­
reactivity between several of the antibodies was found to occur,  it was necessary to 
incubate with each antibody separately.
The procedure was carried out as described above, including the acid treatment steps, 
and incubating with  a first primary  antibody  which was  usually  a cell  type  marker 
antibody (NeuN,  |33-tubulin, HuC/D, Transitin or GFAP) overnight at 4°C. Following 
incubation with the appropriate secondary antibody, the sections were rinsed 3  times 
with PBS and a second primary antibody (usually anti-BrdU) was applied and incubated 
for 2 hours at room temperature. This was followed by incubation with the appropriate 
secondary antibody, conjugated to a different fluorescent dye, before mounting. In order 
to  minimise  cross-reactivity  between  the  second  secondary  antibody  and  the  first 
primary antibody it was found necessary to use an antibody which was pre-absorbed 
against the species in question (usually mouse).  Throughout the second round of the 
staining  it  was  important  to  protect  the  sections  from  light  as  far  as  possible,  to 
minimise bleaching of the fluorescent staining.
3.8.3 Immunostaining floating sections
For  immunostaining  floating  sections  the  steps  were  essentially  the  same  as  those 
described above. Floating sections were stained in 24 well plates, with up to 4 sections 
in each well.  200pi of each solution was used per well  and  solutions were changed 
using a fine-tipped micro-pasteur pipette. All incubations were carried out with gentle 
shaking to ensure adequate penetration of the solutions. After staining, sections were
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removed from the wells using a  ‘hockey stick’, formed from a glass Pasteur pipette 
heated and bent to form an L-shape,  and were placed on TESPA-coated  slides.  The 
sections  were  briefly  air-dried  to  ensure  good  adherence,  and  were  mounted  using 
Citifluor and a glass coverslip.
3.8.4. Immunostaining cytospin preparations
For cytospin preparations, the immunostaining procedure was carried out as detailed 
above, however all incubation times were shorter.  For BrdU staining the slides were 
incubated in 2M HC1 for 10 minutes at 37°C and for 10 minutes in 0.1 M Sodium Borate 
at room temperature. Non-specific binding was blocked by incubating the slides for 20 
minutes in serum at room temperature. One hour incubations in primary antibodies and 
30 minute incubations in secondary antibodies were carried out at room temperature.
3.8.5. Immunostaining cell cultures
For immunostaining cells cultured on glass coverslips the cells were first fixed for 20 
minutes in PFA. The coverslips were removed from the dish using a needle and forceps 
and were rested on inverted micro tube lids throughout the immunostaining procedure. 
The  steps  were  as  detailed  above,  however all  incubation times  were  shorter;  non­
specific  binding  was  blocked  by  incubating  in  serum  for  30  minutes  at  room 
temperature,  whereas primary  antibodies were  incubated for 2 hours and  secondary 
antibodies for 1  hour at room temperature.
3.9.  Enzyme-linked immunosorbent assay (ELISA)
In order to quantify doublecortin protein levels in SH-SY5Y cells an adaptation of the 
standard  ELISA protocol  was  used  (Parnas  and  Linial  1998;  Corcoran  and Ferretti 
1997). In this method cells are immunostained for doublecortin. In order to quantify the 
staining, a secondary antibody is used which is conjugated to an enzyme, horseradish 
peroxidase  (HRP).  Application of a chromogenic  substrate for HRP then produces a 
measurable  colour change  in the  solution which is related to the  amount of antigen 
present allowing the determination of relative protein levels.
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Cells were grown in 96 well plates and at the end of the experiment were fixed with 4% 
PFA for 20 minutes. Following fixation the cells were rinsed once in PBS for 5 minutes. 
In order to improve penetration for the reagents and allow access to the antigen, the 
cells were next rinsed in PBS containing a detergent, 0.1% triton-X  100. Endogenous 
peroxidase  activity  was  quenched by  incubating  with 2%  hydrogen peroxide  for  5 
minutes.  The  cells were  rinsed  again in PBS  with  0.1% triton-X  100.  Non-specific 
background staining was prevented by incubating the cells in 10% FCS/ 1% BSA for 1  
hour at room temperature. A primary antibody against the antigen, doublecortin (Table
2.3,  page 90) was diluted 1:200 in serum block and incubated with the cells for 2 hours 
at room temperature.  The cells were rinsed thoroughly with PBS  and then incubated 
with  an  HRP-conjugated rabbit anti-goat  secondary  antibody  (Table  2.4,  page  91), 
diluted  1: 2000 in serum block, for 45 minutes. The cells were then rinsed again with 
PBS.  1  OOpil of a soluble chromogenic substrate o- phenylenediamine dihydrochloride 
(OPD) was added to each well and the plate was covered with foil and incubated on a 
plate  shaker for  30  minutes  at room temperature.  A microplate  reader was used to 
measure the optical density (OD) at 450nm.
3.10.  TdT-mediated dUTP nick end labelling (TUNEL)
3.10.1. Principles of TUNEL staining
Apoptotic  cells  were  detected  using  TUNEL  staining.  This  assay  is  based  on  the 
detection of single strand breaks, or ‘nicks’  which are characteristic of the apoptotic 
process.  These  ‘nicks’  leave  free  3’-OH DNA ends, to which a labelled nucleotide, 
fluorescein-dUTP  is  attached  during  the  TUNEL  procedure.  The  attachment  of 
fluorescein-dUTP is catalysed by Terminal deoxynucleotodyl transferase enzyme (TdT) 
(Gavrieli et al.  1992).
3.10.2. TUNEL staining on wax sections
Wax sections were deparaffmised and rehydrated as described previously (see section 
3.5), isolated using a PAP pen, and placed in a humidity chamber. In order to allow the 
TUNEL reagents to reach their target DNA inside cells the sections were permeabilised 
by  incubating  in  proteinase  K  permeabilisation  solution  for  15  minutes  at  room
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temperature. The sections were then rinsed 3 times in PBS. TUNEL reaction mixture 
was  prepared  on  ice  immediately  before  use  by  mixing  TdT  enzyme  solution  and 
labelling  solution containing  fluorescein-dUTP  in a  1:10  ratio.  50p,l of this reaction 
mixture was used to cover each section. As a control,  some sections were incubated 
with 50pl labelling solution with no enzyme added. The sections were incubated with 
the reaction mixture for 1  hour at 37°C to promote enzyme activity. After rinsing again 
in PBS  the  sections were  incubated with a  1:500  solution of Hoescht 33258  for  10 
minutes at room temperature, to allow nuclear morphology to be assessed. The sections 
were mounted and coverslipped with Citifluor.
3.10.3.  Whole-mount TUNEL staining/ Immunostaining
Apoptosis was assessed in 500^im spinal cord slices by whole-mount TUNEL staining, 
using an adaptation of the protocol described by Yamamoto & Henderson,  1999. The 
staining was carried out in 1.5ml micro-tubes. The slices were removed from storage in 
100% ethanol at -20°C and incubated in a mix of ethanol: DMSO: H20 (4:1:1) for 5-10 
hours  at  room  temperature  to  aid  permeabilisation  of the  tissue.  They  were  then 
rehydrated and further permeabilised by incubating in 50% ethanol for 20mins followed 
by 3 changes of PBS, containing 0.5%Triton X-100 for 15 minutes each. Following this, 
the TUNEL mixture was prepared as described above, allowing 75pil total volume for 3- 
4 slices and the slices were incubated in the reaction mixture overnight at 4°C and then 
for 2 hours at 37 °C. This was followed by three  15 minute rinses with PBS containing 
0.5% Triton X-100.
In order to assess neuronal apoptosis in the slices, whole-mount immunostaining was 
carried  out  following  TUNEL  staining.  The  slices  were  incubated  in  serum  block 
containing  10%FCS/  1%BSA  and  0.5%  Triton X-100  in  PBS  for  2  hours  at  room 
temperature. The serum block was then replaced by the primary antibody, anti NeuN, 
diluted  1:20, and incubated for 48 hours at 4 °C.  After 3  rinses with PBS containing 
0.5% Triton X-100, an appropriate secondary antibody was diluted  1:50 in PBS  and 
incubated overnight with the slices. A nuclear dye, To-Pro-3  iodide was added to the 
secondary antibody to visualise all nuclei.  After rinsing, the slices were mounted on 
slides with Citifluor.
113Methods
3.11.  Image Analysis
3.11.1. Microscopy
Light  and  fluorescence  microscopy  was  carried  out  using  a  Zeiss  Axioplan  2 
microscope and digital images were captured using a ProgRes C14 camera, directly into 
Openlab  software.  Alterations to brightness and contrast were primarily made using 
Adobe Photoshop, and were kept constant within each experiment.
Confocal microscopy was carried out using a Leica TCS  SP2  laser scanning spectral 
confocal microscope and Leica Confocal Software, using the settings shown in Table.
3.1.  In order to  avoid crossover between the  emissions  from different dyes, such as 
fluorescein and Cy3, each channel was captured separately using the sequence function. 
To visualise cells in 3  dimensions, z series were captured with steps of between 0.2- 
10pm.  Subsequent manipulations  of the  data,  including  averaging,  separations  and 
cross-sectional analysis were carried our using Leica Confocal Software Lite.
Table 3.1. Confocal microscope settings for different fluorescent dyes
Dye Laser Min emission Max emission
FITC 488nm 497nm 524nm
Cy3 543nm 561nm 634nm
To-Pro-3-iodide 633nm 662nm 802nm
3.11.2.  Quantification
Measurement of haemorrhage and cavitation in the spinal cord
To  quantify  haemorrhage  within  the  spinal  cord,  sections  stained  with  H&E  were 
imaged by light microscopy. A series of overlapping images were generated and used to 
create a composite of longitudinal sections of spinal cord at a level close to the centre of 
the injury. The extent of haemorrhage was quantified using these images by measuring 
the  distance between the  site of injury  and the point where  bleeding was no  longer 
observed. Similarly, the size of visible cavities and tissue damage were measured from 
the site of injury.
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Quantification of TUNEL labelling in longitudinal sections of spinal cord
To  quantify  TUNEL  labelling  in  longitudinal  sections  of spinal  cord,  fluorescent 
microscopy was used to generate a series of overlapping images along the length of the 
cord. A scoring system was used to quantify the intensity of TUNEL staining. At each 
1mm interval from the injury site a score from 0 (no staining) -  4 (intense staining) was 
given (Fig. 4.7, page  149). For each data point TUNEL scores from 3-6 animals were 
averaged.  The maximum distance from the injury  site at which apoptotic cells were 
observed was also recorded.
Quantification of TUNEL labelling in slice cultures
To quantify TUNEL labelling in the organotypic slice cultures, confocal microscopy 
was used to capture images every  10pm through the slice. Volocity software was used 
to measure the intensity of the TUNEL signal in the first 5 images collected from each 
slice. Each image was opened in the software and the region of interest (ROI) tool was 
used to outline the area of the slice. The measurements module was used to measure the 
total  green  intensity  and  the  total  area  of the  slice.  To  control  for  background 
fluorescence, which might show variation between experiments, an area of each image 
showing no positive TUNEL staining was outlined and the total green intensity in this 
area was also measured.  The TUNEL intensity was expressed relative to the area of the 
ROI and the background fluorescence was deducted from each measurement. Data from 
at least 6 slices were obtained per experimental group.
BrdU cell counting
In order to generate a quantitative measure of proliferation, BrdU labelled cells in 30pm 
sections located 300 pm from the injury site were imaged on the confocal and average 
projections were  generated using  the  Leica Confocal  Software.  Cells were  counted 
manually using Openlab software. Each image was opened individually in Openlab. The 
ependymal region, grey matter and white matter were determined by eye and outlined 
using  the  region  of interest  (ROI)  tool  (see  Fig  7.1).  The  area of each region was 
measured  automatically  by  the  software.  All  BrdU  labelled  cells  in  each  area were 
counted by hand using the point measurement tool and were expressed as number of 
cells per pm2. For each data point, cell counts from 3-6 animals were averaged, and up 
to two sections were measured for each animal.
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Analysis of double labelling
To identify cells double labelled with BrdU and a neuronal marker in 30_m spinal cord 
sections,  confocal  microscopy  was  used  to  generate  a  z-series  of images  captured 
through the section. Using the Leica Confocal Software, each stack was then separated 
into 4 stacks, in order to visualise the cells at a higher magnification. The cross-section 
tool was used to investigate each stack for double labelled cells. This enabled each cell 
in the  stack to be visualised in 3  dimensions.  In order for a cell to be identified as 
double-labelled with 2 markers, overlap of the signal in all dimensions was necessary. 
The number of double labelled cells per stack was determined.
In order to quantify double labelling in cytospin preparations, each slide was observed 
using a fluorescent microscope with a 40x objective.  The numbers of BrdU labelled 
cells,  and  cells  labelled  with  neuronal  markers  were  counted  blind  in  each  of 5 
randomly selected fields of view. The number of double-labelled cells was expressed as 
a percentage of the total number of BrdU labelled cells. For each data point, cell counts 
from at least 2 different animals were averaged.
3.12.  RT-PCR
3.12.1.  Principles of RT-PCR
To examine the expression of a particular gene it is necessary to be able to detect and 
quantify specific mRNA molecules from within the mixture of mRNAs found in a cell 
or tissue. In order to do this, the principle of the polymerase chain reaction is employed 
(Saiki et al.  1985).
The polymerase chain reaction allows a precise DNA fragment to be amplified from a 
relatively small amount of starting material, termed the template. This is achieved by 
using two oligonucleotide primers which bind to each DNA strand, just up-stream of the 
sequence to be amplified, and a DNA polymerase enzyme which uses these primers to 
generate new DNA molecules complementary to those of the target sequence. During 
the first step of a PCR reaction, the target sequence is exposed by denaturing the DNA 
using a temperature of around 95°C (Fig 3.4). The reaction is then rapidly cooled to a
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Fig 3.4. Principles of semi-quantitative (endpoint) and real time PCR methods. A) During PCR, double stranded DNA is denatured, by heating 
at a high temperature,  to  separate the  strands.  Sequence  specific  primers anneal to  the target region,  at lower temperatures.  Extension of DNA 
strands is catalysed by DNA polymerase, giving rise to two new strands of the target DNA. As the process is repeated the amount of target DNA 
increases exponentially while reagents are available but slows as reagents are used up. B) Real-time PCR using the 5’nuclease assay involves the 
binding of specific primers and a special TaqMan Probe. The probe is labelled with a reporter fluorescent dye and a quencher dye, which prevents 
fluorescence  being emitted  while the  probe  is  intact.  During  the  extension  phase  of each  PCR  cycle,  the  probe  is  displaced  by  the  activity  of 
AmpliTaq® polymerase and the reporter dye  is  freed,  causing  fluorescence to be emitted.  The real time PCR machine measures the  increase  in 
fluorescence over  time, (adapted from Lewin, 1997 and  Applied Biosv stems  I  aqMan protocol)Methods
temperature  optimal  for  the  primers  to  anneal  to  the  target  sequence.  The  precise 
annealing temperature is dependent on the chemical structure of the oligonucleotides 
and will therefore be different for each set of primers. Finally, the oligonucleotides are 
used to  prime  DNA  synthesis  from  dNTPs  which are  also  included  in the reaction 
mixture. This is catalysed by a thermostable DNA polymerase such as Taq Polymerase. 
In  this  extension  step  a  strand  of DNA  complementary  to  the  target  sequence  is 
generated.  DNA  synthesis  is  stopped  and  the  cycle  of reactions  starts  again  by 
denaturing the DNA. In subsequent rounds of PCR, the newly generated DNA strands 
also act as templates, resulting in an exponential increase in the number of copies of the 
target sequence being generated.  Furthermore,  as the reaction continues most of the 
newly generated strands will be the exact length of the DNA sequence between the two 
primers. At the end of the PCR reaction the amount of product produced is visualised by 
staining the DNA with ethidium bromide and separating by gel electrophoresis. If the 
reaction is stopped during the exponential phase of the reaction, before reagents have 
become a limiting factor, the amount of PCR product detected will be directly related to 
the initial number of starting template molecules.
Since the PCR reaction amplifies DNA,  in order for PCR to be employed to  detect 
levels of mRNA molecules, a reverse transcriptase (RT) enzyme is used in conjunction 
with  random  primers  to  generate  cDNA  sequences  complementary  to  the  mRNA 
sequences present in a preparation.  This cDNA can then be analysed by PCR.
3.12.2.  Semi-quantitative and real-time RT-PCR
Two different RT-PCR methods were used in this project. Traditional semi-quantitative 
RT-PCR  was  used  to  demonstrate  and  investigate  doublecortin  expression  and  the 
newer approach of real-time RT-PCR was used to investigate the expression of serine 
proteases.
In  semi-quantitative  RT-PCR,  PCR  is  used  to  amplify  the  gene  of interest  and  a 
reference gene, which is expected to be expressed at a constant level in all samples, 
such as GAPDH. The reactions are stopped within their exponential phase (established 
in  pilot  studies)  and  the  PCR  products  are  separated  and  quantified  by  gel 
electrophoresis (Fig 3.4.). By normalising the amount of the gene of interest detected to
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the amount of GAPDH it is possible to control for differences in the starting quantities 
of RNA between  samples.  Semi-quantitative  RT-PCR has been extensively used to 
quantify  gene  expression.  The  main  limitations  of this  approach  are relatively  low 
sensitivity and the fact that it is not possible to be certain that a given reaction is during 
exponential amplification, which might lead to imprecise results.
In real-time PCR, the accumulation of PCR products over the course of the reaction is 
directly observed. This may be achieved by means of incorporation of a fluorescent dye 
into the newly synthesised DNA or, as was the case in the present study, by using a 
combination of a special Taq polymerase  enzyme  and fluorescent resonance energy 
transfer  (FRET)  (Morrison  et al.  1998;  Williams  et al.  1996).  In this  approach,  in 
addition to two oligonucleotide primers, a third oligonucleotide, or probe, is designed 
which  binds  to  the  target  sequence  in  between  the  primers  (Fig  3.4).  As  the  Taq 
polymerase enzyme catalyses DNA synthesis it simultaneously cleaves the probe which 
is positioned in the way of the extending DNA strand.  The probe is conjugated to both 
a  fluorescent  reporter  molecule,  which  emits  energy  when  excited  by  light,  and  a 
quencher  molecule.  When  the  probe  is  intact,  these  two  molecules  are  in  close 
proximity to each other and energy is transferred from the reporter to the quencher via 
FRET, preventing energy emission.  However, as the PCR reaction proceeds and the 
probe is cleaved this will separate the reporter and quencher leading to an increase in 
energy  emission  from the  reporter.  The  fluorescence  emitted from the reporter dye 
therefore reflects the  amount of PCR product generated.  During real-time PCR this 
emission is measured throughout the reaction.  The advantage of real-time PCR over 
semi-quantitative PCR is that it allows detection of the accumulation of PCR products 
over  the  course  of the  reaction.  This  means  that  it  is  possible  to  determine  the 
exponential  phase  of the  reaction  more  precisely  making  it  more  likely  that  the 
measurements taken will reflect the starting quantities of template.  However the major 
disadvantage of real-time PCR is the cost which is much greater than traditional semi- 
quantitative methods.
3.12.3.  Tissue Collection
Spinal cords were collected from normal embryos at E3, E7, E ll, and E l5. For injured 
animals, at the required time point after injury (2 hours or 24 hours), spinal cord tissue
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was collected from a 6mm region around the injury site, and two 3mm regions either 
side of the injury site, as illustrated in Fig 3.5.  Briefly, the embryo was sacrificed and 
rapidly dissected on ice. The skin was removed to expose the cervical/ thoracic spinal 
column which was dissected out.  A pair of curved forceps was used to  squeeze the 
spinal cord tissue out. This was rinsed in cold DEPC-treated PBS, transferred to sterile 
eppendorf tubes and quickly frozen on dry ice. Samples from 3 animals were pooled in 
each tube, and stored at -80°C.
3.12.4  RNA Extraction
RNA extraction was performed using an adaptation of the single step RNA isolation 
protocol.  Spinal cord tissue was homogenised in 0.5 ml TRI Reagent, which contains 
guanidine  thiocyanate  to  lyse  cells  and  denature  proteins,  and  an  organic  solvent, 
phenol.  The  mixture  was  left  to  stand  for  5  minutes  at  room  temperature.  0.1  ml 
chloroform was added to each tube and the tubes were shaken for  15 seconds, before 
standing at room temperature for 5 minutes. During this step the mixture separates into 
two  phases,  an organic  phase  and  an aqueous  phase.  Denatured proteins  and DNA 
cannot remain water soluble under these conditions and enter the organic phase of the 
solution, while RNA remains in the aqueous phase.  The samples were centrifuged at 
13,000rpm  (~ll,000xg)  for  15  minutes  at  4°C  to  separate  the  phases.  The  upper, 
aqueous phase was transferred to a sterile eppendorf and 0.25 ml isopropanol was added 
to each tube. This was placed at -20°C overnight to precipitate the RNA. The tubes were 
then centrifuged at 13,000rpm for 30 minutes at 4°C. The supernatant was removed and 
the RNA pellet was washed in 75% ethanol followed by centrifugation at 7,500g for 5 
minutes at 4°C. Finally the supernatant was removed and the pellet allowed to air dry 
before re-suspending in 20p,l DEPC-H2O. The RNA concentration was determined by 
measuring the absorbance at 260nm using a spectrophotometer. In order to confirm that 
the RNA was not contaminated with protein the ratio between absorbance at 260nm and 
280nm was measured. This should be close to 1.8 for a pure RNA preparation.
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Fig 3.5 Tissue collection strategy for RT-PCR after spinal cord injury A).
A  12 mm region of cervical  spinal  cord was dissected at 2 hour or 24 hours 
after spinal cord injury.B) The tissue was divided into a 6mm proximal region 
around the injury site (the proximal region) and two 3mm distal regions which 
were pooled for further analysis.
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3.12.5 RNA Gel Electrophoresis
To check the integrity of the RNA, samples were separated by gel electrophoresis. A 
good RNA preparation should produce two strong bands, corresponding to the highly 
abundant 18S and 28S ribosomal RNA. An RNA gel was prepared by dissolving 0.95g 
electrophoresis grade agarose in 81ml DEPC-treated H2O and adding 9.5ml lOxMOPS 
buffer and 5ml formaldehyde. This was poured into a gel former with comb in place and 
allowed to set at room temperature before covering with  lxMOPS buffer. 3(li1 of each 
sample  was  mixed  with  1  6(lx1  RNA  denaturing  buffer  and  1  pil  of  lmg/ml  ethidium 
bromide. The RNA was denatured by incubating at 70°C for 5 minutes before loading 
onto  the  gel.  Electrophoresis  was  performed  at  100V.  Gels  were  visualised  by 
illuminating with an ultraviolet light, and imaged using a digital camera. Alpha imager 
software was used to capture gel images and to perform densitometry analysis.
3.12.6 Reverse Transcription (RT)
Complementary DNA (cDNA) was prepared from the extracted RNA using M-MLV 
(Murine-Moloney Leukaemia Virus) Reverse Transcriptase.  lp,g total RNA was used 
per reaction and was made up to a volume of lOpl with DEPC-H2O. 2pl of random 
hexamers (50pM), 2pl of dNTPs (2.5mM each) and  lpl of RNaseOUT recombinant 
ribonuclease inhibitor (20U/^il) was added and the mixture was heated at 70°C for 10 
minutes to denature the RNA, followed by immediate cooling on ice. Finally, 2pl of 2x 
PCR Buffer II,  2pil  of MgCh  (2.5mM) and  lpl  of MLV-transcriptase  (50U/p,l) was 
added and the mixture incubated at 42°C for  1   hour, using a PTC-100 Programmable 
Thermal Controller. cDNA samples were stored until required at -20°C.
3.12.7.  Semi-quantitative PCR analysis of doublecortin expression
Each  PCR reaction  was  carried  out  in  20pl  total  volume  containing  the  following 
reagents:
5.9|xl  H20
10|al  2x PCR buffer
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0.5|il  each primer (Table 2.5, page 93)
0.1.pil  Taq DNA Polymerase 
3 |il  cDNA
PCR was carried out using a PTC-100 Programmable Thermal Controller (MJ Research 
Inc, Boston, USA). The programme contained the following steps:
1. 94°C for 3 minutes
2. 94°C for 30 seconds
3. 56°C for 1  minute
4. 72°C for 1  minute
5. Go to step 2 x times
6. 72°C for 10 minutes
7. End
Where x = number of cycles. The number of cycles required to remain within the linear 
range was determined in a separate experiment for each primer set. For quantification 
GAPDH reactions were run for 21 cycles and doublecortin reactions for 26 cycles.  PCR 
products were stored at 4°C before being separated by gel electrophoresis.
3.12.8. DNA Gel electrophoresis
A  1.5%  agarose  gel  was  prepared  by  dissolving  1.5g  agarose  in  100ml  lxTBE. 
Ethidium bromide (4|il) was added and the gel poured into a gel former with comb in 
place.  16pl of each sample was combined with 4\i\ of 5x orange G loading buffer.  16p,l 
of the mixture was then loaded into each well. 5pil of Hyperladder IV was loaded into 
the first lane.  Electrophoresis was performed at 90V for approximately 2 hours. Gels 
were visualised as described previously.
3.12.9. Semi-quantitative PCR data analysis
For  all  experiments  3  different pools  of tissue  samples  were  run  in triplicate  PCR 
reactions.  The  density  of each  band  was  measured  and  recorded  using  Lablmage
123Methods
software. Background density was subtracted from each band. Doublecortin bands were 
normalised to  GAPDH  bands  for  each  sample  by  expressing  as  a ratio to  GAPDH 
levels.  The 3  replicates for each sample were averaged and the mean value for each 
developmental stage or experimental condition was determined.
3.12.10.  Real-Time PCR analysis of serine protease expression
Primers and probes for chick thrombin, urokinase and GAPDH were custom designed 
and synthesised by Applied Biosystems and were supplied as a pre-mixed 20x‘assay  - 
mix’. The sequences of each primer and probe set are given in Table 2.6 (page 93). For 
each PCR reaction, the following reagents were combined:
1.25p,l 20 x assay mix
12.5pl 2x Taqman universal PCR master mix 
10.25pl H20
1  \x\ cDNA prepared as in section 3.11.6
Reactions were carried out in a 96 well microplate, sealed with a clear plastic optical lid 
using an Applied Biosystems 7000 real time PCR machine. The programme consisted 
of the following steps:
1. 50°C for 2 minutes
2. 95°C for 10 minutes
3. 95 °C for 15 seconds
4. 60 °C for 10 seconds
5. Repeat steps 3 and 4 40-45 times
For each sample,  2  wells were prepared with target primers  and probes and 2 with 
reference (GAPDH) primers and probes. Two different negative controls were run; no 
cDNA (water), and RNA only (noRT).
124Methods
3.12.11  Real time PCR data analysis
Following the PCR reaction the amplification curves for each sample were examined. 
Fig. 3.6 shows the typical shape of an amplification curve, together with some examples 
of the curves obtained in this study. As shown in Fig 3.6.A, the real-time PCR machine 
provides a measurement of ARn, which is the  emission intensity of the reporter dye 
normalised to a passive reference dye incorporated in each reaction mix to control for 
loading variations. It was first necessary to calculate which cycles should be considered 
to  represent  the  baseline  value  for  the  background  signal.  This  was  achieved  by 
determining  when the  first  sample  appeared to  emerge  above  the baseline,  and the 
default settings were adjusted accordingly. For each experiment and each gene it was 
next necessary to set the threshold ARn level (see green lines in Fig 3.6.B and C), which 
was used to determine the cycle number at which each sample is amplified significantly 
above  baseline.  This  was  set  within  the  exponential  phase  of the  reaction,  above 
background.  The Applied Biosystems software then calculated the Ct value for each 
well, which is the cycle number at which each sample reaches the threshold.  The Ct 
value  is related to  the  starting quantity  of mRNA as outlined  in section 3.11.12.  A 
reference gene, GAPDH, was used in order to normalise the values obtained according 
to the starting cDNA concentration.
Gene expression levels were compared using the comparative Ct method (ABI User 
Bulletein #2 docs.appriedbiosystems.com/pebiodocs/04303859.pdf). The derivation of 
this  method  is  outlined below.  Briefly,  for each experiment three  separate pools of 
samples were used, and two replicate wells were run per sample. The Ct of each sample 
(see above) was normalised to GAPDH levels by subtracting the Ct of that sample with 
the reference (endogenous control, GAPDH) gene from the Ct with the target gene, to 
give  a value which is termed  ACt (equation 6 below).  The  samples were then each 
normalised relative to a ‘calibrator’ sample (the calibrator was the mean ACt of one of 
the experimental groups, such as the earliest developmental stage or the sham operated 
group) by subtracting the ACt of each sample from the ACt of the calibrator to give a 
value which is termed AACt (see equation 8 below). Each sample was then expressed 
individually  as  ‘relative  expression’  (relative to the  calibrator))  using the  following 
equation:  Relative expression =  2M Cr
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Fig. 3.6. Real-time PCR amplification  curves. A)  Schematic diagram 
illustrating  the  key  features  of a  typical  real-time  PCR  amplification 
curve (adapted from Applied Biosystems TaqMan protocol).  B) and C) 
Representative examples  of graphs plotting  cycle  number against  ARn 
obtained during a real-time PCR run with GAPDH (B) and Urokinase (C)
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The mean relative expression was then determined for each experimental group. This 
method of data analysis is based on the method described by Livak and Schmittgen, 
2001 (Livak and Schmittgen 2001).
3.12.12  Derivation of the 2~aaCT equation
The following derivation is reproduced from the Applied Biosystems User Bulletin 2 
(P/N 4303859).
The equation which describes the exponential amplification of PCR is:
X n  = X 0  x (l + Ex y  [equation 1]
Where:
Xn  = no of target molecules at cycle n 
X0 = initial number of target molecules 
Ex = efficiency of target amplification 
n  = number of cycles
The threshold cycle (Ct) indicates the fractional cycle number at which the amount of 
amplified target reaches a fixed threshold. Thus,
X T  = X 0 x (l + EX JT X  =   Kx  [equation 2]
Where:
Xt  = threshold number of target molecules 
Cj;x = threshold cycle for target amplification 
Kx  = constant
A similar equation for the endogenous reference reaction is:
Rt =R0x(]l + Er J ™  = Kr  [equation 3]
Where:
R t = threshold number of reference molecules 
Ro = initial number of reference molecules 
Er = efficiency of reference amplification 
C t,r = threshold cycle for reference amplification 
K r = constant
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Dividing Xt by Rt gives the following expression
Xr  X„x(l + E j™   k x  k
Rr  R0 x(l + Er)€”   K
[equation 4]
The exact values of Xt and Rt depend on a number of factors including the reported dye 
used in the probe,  the  sequence context effects  on the fluorescence properties  of the 
probe,  the  efficiency  of  probe  cleavage,  purity  of  the  probe  and  setting  of  the 
fluorescence  threshold.  Therefore,  the  constant  K  does  not  have  to  be  equal  to  1. 
Assuming efficiencies of the target and the reference are the same:
The final step is to divide the Xn for any sample q by the Xn for the calibrator (cb)
concentrations have been optimised, the efficiency is close to  1. Therefore, the amount 
of target, normalised to an endogenous reference and relative to a calibrator is given by:
Ex = Er = E
^ -x (l + E)Cr*'Cr*   =K 
Ro
[equation  5]
Or
[equation  6]
Where:
Xn = Xo/Ro, the normalised amount of target
A C t = C t,x -  C t,r, the difference in threshold cycles for target and reference
Rearranging gives the following expression:
XN  =Kx(l + E)-iC r [equation 7]
[equation  8]
Where:
AACt = AGr.q -  ACT.cb
For  amplicons  designed  to  be  less  than  150bp  and  for  which  the  primer  and  Mg2+
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3.13.  Western blotting
3.13.1. Protein extraction for Western blotting
For Western blotting, tissues were collected and rapidly frozen using dry ice and stored 
at -80°C until required. Tissues were homogenised in  1ml ice-cold protein extraction 
buffer  with  added  proteinase  inhibitors  to  prevent  protein  degradation,  by  passing 
repeatedly through progressively smaller gauge needles. The homogenates were placed 
on  ice  for  30  minutes  then  centrifuged  at  12,000g  for  30  minutes  at  4°C.  The 
supernatants, containing the protein extract, were collected and stored in aliquots at -80 
°C until required.
3.13.2. Protein Assay
Protein  concentration  was  determined  using  a  BCA™  Protein  Assay  Kit  (Pierce, 
Rockford, IL), which is based on an adaptation of the biuret method in which Cu2+ is 
reduced to Cu1 +  by protein (Smith et al.  1985). The formation of Cu1 +  is detected by the 
formation  of a  soluble  purple-coloured  complex  when  Cu1 +   reacts  with  a  reagent 
containing bicinchoninic  acid (BCA).  The  formation of the reaction product can be 
determined by absorbance at approximately 562nm.
A series of protein standards ranging from 0-2mg/ml were prepared by diluting albumin 
stock solution (2mg/ml) in protein extraction buffer. Samples were generally diluted 1:5 
with dP^O for the assay. 25pi of standards or diluted samples was added to individual 
wells  of a  96-well  tissue  culture  plate  in  duplicate.  Reagent  A  (sodium  carbonate, 
sodium bicarbonate, BCA and sodium tartrate in 0.1 M sodium hydroxide) and Reagent 
B (4% cupric sulphate), were combined at ratio of 50 parts A to  1  part B. 200pl of this 
mixture was added to each well and the plate was placed on a horizontal shaker for 30 
seconds to ensure adequate mixing, before incubation at 37°C for 30 minutes. After 
cooling to room temperature, which reduces the rate of reaction to negligible levels, the 
absorbance  at  560nm  was  determined  using  a  microplate  reader.  Background 
absorbance was corrected for by subtracting the OD of the ‘blank’ wells from each of 
the standard or sample values. A standard curve was produced by plotting the average
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OD  of replicates  against  BSA  concentration.  The  standard  curve  was  then  used  to 
determine protein concentration of the unknown samples.
3.13.3. Alkaline Phosphatase treatment of protein samples
To remove phosphate groups from proteins several samples were treated with alkaline 
phosphatase.  lOpl of protein (2pg/pl) was mixed with 2\x\  lOx alkaline phosphatase 
reaction buffer, 7pl distilled H2O and  1  pil calf intestinal alkaline phosphatase (20U/pl). 
The  samples  were  incubated  at  37°C  for  30  minutes  before  proceeding  with  gel 
electrophoresis. Control samples were treated as above but had the alkaline phosphatase 
replaced with water.
3.13.4. SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE)
In order to investigate the protein samples for the levels of individual proteins, they 
were  separated  by  denaturing  gel  electrophoresis.  In  this  procedure,  total  protein 
extracts  are  denatured  by  boiling  in  a  loading  buffer  which  contains  SDS  and  p- 
mercaptoethanol.  In addition,  SDS causes the proteins to be  ‘coated’  with a negative 
charge  that  is  directly  proportional  to  the  molecular  weight  of the  protein.  In 
combination,  this  means  that,  when  run  under  denaturing  conditions,  to  prevent 
secondary structures from reforming, proteins migrate down a gel towards a positive 
electrode, with the rate of migration being determined solely by the molecular weight of 
the protein.
Gel casting
A gel cast was prepared by placing two clean glass plates, one large and one slightly 
smaller, on top of each other, separated by  1mm thick gel spacers at either side. This 
was fastened into a gel casting frame and dH2C ) was poured in to ensure that the mould 
was properly sealed. The water was then tipped out of the mould. A 12% resolving gel 
was prepared using the following reagents:
Distilled H20  3.3ml
30% acrylamide  4.0ml
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1.5M Tris pH 8.8  2.5ml
10% SDS  0.1ml
10% ammonium persulphate  0.1 ml 
TEMED  0.004ml
The  gel  was  mixed  briefly  and  then  poured  into  the  mould,  filling  to  a  level 
approximately 4 cm below the top. A layer of isopropanol was poured on top of the gel. 
This helps to flatten the surface of the gel and prevents air reaching the gel, which aids 
setting. The gel was allowed to set for at least 30 minutes and the isopropanol was then 
poured off and the gel was rinsed with distilled H2O. A 5% stacking gel was prepared 
from the following reagents:
Distilled H20   1.4ml
30% acrylamide  0.33ml
1.0M Tris pH 6.8  0.25ml
10% SDS  0.02ml
10% ammonium persulphate  0.02ml 
TEMED  0.02ml
The stacking gel was poured into the mould, on top of the resolving gel. A 1mm thick 
gel comb was inserted into the stacking gel and the level of the gel was topped up to the 
top of the mould. The stacking gel was allowed to set for a further 30 minutes.
Sample preparation
The protein samples were diluted to  lpg/pl in distilled H20.  The samples were then 
mixed  1:1  with protein loading buffer and heated at  100°C for 10 minutes to denature 
the proteins. The samples were then placed on ice until ready for loading.
Electrophoresis
Once the gels were set, the casting mould was attached to a gel frame and placed in an 
electrophoresis tank. The comb was gently removed and distilled H20  was used to rinse 
any bubbles out of the wells. The central and outer reservoirs of the tank were filled 
with lx running buffer.  lOpl of protein standards was loaded into the first well and 15 pi
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of each  sample  was  loaded  into  the  remaining  wells.  The  gel  was run at  120V  for 
approximately 2 hours.
3.13.5.  Western transfer and blotting
Following  SDS  page,  the  separated  proteins  were  transferred  to  a  nitrocellulose 
membrane by Western blotting. In this process, the proteins become attached strongly to 
the membrane according to their precise position in the gel. The membrane can then be 
probed using antibodies specific to the protein of interest in order to visualise protein 
levels.
Western transfer
After removal from the electrophoresis apparatus the gel was placed into transfer buffer. 
The  gel was then placed on top of two  sheets of filter paper,  and the nitrocellulose 
membrane was placed on top of the gel. Both the filter paper and the membrane were 
pre-soaked in transfer buffer. Two more sheets of filter paper were placed on top of the 
membrane and then the paper, gel and membrane were  sandwiched between the two 
electrodes,  so  that  the  gel  was  towards  the  anode  and  the  membrane  towards  the 
cathode.  This was placed into the tank, filled with transfer buffer. The proteins were 
transferred for 2  hours at  100-200 mA at 4°C.  Following transfer the apparatus was 
disassembled  and the  membrane was marked,  by  cutting  off one  comer, to provide 
orientation. In order to determine equal protein transfer, the membrane was incubated 
with a general protein stain, Ponceau S solution, for  10 minutes. The membrane was 
rinsed briefly in TBS, wrapped in clean Saran Wrap and an image was captured using a 
flat bed scanner.
Probing the blot
The membrane was rinsed in TBS to remove the staining and then incubated in blocking 
buffer overnight at 4°C  to  block hydrophobic binding  sites  on the membrane.  After 
briefly washing in TBS with 0.05% Tween, the membrane was sealed in a small plastic 
bag with 2ml primary antibody (Table 2.3, page  90), which was diluted in blocking 
buffer.  In  some  controls,  the  primary  antibody  was  pre-incubated  with  equivalent 
amounts of a blocking peptide before being applied to the membrane. The membrane 
was incubated for 2 hours at room temperature on a horizontal shaker. Non-specifically
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bound primary  antibody was  removed by  washing for six  10 min.  changes in wash 
buffer.  The  membrane  was  then  incubated with an HRP-linked  secondary  antibody 
(Table 2.4, page 91), diluted in blocking buffer for  1   hour at room temperature. Non- 
specifically bound secondary antibody was removed with six  10 min. washes in wash 
buffer,  followed  by  two  5  min.  washes  in  TBS.  To  visualise  antibody  binding the 
membrane was incubated with a chemoluminescent substrate, which emits light when 
oxidised in a reaction catalysed by HRP.  The membrane was placed in a clean petri 
dish.  A  1:1  mix  of ECL  components  was prepared and poured over the membrane, 
ensuring the whole  surface was covered.  After  1   min., the membrane was removed, 
blotted  to  remove  excess  reagents,  and  wrapped  in  cling  film.  In  a  dark  room, 
photographic film was exposed to the membrane for intervals of up to  lOmin. before 
developing and fixing with a film processor.
3.14.  Thrombin Activity Assay
3.14.1. Protein extraction for activity assay
For activity assays tissues were collected and rapidly frozen using dry ice and stored at - 
80°C  until  required.  They  were then homogenised  on  ice  in 400ul  assay  buffer by 
drawing  the  solution  in  and  out  of  progressively  smaller  gauge  needles.  The 
homogenates were centrifuged at  12,000g for 30 minutes at 4°C and the supernatants, 
containing the protein  extract,  were  collected and  stored in aliquots at -80  °C until 
required. Protein concentration was determined as described in section 3.12.2.
3.14.2. Activity assay
The  activity  of thrombin  was  measured  using  a  chromogenic  substrate  specific  to 
thrombin, D-Phe-Pip-Arg-p-nitroanilide (CS-01(38)).  When cleaved by thrombin this 
substrate releases a coloured reaction product, p-nitroanilide (pNA), producing a change 
in absorbance which can be measured and is proportional to thrombin activity (Fig 3.7). 
The protocol for this assay was adapted from that described by Smirnova et al, 1996.
In order to confirm the linearity of the reaction, a standard curve of bovine thrombin 
ranging from 0.00002U/pl to 0.00lU/pil was prepared in assay buffer and run alongside
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Fig. 3.7. Principles of thrombin activity assay. The semi-specific 
thrombin substrate CS(01)38  releases p-nitroanilide on cleavage by 
thrombin. This results in a measurable change in the optical density 
of the solution. The highly specific thrombin inhibitor, hirudin, can 
be  used  to  block  thrombin  activity,  allowing  the  determination  of 
non-specific cleavage of the substrate by other proteases.
134Methods
the experimental samples. The assay was carried out by incubating lOpl of the standards 
or 30pl of samples (approx  150pig/ well) with 50pl of the substrate (lmg/ml) in a total 
volume of 200pd for 30 minutes at 37°C in a 96 well plate. Following the incubation 
period the  absorbance  at 410nm  was  measured on a microplate reader.  Blank wells 
contained the substrate only, and were subtracted from all other values. To control for 
non-thrombin specific  activity,  in  some  wells each sample was incubated with 30pl 
hirudin,  a thrombin  specific  inhibitor.  The  absorbance  recorded in these  wells  was 
subtracted from the relevant sample values to give a final measure of thrombin specific 
activity.
3.15.  Statistical Analysis
All statistical analysis was performed using SPSS version 12 (SPSS, Woking, UK). The 
statistical support service at the Centre for Paediatric Epidemiology and Biostatistics, 
ICH also provided helpful assistance in the choice of statistical tests.  Since sample 
sizes were necessarily small in most of the experiments described in this study, it was 
not possible to estimate the distribution of the population from which the samples were 
taken. Because it was not possible to assume a normal distribution on the basis of these 
sample sizes, non-parametric statistical analyses were used wherever possible.  For all 
statistical  tests  significance  was  set  at  a p  value  of 0.05  or  less.  For analysis  of 1  
variable between 2  independent experimental  groups, the data were compared using 
Mann Whitney Tests (Mann and  Whitney  1947).  For analysis of 1   variable between 
several  groups,  a  Kruskal-Wallis  test  was  performed  (Kruskal  and  Wallis  1952). 
Following  the  Kruskal-Wallis  test,  in  order  to  test  the  significance  of differences 
between individual pairs of experimental groups, Mann Whitney Tests were performed. 
The p value was then multiplied by the total number of possible pairs which could be 
compared,  according  to  the  Bonferroni  adjustment,  which  takes  into  account  the 
increased probability of finding a difference between a pair of groups when multiple 
comparisons are being made.
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4.1 Introduction
A  major  focus  of much  spinal  cord  injury  research  has  been  to  understand  the 
mechanisms which directly promote or impair axonal regeneration in the injured spinal 
cord (Sandvig et al.  2004). However, successful axonal regeneration also depends upon 
the  presence  in the  spinal  cord  of surviving neurons that can participate  in this re­
growth. It is clear, therefore, that the extent of cell death and the capacity of spinal cord 
cells to survive an insult are likely to be important contributors to the success or failure 
of  any  such  regeneration.  How  changes  in  these  factors  contribute  to  loss  of 
regenerative capacity in the chick spinal cord has not been investigated in detail and 
may provide information about the contribution of such mechanisms to the response of 
non-regenerative systems, such as the adult human spinal cord.
Following primary mechanical damage to the spinal cord, tissue damage and cell death 
are  progressively  expanded by  various  pathological  events  which  contribute to the 
secondary injury (Dumont et al.  2001). One of the earliest secondary injury events is 
haemorrhage within the spinal cord, which occurs as a direct result of the mechanical 
damage to the  delicate blood vessel network of the  spinal  cord (Tator and Fehlings 
1991; Mautes et al.  2000). The importance of such haemorrhage to spinal cord damage 
is indicated by the formation, at later stages, of cavitation within the cord which closely 
matches  the  early  spread  of haemorrhage  (Noble  and  Wrathall  1989b;  Noble  and 
Wrathall 1989a; O'Neill 2002; Velardo et al. 2000). In addition to the loss of spinal cord 
cells, the formation of such cavities is itself a physical inhibitor to axonal re-growth. 
Haemorrhage within the cord leads to ischemic damage and consequent cell death by 
both necrotic and apoptotic mechanisms and exposes neurons and glia to a range of 
potentially toxic molecules and cell types which are normally excluded by the intact 
blood brain barrier (Dumont et al. 2001; Tator and Fehlings 1991).
Previous work in this laboratory has demonstrated an association between the loss of 
regenerative capacity in the chick at around E l3  and an increase in secondary injury 
damage  and  apoptosis  in the  spinal  cord  (O'Neill  2002;  Whalley et al.  2006).  This
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increase  in cell  death and tissue  damage  is likely to  be  an important contributor to 
reduced regenerative capacity in the post-El3 spinal cord. In particular, an increase in 
haemorrhage  within the  spinal  cord  after injury  was  observed to  correlate with the 
developmental change from regeneration competent to incompetent stages. A dramatic 
increase in the vascularisation of the spinal cord was demonstrated to occur between 
Ell  and E l5, which is likely to account for the increased haemorrhagic response, and 
therefore may be a key factor in the loss of regenerative ability. There are evidently 
numerous additional changes occurring within this developmental window that might 
contribute  to  increased  cell  death.  However,  the  link  between  haemorrhage  and 
apoptosis was  strengthened further by the observation that diazepam administration, 
which increased the extent of haemorrhage within the cord by unknown mechanisms, 
produced a large apoptotic response in the E ll  spinal cord after injury; a situation in 
which cell death is normally low (O'Neill 2002; Whalley et al. 2006).
In order to validate the experimental model to be used and to check for any variations in 
surgical technique between myself and other investigators this project began with an 
initial  attempt to  replicate  some  of these results,  before  further investigation of the 
underlying mechanisms. The previous findings were highly suggestive of a causal link 
between  haemorrhage  and  apoptosis  but  did  not  address  the  effects  of reducing 
haemorrhage on consequent tissue damage and cell death in a system in which apoptosis 
is normally high.  The work described in this chapter therefore aimed to continue the 
study by devising a pharmacological method to reduce haemorrhage at regeneration- 
incompetent stages and to assess its effects on the apoptotic response and the extent of 
spinal cord damage. To this end, a haemostatic drug, the synthetic vasopressin analogue, 
desmopressin, which is used in the treatment of haemophilia, was selected for use in 
these experiments (Kaufmann and Vischer 2003; Mannucci, 2000). Next, the molecular 
pathways involved in the apoptotic response at non-regenerating stages were explored 
by  investigating the  effects  of an  irreversible  caspase-3  inhibitor on apoptosis after 
injury.
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4.2.  Results
4.2.1. Comparison of the response of the chick spinal cord to injury at E ll and E15
The  surgical  techniques  which  are  used  in  this  study  are  an  adaptation  of  those 
described by Shimizu and colleagues in studies in which the initial observations of loss 
of  regenerative  capacity  were  made  (Shimizu  et  al.  1990).  In  previous  work  in  our 
laboratory,  a  detailed  study  of the  morphological  changes  occurring  after  transection 
injury  at  E ll  and  E15  was  carried out  (O'Neill  2002).  As  the current  study  aimed  to 
follow  on  from these experiments,  it was first necessary  to confirm that the responses 
observed after injury were the same as those previously described.
Spinal  cord  transections  were  carried  out  at  either  E ll  or  E l5,  and  tissues  were 
collected at either 24 hours or 4 days after injury.  Sham operated controls consisted of 
embryos  in  which  the  egg  was  windowed  and  all  manipulations  were  identical  to  the 
injured  embryos  except  the  injury  itself.  It  was  found,  throughout  the  course  of this 
study  that survival rates after injury were typically lower at E ll  than at E15.  Survival 
was  also  reduced  at  4  days  after  injury  at  both  stages  in  comparison  to  earlier  time 
points.  These  observations  are  in  agreement  with  findings  by other groups  and in our 
own laboratory (O’Neill 2002; Shimizu et al.  1990).
Longitudinal  sections  were  stained  with  haematoxylin  and  eosin  (H&E)  in  order  to 
examine  morphological  changes  after  injury.  Twenty-four  hours  after  injury  to  the 
spinal  cord  at  Ell,  a  relatively  small  and  localised  injury  was  typically  observed, 
extending less then 500 pm rostrally and caudally from the injury site, as shown in Fig.
4.1.B.
Fig.  4.1  (next  page)  Analysis  of  morphological  changes  after  injury  at  E ll.
Longitudinal  sections of spinal  cords collected  at  various  time  points after transection 
injury at Ell, stained with haematoxylin and eosin (H&E) to illustrate morphology. A) 
Sham  operated  control  spinal  cord  at  El2.  *  -  ependymal  region  around  the  central 
canal, G -  grey matter, W - white matter B) Spinal cord twenty four hours after injury. 
The injury site is shown by the arrow. Asterisk indicates a sectioning artefact. B’) High 
magnification  view  of the  injury  site  at  24  hours.  C)  H&E  staining at  four days  after 
injury. The injury site is shown by the arrow. C’) High magnification view of the injury 
site at 4 days. The injury site is shown by the arrow. Scale bars: A,B,C =  1   mm. B’, C’ 
=250 pm
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A small amount of haemorrhage, close to the injury site could be observed (Fig. 4.1.B’); 
however there was little evidence of cavitation at this stage. By 4 days after injury at 
E ll  the  injury  appeared to  have  almost completely  repaired  with  very  little  evident 
tissue damage, as shown in Fig. 4.I.C. In many cases it was difficult to determine the 
original injury site; however in some cases the position of re-connected stumps could be 
observed (Fig. 4.1.C’).
The response to injury at E15 was markedly different to that at El 1. Twenty-four hours 
after  injury  at  E15  there  was  typically  a  large  amount  of tissue  damage,  extending 
several  millimetres  rostrally  and  caudally  from  the  transection  site,  accompanied  by 
extensive haemorrhage as shown in Fig. 4.2.B. In many cases the extensive nature of the 
tissue damage made it impossible to determine the exact injury site. Fluid-filled cavities, 
containing blood cells and tissue debris, had begun to form in the spinal cord. By 4 days 
after injury at E15 tissue damage was still extensive, with little evidence of repair, and 
large cavities, several millimetres long, had formed within the cord (see Fig. 4.2.C).
In  order  to  detect  apoptosis,  TdT-mediated  dUTP  nick-end  labelling  (TUNEL)  was 
carried  out  in  consecutive  sections  to  those  stained  for  morphological  analyses. 
Negative  control  sections  from  the  same  embryos,  in  which  the  TdT  enzyme  was 
omitted from the reactions, showed no fluorescent staining, demonstrating lack of non­
specific  binding  (Fig.  4.3.D).  Similarly,  in  sham  operated  control  samples,  TUNEL 
staining was negative, indicating an absence of false positive staining (Fig. 4.3.E and 
Fig. 4.4.C). In order to validate the specificity of the TUNEL staining for apoptosis the 
nuclear morphology of TUNEL positive cells was examined by staining with Hoechst 
dye (see Fig. 4.3.B and Fig. 4.3.C), revealing condensed and fragmented nuclei typical 
of apoptosis.
TUNEL  staining  in  longitudinal  sections  demonstrated  marked  differences  in  the 
apoptotic  response  between  E ll  and  E15.  Twenty-four  hours  after  injury  at  Ell, 
TUNEL positive cells were localised close to the injury site (Fig. 4.3.A). The apoptotic 
region corresponded closely to the region showing evident morphological damage and 
haemorrhage  (Fig.  4.1.B).  In contrast,  24 hours  after injury  at E l5,  TUNEL  staining 
demonstrated a large apoptotic response that extended several millimetres rostrally and 
caudally from the injury site (Fig 4.4.A and Fig. 4.4.B), again corresponding closely to
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Fig. 4.2. Analysis of morphological changes after injury at E15.
Longitudinal  sections  of  spinal  cords  collected  at  various  time 
points  after  transection  injury  at  E l5,  stained  with  Haematoxylin 
and  Eosin  (H&E)  to  illustrate  morphology.  A)  Sham  operated 
control spinal cord at El6. B) Spinal cord 24 hours after injury. The 
precise injury site cannot be determined due to the extensive nature 
of the injury. C) Spinal cord 4 days after injury. Large cavities are 
indicated by asterisks Scale bars = 1  mm.
141Fig.  4.3.  Analysis  of the  apoptotic  response  to  injury  at  E ll.  A)  TUNEL  staining 
(green) in a longitudinal section of spinal cord at 24 hours after transection injury at El 1. 
The injury site is shown by the arrow. B) and C) nuclear morphology of apoptotic cells 
stained with TUNEL (B) and Hoechst (C) D) Negative control is a section from the same 
embryo as in A in which the TdT enzyme is omitted to control for non-specific labelling 
E) TUNEL staining in sham operated control spinal cord  at El2.  Scale bars A,D,E =  1  
mm  (D  is  the  same  magnification  as  A).  B,C  =  4pm  (B  and  C  are  the  same 
magnification.Fig.  4.4.  (facing)  Analysis  of  the  apoptotic  response  to  injury  at  E l5.  A)
TUNEL  staining (green) in a longitudinal section of spinal cord at 24 hours after 
transection injury at E l5. A’) Enlarged image showing TUNEL staining in A. B) 
TUNEL staining in a longitudinal section of spinal cord at 4 days after transection 
injury at E l5.  C) TUNEL  staining in sham  operated control spinal cord  at E l6 . 
Scale bars = 1mm.
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the extent of haemorrhage and tissue damage within the cord (Fig.  4.3.B).  By 4 days 
after injury at E15 there was still evidence of apoptosis; however the apoptotic response 
was reduced as compared to 24 hours, with the most intense TUNEL staining observed 
in tissue ‘islands’ within the cavities (Fig 4.4.C).
The morphological and apoptotic responses to injury observed were therefore similar to 
those previously described, suggesting that the techniques were adequate for continuing 
this  study,  and  supporting  the  previously  recorded  relationship  between  extent  of 
haemorrhage after injury and the apoptotic response.
4.2.2.  The effects of desmopressin on haemorrhage after injury at E15
To further investigate the previously described relationship between haemorrhage and 
apoptosis  after injury  a series  of experiments  was  carried out  to reduce  haemorrhage 
after  injury  at  El5,  using  the  haemostatic  compound  desmopressin.  Initially,  it  was 
necessary  to  determine  whether  desmopressin  treatment  could  effectively  reduce 
haemorrhage  after  injury  without  causing  overt  toxicity  and  to  determine  the  most 
effective  dose  of the  drug.  Since  desmopressin  can  be  administered  to  haemophiliac 
patients via a nasal spray, it seemed likely that the drug would be readily absorbed by 
the blood vessels within the chorioallantoic membrane (Lethagen 2003).  Haemorrhage 
occurs  within  the cord almost immediately  after injury  (O'Neill  2002).  Therefore,  the 
effects of three different doses of desmopressin, 7.5, 75 and 150 pg/ml, on haemorrhage 
were  initially  assessed  at  2  hours  after  injury.  A  dose  of  150  pg/ml  desmopressin 
administered just prior to the injury appeared to be effective in reducing haemorrhage 
and  was  therefore  used  in  all  further experiments.  No  noticeable  toxic  effects  of the 
drug were observed.
In  order  to  quantitatively  examine  the  effect  of  desmopressin  on  the  extent  of 
haemorrhage,  the  spinal  cord  was  examined  12  hours  after  a  transection  injury  and 
simultaneous  treatment  with  desmopressin  or  its  vehicle,  phosphate  buffered  saline 
(PBS). This time point was selected as optimal for both the apoptotic response, which 
was  previously  demonstrated to  begin  at  around  8  hours  after injury,  and  in  order to 
examine a relatively early time point within the course of the secondary injury response
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when haemorrhage would still be present in the cord (O'Neill 2002). H&E staining was 
carried  out  on  longitudinal  sections  of  the  spinal  cord  and  composite  images  were 
created in order to examine morphology. Serial sections taken every 80 pm through the 
spinal  cord  were  stained  and  sections  corresponding  to the  centre of the  injury  were 
chosen  for  further  analysis.  Any  samples  for  which  the  injury  site  could  not  be 
adequately  determined  due  to  an  ineffective  injury  or  a  very  extensive  injury  were 
excluded from measurements.
As  illustrated  in  Fig  4.5.A,  in  PBS  treated  embryos  the  injury  produced  extensive 
haemorrhage and tissue disruption  within  the cord by  12  hours.  Of the  desmopressin 
treated group, 4 out of 6 of the embryos had noticeably reduced lesions, with very little 
damage in comparison to the PBS treated group (see Fig. 4.5.B and Fig. 4.5.C). In order 
to assess the extent of haemorrhage in injured spinal cords, the longitudinal extent to 
which haemorrhage extended in each direction from the injury site was measured (Fig. 
4.5.A) and was found to be 4.96±0.53cm (mean ± SEM, n=3) in PBS treated cords at 12 
hours after injury. Haemorrhage in the desmopressin treated group as a whole extended 
to 2.94±1.86cm (mean ± SEM n=6), which was not statistically different from the PBS 
treated group (p=0.197, Mann Whitney Test). However, in the smaller group consisting 
of the 4  embryos  in  which  there  was  a  noticeable  difference  in  the  extent  of injury, 
haemorrhage was significantly reduced in comparison to controls (1.83±0.71, p=0.034, 
Mann  Whitney  Test).  This  sub-group was  subsequently  classified  as  ‘desmopressin  - 
reduced haemorrhage’  for further analysis, in which the aim was to examine the effects 
of reduced haemorrhage on apoptosis.
4.2.3 The effects of desmopressin on the apoptotic response 12 hours after spinal 
cord injury at E15
To determine the effect of reduced haemorrhage on apoptosis, consecutive longitudinal 
sections  to  those  stained  for morphological  analyses  in  section 4.2.2  were  stained by 
TUNEL.  TUNEL  staining  in  the  PBS  treated  group  revealed  extensive  apoptosis 
extending  several  millimetres  rostrally  and  caudally  from  the  injury  site  at  12  hours 
after injury at El5, as shown in Fig. 4.6.A. In the reduced haemorrhage group, TUNEL 
staining was more localised to the injury site, as shown in Fig. 4.6.B and 4.6.C. In all
145Fig 4.5. Analysis of  the effects of desmopressin treatment on haemorrhage  12 hours after injury at E15.  Longitudinal  sections of 
spinal cord  stained with Haematoxylin and Eosin,  12 hours after injury at E l5. A)  Section from embryo treated with vehicle.  B) and C) 
Sections from embryos treated with desmopressin. The extent of haemorrhage within the spinal cord is reduced by desmopressin treatment 
Injury sites are indicated by arrows. The cranial and caudal extent of haemorrhage in each case are indicated by asterisks. Scale bars  = 1mmFig 4.6. Analysis of the effects of desmopressin treatment on apoptosis  12 hours after injury at E15. Longitudinal  sections of 
spinal cord stained by TUNEL for apoptotic cells, 12 hours after injury at El5. A) Section from embryo treated with vehicle B) and C) 
Section from embryo treated with desmopressin. The apoptotic response to  injury  was reduced by  desmopressin treatment.  Injury 
sites are indicated by arrows. Scale bars  = 1mmPharmacological reduction of haemorrhage after injury in the non-regenerating chick spinal cord
cases the extent of TUNEL staining closely corresponded to the extent of haemorrhage 
within the spinal cord.
In order to quantify changes in the apoptotic response, a scoring system, based on the 
intensity of TUNEL staining was devised, using the criteria shown in Fig. 4.7. TUNEL 
staining  was  scored  at  1   mm  intervals  in  both  directions  from  the  injury  site  in 
longitudinal sections of the spinal cord. Mean values for each cord were then averaged 
within  each  of  the  three  groups;  PBS  treated,  desmopressin  treated  and  the 
‘desmopressin -reduced haemorrhage’ sub-group. As shown in Table 4.1, although there 
was a reduced TUNEL score in the desmopressin treated group as compared to the PBS 
treated  group  this  did  not  reach  statistical  significance.  However  the  reduced 
haemorrhage sub-group had significantly lower TUNEL scores at  1, 2 and 4 mm from 
the injury site as compared to the PBS treated group.
4.2.4.  The effects of desmopressin on cavitation and axonal damage 4 days after 
spinal cord injury at E15
To assess the effects of reduced haemorrhage on long-term survival and tissue damage, 
spinal cords were collected 4 days after a transection injury at E l5 and treatment with 
desmopressin or PBS, and longitudinal  sections were stained with H&E. As shown in 
Table  4.2,  the  survival  rate  at 4  days  was  67%  for desmopressin  treated  embryos  as 
compared to 45%  for PBS  treated controls.  At 4 days after injury, large cavities were 
present in many of the PBS treated controls (Fig. 4.8.A and 4.8.B). Although cavitation 
was also present in one sample from the desmopressin treated group, as shown in Fig. 
4.8.C, overall there appeared to be reduced tissue damage in these samples, as shown in 
Fig.  4.8.D.  Cavitation  was  measured  as  the  total  longitudinal  length  of the  cavity  in 
sections taken from approximately the centre of the injury. The number of embryos with 
a  cavity  at  least  1mm  in  length  was  counted  and  was  found  to  be  reduced  in  the 
desmopressin treated group to 13% in comparison to 60% in controls (Table 4.2.).
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Fig.  4.7.  Scoring  criteria  used  for  quantification  of  TUNEL 
staining.  Panels  represent  the  approximate  density  of  TUNEL 
staining  receiving  each  score  in  PBS  and  desmopressin  treated 
spinal cords after  injury.
Treatment
group
TUNEL Score
Injury
site
+lmm +2mm +3mm +4mm +5mm
PBS 4±0 4±0 3.7 ± 
0.3
2.7± 0.9 3 ±0.6 1.7±0.3
Desmopressin 3.1  ±02 3±0.4 2 .2±0 .6 1.8±0.5 1.7±03 1.5±0.3
Desmopressin
(reduced
haemorrhage)
3.5±0.3 2.5±0.3
*
1.3±0.3
**
1.3±0.3 1.3±0.3
***
1.3±0.3
Table 4.1. Quantification of apoptosis in spinal cord slices 12 hours after 
injury  at  E15  and  treatment  with  PBS  or  desmopressin.  Apoptosis  is 
scored according the criteria illustrated in Fig. 4.7., below, at 1   mm intervals 
from  the  injury  site.  Data  shown  are  mean  apoptotic  score  ±  SEM. 
Desmopressin treatment reduced haemorrhage in 4 out of 6 embryos, which 
are  included  in  a  sub-group  named  'reduced  haemorrhage’  for  further 
analysis.  There was a significant reduction  in  apoptosis  at  1mm,  2mm  and 
4mm from the injury site in the reduced haemorrhage group as compared to 
the PBS treated group. * p = 0.025, ** p=0.026, *** p=0.042 (Mann Whitney 
Test). All other p values were greater than 0.05.
149Fig.  4.8.  Analysis  of the  effects  of desmopressin  treatment  on  cavitation  and  tissue  damage  4  days  after  injury  at  E15.
Longitudinal sections of spinal cord stained with Haematoxylin and Eosin 4 days after injury at El 5. A) and B) Sections from embryos 
treated with vehicle. C) and D) Sections from embryos treated with desmopressin. The number of samples in which large cavitation 
was observed was reduced in desmopressin treated animals. Cavities are indicated by asterisks and in D) the injury site is indicated by 
an arrow. Scale bars = 500 pmPharmacological reduction of haemorrhage after injury in the non-regenerating chick spinal cord
In  order  to  examine  the  effects  of  desmopressin  on  axonal  integrity,  consecutive 
sections  to  those  stained  for  H&E  were  stained  using  an  antibody  against 
neurofilaments, RM-270. Surviving intact neuronal bodies were in some cases observed 
close to cavities (Fig. 4.9. A and Fig. 4.10. A.), however a number of features of neuronal 
damage were also observed, including fragmented axons (Fig. 4.9.A and Fig. 4.10.B). 
Also, as shown in Fig. 4.10.C and Fig. 4.10.D, axonal blebbing within the spinal cord, 
indicative of axonal deunage, was observed in several of the embryos. The number of 
embryos in which axonal blebs were observed was reduced in the desmopressin treated 
group to 25% in comparison to 60% in controls (Table 4.2). Neurofilament staining also 
revealed one case of axons partially crossing the injury site in a desmopressin treated 
embryo,  which  was  not observed in any  of the control embryos  (Fig.  4.9.B  and Fig. 
4.11).
4.2.5.  The effects of a caspase inhibitor on apoptosis after injury at E15
Caspase-dependent  apoptotic  pathways  have  been  implicated in  cell  death  caused by 
secondary  injury  mechanisms  (Springer  et  al.  1999).  However,  caspase-independent 
apoptotic pathways  have  also  been described  and  might  also  contribute to cell  death 
after  injury  (Abraham  and  Shaham  2004).  In  order  to  investigate  further  the 
downstream  pathways  involved  in  the  apoptotic  response  to  injury  in  the  non- 
regenerating chick spinal cord, the effects of an irreversible caspase-3 inhibitor, DEVD- 
FMK, on apoptosis after injury at E15  were examined. DEVD-FMK, at 0.5 mM or 2 
mM, or its vehicle, PBS, was administered at the time of injury. Tissue was collected 
after 18 hours and longitudinal sections were stained by TUNEL to detect apoptosis. As 
shown  in  Fig.  4.12.A,  in  PBS  treated  control  animals  extensive  apoptosis  could  be 
observed  expanding  for  several  millimetres  within  the  spinal  cord.  Sham  operated 
samples exhibited no TUNEL staining, confirming a lack of false positive staining (Fig.
4.12.B). Although the data obtained in this preliminary experiment was not quantitative 
due  to  the  low  sample  number,  in  samples  treated  with  2mM  DEVD-FMK  there 
appeared to be a visible reduction in the density of TUNEL staining (Fig. 4.12.C and
4.12.D).  However,  treatment  with  the  caspase-3  inhibitor  did  not  completely  inhibit 
apoptosis, suggesting that caspase-3 independent mechanisms might also be involved in 
the apoptotic response.
151Fig. 4.9. Analysis of the effects of desmopressin treatment on axonal morphology 4 days after injury at E15. Longitudinal sections of spinal 
cord stained for neurofilaments (in green) 4 days after injury at El 5. A) Spinal cord treated with vehicle at the time of injury. Axonal swelling can be 
observed close to the injury site (arrows) and interrupted axonal tracts are clearly visible running in the white matter next to the cavity (arrowheads). 
B)  Spinal cord treated with desmopressin at the time of injury. The injury site is indicated by an arrow. Note the absence of axonal swellings in this 
spinal cord. Scale bars = 500(LimFig. 4.10. Axonal damage four days after injury at E15. Neurofilament 
staining is shown in green and nuclear counterstaining in red in spinal cord 
sections 4 days after injury at E l5 and treatment with PBS. A) Surviving 
neuronal  cell  bodies  within  the  spinal  cord  indicated  by  arrows  B) 
Fragmented axons were found close to cavities indicated by arrows C) and 
D)  Examples  of  axonal  swellings  (arrowheads)  indicating  neuronal 
damage. Scale bars A,D =100 pm, B.C =  80 pm.Survival rate 
(survived/ 
operated)
Injuries > 1mm 
visible damage
Presence 
of axonal 
swellings 
in cord
PBS 5/11  (45%) 3/5  (60%) 3/5 (60%)
Desmopressin 8/12 (67%) 1/8 (13%) 2/8 (25%)
Table  4.2.  Quantification  of the  effects  of desmopressin  treatment  on 
outcome after injury at E15. The number of embryos surviving to four days 
after injury was expressed as  a percentage  of the total injured.  The size of 
visible  cavitation in longitudinal  sections  was  measured  and the number of 
embryos  having  a  cavity  larger  than  1mm  in  length  was  expressed  as  a 
percentage of the total. Finally, neurofilament staining was assessed and the 
number of embryos in which axonal swellings were observed was expressed 
as a percentage of the total. Desmopressin treatment improved outcome by all 
three measures.
154Fig.  4.11.  Analysis  of axonal  integrity  four days  after  injury  at  E15  and 
treatment with desmopressin. Neurofilament staining is shown in green and 
nuclear counterstaining in red in spinal cord sections 4 days after injury at E l5 
and  treatment  with  desmopressin.  A)  Axons  appeared  to  partially  cross  the 
injury  site  after  desmopressin  treatment  (arrows)  B-C)  High  magnification 
view of the areas boxed in A). Scale bars A = 125 pm, B,C =  40 pm.
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Fig. 4.12. (previous page) Analysis of the effects of a caspase inhibitor on apoptosis 
after  ipjury  at  E15.  Longitudinal  sections  of  spinal  cord  stained  by  TUNEL  for 
apoptotic cells  18 hours after injury at E l5  and treatment with the caspase-3  inhibitor 
DEVD-Biotin-FMK.  A)  Section  from  PBS-treated  injured  embryo.  B)  Section  from 
sham-operated control.  C)  Section  from  injured  embryo  treated  with  0.5mM  DEVD- 
FMK. D) Section from injured embryo treated with 2mM DEVD-Biotin-FMK. A’), B’), 
C’)  and  D’)  High  magnification  images  of the  injury  site  in  each  case.  Inhibition  of 
caspase-3 partially reduced the apoptotic response to injury. Scale bars =500pm
43. Discussion
In this chapter a previously observed relationship between increased haemorrhage and 
increased  apoptosis  following  injury  at  non-regenerating  stages  of chick  spinal  cord 
development  was  further investigated.  The results  provide  support for a link between 
haemorrhage and apoptosis after spinal cord injury.  Reduced haemorrhage was shown 
to correspond to reduced apoptosis and reduced cavitation after injury, both of which 
may significantly contribute to the loss of regenerative capacity in the chick spinal cord.
4.3.1.  Verification of the model
Consistent with previous work carried out in our laboratory (O'Neill 2002; Whalley et 
al. 2006), the current results demonstrated several marked differences in the response of 
the chick spinal cord to injury at El 1 and E15. Injury at El 1 resulted in localised tissue 
damage and haemorrhage within the first day after injury and by 4 days after injury, the 
lesion site appeared to have returned to normal and the regenerative process seemed to 
be well advanced. By contrast, injuries at E15 resulted in much greater tissue deunage 
and extensive haemorrhage  and showed no indication of improvement within 4 days. 
The  technique  used  produces  an  injury  that  combines  elements  of  incomplete 
transection with a crush injury, thus mimicking some, but not all, types of human spinal 
cord  injury.  Several  of  the  observed  morphological  changes  after  injury  at  El5, 
including  cavitation  and  haemorrhage,  are  characteristic  of  those  observed  in 
mammalian species, including human and rat, adding further support to this system as a 
useful  model  for  human  spinal  cord  injury  (Velardo  et  al.  2000).  One  potential 
disadvantage of this injury method is that there is variability in the severity of the injury 
between different embryos. Interestingly,  survival rates for E l5  injured embryos were 
consistently  higher  than  those  for  E ll  injured  embryos,  an  observation  which  is
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consistent with previous studies using this model (O’Neill, 2002, PhD thesis, Shimizu et 
al,  1990). This may be due to the smaller size of the embryo at Ell, which makes it 
more likely that essential blood vessels will be damaged during the injury procedure.
The apoptotic response to injury was investigated throughout this study using TUNEL, 
which  allows  the  detection  of  single  strand  breaks  in  genomic  DNA  that  are 
characteristic of the apoptosis process. This technique is generally accepted as a specific 
method  for identifying  apoptosis  in situ  in  tissue  sections;  however it is  important to 
eliminate the possibility of false positive results, which could occur due to non-specific 
background  labelling.  This  was  achieved  by  the  use  of  several  controls,  which 
demonstrated negative results in the absence of the TdT enzyme and in spinal cords in 
which  no  injury  has  taken place.  It has  been  reported  that treatment of sections  with 
diethylpyrocarbonate  (DEPC)  can  reduce  any  false  positive  staining  which  is  due  to 
endogenous nuclease activity (Stahelin et al.  1998). Previous studies in our laboratory 
demonstrated no change in labelling after such treatment using this protocol, suggesting 
that the labelling achieved by this method is accurate (O'Neill 2002). It has also been 
reported  that,  in  some  cases,  TUNEL  may  stain  necrotic  cells,  in  which  DNA 
fragmentation can occur, and it was therefore necessary also to examine the morphology 
of the nuclei for characteristic signs of apoptosis including chromatin condensation and 
fragmentation (Collins et al.  1992). This confirmed that the labelled cells were apoptotic 
rather than necrotic. A final caveat of this method is that some types of apoptosis have 
been described which do not involve DNA fragmentation, and hence may would not be 
detected by TUNEL, although these are thought to be rare (Cohen et al.  1992).
TUNEL  staining  confirmed  the  previous  observation  that there  is  a greatly  increased 
apoptotic response to injury at non-regenerating stages compared to regenerating stages 
in  the  chick.  Apoptotic  cells  were  observed  in  both  the  grey  and  the  white  matter. 
Unfortunately,  although  double-labelling  studies  were  attempted,  it  did  not  prove 
possible  to  identify  the  TUNEL  labelled  cells  as  neurons,  glia  or  microglia  by 
immunohistochemistry, possibly due to the actions of proteinase K, which was used to 
permeabilise  the  sections.  It  would  be  of  interest  to  find  a  way  to  overcome  this 
limitation, as previous reports have demonstrated age-related changes in the apoptotic 
response of glia to injury, which may be linked to the onset of myelination (McBride et 
al.  2003;  Ludwin  1990) The extent of apoptosis  correlated closely  with  the extent of
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haemorrhage  in  the  spinal  cord,  suggesting  the  possibility  of  a  causal  relationship 
between these two factors. Again, these results matched those of previous work carried 
out in our laboratory (O'Neill 2002; Whalley et al. 2006).
4.3.2.  Correlation between haemorrhage and apoptosis
Although both the results presented here and previous work show a correlation between 
increased  haemorrhage  and  apoptosis  in  the  post-El3  chick  spinal cord this  does  not 
necessarily mean that these factors are interrelated.  There are undoubtedly many other 
developmental  changes between  E ll  and  E15  that  might  contribute  to  increased  cell 
death at later developmental stages. It was therefore desirable to be able to manipulate 
the degree of haemorrhage at each time point in order to examine further the evidence 
for a causal effect.
An  ideal  and  obvious  approach  to  test  this  potential  causative  relationship  directly 
would be to administer blood to the El 1  spinal cord and examine the effects of such 
treatment on  apoptosis.  This  approach  is however complicated by difficulties  with  in 
vivo  blood  administration,  since  rapid  clotting  would  necessitate  the  use  of 
anticoagulants. This might mask some of the effects of blood coagulation factors such 
as  thrombin,  which  might  themselves  be  responsible  for  the  effects  on  apoptosis 
(Smirnova et al.  1998; Turgeon et al.  1998). In previous work in this laboratory it was 
demonstrated  that  administration  of  diazepam  at  E ll  resulted  in  both  a  large 
haemorrhagic response after injury, more characteristic of that usually seen at El5, and 
a  greatly  increased  apoptotic  response,  demonstrating  a  correlation  between  the  two 
effects  (O'Neill  2002;  Whalley  et al.  2006).  However,  it  still  remained  important  to 
examine the effects of reduced haemorrhage in the E15 spinal cord on apoptosis, which 
is normally extensive at this stage.
In this chapter, this was addressed using a pharmacological method which was chosen 
to produce an effective reduction in haemorrhage without causing toxicity. The choice 
of  agent  presented  a  challenge  since  many  pro-coagulant  agents,  such  as  thrombin, 
might be expected to cause excessive blood clotting or acute toxicity when administered 
at effective doses (Turgeon and Houenou 1997; Smirnova et al.  1998). The agent which 
was  chosen  for  these  experiments,  desmopressin,  is  used  in  the  treatment  of
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haemophilia,  typically  to reduce bleeding  after  surgery  (Lethagen  2003;  Villar  et al. 
2002). In human patients, desmopressin is commonly administered as a nasal spray. It 
was  therefore  expected  to  be  relatively  easily  absorbed  when  administered  to  the 
chorioallantoic membrane and non-harmful. This proved to be the case and a non-toxic 
dose was established for further experiments.
The  results  presented  here  demonstrate  that  desmopressin  is  capable  of significantly 
reducing haemorrhage at 12 hours after injury, although it appeared to be effective only 
in  a  sub-group  of treated  animals.  This  may be  due to  differences  in  bio-availability 
after  administration  as  similar  variability  has  been  observed  in  the  uptake  of  other 
compounds administered in this way, notably BrdU (see Chapter 7). However, since the 
aim  of  this  study  was  to  investigate  the  effects  of  a  reduction  in  haemorrhage  on 
apoptosis, it was decided to consider the sub-group in which an effective reduction in 
haemorrhage  was  achieved  as  a  separate  group  for  further  analysis.  Subsequently, 
TUNEL staining showed that there was significantly reduced apoptosis in this group of 
animals  in  which  the  haemorrhage  was  reduced  by  desmopressin  treatment. 
Furthermore, 4 days after injury, desmopressin treatment resulted in a lower frequency 
of animals displaying features of tissue and neuronal damage, including large cavities 
within the spinal cord and axonal blebbing.  Desmopressin treatment also resulted in a 
higher survival rate.
The  mechanisms  by  which  desmopressin  exerts  its  haemostatic  effects  are  not  well 
understood, although it is known that desmopressin can specifically activate vasopressin 
V2  receptors  (Kaufmann  J.E.  and  Vischer  U.M  2003).  In  humans,  treatment  with 
desmopressin produces a transient increase in the levels of Factor VIII, a key enzyme in 
the  blood  clotting  cascade,  as  well  as  von  Willebrand  factor,  each  of  which  may 
contribute  to  increased  blood  clotting  (Kaufmann  J.E.  and  Vischer  U.M  2003; 
Mannucci p 2000). It remains possible that desmopressin might have a direct or indirect 
effect on apoptosis unrelated to its role in haemostasis.  However, to date no evidence 
exists showing that spinal cord cells express the V2 receptors or can respond directly to 
this  compound  (Phillips  et  al.  1990).  In  further  support  of  these  findings,  in  a 
compression model of spinal cord injury in the rat, treatment with activated protein C 
has  been  shown  to  reduce  both  haemorrhage  and  motor  disturbances,  although  this
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affect  was  attributed  mainly  to  a  reduction  in  cytokine  production  and  subsequent 
inflammation (Taoka et al.  1998).
Haemorrhage within the spinal cord after injury could produce a number of detrimental 
effects which might result in cell death by apoptosis. Interruption of the blood supply to 
the  spinal  cord deprives  the  spinal  cord  of oxygen  and  glucose  and  leads  rapidly  to 
ischemia,  which  can result in  cell  death  by  excitotoxicity  and the  production  of free 
radicals (Profyris et al  2004; Dumont et al.  2001). The entry of blood into the spinal 
cord  also  exposes  neurons  and  glia  to  a  number  of potentially  toxic  cell  types  and 
molecules normally excluded from the central nervous system by the tight junctions of 
the blood brain barrier. These include inflammatory cells and molecular components of 
the immune response such as cytokines which are considered to be both beneficial and 
harmful to the spinal cord after an injury (Bethea and Dietrich 2002; Kwon et al. 2004). 
There are additionally many other factors present in the blood which can be neurotoxic. 
In  particular,  several  member  of  the  serine  protease  family  of  enzymes,  such  as 
thrombin, well recognised for their essential roles in haemostasis, have been shown to 
have  potentially  detrimental  effects  on  neurons  and  glia  (del  Zoppo  1998;  Lee et al. 
1997;  Smirnova  et al.  1998;  Turgeon  and  Houenou  1997).  Many  of these  enzymes, 
together with their inhibitory counterparts, the serpins, and their specific receptors are 
expressed within the CNS and may have a role during development and in normal CNS 
function  (Turgeon  and  Houenou  1997;  Gingrich  and  Traynelis  2000).  The  serine 
proteases  are  therefore  good  candidate  molecules  for  providing  a  molecular  link 
between haemorrhage and apoptosis and their role in the injured chick spinal cord will 
be explored further in Chapter 5.
4.3.3.  Reduced haemorrhage and axonal regeneration
A reduction in the extent of cavitation and neuronal damage such as that observed in 
this  study  might  be  expected  to  improve  the  likelihood  of  successful  axonal 
regeneration.  Although  a  detailed analysis  of axonal  regeneration  was  not  within  the 
remit  of  this  study,  in  one  desmopressin  treated  embryo,  axons  were  observed 
apparently  crossing  the  injury  site.  However,  it  is  not  possible  to  determine  from 
neurofilament staining alone whether this is the result of axonal re-growth or sprouting. 
In order to determine fully whether reduced haemorrhage alone could result in improved 
axonal regeneration and consequent behavioural recovery it would be necessary to look
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at post-hatching stages and to use a retrograde axonal tracing method such as that used 
to demonstrate regeneration in the El 1 spinal cord (Hasan et al.  1993; Sholomenko and 
Delaney  1998). However, on the basis of examination of sections at 4 days after injury, 
the current study showed little evidence of axonal regeneration,  suggesting that other 
factors in addition to haemorrhage may require manipulation in order to promote axonal 
growth.  This  might  include  inhibition  of  inhibitory  molecules  present  in  damaged 
myelin or the glial scar, or provision of growth-promoting factors necessary to stimulate 
and encourage re-growth (Sandvig et al.  2004;  Profyris et al.  2004).  Nevertheless,  a 
reduction in cavitation and cell death, such as that produced by desmopressin treatment 
would certainly make the process of axonal regeneration much easier to achieve. Even a 
small  increase in the number of axons spared after an injury has been shown to have 
significant effects on recovery and as little as 7% axonal survival below the injury site 
can result in significant motor function in humans (Kwon et al. 2004).
4.3.4.  Caspase-dependent and independent apoptosis after spinal cord injury in the 
chick
Although previous studies had clearly demonstrated an apoptotic response to injury in 
the chick spinal cord, when this study was initiated there had been no attempt to classify 
the apoptosis as caspase-dependent or independent. Both types of apoptosis have been 
demonstrated  to  occur  following  traumatic  injury  to  the  nervous  system  and  it  was 
therefore of interest to understand which type was prominent after spinal cord injury in 
the chick (Citron et al. 2000a; McBride et al. 2003; Springer et al.  1999). The results of 
this  study  suggest that  both  mechanisms  may  be  involved in  the  cell  death  observed 
after  transection  injury  in  the  chick.  Although  the  numbers  of  samples  used  in  the 
present study were too low to give quantitative results, apoptosis appeared to be reduced 
but not abolished by inhibition of the key effector caspase, caspase-3. During the course 
of  these  experiments,  a  study  by  Steeves  and  colleagues  was  published,  which 
demonstrated that caspase dependent mechanisms are involved in the apoptotic response 
of the  chick  spinal  cord  to  injury  (McBride  et al.  2003).  The  study  by  Steeves  and 
colleagues  differed  from  the  present  study  in  a  number  of  ways,  in  particular  by 
focusing on delayed (24 hours -  6 days after injury) apoptosis in oligodendrocytes at a 
greater distance from the injury site (up to 7mm from the injury site). Nevertheless these 
results  support  the  preliminary  findings  outlined  here;  showing  that  inhibition  of
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caspase-1 and caspase-3 reduced but did not eliminate oligodendrocyte apoptosis. It was 
therefore decided not to follow up this preliminary experiment with more investigation 
into the role of caspases. Additionally, caspase activation is a relatively late stage event 
in the apoptotic cascade and it would be desirable to be able to manipulate the factors 
which  are responsible  for initiating  this cascade,  in  order to provide neuroprotection. 
The next chapter will therefore concentrate on the identification of factors up-stream of 
caspase-dependent or independent mechanisms,  which might provide a molecular link 
between haemorrhage and apoptosis.
4.3.5.  Conclusions
Overall the results presented here provide further evidence for a link between the extent 
of  haemorrhage  in  the  spinal  cord  after  injury  and  the  extent  of  apoptosis  and 
subsequent cavitation.  Reducing  haemorrhage  or targeting  the  downstream molecular 
pathways which lead to apoptosis may result in increased neuroprotection and reduced 
tissue damage. This may therefore represent a useful therapeutic strategy to be used in 
conjunction  with  other  therapeutic  approaches  such  as  inhibition  of  myelin  related 
factors or cellular transplantation.
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5.1.  Introduction
As described in the previous chapter, the loss of regenerative capacity in the developing 
chick spinal cord, which occurs around E l3, corresponds to a dramatic change in the 
response of the spinal cord to injury. Previous work in our laboratory, together with the 
results described in Chapter 4, have highlighted the relationship between an increase in 
the extent of haemorrhage in the spinal cord after injury and increased apoptotic cell 
death at non-regenerating stages (O'Neill 2002; Whalley et al.  2006). These findings 
suggest that there may be factors present in the blood that are responsible for triggering 
an  apoptotic  response  in  spinal  cord  neurons  and  glia.  Circulating  blood  carries  a 
number of potentially neurotoxic substances that could be considered candidates for this 
role. Among these, the serine protease family of enzymes, and in particular thrombin, 
have attracted interest for a number of reasons.
As well as being present in the blood, thrombin, together with the PAR-1 receptor and 
several specific inhibitors, are found within the CNS and are thought to play key roles in 
nervous system development as well as in plasticity and homeostasis during adulthood 
(Dihanich et al.  1991; Deschepper et al.  1991; Mansuy et al.  1993; Niclou et al.  1994; 
Reinhard et al.  1994;  Weinstein et al.  1995; Turgeon and Houenou  1997). Thrombin 
signalling has been implicated in nervous system pathology following various types of 
injury and in neurological diseases such as Alzheimer’s disease and stroke (Vaughan et 
al.  1994;  Riek-Burchardt et al.  2002).  In  vitro,  thrombin has  been demonstrated to 
provide protection from or promotion of neuronal cell death by apoptosis, depending on 
the dose and the experimental model used (Turgeon et al.  1998; Turgeon and Houenou 
1999; Vaughan et al.  1995; Donovan et al.  1997; Pike et al.  1996; Smirnova et al.  1998; 
Smith-Swintosky et al.  1995).  Changes  in  endogenous  CNS  levels  of thrombin,  its 
receptor or inhibitors, or the entry of high concentrations of exogenous thrombin from 
the blood after injury, could potentially disrupt the delicate regulatory balance between 
these molecules, leading to neuropathological effects.
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The overall aim of the current study was to determine to what extent serine proteases 
might play a role in the increased apoptotic response observed in the non-regenerating 
chick spinal cord after injury. As outlined above, the available literature suggests that 
thrombin is likely to be a key serine protease involved in apoptosis in the chick spinal 
cord and this  enzyme  was therefore the primary focus of this  study.  In addition, an 
investigation  into  the  plasminogen  activator,  urokinase,  was  initiated.  Two  parallel 
routes of investigation were followed, examining changes in endogenous CNS thrombin 
after injury and the potential of exogenous thrombin to cause apoptosis.
Endogenous  expression  of prothrombin,  the  inactive  precursor  of thrombin,  and 
urokinase has been previously described in the developing mouse and rat (Dihanich et 
al.  1991;  Sumi et al  1992). However the expression of these molecules has not been 
studied  extensively  in  the  chick.  The  first  part  of this  study  therefore  set  out  to 
investigate their expression in the  developing chick spinal cord using real-time RT- 
PCR. Endogenous levels of prothrombin, the PAR-1  receptor and urokinase have been 
demonstrated previously to be altered after spinal cord injury in the rat (Citron et al. 
2 0 0 0 b), a model which bears many morphological similarities to the chick spinal cord at 
E l5. It was of interest to determine whether similar changes are observed in the non­
regenerating chick spinal cord. Changes in the endogenous expression of prothrombin 
and urokinase mRNA after injury at E l5  were therefore investigated using real-time 
RT-PCR.  In  addition to  its regulation at the  level  of mRNA transcription, thrombin 
activity is also regulated by cleavage of its precursor protein, prothrombin, to active 
thrombin. Consistent with this, changes in the levels of thrombin activity have also been 
described after insults to the nervous system (Smirnova et al.  1996). Therefore, in the 
following experiments an assay for the measurement of endogenous thrombin activity in 
the spinal cord was developed and used to investigate changes in activity after injury at 
E15.
In  parallel  to  these  investigations,  the  possible  effects  of exogenous  thrombin  on 
apoptosis in the spinal cord were considered. After an injury, thrombin might enter the 
nervous  tissue  from  the  blood  during  haemorrhage.  In  order  to  investigate  this 
possibility, an organotypic culture system, which would mimic as closely as possible 
the in vivo situation, was set up and used to test the potential effects of thrombin and 
thrombin inhibition on apoptosis.
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5.2.  Results
5.2.1. Real time PCR analysis of serine protease expression in the spinal cord
In order to examine the expression of prothrombin and urokinase, RT-PCR was carried 
out on pools of spinal cord samples. A preliminary analysis by semi-quantitative PCR 
showed that both prothrombin and urokinase mRNA, but not tPA mRNA, is expressed 
in the developing spinal cord. To obtain more accurate and quantifiable information of 
the  expression  levels  of these  molecules  a  real-time  PCR  strategy  was  employed. 
Primers  and probes  against chick prothrombin, urokinase  and GAPDH were custom 
designed  by  Applied  Biosystems.  In  order  to  use  these  primer  sets  for  relative 
quantitative  analysis  using the  comparative  Ct method  (see  Chapter  3),  it was  first 
necessary to confirm that the efficiency of amplification of each set were approximately 
identical. Standard curves were set up for each set of primers in which 10 fold dilutions 
of cDNA were added to each reaction. Fig 5.1  shows the standard curves produced for 
each primer and probe set. As shown in Fig 5.1, the slopes of the standard curves for 
prothrombin,  urokinase  and GAPDH were approximately equal, which demonstrates 
that the  efficiency  of amplification  was  equivalent  and that these primer  sets  were 
appropriate for determining relative gene expression by the comparative Ct method.
5.2.2. Analysis of the expression of prothrombin and urokinase in the developing 
chick spinal cord
Having  verified  the  amplification  efficiency  of each  probe  set,  the  expression  of 
prothrombin  mRNA  in  the  developing  chick  spinal  cord  was  examined  in  three 
independent pools of samples at each time point and the comparative Ct method was 
employed in order to analyse the results (see Chapter 3  and Discussion). Briefly, the 
mean Ct for each sample was normalised to GAPDH levels and then the fold change in 
expression  relative  to  the  E3  group  was  determined.  Fig  5.2  shows  the  relative 
expression levels of prothrombin mRNA, compared to the E3 group, at four different 
developmental  stages.  Prothrombin  was  found  to  be  expressed  throughout  the 
developmental  stages examined.  Statistical analysis was used to compare the relative 
expression at each stage and showed that there was no significant change in expression
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Fig. 5.1. Validation experiment for  primers for real-time PCR.
Standard  curves  are  shown  for  primer  and  probe  sets  for  chick 
GAPDH (A) prothrombin (B) and urokinase (C). Graphs show log 
[cDNA]  against  threshold  cycle  number  (Cj)  in  each  case  (see 
Chapter 3). The slope of the standard curve is approximately equal 
in each case, demonstrating equal amplification efficiency.
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Fig.5.2.  Analysis  of  the  expression  of  prothrombin  mRNA  in  the 
developing chick spinal cord. Real time RT-PCR data showing prothrombin 
mRNA expression  levels  at  four different developmental  stages.  Levels are 
normalised  to  GAPDH  and  expressed  relative  to  the  E3  group  by  the 
comparative CT method. Data show mean relative expression level ± SEM in 
three pools of samples for each data point. Thrombin is expressed throughout 
development  with  no  significant  change  in  expression  levels.  P=0.070 
(Kruskal-Wallis Test).
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levels with development.  Similarly, real-time RT-PCR analysis  of the expression of 
urokinase  mRNA  showed that urokinase  is  expressed throughout development  (Fig
5.3.). Expression was lowest at E3  and then increased by more than  15-fold by Ell, 
although this increase did not prove statistically significant.
5.2.3. Analysis of the expression of prothrombin and urokinase after injury at E15
In order to determine whether the expression of the serine proteases prothrombin and 
urokinase is regulated in the spinal cord after injury, real-time RT-PCR analysis was 
used to  examine expression levels in pools of samples taken from injured or sham- 
operated embryos at various time-points after injury at E l5. To provide a more detailed 
analysis  of the  location  of any  such  changes,  each  spinal  cord  was  divided  into  a 
‘proximal’  region,  spanning  3mm  cranially  and  caudally  from the  injury  site  and a 
‘distal  region’,  encompassing  a  further  3mm  in  either  direction  (see  Fig  3.5).  All 
samples were run together in one experiment to minimise variability and the relative 
expression level was compared to the ‘proximal’ region from the sham operated group 
by the comparative Ct method. As shown in Fig 5.4.A, 2 hours after injury at El5 there 
was no significant increase in the expression of prothrombin mRNA in either region. 
Similarly, by 24 hours after injury at E l5, no significant increase in prothrombin mRNA 
expression could be observed (Fig 5.4.B). Analysis of urokinase expression at 2 hours 
after injury at E l5 showed no significant difference between injured and sham operated 
spinal cords in either the proximal or the distal region (Fig 5.5.A). Again, at 24 hours 
after injury at E l5 there were no significant changes in urokinase mRNA expression 
(Fig 5.5.B).
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Fig. 5.3. Analysis of the expression of urokinase mRNA in the developing 
chick  spinal  cord.  Real  time  RT-PCR  data  showing  urokinase  mRNA 
expression levels at different developmental stages. Levels are normalised to 
GAPDH  and  expressed  relative  to  the  E3  group  by  the  comparative  CT 
method.  Data show mean relative expression level ± SEM in three pools of 
samples for each data point  Urokinase is expressed throughout development 
with  no  significant  change  in  expression  levels.  P=0.086  (Kruskal-Wallis 
Test).
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Fig  5.4.  Analysis  of prothrombin  mRNA expression  after  injury  to  the 
spinal  cord  at E15.  A)  2  hours  after injury.  B) 24  hours after  injury.  Real 
time  RT-PCR data showing prothrombin mRNA expression within a region 
expanding  3mm  rostrally  and  caudally  from  the  injury  site  (the  proximal 
region)  and  in  a region  between  3mm-6mm  from the  injury  site  (the  distal 
region).  Levels  are  normalised  to  GAPDH  and  expressed  relative  to  the 
‘proximal sham’  group by the comparative CT method (see chapter 3). Data 
show mean relative expression level ± SEM in three pools of samples for each 
data point. Prothrombin mRNA levels are not significantly altered by injury at 
this time point. A) p=0.275 for proximal region, p=0.513 for distal region B) 
p=0.513 for proximal region, p=0.827 (Mann Whitney Test)
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Fig 5.5. Analysis of urokinase mRNA expression after injury to the spinal 
cord at E l5. A) 2 hours after injury. B) 24 hours after injury. Real time RT- 
PCR data showing mRNA expression levels within a region expanding 3mm 
rostrally  and  caudally  from  the  injury  site  (the  proximal  region)  and  in  a 
region between 3mm-6mm from the injury site (the distal region). Levels are 
normalised to GAPDH and expressed relative to the  ‘proximal  sham’  group 
by  the  comparative  CT  method  (see  chapter  3).  Data  show  mean  relative 
expression  level  ±  SEM  in  three  pools  of  samples  for  each  data  point. 
Urokinase  mRNA  levels  are  not  significantly  altered  by  injury  at  this  time 
point. A) p=0.827 for proximal region, p=0.827 for distal region B) p=0.127 
for proximal region, p=0.513 for distal region (Mann Whitney Test)
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5.2.4.  Analysis of thrombin activity after injury
Although no significant regulation of prothrombin expression at the mRNA level was 
observed, thrombin activity is also regulated by cleavage of its precursor prothrombin to 
thrombin  and  this  level  of regulation  could  make  a  more  important  contribution  to 
changes in thrombin signalling after injury. In order to examine whether there was an 
increase in endogenous thrombin activity levels after an injury at E15, a chromogenic 
activity  assay  was  developed,  based  on  a  protocol  kindly  provided  by  Professor  B. 
Festoff (Smirnova et al.  1996). The chromogenic substrate, CS-01(38), which is cleaved 
by thrombin to produce a measurable colour change, was incubated at 37°C with protein 
extracts  from  pools  of  spinal  cord  samples  taken  from  injured  or  sham  operated 
embryos. The colour change resulting from cleavage of the substrate was determined by 
measuring  optical  density.  According  to  the  initial  protocol  provided,  in  initial 
experiments, readings were taken at various intervals for up to 3 hours. The change in 
OD produced by incubation of the substrate with one set of spinal cord samples over 
this  time-frame  is  shown  in  Fig.  5.6.  This  illustrates  that  over  the  first  hour  of the 
reaction  the  OD  increases  in  a  linear  manner,  with  the  reaction  later slowing  as  the 
substrate is consumed.  In the example shown in Fig.  5.6,  the pooled protein  samples 
taken from the injured group produced a higher degree of substrate cleavage than those 
from the sham samples, indicating higher thrombin activity.  However,  this result was 
not  observed  reproducibly  with  each  of  three  independent  sets  of  samples,  and 
variations in the rate of reaction were observed between different experiments, probably 
due to temperature fluctuations during the transfer from incubator to plate reader (see 
section 3.13.2).
In order to obtain results that could be  statistically analysed,  it was decided to take a 
single reading after 30 minutes incubation,  during the linear part of the amplification 
and to run three independent sample pools for each group together in one reaction. In 
order  to  further  confirm  that  the  reaction  was  linear  at  this  time  point,  a  range  of 
standard  concentrations  of  pure  bovine  thrombin  were  incubated  alongside  the 
experimental samples. As shown in Fig. 5.7, after 30 minutes incubation there is a linear 
relationship (correlation co-efficient 0.99) between the concentration of active thrombin 
and the colour change. This also confirmed that,  at this time point, availability of the 
substrate had not become a limiting factor, as even at very high concentrations of
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Fig.  5.6.  Analysis  of  the  cleavage  of  a  chromogenic  substrate  by
thrombin in spinal cord samples. Graph shows mOD measured at various 
intervals  after  incubation  of  the  chromogenic  substrate  CS-01(38)  with 
protein extracts from pools of samples from injured or sham operated spinal 
cord.
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Fig.  5.7.  Standard  curve  demonstrating  relationship  between  thrombin 
activity  and  cleavage  of  CS-01(38)  after  30  minutes  incubation.  Red  line 
shows mOD measured 30 minutes after incubation of various concentrations of 
bovine  thrombin  with  the  chromogenic  substrate  CS-01(38).  Correlation  co­
efficient: R=0.99 (trendline shown in black).
175Endogenous and exogenous serine proteases in the developing and injured spinal cord
thrombin, in excess of that which was seen in our samples, the relationship remained 
linear.  CS-01(38)  is  among  the  most  specific  substrates  available  for  thrombin. 
However, cleavage by other serine proteases can also take place, although these have a 
greatly reduced affinity for the substrate in comparison to thrombin. For example, single 
chain tPA is 5% as reactive as thrombin with this substrate, while activated protein C 
shows about 40% reactivity  in comparison to thrombin (www.chromogenix.com). In 
order to control for this non-specific cleavage the highly specific thrombin inhibitor, 
hirudin,  was  incubated  together  with  the  sample  and  substrate  in  parallel  to  the 
experimental samples. Any colour change produced by the reactions in which hirudin 
was present could therefore be assumed to be due to non-specific substrate cleavage. 
This was then deducted from experimental samples to give a measure of the specific 
thrombin activity. As shown in Fig. 5.8, hirudin was able to almost completely inhibit 
the colour change in the presence of a concentration of pure bovine thrombin in excess 
of that which was typically observed in the samples.
With these controls in place, activity assays were carried out on three pools of samples 
from injured and sham operated embryos at 2 hours and 24 hours after injury. These 
time points were selected to examine the activity of thrombin prior to the onset of the 
apoptotic response (2 hours) and during the maximum apoptotic response (24 hours), in 
order to provide an indication of the potential role of thrombin in this response.  The 
protein concentration of each sample was determined prior to starting the assay and the 
total protein loaded in each case was approximately equal.  However, in order to take 
into account variations in protein loading, the OD measured was normalised to total 
protein in each case. As shown in Fig.  5.9, at 2 hours after injury the total substrate 
cleavage after 30 minutes incubation was significantly higher in the injured than the 
sham operated samples,  indicating an increase in overall pro  tease activity.  However, 
most of this  activity  was  not  inhibited by treatment with  hirudin  and there was  no 
significant difference in specific thrombin activity  detectable.  Similarly,  at 24 hours 
after injury, there was an overall significant increase in protease activity, but, although 
at this time point a trend towards  an increase  in thrombin-specific  activity could be 
observed, this did not prove significant (Fig. 5.10). The magnitude of the non-specific 
activity increase was also noticeably greater at 24 hours when compared to 2 hours after 
injury.
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Fig 5.8. Determination of the inhibition of thrombin activity by hirudin.
Graph  shows  OD  measured  30  minutes  after  incubation  of  1  unit/ml  of 
thrombin with the chromogenic substrate CS-01(38) with or without hirudin 
(2U/pl).  The  addition  of hirudin  almost  completely  eradicates  thrombin 
activity.
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Fig. 5.9. Analysis of thrombin activity two hours after injury at E15.
Graph  shows  mOD per  pg  protein  after  30  minutes  incubation  with  the 
chromogenic  substrate CS-01(38).  Specific  activity  is  determined  as  the 
difference between total activity and that measured in reactions carried out 
in the  presence  of hirudin.  Data shown are mean ±  SEM  for 3  pools of 
samples per group.  There is a significant increase in total activity but no 
increase in specific thrombin activity at this time point. * p=0.050 for total 
activity, p=0.827 for specific activity (Mann Whitney Test)
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Fig.  5.10  Analysis  of thrombin  activity  24  hours  after injury  at  E15.
Graph  shows  mOD  per  pg  protein  after  30  minutes  incubation  with  the 
chromogenic  substrate  CS-01(38).  Specific  activity  is  determined  as  the 
difference between total activity and that measured in reactions carried out 
in the presence  of hirudin.  Data shown is mean±  SEM for three pools of 
samples per group.  There  is a significant increase  in total activity but no 
significant  increase  in thrombin specific  activity  at this time point.  *  p = 
0.050 for total activity, p=0.127 for specific activity  (Mann Whitney Test).
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5.2.5  Analysis of the apoptosis-inducing effects of thrombin.
As  described  above,  endogenous  thrombin  mRNA  expression  or  activity  does  not 
appear to be significantly altered by injury at E l5. However, following injury at non­
regenerating  stages  haemorrhage  is  likely  to  result  in  the  entry  of high  levels  of 
exogenous thrombin into the spinal cord. The previously observed relationship between 
haemorrhage and cell death after injury suggests that toxic factors present in the blood 
may be capable of triggering apoptosis.  It was therefore of interest to investigate the 
ability of exogenous thrombin to increase apoptosis in the spinal cord. In order to test 
the potential  for thrombin to cause cell  death in a simple culture  system,  SH-SY5Y 
human neuroblastoma cells were grown on glass coverslips and cultured for 14 hours in 
the  presence  of 500nM  thrombin  (Fig.  5.11).  As  shown  in  Fig.  5.1 l.B,  thrombin 
treatment  caused  a  change  in the  morphology  of the  cells,  which  rounded  up  and 
detached from the dish, which suggests that the cells were dying. Interestingly, when the 
cells  were  grown  on tissue  culture  treated  plastic,  there  was  no  apparent  effect  of 
thrombin on cellular morphology, suggesting that attachment to a substrate may alter 
sensitivity of these cells to thrombin.
5.2.6.  Establishing an organotypic spinal cord slice culture system.
The results obtained when neuroblastoma cells were cultured with thrombin confirmed 
the potential of this molecule to cause cell death, but also suggested that interactions 
with the cellular environment are likely to influence the sensitivity of cells to this factor. 
It was desirable to be able to test the effect of thrombin in an environment more similar 
to that which spinal cord cells would experience in vivo. Owing to the potential toxic 
effects  of  systemic  thrombin  treatment  in  vivo,  it  was  decided  that  an  in  vitro 
organotypic culture system would provide the best method for investigating the specific 
effects of thrombin in the spinal cord. A slice culture system was chosen to maximise 
the number of cultures which could be obtained per embryo. Initially, several different 
methods of cutting fresh spinal cord slices were tested. Of these, cutting slices by eye 
with a small  surgical  scalpel blade,  proved to be the  quickest method but produced 
slices of uneven thickness, which might have an impact on the availability and effects of 
exogenous treatments. The final method chosen for consistency in slice thickness and
180Fig. 5.11. Analysis of the effects of thrombin on human neuroblastoma cells. Images shown SH-SY5Y cells after culturing for 14 hours 
in three different conditions. A) cells cultured on glass coverslips in normal medium showing normal morphology. B) cells cultured on glass 
coverslips in the presence of 500nM thrombin. C) cells cultured on plastic in the presence of 500nM thrombin. Scale bars = 100 pm.Endogenous and exogenous serine proteases in the developing and injured spinal cord
for reduced damage to the slices during cutting was therefore to use a vibratome to cut 
500 pm slices of spinal cord embedded in agarose.
Two different methods of culturing the slices were tested. Culturing on filter paper in 
organ culture dishes produced slices with good morphology after 24 hours, in which the 
grey  and  white  matter  could  be  clearly  distinguished  and  the  nuclear  morphology 
appeared normal (Fig 5.12A). However, the volume of medium required for this method 
would have  added considerably to  the expense of the pharmacological  manipulations 
required for the following experiments,  and therefore reduced the sample size. It was 
therefore decided to culture the slices in small hanging drop cultures. This method also 
resulted in a good morphology and little sign of tissue degradation over 24 hours, and 
had the advantage of requiring only a small volume of medium.  Fig.  5.12.B  shows a 
hanging drop culture in which it is still possible to distinguish the various spinal cord 
regions,  including  the  central  canal,  although  the  morphology  is  not  as  good as that 
obtained by the organ culture dish method.
Having  established  a  culture  system  capable  of  maintaining  slices  with  good 
morphology over 24 hours a method for the detection of apoptosis in these slices was 
developed. Whole-mount TUNEL staining of the slices was used as this minimised the 
amount of reagents used and the time taken to process the samples in comparison to 
staining individual thin sections of the slices. Under normal culture conditions, TUNEL 
staining can be observed in all regions of the spinal cord and is particularly concentrated 
around the periphery (Fig 5.13). Confocal analysis allowed images to be captured up to 
40  pm  depth  into  the  slice.  TUNEL  staining  was  always  more  intense  towards  the 
outside  of the  slice.  To  determine  whether  the  observed  apoptosis  was  occurring  in 
neurons,  whole-mount  immunostaining  for the  neuron-specific  nuclear antigen NeuN 
was carried out following TUNEL staining. Many TUNEL labelled nuclei co-localised 
with NeuN, demonstrating that neuronal apoptosis can also be observed in this model 
(Fig 5.14).  Successful immunostaining up to at least 50 pm depth into the slices also 
confirmed  that  penetration  of the  slices  by  reagents  was  possible  using  this  method, 
suggesting that the reduction in TUNEL labelling towards the centre of the slice is the 
result  of  reduced  apoptosis  in  the  centre,  rather  than  decreased  penetration  of  the 
reagents.
182Fig 5.12. Comparison of the morphology of slice cultures prepared and 
cultured  by  different  methods  A)  Haematoxylin  and  Eosin  (H&E) 
staining of section taken from a slice cultured on filter paper in an organ 
culture  dish  for  24  hours  shows  excellent  morphology  with  clearly 
distinguishable  grey  (arrow)  and  white  (arrowhead)  matter.  B)  H&E 
staining of section taken from a slice cultured in a hanging drop for twenty 
four  hours  shows  good  morphology,  with  the  ependymal  region  being 
clearly identifiable (arrow). Scale bars = 200 pm.
183Fig. 5.13 Whole-mount TUNEL labelling of spinal cord slice cultures. 500 pm slice cultures of spinal cord maintained in hanging drop 
cultures  for  twenty  four  hours  before  whole-mount  TUNEL  staining  for  apoptosis  (green).  Nuclei  are  counterstained  with  To-Pro-3- 
isomerase (blue).  Images show,  from  left to  right, confocal  scans taken every  10  pm through  a typical  slice culture.  Asterisks indicate 
position of central canal. Scale bars = 80 pm.Fig. 5.14. Analysis of neuronal apoptosis in spinal cord slice cultures. A)
500  pm  slice  culture  maintained  in  hanging  drop  cultures  for  24  hours 
before whole-mount TUNEL  (green) and  immunostaining  for NeuN  (red). 
Nuclei  are  counterstained  with  To-Pro-3-isomerase  (blue).  B)  High 
magnification view of grey matter shows apoptotic neuronal cells (arrows). 
Scale bars = 80 pm
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Once  a  method  for  obtaining  good  TUNEL  staining  had  been  optimised  it  was 
necessary to confirm that quantifiable differences in apoptosis could be detected by this 
method. In order to do this, slices from El 1  and E l5 spinal cords were cultured in either 
10% serum or  1% serum for 24 hours, and whole-mount TUNEL staining was carried 
out to detect apoptosis. In order to ensure that changes in apoptosis reflect the treatment 
rather than inter-embryo variability, in each experiment at least three different embryos 
were used and slices from each were randomly assigned to treatment groups.  In El 1  
slices there was little difference in the amount of TUNEL staining in slices cultured in 
1%  or  10%  serum  (Fig.  5.15.A-D).  In E l5  slices,  however,  culturing  in  1%  serum 
produced an increased apoptotic response  in comparison to  culturing  in  1 0% serum 
(Fig. 5.16.A-D).
In order to quantify the apoptosis, confocal images were captured every 10 pm through 
the first 40 pm of each slice from the cut surface. For each image, software was used to 
measure the total intensity of green fluorescence in the image.  These measurements 
were  normalised  to  the  area,  and  the  average  intensity  /area  within  each  slice  was 
determined. Measurements from a minimum of six different slices in each experimental 
group were then averaged. As shown in Fig. 5.17, low serum conditions did not affect 
the extent of apoptosis in E ll  slices, whereas in E l5  slices there was a significantly 
increased apoptotic response as a result of culturing in 1% serum. It was notable that the 
TUNEL  staining  intensity  was always higher in the  E ll  slices than the E l5  slices. 
However, this probably does not reflect a larger apoptotic response to culture at El 1. 
The larger width of the El 5 slices meant that some of the slice edges, where the greatest 
staining was usually found, were cut off from each image captured by the confocal, 
whereas at El 1, the entire slice fit into the frame. This is likely to have contributed to 
the higher TUNEL measurements at El 1.
186Fig.  5.15.  Analysis  of the  effects  of low  serum  on  E ll  spinal  cord  slice 
cultures.  E ll  slice culture maintained in  10% serum (A &  B) or  1% serum 
(C &  D) for 24 hours before whole mount TUNEL staining (B &  D, green). 
Nuclei are counterstained with To-Pro-3-isomerase (A & C, blue). There is no 
noticeable  difference  in  the  extent  of  apoptosis  between  the  two  culture 
conditions. Scale bars = 80 p m
187Fig.  5.16.  Analysis  of the  effects  of low  serum  on  E15  spinal  cord  slice 
cultures.  E15  slice culture maintained in  10% serum (A &  B) or  1% serum 
(C &  D) for 24 hours before whole mount TUNEL staining (B &  D,  green). 
Nuclei are counterstained with To-Pro-3-isomerase (A & C, blue).  There is a 
noticeable  increase in apoptosis in slices cultured  in  1% serum.  Scale bars = 
80 pm
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Fig 5.17. Analysis of the effect of low serum conditions on apoptosis in 
spinal cord slice cultures. Data show relative intensity of TUNEL staining 
for apoptotic cells in slice cultures of E ll  or El 5  spinal cords maintained 
for 24 hours in  10% or 1% serum. Levels of apoptosis were not affected by 
low  serum  levels  in  E ll  slice  cultures.  However,  apoptosis  increased 
significantly  in  the  presence  of  low  serum  concentrations  in  E l5  slice 
cultures. p= 0.551  for El 1,  * p<0.001  for E l5 (Mann Whitney Test)
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5.2.6.  Analysis of the effects of exogenous  thrombin and thrombin inhibitors on 
apoptosis in £11 and E15 slice cultures
In order to determine whether thrombin could trigger apoptosis in organotypic cultures 
of spinal cord, and whether the response of the spinal cord to thrombin is affected by 
developmental  age,  slice  cultures  from  E ll  and  E15  embryos  were  maintained  in 
various  culture  conditions  for  24  hours  before  whole-mount  TUNEL  staining  was 
carried  out.  Two  different  doses  of thrombin,  lOOnM  and  lpM,  were  added  to  the 
culture  medium.  Additionally,  two  different  thrombin  inhibitors,  the  highly  specific 
inhibitor  hirudin,  and  the  slightly  less  specific  inhibitor  PPACK  were  added  to  the 
culture medium.
In  E ll  spinal  cord  slice  cultures,  treatment  with  thrombin  did  not  elicit  any  visibly 
increased  apoptotic  response  (compare  Fig.  5.18B  with  Fig.  5.15B).  Similarly, 
treatment  with  the  thrombin  inhibitors  hirudin  and  PPACK  did  not  produce  any 
noticeable change in TUNEL labelling (Fig.  5.18.F and 5.18.H). Quantification of the 
TUNEL staining intensity in these slices confirmed that there was no significant change 
in apoptosis in any of the culture conditions, although slices cultures with PPACK did 
have noticeably low levels apoptosis (Fig. 5.19).
Next, the effect of thrombin on E l5 slice cultures was tested. As shown in Fig. 5.20B 
(compare with  Fig  5.16.B)  and Fig.  5.21,  there  was  no  increase in  apoptosis  in  E l5 
slices after thrombin treatment. Similarly, the thrombin inhibitors hirudin and PPACK 
did not produce any significant changes in the apoptotic response as compared to the 
control (Compare Fig. 5.20F and Fig. 5.20H with Fig. 5.16.B).
In  order  to  determine  whether  there  was  any  interaction  between  the  effects  of low 
serum conditions and thrombin on apoptosis, the slices were also cultured in  1% serum 
with the addition of lfiM thrombin. In the El 1   slices, treatment with both thrombin and 
low serum did not produce any increased apoptotic response (Fig. 5.18.D compared to 
Fig. 5.15.B, and Fig. 5.19). Similarly, treatment of the E15 cultures with thrombin and 
low serum conditions did not result in significantly increased apoptosis as compared to 
the control (Fig. 5.20.D compared to Fig. 5.16.B). This is confirmed by quantification
190191Fig. 5.18 (previous page). Analysis of the effect of thrombin and thrombin 
inhibitors on apoptosis in E ll slice cultures. E ll  slice culture maintained in 
medium containing  lpM thrombin with  10%  serum (A & B),  lpM thrombin 
with 1% serum (C & D), hirudin with 10% serum (E & F) or PPACK with 10% 
serum (G & H) for 24 hours before whole mount TUNEL staining  (B,D,F,H 
green).  Nuclei  are  counterstained  with  To-Pro-3-isomerase  (A,C,E,G  blue). 
There is no noticeable increase in apoptosis above control (Fig. 5.16.B) in any 
culture condition. Scale bars = 80pm
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Fig. 5.19. Quantification of the effects of exogenous thrombin and thrombin 
inhibitors  on  apoptosis  in E ll  spinal  cord  slice  cultures.  Dot-plots  showing 
TUNEL intensity in organotypic slice cultures of E ll  spinal cord maintained for 
24 hours in the presence of increasing concentrations of thrombin, the thrombin 
inhibitors  hirudin  and PPACK,  thrombin  in  combination  with  low  serum levels 
and low serum levels alone. Images are captured by confocal microscopy at 10 pm 
intervals through the first 40 pm of each slice after whole mount TUNEL staining 
and fluorescence intensity is measured and normalised to area. Data shows mean ± 
SEM for at least 6 samples per group.  No significant change in TUNEL intensity 
is observed with any treatment. P=0.436 (Kruskal-Wallis Test)
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Fig.  5.20.  (previous  page)  Analysis  of  the  effect  of  thrombin  and  thrombin 
inhibitors on apoptosis in E15 slice cultures. E l5 slice culture maintained in medium 
containing  lpM thrombin with  10% serum (A & B),  lpM thrombin with  1% serum (C 
&  D), hirudin with  10%  serum (E & F) or PPACK with  10%  serum (G & H) for 24 
hours before whole mount TUNEL staining (B,D,F,H green). Nuclei are counterstained 
with To-Pro-3-isomerase (A,C,E,G blue). There is no noticeable increase in apoptosis 
above control (Fig. 5.17.B) in any culture condition. Scale bars = 80pm
of the TUNEL staining which reveals that there is no significant change in the apoptotic 
response in the presence of thrombin and low serum as compared to controls at El 1 or 
E15  (Fig. 5.21). This suggests that the addition of thrombin to the medium containing 
1% serum may to some extent rescue the E15 slice cultures from the increased apoptosis 
occurring in the presence of low serum concentrations (Fig. 5.20.B)
5.3.  Discussion
In  this  chapter,  two  parallel  sets  of experiments  were  carried  out  to  investigate  the 
potential role of endogenous and exogenous serine proteases, with a particular emphasis 
on thrombin, in the response of the chick spinal cord to injury. The results demonstrated 
that,  in  contrast to reports  in  other species  thrombin  is  not significantly regulated by 
injury  in  this  model.  However,  the  study  indicated  that further investigation  of other 
serine protease family members might be of interest.
5.3.1.  The use of real-time PCR for gene expression analyses
Following initial experiments in which expression of prothrombin and urokinase mRNA 
was confirmed by conventional RT-PCR, a real-time RT-PCR approach was chosen to 
study the endogenous expression levels of thrombin and urokinase in the spinal cord. 
This  technology  allows  for  the  accurate  determination  of  small  changes  in  gene 
expression. For the purposes of these experiments, relative changes in gene expression 
between  different  samples  are  more  relevant  than  absolute  quantification  and  the 
comparative Gr method was therefore chosen for data analysis. A number of different 
factors  must  be  taken  into  consideration  when  using  this  method.  In  particular  the 
choice  of housekeeping  gene  must  be  taken  with  care  as  a  number  of studies  have 
highlighted the limitations of various commonly used genes (Bustin 2002; Dheda et al. 
2005). In this study GAPDH was chosen as a housekeeping gene principally because it
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Fig.  5.21.  Quantification  of  the  effects  of  exogenous  thrombin  and 
thrombin inhibitors on  apoptosis  in  E15  spinal cord slice cultures.  Dot- 
plots  showing  TUNEL  intensity  in  organotypic  slice  cultures  of El5  spinal 
cord maintained for 24 hours in the presence of increasing concentrations of 
thrombin,  the  thrombin  inhibitors  hirudin  and  PPACK,  thrombin  in 
combination with  low  serum  levels  and  low serum  levels alone.  Images are 
captured by confocal microscopy at 10 pm intervals through the first 40 pm of 
each  slice  after whole mount  TUNEL  staining  and  fluorescence  intensity  is 
measured  and  normalised  to  area.  Data  shows  mean  ±  SEM  for  at  least  6  
samples per group.  No  significant  change  in  TUNEL  intensity  is  observed 
with thrombin or thrombin inhibitor treatment, although a significant increase 
in TUNEL intensity is observed in low serum conditions.  P=0.002  (Kruskal- 
Wallis Test), *p<0.002 (Mann Whitney Test with Bonferroni adjustment).
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has been used reliably in the past for this purpose. In this study no obvious changes in 
GAPDH  expression  were  noted  in  different  experimental  conditions.  Comparison  of 
‘relative  expression’  values  obtained  using  a  different  housekeeping  gene,  the  18S 
RNA,  was  carried  out  on  one  set  of samples  and  did  not  reveal  obviously  different 
results  to  those  using  GAPDH.  Nevertheless,  finances  permitting,  ideally  more than 
one housekeeping gene would be used in every experiment to validate the results.  As 
described in Chapter 3, the comparative Or method assumes that the primer sets used 
for  both  endogenous  control  and  experimental  genes  have  equivalent  amplification 
efficiency. This was therefore validated for each set of primers to be used in the current 
experiments.  One  major  disadvantage  of real-time  PCR  is  that,  as  a  relatively  new 
methodology,  conventions  on  data  analysis  and  in  particular  statistical  analysis  of 
results are still in the process of being established. The comparative C t method involves 
a  series  of  mathematical  manipulations,  starting  with  the  Ct  read-outs  from  the 
software, to produce a measurement of ‘relative expression’, in which all the samples 
are expressed relative to one sample which is nominated as a ‘calibrator’, as outlined in 
Chapter 3.  However as yet there is  no  established convention  on the best method of 
reporting  these  results  or  comparing  them  statistically,  although  a  number  of recent 
papers  have  attempted  to  address  this  issue  (Ginzinger  2002;  Livak  and  Schmittgen 
2001). In the current experiments, each of the three individual pools of samples run for 
each experimental group was separately converted to ‘relative expression’ and statistical 
analysis was also performed at this  stage,  according to previously reported guidelines 
(Livak and Schmittgen,  2001). There may be other valid methods of carrying out the 
data analysis for these experiments. However, given that in this case the results did not 
indicate  any  large  changes  in  gene  expression,  these  would  be  unlikely  to  affect  the 
overall outcome of these experiments.
It was noted in the course of these experiments that there was often some detection of 
amplification  in  negative  control  samples  that  contained  RNA  but  did  not  undergo 
reverse transcription,  although reactions containing only  water in place of RNA were 
almost  always  negative.  This  suggests  that  any  contamination  must have  been  in  the 
RNA  samples  themselves,  despite  all  attempts  to  minimise  this  risk.  These  controls 
were, however, always amplified only at very high cycle numbers, suggesting that they 
would not significantly impair the experimental analyses.
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5.3.2. Analysis of serine protease expression in the developing chick spinal cord.
The expression of serine proteases in the nervous system has been investigated to some 
extent in rodent embryo development (Dihanich et al.  1991; Sumi et al.  1992); however, 
their expression in the developing chick spinal cord has not been described. Therefore it 
was  important  first  to  establish  whether  these  molecules  are  expressed  in  the  chick 
spinal  cord  at  relevant  stages  and  whether  any  developmental  changes  in  expression 
could  be  observed  which  might correspond  to  the  loss  of regenerative  capacity.  The 
results described in this chapter demonstrate that both prothrombin and urokinase are 
expressed  in  the  chick  spinal  cord  throughout  development.  There  was  no  particular 
correlation between the levels of expression of either prothrombin or urokinase mRNA 
and the transitional period from E ll to El 5, suggesting that regulation of these genes at 
the  transcriptional  level  does  not  make  an  important  contribution  to  the  loss  of 
regenerative  capacity.  In  previous  experiments  in  the  rat,  prothrombin  mRNA  was 
demonstrated to be expressed in the brain from E l3  onwards,  with  a decrease in the 
level  of  expression  postnatally,  followed  by  an  up-regulation  during  adulthood 
(Dihanich  et  al.  1991).  The  results  of  the  current  study  show  that  prothrombin 
expression is present at slightly earlier stages in the chick than that reported in the rat 
and no significant changes in expression level are observed at later stages.  Urokinase 
mRNA has been previously demonstrated to be expressed in the spinal cord at E l2.5 but 
not at E l0.5 in the rat, and to increase into early postnatal life (Sumi et al  1992). These 
previous  findings  have  pointed  to  a  role  for  urokinase  in  axonal  growth  during 
development.  The  temporal  expression  pattern  of  urokinase  mRNA  in  the  chick 
demonstrated  in  the  current  study,  with  low  levels  of  expression  during  early 
development and a trend towards high levels of expression at later stages, agrees with 
these  previous  findings,  and  also  with  preliminary  results  obtained  using  semi- 
quantitative PCR. The remit of the current study did not include an in depth analysis of 
the function of these serine proteases in spinal cord development in the chick; however 
it would be of interest in the future to determine the localisation of the expression of 
serine protease mRNA and protein in the developing chick spinal cord.
5.3.3. Analysis of serine protease expression and activity after injury
In  previous  experiments,  in  various  animal  models  of injury  or insult to  the nervous 
system, endogenous levels of serine proteases have been shown to be altered after injury
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(Friedmann et al.  1999).  Of particular note,  in a rat controlled weight drop model of 
spinal cord injury, thrombin, its receptor PAR-1 and its specific inhibitor PN-1 were all 
up  regulated,  as  were  tPA  and  urokinase  (Citron  et al.  2000b).  However,  the results 
presented in this chapter suggest that, in the developing chick spinal cord, alterations in 
endogenous prothrombin mRNA expression or thrombin activity levels are unlikely to 
play a major role after spinal cord injury.
No changes in gene expression were observed at either 2 hours or 24 hours after injury 
and activity levels of thrombin were unchanged at the same time points. These two time 
points were selected for investigation based on the timing of the apoptotic response in 
the chick, which has been shown to begin  8 hours after injury and to peak around 24 
hours  (O'Neill  2002).  The  experiments  were  therefore  designed  to  examine  the 
regulation of thrombin before and during the apoptotic response. These time points also 
correspond to previously reported changes in gene expression and thrombin activity in 
different experimental models  (Citron  et al.  2000b;  Friedmann et al.  1999),  and it is 
therefore  possible  that  the  time  frame  for any  such  changes  in  the  developing  chick 
might be different and therefore precluded from the current study.
The sample numbers used in these experiments were limited by both survival rates after 
injury and the number of samples which it was possible to run in any one experiment. 
This, together with inter-sample variability, means that a very small change in either the 
expression  levels  or activity  of thrombin  would  not  be  detectable  by  these  methods. 
Retrospective  power calculations  suggest that with  these  numbers  a 4-fold change in 
gene  expression  could  be  detected  with  greater than  97%  power.  Similarly,  a  3-fold 
change  in  specific  thrombin  activity  could be detected with  greater than 98%  power. 
However, it is possible that changes smaller than this might be of biological significance 
and  missed  by  this  assay.  For example,  in  the  rat  spinal  cord  a  1.4-fold  increase  in 
prothrombin mRNA levels was observed after injury using a Gene Filter hybrisisation 
technique  while  in  a  model  of  cerebral  iscahemia  prothrombin  mRNA  levels  were 
increased by approximately 2.5-fold (Citron et al.  2000b; Riek-Burchardt et al.  2002). 
The  sensitivity  of  the  assay  could  be  improved  by  increasing  the  sample  numbers, 
although this would have to be balanced by the increase in variability likely if more than 
one plate is required. Nevertheless, these experiments do not provide any evidence for a 
large up-regulation of thrombin activity in the chick spinal cord after injury.
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These results do not necessarily mean that endogenous thrombin does not contribute to 
tissue damage after injury. It is clear that active thrombin is present in the spinal cord at 
relevant stages of development and it is possible that changes in the expression of the 
thrombin receptor or the levels of thrombin inhibitors could result in a greater amount of 
thrombin  signalling  after  an  injury.  Changes  in  the  levels  of PAR-1  and  the  serpin, 
protease nexin-1, have been observed in a number of models of traumatic injury to the 
nervous system (Niclou et al.  1998; Citron et al. 2000b; Striggow et al. 2001).  Analysis 
of the expression levels of these molecules in the chick spinal cord after injury would be 
required to investigate this possibility. Additionally, it would be interesting to determine 
whether there are changes in the localisation of thrombin activity within the spinal cord 
after  injury.  Methods  for  investigating  thrombin  activity  in  situ,  using  membranes 
impregnated with a chromogenic thrombin substrate which can be placed over frozen 
sections, have been described (Imokawa and Brockes 2003). However, initial attempts 
to  use  this  method  in  the  current  experiments  were  unsuccessful  and  the  procedure 
would need to be fully optimised for this application.
Whereas  significant changes in thrombin activity  were not detected in this  study,  the 
results presented here do suggest that there may be a greater role for other endogenous 
serine  proteases.  The  overall  protease  activity  in  the  spinal  cord  was  increased  at  2 
hours  and  even  more  so  at  24  hours  after injury  at  E l5,  as  determined  by  the  non­
specific cleavage  of the  substrate CS-01(38).  A number of other serine proteases  are 
able to cleave this substrate including tPA,  activated protein C and plasmin, although 
cleavage by  urokinase has not been described (www.chromogenix.com).  Other serine 
proteases  which  could be  involved  in  tissue  damage  and  cell  death  after  spinal  cord 
injury  include  the  plasminogen  activators  tPA  and  urokinase.  These  molecules  have 
been demonstrated to be up-regulated after spinal cord injury in the rat (Citron et al. 
2000).  Modulation  of  the  activity  of  plasminogen  activators  has  demonstrated  the 
detrimental effects of these molecules in a number of models of nervous system damage 
including spinal cord injury (Abe et al.  2003; Chen and Strickland  1997; Tsirka et al. 
1995; Wang et al.  1998). As shown in the results presented in this chapter, endogenous 
urokinase mRNA expression in the spinal cord was not increased after injury. However, 
changes  in the  specific  activity  of urokinase  after injury  were  not determined  in  this 
experiment. The extent to which urokinase can cleave the substrate used in this study, 
CS-01(38),  is  unknown;  however,  specific  chromogenic  substrates  for  urokinase  do
199Endogenous and exogenous serine proteases in the developing and injured spinal cord
exist and these could be used to investigate this further. It would also be of interest to 
determine the duration of the elevated serine protease activity, by examining later time 
points after injury.
Although  the  study  presented  in  this  chapter was  designed  to  investigate  the  role  of 
serine proteases in the non-regenerating chick spinal cord, it might also be of interest to 
carry  out  similar  analyses  in  the  regenerating  (Ell)  spinal  cord.  Although  the 
potentially  detrimental  effects  of  thrombin  after  injury  have  been  highlighted  by  a 
number of studies, other findings have pointed to a role for thrombin in the regenerative 
response of the newt limb and lens (Imokawa and Brockes 2003; Tanaka et al.  1999).  It 
would therefore be interesting to determine whether this molecule might be involved in 
the regenerative response of the El 1 spinal cord.
Gene expression changes after injury have been successfully investigated in both human 
and rodent tissue by micro array gene expression analyses.  This type of investigation 
has the ability to assess a large number of potential candidate molecules for up or down- 
regulation  after injury.  Considering  the  vast  array  of genes  expressed within  a tissue 
such  as  the  spinal  cord,  many  of  which  have  the  potential  to  be  involved  in 
neuropathological  situations,  this  approach  could  save  both  time  and  money  in 
comparison to investigating each candidate gene individually. Unfortunately, at the time 
of  commencement  of  the  current  investigations,  gene  chips  useful  for  this  type  of 
analysis in the chick were not available and so this approach was not feasible. However, 
in more recent years this technology has become more widely used and such gene chips 
are now available.  This therefore represents an excellent opportunity to determine the 
relative changes in expression of various genes, including a comprehensive analysis of 
the serine proteases, serpins and their receptors.
5.3.4.  The effects of exogenous thrombin on apoptosis in slice cultures
In parallel to the investigation of changes in endogenous levels of serine proteases, the 
effects  of exogenous  serine proteases  on the  spinal cord were examined.  Following a 
traumatic  injury  to  the  nervous  system,  haemorrhage  and  the  disruption  of the  blood 
brain  barrier  expose  the  spinal  cord  to  molecules  carried  in  the  blood,  including 
thrombin, which are potentially neurotoxic. The in vitro effects of thrombin on neural
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cell  types  suggest  that  the  arrival  of high  concentrations  of thrombin  after an  injury 
could have an effect on cell viability (Turgeon et al.  1998; Turgeon and Houenou 1999; 
Donovan et al.  1997;  Pike et al.  1996;  Smirnova et al.  1998;  Smith-Swintosky et al. 
1995).  In  the current  study,  the potentially  toxic  effects  of thrombin  were  confirmed 
initially  by  examining  the  effects  of  thrombin  treatment  in  neuroblastoma  cells,  in 
which  an  altered morphology,  reminiscent of the cell  death processes,  was  observed. 
Interestingly, cells which were attached to plastic rather than glass, appeared to be more 
resistant to the effects of thrombin. This finding is in agreement with previous studies 
which  have  shown  that  the  susceptibility  of neuroblastoma  cells  to  toxic  stimuli  is 
regulated by integrin-mediated cell adhesion (Bozzo et al.  2004). The primary aim of 
this part of the study was therefore to determine whether exogenous thrombin treatment 
could similarly cause apoptosis in the developing chick spinal cord.
In order to investigate the effects of exogenous thrombin treatment on apoptosis it was 
decided to set up an organotypic culture system of the spinal cord. This overcomes a 
number of the problems associated with treating the spinal cord directly with thrombin, 
which is both technically difficult and likely to prove toxic, due to its potential to cause 
blood clotting. Also, by using slice cultures, it was possible to obtain several samples 
from each embryo, minimising the number of animals which needed to be used in order 
to produce  a quantitative result.  By  culturing  the  slices in hanging drop cultures,  the 
amount of medium and therefore pharmacological treatments required was minimised, 
again allowing the numbers of samples which could be tested to be increased. Finally, 
the  organotypic  culture  system  has  advantages  over a cell  culture  model,  as  it  more 
closely represents  the cellular environment  which  would be found  in  vivo.  This  is  of 
particular importance given that the results obtained with cultured neuroblastoma cells 
strongly suggested that cellular attachment could modify the responsiveness to thrombin 
treatment.
The  ability  of  the  system  to  demonstrate  changes  in  apoptosis  was  validated  by 
comparing the effects  of culturing  in low  serum conditions between regenerating  and 
non-regenerating stages of the chick spinal cord.  The E ll spinal cord was demonstrated 
to be resistant to low serum conditions, while, in contrast, the E l5 spinal cord showed a 
large increase in apoptosis in low serum conditions. This developmental change in the 
response of the spinal cord cultures to low serum conditions mimics the in vivo response
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to injury, in which there is a much greater apoptotic response at E l5 than at El 1, which 
suggests that this model appropriately represents the in vivo situation.
The  effects  of  exogenous  thrombin  treatment  on  apoptosis  at  E ll  and  E l5  were 
compared in the slice culture system. From these results, exogenous thrombin does not 
appear to cause an apoptotic response in the spinal cord at either developmental stage. 
These results therefore differ from reports in the literature demonstrating that exogenous 
thrombin  can  cause  increased  apoptosis  in  several  in  vitro  systems  (Donovan  et  al. 
1997; Smirnova et al.  1998; Smith-Swintosky et al.  1995; Turgeon et al.  1998; Turgeon 
and  Houenou  1999).  Similarly,  a  number  of previous  studies  have  demonstrated  the 
ability  of thrombin  inhibitors  to reduce  cell  death  in  various  in  vitro  models  (Smith- 
Swintosky et al.  1995; Houenou et al.  1995). In contrast, the results of the current study 
show  that  inhibition  of endogenous  thrombin  activity  in  the  slices  by  two  different 
thrombin inhibitors did not result in any significant changes in the apoptotic response, 
although the less specific inhibitor, PPACK, did show a trend towards lower apoptosis. 
Overall,  these  findings  suggest  that  endogenous  thrombin  in  not  involved  in  the 
signalling pathways leading to apoptosis in these cultures.
The discrepancies between results obtained in the current experiment and those reported 
in  the  literature  may  to  an  extent  be  explained  by  the  different  apoptotic  stimuli 
involved in the experiments. Additionally, there was a fairly large variability in results 
obtained from different slices, which meant that only large differences in the apoptotic 
response could  be  distinguished  statistically.  This  may  have  been  accentuated by  the 
fact  that  the  results  were  obtained  from  a  series  of  experiments  due  to  practical 
difficulties  in  handling  large  sample  numbers.  This  problem  might  therefore  be 
alleviated  by  carrying  out  this  type  of  testing  on  a  larger  scale  in  the  future.  One 
probable explanation  for the differences  between  the results  of the current study  and 
those of previous reports is that the slice culture method may result in better protection 
of neurons and glia from cell death than the dissociated systems used in most previous 
experiments. This could be due to the presence of protective factors or cell types, or the 
reduced  accessibility  of  the  drug  to  its  target  cells  or  receptors.  Additionally,  the 
interaction of cells with their neighbours and the extracellular substrate might provide a 
protective effect against the effects of thrombin, as was observed in the neuroblastoma 
cultures. Organotypic slice culture protocols have been shown in some cases to be less
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susceptible  to  neurotoxic  stimuli  (Keynes  et al.  2004).  However,  thrombin  has  been 
shown at equivalent doses to those used in the current experiment to cause cell death in 
organotypic slice cultures of rat hippocampus (Striggow et al. 2000). It is also possible 
that these differences represent either differences between species, developmental stages 
or  the  CNS  region  being  studied,  with  the  hippocampus  being  more  sensitive  to 
thrombin-induced cell death. In the chick spinal cord the blood brain barrier may not be 
completely formed by the stages being  examined in this  study  (Wakai  and Hirokawa 
1978). This may necessitate higher levels of endogenous protection against blood-borne 
neurotoxins at these stages than in the adult. It is also important to note that the current 
study  investigated  only  apoptotic  cell  death;  whereas  cell  death  in  the  hippocampal 
slices  following  thrombin  treatment  was  not  defined  as  apoptotic  or  necrotic. 
Nevertheless, these results suggest that neither an increased susceptibility to thrombin- 
induced cell death at E l5, nor the increased exposure of the E15 spinal cord to thrombin 
due to increased haemorrhage, is likely to account for the increased apoptosis  seen at 
non-regenerating stages in the chick after injury.
However,  it is  also  worth  considering  the  possibility  that a combination  of thrombin 
with other active molecules, which might be present in the blood which enters the spinal 
cord after an injury but which were missing from this model, may be required in order 
to  induce  apoptosis.  In  order to  address  this  issue,  attempts  were  made  to determine 
whether whole blood could induce apoptosis in the slice cultures. Unfortunately due to 
the blood clotting rapidly, and the desire not to pre-treat the blood with anticoagulants 
which might affect key factors such as thrombin, this was not possible. Factors present 
in blood which might act together with thrombin might include other serine proteases. 
Indeed one previous report has demonstrated that the detrimental effects of thrombin in 
a brain injury model are increased by treatment with plasminogen activators (Figueroa 
et al.  1998). It is interesting to note that treatment of the slice cultures with the thrombin 
inhibitor PPACK  produced  an  indication  of reduced  apoptosis,  although  this  did  not 
prove statistically significant. As PPACK is also thought to inhibit the activity of other 
serine proteases to a lesser extent (Weitz and Hirsh 2001), this suggests that inhibition 
of  the  activity  of  one  or  more  serine  proteases  other  than  thrombin  might  be 
neuroprotective. It would be of great interest to assess the potentially neurotoxic effects 
of other serine proteases such as urokinase in this model.
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Although  the  main  focus  of this  study  was  to  investigate  the  potentially  neurotoxic 
effects of thrombin in the chick spinal cord, there are indications that thrombin may also 
be  of benefit  to  the  injured  nervous  system.  Some  previously  reported  studies  have 
demonstrated  protective  effects  of low  concentrations  of thrombin  against  apoptosis 
following various stimuli (Pike et al.  1996; Vaughan et al  1995). In the current study, 
thrombin  treatment did  not reduce  apoptosis  under normal  culture conditions  in  1 0% 
serum.  However,  the  results  suggest  a  slight  reduction  in  the  increased  apoptotic 
response to low serum conditions in the E l5 slice cultures. This suggests that thrombin 
may  be  neuroprotective  against  the  apoptotic  response  induced  by  low  serum 
conditions.  Furthermore,  as  mentioned  above,  thrombin  has  also  been  reported  to 
promote  regenerative  responses  in  the  newt  limb  and  lens  by  stimulating 
dedifferentiation and proliferative responses (Tanaka et al  1999; Imokawa and Brockes
2003).  It  would  be  of interest to  determine  whether thrombin  activity  is  involved  in 
these processes in the regenerating chick spinal cord.
5.3.5. Serine proteases and the injury response
In this chapter, the hypothesis that serine proteases, and in particular thrombin, might 
have a role in the increased apoptotic response of the non-regenerating chick spinal cord 
to  injury  has  been  investigated.  The  results  presented  here  suggest  that  although 
thrombin may not play this role in this system as it does in other experimental models, 
perhaps  due  to  differences  in  the  developmental  stage  or  species  used,  other  serine 
proteases are likely to be of importance. Importantly, the results demonstrate an increase 
in total serine protease activity after injury, pointing to a potential role for other serine 
proteases which cleave the substrate CS-01(38).  This was also supported by the trend 
towards a decrease in the apoptotic response in slice cultures treated with the relatively 
non-specific thrombin inhibitor PPACK. This study has concentrated on the apoptotic 
response  to  injury;  however,  thrombin  may  have  other detrimental  effects  within  the 
injured  nervous  system.  For  example,  thrombin  has  been  shown  to  cause  neurite 
retraction,  growth  cone collapse  and  microglial  activation  (Gurwitz  and Cunningham 
1988;  Jalink  and  Moolenaar  1992;  Suidan  et  al  1992;  Fritsche  et  al  1999).  The 
organotypic culture system which  was devised for these experiments may represent a 
good model for screening for the effects of potentially neurotoxic molecules, including 
other serine proteases such as urokinase.
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6.1.  Introduction
In  order  for the  spinal  cord to  be  capable  of regeneration  after  injury,  a  sufficient 
number of viable neurons must be present to re-establish functional neural networks. As 
described in Chapters 4 and  5,  cell  death following injury is a major contributor to 
neuronal loss and neuroprotective strategies represent one way to improve the ability of 
the  spinal  cord  to  recover  from  injury.  Another therapeutic  avenue  which may  be 
explored would be to enhance the endogenous repair responses of the spinal cord and 
this may include the replacement of lost or damaged cells with newly generated cells 
from  pools  of endogenous  neural  stem  or  progenitor  cells.  In  assessing  the  likely 
success of this strategy, an understanding of the relative contribution of endogenous 
neurogenesis to repair in regenerative species would be of great benefit.
Endogenous stem cells capable of differentiating into neurons and glia, as well as cells 
with a more restricted potential, have been identified in the mammalian brain and spinal 
cord (Gage 2000; Homer et al.  2000; McKay  1997; Nunes et al.  2003; Shihabuddin et 
al.  2000; van der and Weiss 2000). A proliferative response to spinal cord injury has 
also been observed in the adult rat (Mothe and Tator 2005; Namiki and Tator  1999; 
Yamamoto  et al.  2001).  The  presence  of endogenous neural progenitors within the 
spinal cord does not result in significant regenerative capacity in the adult mammal but 
does  suggest  potential  for  the  stimulation  of these  endogenous  cells  to  produce 
replacement neurons and glia. In contrast to the situation in the adult mammal, in many 
regenerative  lower vertebrate  species proliferation and the  subsequent generation of 
neural  cells  appears  to  make  a  significant  contribution to  the  regenerative  process 
(Benraiss et al.  1999; Nordlander and Singer 1978; Anderson et al.  1994).  In species 
which undergo a developmental change in regenerative capacity, such as the opossum 
and the chick, the contribution of a proliferative response to the regenerative process is 
less clear and is of particular interest (Shimizu et al.  1990; Hasan et al.  1993; Saunders 
et al.  1998).  In these  species,  most research to  date  has  tended to  focus  on axonal 
regenerative capacity. However it is possible that a loss of an early ability to stimulate 
endogenous progenitors to replace lost cells may also be important.  It is therefore of
205Expression and regulation of doublecortin in the normal and injured chick spinal cord
interest  to  determine  whether  neurogenesis  occurs  after  injury  at  regeneration- 
competent stages of chick development.
To this end, the  identification of a marker of newly born neurons would be of great 
benefit and, in this study, the expression and regulation of doublecortin, a microtubule- 
associated protein which is expressed early during neuronal development and has been 
shown to accurately reflect levels of neurogenesis in the adult mammalian brain was 
investigated (Couillard-Despres et al  2005; Francis et al.  1999; Gleeson et al  1999; 
Rao and Shetty 2004;  Sossey-Alaoui et al  1998). Doublecortin has been shown to be 
down regulated as neurons mature, resulting in its transient expression in newly bom 
neuron populations (Brown et al  2003). Doublecortin may therefore be a potentially 
useful marker for newly generated neurons in the embryonic chick nervous system. In 
addition to its potential role as a marker of neurogenesis, doublecortin has a number of 
features that make it an interesting molecule to consider in the context of spinal cord 
regenerative capacity. Doublecortin contributes to the control of microtubule stability 
and  is  likely  be  involved  in  situations  in  which  cytoskeletal  reorganisation  is  of 
importance (Bai et al 2003; Gleeson et al  1999; Horesh et al.  1999; Nacher et al. 2001; 
Shmueli et al. 2001).
The current study initially considered whether doublecortin might prove to be a useful 
marker for neurogenesis in the E ll  chick spinal cord.  In order to be suitable for this 
purpose doublecortin expression would have to be otherwise absent or low at this stage, 
as in the adult mammalian brain (Nacher et al.  2001). Neurogenesis in the chick spinal 
cord has been reported to be complete by E9 and the formation of major descending 
neuronal tracts  is complete around E ll  (Fujita  1964;  Okado  and Oppenheim  1985). 
These experiments therefore set out to determine whether doublecortin expression is 
down-regulated with development in the chick in a manner which would be compatible 
with its use  as a marker of neurogenesis.  In subsequent experiments changes in the 
expression of doublecortin in the normal and injured spinal cord were investigated in 
order  to  determine  whether  they  are  compatible  with  a  role  in  controlling  the 
regenerative capacity of the chick spinal cord.
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6.2. Results 
6.2.1. Selection of doublecortin antibody for use in the chick.
The  expression  of doublecortin  in the  chick  spinal  cord  was  investigated using  an 
antibody against the C-terminal region of human doublecortin. As this antibody has not 
been previously used in chick, it was necessary to confirm the specific recognition of 
doublecortin in the chick. Protein samples from E ll  chick spinal cord and liver were 
separated by SDS-PAGE, transferred to nitrocellulose membranes and incubated with 
either the  doublecortin  antibody  or  antibody  which  had  been  pre-incubated with a 
blocking peptide. As shown in Fig. 6.1, in El 1  chick spinal cord samples a doublet was 
detected at approximately 40kDa. This corresponds to the previously reported size of 
chick  doublecortin.  The  second  band  observed  probably  corresponds  to  a 
phosphorylated form of the protein, as previously described (Tanaka et al.  2004). No 
bands  were  observed  in  the  liver  sample,  confirming  the  neuronal  specificity  of 
doublecortin. Likewise, no bands were observed when the antibody was pre-incubated 
with blocking peptide, which confirms that the antibody recognises the correct antigen.
6.2.2. Expression of doublecortin protein in the developing chick spinal cord
The  expression of doublecortin  in the  chick  spinal  cord was  investigated firstly by 
immunostaining  sections  taken  from  embryos  at  various  developmental  stages.  As 
shown in Fig. 6.2.A and B, at E4, doublecortin is expressed in the ventral and lateral 
parts of the neural tube, where the post-mitotic neurons reside. No doublecortin staining 
was observed at the ventricular surface, suggesting that doublecortin is not expressed in 
proliferating  neuronal  precursors.  At E8  and  E ll,  doublecortin is  expressed at low 
levels throughout the grey matter (Fig.  6.2.C-F).  In the E l3  and E l5  spinal cord, the 
strength of doublecortin expression is much lower than at earlier stages, and appears to 
have become restricted to the dorsal horns of the grey matter (Fig. 6.3.A-D). In order to 
confirm that the staining observed was due to specific binding to doublecortin, some 
sections  were  incubated  with  antibody  that  had  been  pre-incubated  with  blocking 
peptide.  This  resulted  in the  complete  absence  of any  staining;  suggesting that the 
staining  observed  with  this  antibody  is  specific  (Fig.  6.3.E  and  F.).  These  results 
showed that doublecortin is down-regulated as development progresses. However, there
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Fig. 6.1. Western blot showing specificity of doublecortin antibody in 
chick. Western blot showing binding of anti -doublecortin (C-l 8) in chick 
spinal  cord  (SC)  and  liver  (L)  samples.  A  40kDa band  is visible  in the 
spinal cord  samples but not  in the  liver.  Half the  samples  were  stained 
using  the  antibody after pre-incubation with blocking peptide  to confirm 
specificity.Fig.  6.2.  Expression  of doublecortin  in  the developing chick spinal  cord  I.
Doublecortin  immunostaining  (red)  and  nuclear  counterstaining  with  Hoechst 
(blue)  in  transverse  sections  of spinal  cord  at  A)  and  B)  E4  (arrow  indicates 
doublecortin staining in the ventrolateral neural tube), C) and D) E8, and E) and 
F) El 1.  Scale bars: A,B-250 pm, B-F-500 pm.  In all images dorsal is at the top 
of the picture.A B
Fig. 63. Expression of doublecortin  in the developing chick spinal cord II.
Doublecortin  immunostaining  (red)  and  nuclear  counterstaining  with  Hoechst 
(blue)  in transverse  sections of spinal  cord at A)  and  B) E l3,  and  C)  and D) 
El 5. Inset in D shows higher magnification view of doublecortin staining in the 
E15  dorsal  horns.  In order to  confirm specificity  of the  antibody  staining  was 
carried  out  after  pre-absorption  with  blocking  peptide,  producing  a  negative 
result as shown  in  E  and  F.  Scale  bars:  A,B,E  and  F-500  pm  and C  and  D- 
1000 pm. In all images dorsal is at the top of the picture.
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is still a widespread low level expression of doublecortin throughout the grey matter at 
El 1, suggesting that at this stage many neurons are still not fully mature. Doublecortin 
is therefore unlikely to be useful as a marker of neurogenesis in the spinal cord at this 
stage.
The  results  of the  immunostaining  study  described  above  suggested  a  correlation 
between the level of doublecortin expression and developmental  stage.  In particular 
there  appeared to  be  a reduction in the  level  and extent of doublecortin expression 
between E ll and E l5. In order to confirm these results Western blotting was carried out 
on chick spinal cord samples collected at various developmental stages. As shown in 
Fig.  6.4, there was an overall reduction in the level of doublecortin protein present in 
spinal cord samples between El 1  and E l5.
As before, in some of the samples two bands were observed following blotting with the 
doublecortin  antibody  (Fig.  6.4.).  Doublecortin has  been  shown to  be  regulated by 
phosphorylation and the upper band probably represents a phosphorylated form of the 
protein (Tanaka et al.  2004).  In order to  confirm this, half of the samples were pre- 
incubated with calf intestinal alkaline phosphatase (CIAP) before being separated by 
electrophoresis.  Treatment  with  CIAP  completely  eliminated  the  upper  band, 
confirming that this was a phosphorylated protein (Fig 6.4). In addition to the overall 
reduction  in  doublecortin  levels  with  development,  this  analysis  also  revealed  a 
reduction in the amount of the phosphorylated form of the protein. As shown in Fig. 6.4, 
at E8 and E ll  the upper band representing the phosphorylated form of doublecortin is 
strong. However by E l3, this band has been markedly down-regulated and by E l5, no 
upper band can be observed. This demonstrates that the phosphorylation of doublecortin 
in  the  chick  spinal  cord  is  developmentally  regulated  over  a  time-period  that 
corresponds to the loss of regenerative capacity.
6.2.3.  Expression of doublecortin mRNA in the developing chick spinal cord
The results outlined above revealed that doublecortin protein is present at relatively high 
levels  at  fairly  late  stages  of development  in  the  chick  spinal  cord,  and  that  this 
expression may be developmentally regulated. Doublecortin is thought to be expressed 
early during neuronal differentiation and migration and then down-regulated in mature
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Fig 6.4.  Doublecortin  protein  levels  in  the developing chick spinal 
cord A) Western blot data showing changes in doublecortin levels and 
phosphorylation  at  different  developmental  stages.  Samples  were 
incubated  either  with  or  without  calf  intestinal  alkaline  phosphatase 
(CIAP) before SDS-PAGE. B) Ponceau Red staining of the same blot to 
show protein loading.
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neurons (Brown et al. 2003). In order to determine whether the presence of doublecortin 
in the chick spinal cord is the result of continued gene expression or persistence of the 
protein, the mRNA levels of doublecortin were investigated by semi-quantitative RT- 
PCR. In this method, the levels of PCR product are measured after a specified number 
of PCR cycles have taken place. For this to provide a reliable measure of the starting 
mRNA levels for a particular gene, the end-point must be taken during the linear phase 
of the  PCR  reaction.  Linear  curves  for  the  amplification  of doublecortin  and  an 
endogenous reference gene, GAPDH, were therefore constructed as shown in Fig. 6.5.
Semi-quantitative RT-PCR was used to compare the levels of doublecortin in spinal 
cord  samples collected at various developmental time points.  As  shown in Fig.  6.6, 
doublecortin mRNA levels are low at E3 and then increase to a maximum by E7. The 
levels  of doublecortin  mRNA  then  gradually  decrease  up  to  the  latest  time  point 
measured,  E l5.  These results show that the pattern of doublecortin gene expression 
matches  the  protein  expression  data.  Expression  is  highest  during  the  period  of 
neurogenesis in the chick spinal cord. However doublecortin continues to be expressed 
in the  chick  spinal  cord until  at  least  E l5.  In agreement with the protein levels  of 
doublecortin described above, there is a decrease  in doublecortin mRNA expression 
between  E ll  and  E l5,  corresponding  to  the  period  in  which  there  is  a  loss  of 
regenerative capacity in the chick spinal cord.
6.2.4.  Expression  of doublecortin  protein  in  the  mouse  and  human developing 
spinal cord
Although  doublecortin  expression  in  the  developing  brain  has  been  previously 
examined, its expression in the spinal cord has not been investigated to any great extent. 
In order to  determine whether the expression pattern in chick spinal cord described 
above  is  conserved  in other species,  immunostaining  was carried out in mouse  and 
human spinal cord sections collected at various developmental stages.
In mouse embryos at E l3.5 and El4.5, which corresponds to approximately E5-E7 in 
the chick, doublecortin expression was detected throughout the grey matter of the spinal 
cord (Fig. 6.7.A-D). However, in the adult mouse spinal cord, doublecortin expression
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Fig.  6.5.  Determination  of the  linear  range  for  semi-quantitative  RT-
PCR.  PCR  reactions  using  A)  doublecortin  and  B)  GAPDH  primers  were 
stopped  after  various  cycles  and  the  PCR  products  were  separated  by  gel 
electrophoresis. Band intensity was measured by densitometry and plotted to 
give an amplification curve. For following experiments a cycle number from 
within the linear part of the graph was chosen.
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Fig 6.6. Expression of doublecortin mRNA in the developing chick spinal 
cord. Semi-quantitative RT-PCR data showing expression of doublecortin 
mRNA in the chick spinal cord at four different developmental stages. Data 
show mean ± SEM for three pools of samples for each data point and are 
normalised to GAPDH levels. Doublecortin mRNA is expressed throughout 
development, with the highest peak of expression around E7. * p = 0.05 
(Kruskal Wallis test with post hoc paired comparisons).
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Fig.  6.7.  Expression of doublecortin  in  the  developing mouse spinal cord.
DCX immunostaining is shown in red and nuclear counterstaining with Hoechst 
is shown  in blue at A)  and  B) E l3.5, C)  and  D) E14.5  and E)  and  F) adult 
mouse. Scale bars: A and B-200 pm. C-F -  100 pm. In all images dorsal is at 
the top of the picture.
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was virtually absent, suggesting that neurons in the spinal cord are fully mature by this 
stage (Fig. 6.7.E and F).
Immunostaining for doublecortin in the human embryonic spinal cord revealed that in 
embryos between 32-39 days gestation, corresponding to approximately E3-E4 in the 
chick, doublecortin expression was found in the ventral and lateral neural tube and was 
also  observed in the dorsal and ventral roots and dorsal root ganglia (Fig.  6.8.A-F). 
Although the precise rostral-caudal levels of these sections is unknown, it is likely that 
the open neural tube seen in Fig. 6.8.C and D is taken from a slightly different region of 
the  spinal  cord  than  those  observed  in  Fig  6.8.A  and  B.  By  44  days  gestation, 
corresponding to around E5.5 in the chick, doublecortin expression was observed most 
strongly in the ventral horns of the spinal cord (Fig. 6.9.A and B). At 54 days gestation, 
corresponding to approximately E8 in the chick, doublecortin expression was absent 
from the spinal cord (Fig. 6.9.C and D). Similarly, by 9 weeks gestation, corresponding 
to around El 1   in the chick, doublecortin expression could not be detected in the human 
spinal cord (Fig. 6.9.E and F). These results suggest that the expression pattern observed 
for doublecortin in the chick spinal cord is broadly conserved across different species, 
although doublecortin expression appears to be down-regulated slightly earlier in the 
human spinal cord.
6.2.5.  Expression of doublecortin in a human neuroblastoma cell line
The  results  described  above  revealed  a  developmental  regulation  of doublecortin 
expression and post-translational modification, which appears to correspond to the loss 
of regenerative capacity in the chick spinal cord. Although doublecortin continues to be 
expressed throughout spinal cord development the expression level and, in particular, 
the level of the phosphorylated form of the protein, seems to correlate with a less mature 
neuronal state. In order to further confirm these findings, the expression of doublecortin 
in a neuroblastoma cell line, composed of immature neural precursors, was assessed. 
Doublecortin expression was investigated in the human neuroblastoma cell line,  SH- 
SY5Y. Twenty four hours after plating,  immunostaining showed that doublecortin is 
expressed in many SH-SY5Y cells (Fig 6.10.A-D). The specificity of the staining was 
confirmed by staining separate coverslips with the antibody after pre-incubation with
217Fig.  6.8.  Expression  of doublecortin  in  the  embryonic  human  spinal 
cord  I.  DCX immunostaining is shown in red and nuclear counterstaining 
with  Hoechst  is  shown  in  blue  at  A)  and  B)  32  days  (arrow  indicates 
doublecortin  staining  in  the  ventrolateral  neural  tube)  C)  and  D)  37days 
(arrows indicate staining in the dorsal (arrowhead) and ventral (arrow) roots) 
and  E) and F) 39days (asterisks indicates staining in the dorsal root ganglia) 
Scale bars:  A,B,E and F - 500 pm. C and D- 1000 pm
218Fig.  6.9.  Expression  of doublecortin  in  the  embryonic  human  spinal 
cord II. DCX immunostaining is shown in red and nuclear counterstaining 
with Hoechst is shown in blue at A) and B) 44 days C) and D) 54days and 
E) and F) 9 weeks. Scale bars: 500 pm.
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Fig.  6.10.  Expression  of doublecortin  in  a  human  neuroblastoma  cell 
line.  A)-D)  Immunostaining  for  doublecortin  (red,  A,C)  and  nuclear 
counterstaining  (blue,  B,D)  in  SH-SY5Y  cells.  E)  Staining  using 
doublecortin  antibody  after  pre-incubation  with  blocking  peptide.  F) 
Western blotting for doublecortin on SH-SY5Y cells. Scale bars = 50pm.
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the  blocking peptide,  resulting  in an absence of staining  (Fig,  6.10.E).  This  further 
supports the specificity of the staining observed in human spinal cord sections, on which 
it was not possible to use the blocking peptide due to limited material being available. 
Western  blotting  of  protein  extracts  from  the  cells  demonstrated  two  bands  at 
approximately 40kDa, revealing strong expression of the phosphorylated form of the 
protein  in  this  cell  line  (Fig.  6.10.F).  These  results  support  the  suggestion  that 
expression of the phosphorylated form of doublecortin is a hallmark immature neuronal 
cell types. These results also indicated that this cell line could be useful to investigate 
the functional effects of doublecortin in future experiments.
6.2.6.  Analysis  of changes  in  the  expression  of doublecortin  after injury  in the 
chick spinal cord.
The results described above revealed that doublecortin is expressed in the chick spinal 
cord at relatively late developmental stages and that levels of doublecortin are reduced 
at  developmental  stages  corresponding  to  the  loss  of  regenerative  capacity. 
Additionally, doublecortin phosphorylation was shown to be developmentally regulated. 
It  is  possible  that  down-regulation  of this  protein  might  contribute  to  the  loss  of 
regenerative capacity in the chick spinal cord. It was therefore of interest to determine 
whether doublecortin  expression  is regulated by  injury  and  whether this regulation 
differs in the regenerating and non-regenerating spinal cord.
Initially, mRNA levels of doublecortin were compared, by semi-quantitative RT-PCR, 
in the injured and sham-operated spinal cord 24 hours after injury at either Ell or El5. 
There was a significant increase in the mRNA expression of doublecortin after injury at 
E ll  (Fig  6.11 A).  Although,  24  hours  after  injury  at  E l5,  there  appeared to  be  an 
increase  in  doublecortin  mRNA  expression,  this  did  not  prove  to  be  statistically 
significant (Fig.  6.1 l.B). These results suggest that doublecortin up-regulation occurs 
after  injury  in  the  regenerating  but  not  in  the  non-regenerating  spinal  cord.  Next, 
doublecortin protein levels were investigated in sham-operated and injured spinal cords 
24 hours after injury at Ell  or E l5 by Western blotting. There appeared to be an up- 
regulation in the overall protein level of doublecortin in injured spinal cord samples as 
compared to sham operated samples at 24 hours after injury at El 1  (Fig 6.12).
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Fig. 6.11. Analysis of doublecortin mRNA expression after injury to the 
spinal  cord.  Semi-quantitative  RT-PCR  data  showing  expression  of
doublecortin mRNA 24 hours after injury at A) El 1   and B) El5.  Data show 
mean  ±  SEM  for  three  pools  of  samples  for  each  data  point  and  are 
normalised  to  GAPDH  levels.  There  was  a  significant  increase  in 
doublecortin mRNA expression after injury at Ell  but not at El5.  * p=0.05 
for El 1   (Mann-Whitney Test), p=0.376 for El 5 (Mann Whitney Test)
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Fig  6.12.  Analysis  of doublecortin  protein  levels  24  hours  after 
spinal  cord  injury  at  E ll.  A)  Western  blot  showing  doublecortin 
levels  and  phosphorylation  at  24  hours  after  injury  at  E ll.  Two 
different  pools  of samples  for  each  group  were  run  in  duplicate  B) 
Ponceau Red staining of the same blot to show protein loading. There 
was an increase in doublecortin levels and in the phosphorylation of the 
protein in the injured samples as compared to the shams.
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There was also a striking increase in the intensity of the upper band, representing the 
phosphorylated form of the protein, in injured samples at this time point.
In contrast, 24 hours after injury at E l5, there was no observable difference in the level 
of doublecortin protein in injured and sham-operated samples (Fig.  6.13.). Likewise, 
there was no up-regulation of the phosphorylated form of the protein at this time point. 
These results demonstrate that protein levels and phosphorylation of doublecortin are 
up-regulated  after  injury  at  regeneration-competent  stages  but  not  at regeneration- 
incompetent stages,  suggesting that this protein may play  a role in the regeneration 
process.
6.3.  Discussion
In this study, the expression of doublecortin in the developing and injured chick spinal 
cord  was  assessed  using  immunostaining,  PCR  and  Western  blotting.  The  results 
suggest that changes in the expression level and phosphorylation state of doublecortin 
may contribute to the regenerative capacity of the E ll chick spinal cord.
6.3.1.  Doublecortin as a marker of neurogenesis in the chick spinal cord
The initial aim of these experiments was to determine whether doublecortin might act as 
a marker of neurogenesis in the embryonic chick spinal cord. The results described in 
this chapter demonstrate that there is a strong correlation between the expression of 
doublecortin  and  neurogenesis.  However these  results  have  also  demonstrated  the 
persistence of doublecortin gene and protein expression to developmental stages beyond 
the period of neurogenesis in the chick spinal cord. This means that doublecortin would 
not make an adequate marker for neurogenesis in this model, in contrast to findings in 
the adult mammalian brain (Brown et al.  2003; Couillard-Despres et al.  2005; Rao and 
Shetty 2004).  Strikingly, doublecortin was downregulated at an earlier equivalent stage 
in the human spinal cord, suggesting that the human spinal cord is more mature than the 
chick spinal cord at similar gestational ages.
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Fig 6.13. Analysis of doublecortin protein levels 24 hours after spinal 
cord  injury  at  E15  A)  Western  blot  showing  doublecortin  levels  and 
phosphorylation at 24 hours after injury at E l5.  Two different pools of 
samples for each group were run.  B) Ponceau Red staining of the same 
blot  to  show  protein  loading.  There  was  no  increase  in  doublecortin 
levels or phosphorylation of the protein after injury at this stage.
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6.3.2.  The role of doublecortin in neuronal development
By investigating the expression pattern of doublecortin in relation to known periods of 
neuronal development, the results of the current study provide some new insights into 
the  potential  role  of doublecortin  in the  developing  spinal  cord.  The  expression of 
doublecortin was shown to increase at early developmental stages, coinciding with the 
major period of neurogenesis in the chick spinal cord which takes place between E3-E9 
(Fujita  1964).  Doublecortin  expression  is  then reduced  as  development progresses, 
suggesting that expression of doublecortin begins to be lost as neuronal cells reach full 
maturity. The expression pattern of doublecortin in the chick spinal cord was shown to 
be closely matched by that in the mouse and human spinal cord, although the timing of 
the down-regulation of doublecortin appears to differ between species.  These findings 
are  in agreement with previous findings which have  shown doublecortin expression 
during  neuronal  differentiation,  migration  and  maturation  followed  by  a  down- 
regulation  of doublecortin in the  adult CNS,  although only  one previous study has 
included the  spinal  cord in this  analysis  (Gleeson et al.  1999;  Hannan et al.  1999; 
Nacher et al. 2001).
There has been some controversy surrounding the timing of the earliest doublecortin 
expression  during  neuronal  development  with  conflicting  reports  as  to  whether 
doublecortin  is  co-expressed with nestin,  a marker of neural  stem  cells  (Couillard- 
Despres et al.  2005; Rao and Shetty 2004; Kempermann et al.  2003; Kronenberg et al.
2003).  This  could not be tested in this model  since there  is no chick homologue of 
nestin.  However,  doublecortin  was  not  expressed  at the  ventricular  surface  at  any 
developmental age tested,  indicating that this protein is not expressed in neural stem 
cells but begins to be expressed only once a neuron becomes a neuroblast. Indeed, most 
previous studies that have described an overlap of doublecortin and nestin expression 
have  employed  a  nestin-GFP  construct  for this  purpose  rather than  examining  the 
endogenous protein, suggesting that what has been detected is GFP protein which has 
not yet been cleared from the cell.
Likewise,  many  studies  have  not  attempted  to  determine  the  stage  of neuronal 
development at which doublecortin is down-regulated. Previous studies have shown an 
almost complete absence of doublecortin expression in the adult brain, suggesting that it
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is  not  expressed  in  mature  neurons  (Nacher  et al.  2001).  However,  low  levels  of 
doublecortin expression have been observed in diverse brain regions in the adult and it 
has been suggested that this reflects a role in processes such as synapse formation and 
neurite outgrowth (Nacher et al.  2001). In the current study, doublecortin expression 
continues beyond the  established period of neurogenesis  and migration in the chick 
spinal cord. This expression was shown to be the result of ongoing gene expression and 
not merely the persistence of the protein in maturing neurons. Continued expression of 
doublecortin at stages beyond neurogenesis and migration suggests that this protein may 
have  a  functional  role  beyond  its  involvement  in  these  processes.  At  later  stages, 
doublecortin expression is  seen to  become restricted to the  dorsal horns in the grey 
matter, which are known to be among the latest regions of the spinal cord to mature. 
Neurons in this region continue to receive and make new synaptic inputs from primary 
sensory neurons entering the spinal cord from the grey matter. The continued expression 
of doublecortin in these regions might therefore reflect a role in this process.
6.3.3.  Doublecortin expression changes during the transition between regeneration- 
competent and incompetent developmental stages
This study has revealed a number of key differences in the expression and regulation of 
doublecortin between regeneration competent and incompetent stages of the spinal cord. 
Taken together, these findings suggest that doublecortin might make a contribution to 
the regenerative capacity of the chick spinal cord.
These results show that doublecortin expression levels in the chick spinal cord undergo 
a  marked  reduction  during  the  period  in  which  the  spinal  cord  loses  its  ability to 
regenerate after injury.  This reduction takes place at both the mRNA and the protein 
level. The immunostaining studies described in this chapter illustrate that, in the period 
between E ll  and E l5, doublecortin expression is reduced and becomes restricted to the 
dorsal horns of the spinal cord, with no expression observed in any other part of the 
spinal  cord.  The  results  of the  Western blotting  experiments  further confirmed the 
dramatic  reduction  in protein  levels between E ll  and E l5  and also provided  some 
interesting findings about changes in the post-translational modification of doublecortin 
at these stages.
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These  results  illustrated  that  at  early,  regeneration-competent  stages  doublecortin 
appears to be highly phosphorylated. However, by E l5, virtually all the doublecortin 
present appears to be in the un-phosphorylated form. A highly phosphorylated form of 
doublecortin therefore appears to be a hallmark of less mature neurons and this was 
further confirmed by the presence of this form of doublecortin in human neuroblastoma 
cells. As will be described further below, the phosphorylation state of doublecortin is 
likely to affect its function and localisation and the disappearance of the phosphorylated 
form of the protein between E ll  and El 5 may therefore represent a key difference in 
the function of doublecortin at these two developmental stages. At the very least, the 
expression of phosphorylated doublecortin in the E ll  spinal cord suggests that, at this 
stage,  the  spinal cord is  still  some way from full maturity.  It is apparent that a less 
mature spinal cord may be better capable of responding to injury as any repair processes 
which would otherwise need to be up-regulated may already be ongoing at this stage.
6.3.4.  Regulation of doublecortin  in  response to  injury suggests  a role in spinal 
cord regeneration
Investigation  of the  effects  of injury  on  doublecortin  expression  revealed  further 
differences  between the  E ll  and  E l5  spinal  cord,  which correspond to the  loss  of 
regenerative capacity. Injury to the E ll  spinal cord resulted in a significant increase in 
doublecortin mRNA levels. In contrast, after injury at E l5, although there did appear to 
be an increase in doublecortin mRNA levels, this did not prove statistically significant. 
Nor was this increase mimicked by an increase at the protein level. While it is possible 
that with increased sample numbers this increase might be shown to be significant, it is 
clear that the greatest increase in doublecortin mRNA occurs at regenerating stages.  At 
E ll  this  was  accompanied by  an  increase  in the  level  of doublecortin protein and, 
interestingly, a noticeable increase in the amount of phosphorylated doublecortin in the 
spinal cord. At E l5 there was no such response at the protein level. This suggests that 
the  up-regulation  of doublecortin  in  the  E ll  spinal  cord  and  an  increase  in  the 
proportion of phosphorylated doublecortin might contribute to a favourable regenerative 
response after injury.
This  study  initially  began  with  the  consideration  of doublecortin  as  a  marker  of 
neurogenesis.  Although the extensive nature of doublecortin expression at this stage
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means that detection of doublecortin alone is not sufficient to establish unequivocally 
new neuronal cell birth, it is certain that any up-regulation in neurogenesis after injury 
would ultimately result in increased doublecortin expression.  Furthermore, from the 
results  of the  current  study,  newly  born  neurons  are  more  likely  to  express  the 
phosphorylated form of the protein.  It is therefore possible that the up-regulation of 
phosphorylated  doublecortin  observed  in the  chick  spinal  cord  after  injury  at Ell 
reflects an increase in neurogenesis. The results of these experiments are not sufficient 
to determine whether this is the case and further analysis of the potential increase in 
neurogenesis after injury at El 1 is required. This will be addressed further in Chapter 7.
6.3.5.  Potential  mechanisms  by  which  doublecortin  might  contribute  to 
regenerative capacity
The results described above are suggestive of a role for doublecortin in determining the 
regenerative capacity of the chick spinal cord. If this were the case then it is possible 
that the presence of high levels of the phosphorylated form of doublecortin present at 
E ll  itself  contributes  to  the  regenerative  capacity  of  the  chick  spinal  cord. 
Alternatively, up-regulation of doublecortin after injury at E ll  may have a beneficial 
effect  on the  outcome  of the  injury.  There  are  a number of mechanisms  by which 
doublecortin might contribute to the regenerative capacity of the spinal cord.
Doublecortin has been demonstrated to be associated with microtubules and to have a 
role in the control of microtubule stability (Gleeson et al.  1999; Horesh et al.  1999). 
Doublecortin associates with microtubules via a conserved doublecortin domain (Kim et 
al.  2003b;  Sapir et al.  2000; Taylor et al.  2000).  In common with a number of other 
MAPs,  the  binding  of  doublecortin  to  microtubules  is  regulated  in  part  by 
phosphorylation  (Tanaka  et al.  2004).  Doublecortin  has  been  demonstrated  to  be 
phosphorylated by Cdk5, JNK, protein kinase A (PKA) and MAP/ microtubule affinity 
regulatory kinase (MARK) (Schaar et al.  2004;  Tanaka et al.  2004;  Gdalyahu et al.
2004). These kinases act at a range of different phosphorylation sites and the different 
combinations of possible phosphorylation states add to the complexity of the regulation 
of doublecortin (Reiner et al. 2004). Phosphorylation of doublecortin by Cdk5, PKA or 
MARK reduces the affinity of doublecortin for microtubules and thus results in reduced 
microtubule  stability.  This  is  likely  to  be  important  in  situations  in  which  the
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cytoskeleton  undergoes  dynamic  changes  and  can  explain  the  important  role  of 
doublecortin in neuronal migration during development. Furthermore, phosphorylation 
of doublecortin  by  Cdk5  may  result  in the  preferential  binding  of doublecortin to 
microtubules  in  the  perinuclear  region,  which  has  been  suggested  to  have  role  in 
translocation of the cell soma during radial migration (Reiner et al. 2004; Tanaka et al.
2004).  Phosphorylation of doublecortin by  JNK has  also  been reported to  enhance 
neurite outgrowth (Gdalyahu et al. 2004). In humans, mutations in doublecortin result in 
x-linked  lissencephaly,  a disorder  linked to  abnormal migration of cortical neurons 
during  development  (des  Portes  et al.  1998;  Gleeson et al.  1998).  Similarly, RNAi 
knockdown of doublecortin in the rat results in disrupted neuronal migration (Bai et al. 
2003).
The role of doublecortin in microtubule stabilisation provides some suggestions as to a 
potential  mechanism  by  which  this  protein  might  be  involved  in  spinal  cord 
regeneration. The high levels of the phosphorylated form of doublecortin present in the 
E ll  spinal  cord  suggest that at this  stage  the  cytoskeleton may  be  still  in  a fairly 
dynamic state and that the spinal cord may be fairly plastic. This would lead to more 
rapid responses to an injury than at later, less dynamic stages of development. After an 
injury, repair processes are likely to include neurite sprouting and outgrowth and the 
formation  of new  synapses.  Neuronal  migration  may  also  take  place  in  the  re­
organisation of the neuronal circuitry. These processes all involve re-organisation of the 
cytoskeleton  and  might therefore  be  expected to  be  accompanied  by  a decrease  in 
microtubule  stability.  Increased phosphorylation  of doublecortin  after  injury  might 
therefore greatly facilitate these processes.
Another interesting possibility is that doublecortin might contribute to the survival of 
spinal  cord  neurons  after  injury.  It  has  been  demonstrated  that  overexpression  of 
doublecortin can protect PC 12 cells from apoptosis (Shmueli et al. 2001). As described 
in Chapter 4, a dramatic increase in the apoptotic response of the spinal cord to injury is 
likely  to  make  an  important contribution to  the  loss  of regenerative  capacity.  It  is 
therefore  intriguing  to  consider  the  possibility  that  doublecortin  might  be  in  part 
responsible  for the  reduced  apoptotic  response  observed  at regeneration-competent 
stages.  In support of this,  inhibition of Cdk5 with roscovitine, which might result in 
reduced doublecortin phosphorylation, causes cell death in SH-SY5Y cells (Appendix
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Fig.  1). It is not possible to determine from this experiment, however, whether this was 
due to reduced phosphorylation of doublecortin.
As an attempt to investigate this possibility further experiments have been initiated to 
investigate  the  effect  of doublecortin  knockdown,  using  an  antisense  approach,  on 
apoptosis in SH-SY5Y neuroblastoma cells. As shown in this chapter, these cells have 
been shown to express doublecortin. Furthermore, apoptosis can be triggered in these 
cells by a number of different apoptotic agents including thrombin (Appendix Fig. 2 and 
Chapter 5, Fig 5.11). Experiments have been carried out to determine the threshold dose 
of these drugs which is required to cause apoptosis and methods for the measurement of 
apoptosis  have  been  developed  (Appendix  Fig.  2  and  Fig.  3).  Finally,  antisense 
oligodeoxynucleotides  have  been  designed  for the  knockdown of doublecortin and 
experiments  have  been  initiated  to  optimise  the  conditions  required  for  successful 
knockdown  (Appendix  Fig.  4).  Unfortunately,  to  date  antisense  treatment  has  not 
produced  a  consistent reduction  in  doublecortin  levels,  probably  due  to  inefficient 
transfection.  Nevertheless these preliminary  experiments have  set in place  a viable 
method to  assess whether knockdown of doublecortin increases the susceptibility of 
these cells to apoptosis-inducing agents.
6.3.6.  Conclusions
In this chapter the potential role of a microtubule protein, doublecortin, in determining 
the regenerative  capacity  of the  chick  spinal  cord has  been  explored.  These results 
provide novel information about the regulation of doublecortin expression in the normal 
and injured chick spinal cord. Further work will be required to determine whether the 
up-regulation in phosphorylated doublecortin expression after injury at Ell  reflects 
changes in neurogenesis (which will be explored in Chapter 7), cytoskeletal dynamics 
or a novel neuroprotective response.
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7.1. Introduction
The previous chapter described attempts to establish the contribution of neurogenesis to 
spinal cord regenerative capacity in the chick, using the microtubule-associated protein, 
doublecortin, as a marker of newly bom neurons. The results of these studies showed 
that, in the developing spinal cord, expression of doublecortin persists beyond the stages 
at which neurogenesis is expected to be complete, suggesting that this marker could not 
be used for this purpose.  However the up-regulation of doublecortin expression and 
increased levels of the phosphorylated form of this protein after injury at Ell but not 
El 5 might indicate the induction of neurogenesis in the regenerating chick spinal cord. 
In order to test this hypothesis, an alternative method for measuring neurogenesis was 
therefore sought.
Although no specific markers for neurogenesis are known, it is possible to assess the 
birth of neurons by labelling cells as they are bom with a marker which is incorporated 
into DNA during synthesis, such as BrdU. BrdU is a synthetic analogue of thymidine 
that  is  incorporated  into  DNA  in  proliferating  cells  during  S-phase.  Double 
immunostaining for both BrdU and markers of neuronal differentiation can then provide 
evidence  for  neurogenesis  and,  therefore,  this  strategy  was  chosen  for  this  study. 
Neurogenesis  has  been  reported  to  be  complete  by  E9  in the  chick (Fujita  1964). 
Therefore,  it was  expected that no neurogenesis would be detected in the uninjured 
spinal cord at El 1. This chapter describes the development and application of strategies 
to detect neurogenesis in the chick spinal cord in order to determine to what extent this 
process is re-instated after injury.
7.2. Results
7.2.1.  Analysis of proliferation in the developing chick spinal cord
In order to investigate proliferation in the spinal cord, a method for labelling dividing 
cells in ovo with BrdU was developed.  In preliminary experiments,  several different 
methods of administering BrdU in ovo, were tested, including injecting under and on
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top of the chorioallantoic membranes and injecting subcutaneously in the embryo. As 
these did not lead to a significantly different amount of labelling, it was decided that 
application  of  the  BrdU  onto  the  chorioallantoic  membrane  would  be  used  for  all 
subsequent  experiments.  BrdU  labelling  was  carried  out  at  several  different 
developmental stages and spinal cords were collected after 24 hours and immunostained 
using an antibody to detect BrdU incorporation. As shown in Fig. 7.1, BrdU labelling 
was successful at all developmental stages tested. In this and subsequent experiments, 
attempts  to  use  Hoechst  dye  for  nuclear  counterstaining  with  BrdU  staining  were 
unsuccessful,  possibly  due  to  the  effects  of  the  acid-treatment  required  for  BrdU 
staining. BrdU labelling revealed that, at E4, proliferation is taking place throughout the 
neural tube (Fig. 7.1.A). Twenty-four hours after labelling at E10, BrdU labelling was 
observed  in  all  regions  of the  spinal  cord,  with  the  highest  concentration  of DNA 
synthesis found in the ependymal region surrounding the central canal (Fig. 7.1.B, and 
B’, see Fig. 7.1.D for illustration of the regions). At E16, 24 hours after labelling at E15, 
DNA synthesis was still observed in all regions of the spinal cord; however there were 
noticeably high levels of proliferation in the white matter at this stage, consistent with 
the birth of glial cells (Fig. 7.1.C). Therefore, these results indicated that a reduction in 
BrdU labelling in the grey matter corresponds to an increase in BrdU labelling in the 
white  matter  between  E ll  and  E15,  probably  reflecting  an  increase  in  the  birth  of 
astrocytes.  These  results  are  in  agreement  with  previous  work  in  our  laboratory  in 
which proliferating cells were stained for PCNA or phosphorylated histone-3  (O'Neill 
2002). It was noted in the course of these experiments that the BrdU labelling was never 
1 0 0% effective; at all developmental time points tested some embryos were not labelled 
at all, suggesting that they had not effectively taken up the BrdU.
7.2.2.  Analysis of the expression of transitin in the developing and injured chick 
spinal cord
The previous results demonstrated that high levels of proliferation are ongoing in the 
chick  spinal  cord  at  both  E ll  and  E l5,  with  a  shift  in  the  location  of the  highest 
concentration of BrdU positive cells from the grey to the white matter between these 
two time points. The aim of this study was to determine whether neurogenesis can be 
induced in the E ll  spinal cord in response to injury.  Therefore,  it was  of interest to 
determine whether these proliferating cells have the capacity to adopt a neuronal fate in
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Fig. 7.1. Analysis  of proliferation in the developing chick spinal cord by 
BrdU labelling. BrdU immunostaining (green) in transverse sections of spinal 
cord 24  hours  after  labelling with BrdU. A)  Spinal  cord  labelled at E3  and 
collected at  E4.  B)  Spinal  cord  labelled at E10 and collected  at  Ell.  High 
levels  of proliferation  in  the  ependymal  region  are  indicated by  the  arrow. 
Asterisk  indicates  the  central  canal  B’)  High  magnification  view  of BrdU 
labelling in the ependymal region at El 1. The central canal is marked by an 
asterisk. C) Spinal cord labelled at E l5 and collected at El6 . The central canal 
is indicated by an asterisk. C’) High magnification view of BrdU labelling in 
the  white  matter  at  E l6 .  Dashed  line  indicates  the  approximate  boundary 
between the grey matter (GM) and the white matter (WM) D) Haemotoxylin 
and Eosin staining of transverse section of E12 spinal cord showing the three 
main regions assessed for BrdU labelling.  Scale bars = 500 pm. In all images 
dorsal is at the top and ventral at the bottom of the picture.
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response to injury. In a number of studies in mammalian species, the expression of the 
intermediate filament nestin has been used as a marker of neural precursors, including 
both neuroepithelial cells and radial glia, although it has also been shown that nestin is 
expressed by reactive astrocytes (Lendahl et al.  1990; Brewer  1999; Dahlstrand et al. 
1995; Reynolds and Weiss  1992; Weiss et al.  1996). Although no chick homologue of 
nestin has yet been identified, transitin, a member of the same subgroup of intermediate 
filaments, has been suggested to be expressed in neural precursors as well as radial glia 
(Cole and Lee  1997; Lee and Cole 2000; Napier et al.  1999; Yuan et al.  1997). It was 
therefore of interest to determine whether a change in the expression of transitin and/ or 
double-labelling with BrdU and transitin occurs in the chick spinal cord after injury.
Initially, the expression of transitin in the developing chick spinal cord was examined. 
As  shown in Fig.  7.2.A,  at E5, transitin was  shown to be  expressed throughout the 
neural tube.  At later stages (E7 and E9), transitin expression was most prominent in 
radial processes spanning the width of the spinal cord (Fig. 7.2.B and D). Transitin was 
also highly expressed along the dorsal midline (Fig. 7.2.C). From El 1  onwards, most 
transitin  expression became  largely  restricted to  the  dorsal  midline,  with low-level 
expression continuing in some radial fibres (Fig 7.2E). Expression of transitin remained 
in these regions until at least El 5 (Fig. 7.2.E and F).
From  these  results,  the  expression  pattern  of transitin  in  the  chick  spinal  cord 
corresponds closely to the developmental expression of nestin in other species (Takano 
and Becker 1997). Nestin has been reported to be up-regulated after spinal cord injury 
(Frisen et al.  1995; Namiki and Tator 1999; Shibuya et al. 2002) and it was therefore of 
interest to determine whether transitin expression is similarly up-regulated in the chick. 
Spinal cord injury was performed at El 1   and the spinal cords were collected 24 hours 
after injury. 7jam sections, taken less than 500pm from the injury site were prepared and 
stained for transitin. As shown in Fig. 7.3, an increase in the expression of transitin in 
radial processes and scattered cells throughout the spinal cord was observed 24 hours 
after injury at El 1.  Some of the up-regulated transitin seemed to be localised in cells 
that extend radial fibres from the ependymal region towards the spinal cord surface, 
reminiscent of patterns of radial glia during development. Other staining appeared to be 
in scattered cells with short processes. In order to determine whether newly proliferating 
cells begin to express transitin after injury at El 1, or whether transitin expression is
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Fig.7.2.  Expression  of  transitin  in  the  developing  chick  spinal  cord.
Immunostaining  for  the  chick  nestin  homologue,  transitin  (red),  in  transverse 
sections of the developing spinal cord. A) E5  spinal  cord.  Transitin is expressed 
throughout  the  early  neural  tube.  B)  E7  spinal  cord.  Transitin  is expressed  in 
radially  oriented  processes  (arrow).  C)  and  D)  E9  spinal  cord.  Transitin  is 
expressed in both the dorsal midline (arrowhead in C) and radial fibres (arrow in 
D) which extend to pial end feet at the spinal cord surface (arrowhead in D). E) 
E ll  spinal  cord.  Transitin  expression  is  restricted  to  the  dorsal  midline  and 
transitin  expression  in  radial  fibres  is  absent.  F)  E l5  spinal  cord.  Transitin 
continues  to  be  expressed  predominantly  in  the  dorsal  midline.  Scale  bars: 
500pm.
236Fig.  7.3.  Changes  in  transitin  expression  after  injury  at  E ll.
Immunostaining for transitin (red)  in transverse  sections of spinal  cord, 
24  hours  after  injury  at Ell.  A)  and  B)  Sections  from  sham-operated 
embryos  at  El2.  C)  and  D)  Sections  from  injured  embryos,  24  hours 
after injury at Ell. There is a clear up-regulation of transitin expression 
in radial processes after injury. Scale bars = 500pm
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up-regulated in existing differentiated cells, double labelling for transitin and BrdU was 
assessed in spinal cord sections, 24 hours after injury and labelling with BrdU (Fig. 
7.4).  The  filamentous  nature  of the transitin staining made  it difficult to  assess co­
localisation with any certainty. However, as shown in Fig. 7.4.B and Fig. 7.4.C, some 
cells in the injured spinal cord did appear to be labelled by both markers, including 
some in the grey matter. This suggests that the up-regulation of transitin after injury 
may be due, in part, to the expansion of progenitor cell populations.
In order to determine whether this up-regulation in transitin expression may contribute 
to the regenerative response at El 1  it would be necessary to determine whether the same 
change in expression occurs after injury at non-regenerating stages. Transitin staining 
was therefore carried out in transverse sections of spinal cord 24 hours after injury at 
E l5. As shown in Fig. 7.5, there was no obvious increase in transitin expression after 
injury  at  El5.  Given  the  limited  numbers  of embryos  that  were  available  for this 
analysis  (n=l),  no  firm  conclusions  can  be  drawn  about  the  changes  in  transitin 
expression after injury  at El5.  However, these findings suggest that the increase in 
transitin expression may be specific to El 1.
7.2.3.  Analysis of the expression of 3CB2 in the developing and injured chick spinal 
cord
It has been suggested that,  during  development,  radial  glial  cells  may act as neural 
precursors (Gregg et al.  2002; Malatesta et al.  2000). Markers of radial glia have been 
demonstrated to be up-regulated after injury in the rat spinal cord (Namiki and Tator 
1999; Shibuya et al.  2003). Furthermore transitin, like nestin in the mammal, has been 
reported to  be  expressed  in radial  glia and  appeared in the  current study to be up- 
regulated after injury at El 1. It was therefore of interest to determine whether there are 
any changes in the number or localisation of radial glial cells after injury in the chick 
spinal cord. This was investigated by immunostaining using an antibody against radial 
glial cells, 3CB2 (Prada et al.  1995).
238Fig.  7.4.  Double  labelling with BrdU and  transitin  after injury  at Ell.
Immunostaining for BrdU (green) and transitin (red) in transverse sections of 
spinal cord 24 hours after injury and labelling with BrdU at El 1. A) Sham- 
operated  spinal  cord  at  El2.  B)  and  C)  Injured  spinal  cord 24  hours  after 
injury  at  Ell.  B’,  B”  and C’  show high magnification view of potentially 
double-labelled cells (arrows) Scale bars = 500 pm.
239Fig. 7.5. Analysis of transitin expression after injury at E l5. Immunostaining for 
transitin (red) in transverse sections of spinal cord, twenty four hours after injury at 
El 5. A) and B) Section from a sham-operated embryo at El 6 . C)-F)  Sections from 
an injured  embryo, taken from two  different levels,  24  hours after injury at El5. 
Scale bars A,C,E = 200 pm, B,D,F =100 pmAnalysis of neurogenesis in the regenerating chick spinal cord
Initially, the expression of 3CB2 was investigated in the developing chick spinal cord 
(Fig.  7.6).  At E4,  3CB2 was  expressed in cells  lining the ventricular surface of the 
neural tube. By E5 3CB2 expression was observed in radial fibres projecting away from 
the  ventricular  zone  and  across  the  neural  tube  (Fig,  7.6 .A  and  B).  By  E9,  3CB2 
expression was more diffusely spread within the spinal cord; however the highest levels 
of expression remained in the cells surrounding the central canal (Fig. 7.6.C). By Ell, 
the expression of 3CB2 was restricted mainly to the dorsal midline, spanning from the 
central  canal  to  the  dorsal  surface  of the  spinal  cord.  Some  expression  was  also 
observed in the ventral midline, close to the central canal (Fig. 7.6.D). This expression 
pattern was maintained until at least E l6 , with low levels of expression still visible in 
some radial fibres (Fig. 7.6.E and F).
The  expression  pattern  of  3CB2  was  consistent  with  previous  reports  and  was 
noticeably  similar  to  the  expression  pattern  of transitin  in  the  chick  spinal  cord. 
Consequently, it was of interest to determine whether 3CB2 is up-regulated after spinal 
cord injury in the same manner as transitin. In order to do this, 3CB2 expression was 
examined in transverse sections of the spinal cord. Twenty-four hours after injury at 
E ll (Fig. 7.7) there did not appear to be a significant up-regulation of 3CB2 expression. 
This  suggests that 3CB2 positive radial  glia were not up-regulated by injury in this 
model and that progenitor cells do not begin to express the 3CB2 antigen in response to 
injury. Similarly, after injury at El5, there was no noticeable increase in 3CB2 staining. 
In contrast, there appeared to be a decrease in the intensity of 3CB2  staining in the 
dorsal midline, although it was not possible to determine whether this was due to the 
extensive  tissue  damage  occurring  at E l5  or represented a true  down-regulation of 
protein expression (Fig. 7.8).
7.2.4.  Selection of neuron-specific markers for the analysis of neurogenesis in the 
chick spinal cord
The experiments described above, showing changes in the expression of transitin, may 
be indicative of an up-regulation of neural precursors in the spinal cord after injury at 
regenerating stages.  However, this does not necessarily mean that these cells will go on 
to produce new neurons. Thus, in order to investigate whether neurogenesis takes place 
in the regenerating chick spinal cord after injury cells in the spinal cord were assessed
241Fig  7.6.  Expression  of  3CB2  in  the  developing  chick  spinal  cord.
Immunostaining for a marker of radial glia, 3CB2 (red), in transverse sections 
of the developing  spinal  cord.  A)  E4  spinal  cord.  3CB2  is  expressed  in cells 
lining the ventricular canal (arrows).  B) E5  spinal cord.  3CB2 is expressed in 
radial  fibres  projecting  from  the  ventricular  zone  of the  early  neural  tube 
(arrows). C) E9 spinal cord. 3CB2 expression has become more diffuse but can 
still be observed around the ventricular zone (arrow in C). D) El 1   spinal cord. 
3CB2  is  expressed  in  the  dorsal  midline  (arrowhead)  and  extends  into  the 
ventral  midline  (arrow) E)  E13  spinal  cord.  F)  E16  spinal  cord.  Inset  shows 
high  magnification  picture  of 3CB2  staining  in  the  ependyma  and  in  radial 
processes (arrow).  Scale bars: 500pm. In A) dorsal  is to the left and ventral to 
the right. In all other pictures dorsal is at the top of the picture.
242Fig.  7.7.  Analysis  of  3CB2  expression  after  injury  at  Ell.
Immunostaining  for 3CB2  (red)  in transverse sections  of spinal cord,  24 
hours after injury at El 1. A) and B) Sections from sham-operated embryos 
at El2. C) and D) Sections from injured embiyos, 24 hours after injury at 
Ell. There is no up-regulation of 3CB2 expression after injury. Scale bars: 
500pm
243Fig. 7.8. Analysis of 3CB2 expression after injury at E15. Immunostaining for 
3CB2 (red) in transverse sections of spinal cord, twenty four hours after injury at 
El5. A) and B)  Section from a  sham-operated embryo at El6 .  C)-F)  Sections 
from an injured embryo, taken from two different levels,  24 hours after injury at 
El5. Scale bars A,C,E = 200 pm, B,D,F = 100 pmAnalysis of neurogenesis in the regenerating chick spinal cord
for double labelling with BrdU and markers of a neuronal phenotype. According to this 
strategy, cells dividing at the time of, or subsequent to, an injury will be labelled with 
BrdU and, if they go on to become neurons, will begin to express neuronal markers. By 
assessing the  spinal  cord for cells which are double-labelled for both BrdU and the 
neuronal marker it should be possible to identify neurons that have been generated in 
response to the injury. Previously existing neurons or dividing cells that adopt a glial 
phenotype  will  be  labelled  with  only  one  of the  markers  (Fig.  7.9).  This  strategy 
required the  selection of multiple  specific  markers  for neuronal  differentiation and, 
therefore, several different commonly-used antibodies were considered for this purpose.
The first antibody tested for the purpose of assessing neurogenesis was anti-p3-tubulin, 
an early marker of post-mitotic neurons.  P3-tubulin is expressed in the cell body and 
processes of neurons and has been used in a number of similar double labelling studies 
in conjunction with BrdU. In order to determine the usefulness of (33-tubulin for this 
purpose, embryos were collected during the period of neurogenesis, at E4, and stained 
for p3-tubulin and BrdU. As shown in Fig. 7.10.A, at E4, 24 hours after labelling with 
BrdU,  (33-tubulin was expressed in the ventral and lateral regions of the neural tube, 
where the post-mitotic neurons are residing.  Expression of p3-tubulin could also be 
observed in the axonal projections exiting the ventral and dorsal regions of the neural 
tube.  Double  labelling  of cells  in these regions  with BrdU  and  |33-tubulin could be 
observed, suggesting that at this developmental stage cells begin to express P3-tubulin 
within 24 hours of dividing (Fig. 7.10.A’). At E12, 24 hours after BrdU labelling, (33- 
tubulin  expression  was  widespread  throughout  the  spinal  cord  (Fig.  7.10.B).  This 
widespread expression, together with the non-nuclear localisation of P3-tubulin, means 
that  it was  virtually  impossible  to  determine conclusively  whether cells are  double 
labelled with this antibody and BrdU. Consequently, it was decided that this neuronal 
marker would be unsuitable for double-labelling analysis. Analysis of the expression 
pattern of doublecortin (Chapter  6) suggested that,  similar to p3-tubulin, this marker 
would  be  unsuitable  for  double-labelling  owing  to  its  widespread,  non-nuclear 
expression.
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Fig. 7.9. Strategy for assessing neurogenesis in the chick spinal cord. Schematic diagram illustrating the use of double-labelling studies 
to detect neurogenesis.  1) cells dividing at the time of or subsequent to the injury are labelled with BrdU (green). 2) During the following 
incubation period  of 1-4  days,  cells  which are  becoming neuronal  will  begin expressing early  ((33-tubulin, HuC/D),  then  late  (NeuN) 
neuronal markers (red).  3)  Immunostaining for BrdU and neuronal markers unequivocally  identifies newly  generated neurons (red and 
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Fig. 7.10 (previous page). Comparison of different neuronal markers for assessing 
neurogenesis.  Immunostaining  of  transverse  sections  of  spinal  cord  at  different 
developmental  stages  with  three  different neuronal  markers  and BrdU.  A)  E4  spinal 
cord  stained for  (33-tubulin  (red)  and BrdU  (green).  A’)  High  magnification view of 
cells in the ventrolateral neural tube double-labelled with (33-tubulin  and BrdU (arrow). 
B)  E l2  spinal cord  stained for (33-tubulin (red)  and BrdU (green),  demonstrating the 
extensive nature of p3-tubulin immunostaining at this stage. C) E4 spinal cord stained 
for  HuCD  (red)  and  BrdU  (green).  C’)  High  magnification  view  of  cells  in  the 
ventrolateral neural tube double-labelled with HuCD and BrdU (arrow). D) El5 spinal 
cord  stained for HuCD  (red)  and BrdU  (green).  E) E4  spinal  cord  stained for NeuN 
(red) and BrdU (green). No double-labelling can be observed at this stage. F) El2 spinal 
cord stained for NeuN (red) and BrdU (green). Scale bars = 0.5mm
Another antibody used to detect neurons is anti-HuC/D. This antibody detects a neuron 
specific family of RNA binding proteins, including HuC, HuD and Hel-Nl (Marusich et 
al.  1994).  Like  p3-tubulin,  HuC/D  has  been  shown  to  be  expressed  early  during 
neuronal differentiation and has a non-nuclear expression pattern (Fomaro et al. 2003). 
However,  since  HuCD  is  not  expressed  in  neuronal  processes  its  expression  was 
expected to be slightly less widespread than that of P3-tubulin, and it was hoped that 
this  might provide a more  suitable neuronal  marker for double labelling  analysis. As 
shown  in  Fig.  7.10.C,  HuC/D expression at E4  was localised towards to  ventral and 
lateral parts of the neural tube. Again, it was possible to observe some overlap between 
HuC/D  and BrdU  labelling  at this  stage  (Fig.  7.10.C’).  At E l2,  HuC/D  is expressed 
throughout  the  grey  matter  of  the  spinal  cord  (Fig  7.10.D).  Unlike  P3-tubulin 
expression,  it  was  possible  to  distinguish individual  cells  using  this  antibody  and to 
determine  more  easily  whether  cells  co-express  BrdU,  although  the  non-nuclear 
expression  pattern  still  presented  a  challenge  for  double  labelling.  Therefore,  it was 
decided  that  HuC/D  would  be  an  appropriate  neuronal  marker  for  future  double­
labelling studies.
As  described  previously,  the  early  neuronal  markers  |33-tubulin  and  HuC/D  present 
complications for double-staining analysis due to their non-nuclear expression patterns. 
NeuN is a neuronal marker that has a nuclear expression pattern (Mullen et al.  1992). 
NeuN is expressed in post-mitotic neurons and is reported to be expressed relatively late 
during neuronal development. As shown in Fig. 7.10.E, at E4, cells in the ventral and 
lateral parts of the neural tube were shown to express NeuN.  However,  at this  stage, 
after 24 hours labelling with BrdU, no cells double labelled for BrdU and NeuN could
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be observed. This suggests that more than 24 hours are required for a newly bom neuron 
to begin to express  NeuN  at this  developmental  stage.  At E l2, NeuN was expressed 
throughout  the  grey  matter  of  the  spinal  cord  (Fig,  7.10.F).  Due  to  the  nuclear 
localisation of the NeuN labelling it was possible to distinguish cells double-labelled for 
BrdU  and NeuN relatively  easily  since the  signals  for both  overlap.  It was therefore 
decided  that  NeuN  would  be  an  appropriate  marker  for  double-labelling  studies, 
although it was  expected that longer incubation periods would be required for newly 
bom neurons to begin to express NeuN.
7.2.5.  Analysis  of neurogenesis  in the  chick spinal cord at 24 or 48 hours after 
injury at Ell.
In order to determine whether neurogenesis occurs in the chick spinal cord following an 
injury  at  regenerating  stages,  transection  injuries  were  performed  at  E ll  and  BrdU 
labelling was carried out at the time of injury. Immunostaining for HuC/D and BrdU 
was carried out on 30 pm sections of spinal cord, 300 pm from the injury site, 24 hours 
after injury and labelling with BrdU. Since the egg represents a closed system, BrdU is 
expected to remain available over the course of the 24 hour period and this therefore 
represents  a  cumulative  labelling  strategy.  Confocal  imaging  was  used  to  generate 
stacks of images in order to visualise cells three dimensionally. For each section up to 
two  individual  stacks  in  different regions  of the  spinal cord were constructed.  These 
were  further  sub-divided  into  4  higher  magnification  stacks  using  the  ‘separation’ 
function  in  the  confocal  software.  Once  a  stack of images  had been generated these 
were exhaustively searched for potentially double labelled cells using the ‘cross section’ 
function, as illustrated in Fig. 7.11.
Fig. 7.11. (next page) Analysis of neurogenesis in sections of sham operated spinal 
cord at E12 . Confocal images of immunostaining for HuC/D (red) and BrdU (green) in 
30  pm  transverse  sections  of spinal  cord 24 hours  after BrdU labelling  at Ell.  The 
central panel of each images shows a single confocal scan in the x-y plane taken from a 
stack of confocal images. Side panels to the right and bottom show cross sectional view 
in the x-z and y-z planes through the stack in the places indicated by the dashed white 
lines.  A) Sham-operated spinal cord in which one double labelled cell was identified 
(arrows).  Inset pictures  show high magnification view of the double-labelled cell. B) 
Sham operated  spinal  cord in  which no double labelled cells  were found.  The arrow 
indicates  a  potentially  double-labelled  cell  which  was  eliminated  from  the  analysis 
using this technique, Scale bars = 50 pm (same magnification in each)
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Fig. 7.12. (previous page) Analysis of neurogenesis in sections of spinal cord twenty- 
four hours after injury at E ll. Confocal images of immunostaining for HuC/D (red) 
and BrdU (green) in 30 pm transverse sections of spinal cord 24 hours after injury and 
BrdU  labelling  at Ell.  Sections  are approximately  300  pm from the injury site. The 
central panel of each images shows a single confocal scan in the x-y plane taken from a 
stack of confocal images. Side panels to the right and bottom show cross sectional view 
in the x-z and y-z planes through the stack in the places indicated by the dashed white 
lines.  Double-labelled  cells  are  indicated  by  the  arrows.  Inset  pictures  show  a  high 
magnification  view  of  the  double-labelled  cells,  Scale  bars  =  50  pm  (same 
magnification in all pictures)
Since  HuC/D  does  not  label  the  nucleus  and  will  therefore  not  overlap  with  BrdU 
labelling  directly  it  was  decided  that,  in  order  for  a  cell  to  be  classified  as  double 
labelled  there  must  be  unequivocal  evidence  of  a  BrdU  labelled  nucleus  (green) 
surrounded by  a HuC/D  labelled cell body  (red)  in  all  dimensions.  As  shown in Fig 
7.11, and Fig 7.12, using this method double-labelled cells were identified in both sham 
operated and injured spinal cord samples. Only one double-labelled cell was found out 
of 6 sections taken from 3 different sham-operated embryos was identified. A total of 8 
double  labelled cells  were found out of 7  sections  taken from three different injured 
embryos  were identified.  This  suggests  that neurogenesis is up-regulated after injury, 
although  the  sample  numbers  of cells  which  could  be  identified  even  in  these  thick 
sections used were not compatible with statistical analysis.
Although the analysis of neurogenesis in sections with HuC/D and BrdU indicated that 
neurogenesis  does  occur  after  injury,  there  were  still  a  number  of  difficulties  in 
identifying double labelled cells with this method. The closely packed nature of neurons 
in the spinal cord means that it is often difficult to determine whether the BrdU labelled 
nucleus lies within a single HuC/D labelled cell or between two or more labelled cells.
This means that it is possible to mistakenly exclude a double-labelled cell or to wrongly 
identify a cell as double labelled. To overcome this problem each cell would need to be 
visualised  at  a  single  cell  level.  For  this  reason,  it  was  decided  that  analysis  of 
neurogenesis on dissociated spinal cord preparation would be advantageous to confirm 
these results.  Cytospin preparations of dissociated spinal cord cells were prepared 48 
hours after injury and simultaneous labelling with BrdU at Ell. The cytospin produced 
an  even  spread  of cells  which  could  be  easily  distinguished  from  one  another  (Fig. 
7.13 A). In order to confirm that neurons could be identified in the cytospin, some
252Fig. 7.13. Analysis of cell types present in cytospin preparations of spinal 
cord.  A)  H&E  staining  of  a  cytospin  preparation.  B)  and  C) 
Immunostaining for HuC/D (B) or NeuN (C) (red) in a cytospin taken from 
E l3 spinal cord. Nuclei were counterstained with Hoechst (blue). D), E) and 
F)  Immunostaining  for  GFAP  (red)  and  BrdU  (green)  in  cytospin 
preparations from El3  (D) and E l5 (E and F) spinal  cord, after continuous 
labelling  with  BrdU  from  Ell.  Only  a  low  number  of neurons  or  GFAP 
positive cells were found in a typical cytospin preparation. Scale bars A-C = 
50pm D-F =16 pm
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preparations were stained for the neuronal markers HuCD and NeuN. As shown in Fig. 
7.13B and 7.13C, a low proportion of cells in the preparation were identified as neurons, 
suggesting  that  many  neurons  are  lost  during  the  preparation  of  the  cytospin.  The 
cytospin preparations were also stained for a marker of astrocytes, GFAP. As shown in 
Fig 7.13D-F, GFAP positive cells could be identified in the cytospin preparation. This is 
not surprising given that astrocyte development is ongoing at this stage; however again 
GFAP  positive  cells  did  not  make  up  the  majority  of the  cells  in  the  sample.  This 
suggests that the remainder of the BrdU positive cells in the spinal cord would adopt an 
oligodendroglial fate, which is consistent with the timing of the birth of these cells (Ono 
et  al.  2001).  Immunostaining  for  GFAP  and  BrdU  revealed  a  number  of double­
labelled cells, indicating that, as expected, some cells undergoing division at this time 
point are fated to become astrocytes (Fig. 7.13D-F).
Immunostaining  for  HuC/D  and  BrdU  in  cytospin  preparations  demonstrated  the 
existence of double-labelled cells in both sham operated and injured spinal cord samples 
in agreement with the findings in spinal cord sections (Fig. 7.14A-E). The numbers of 
double-labelled cells were very low (Table 7.1); less than 2% of BrdU positive cells co­
expressed HuC/D. Although the percentage of double-labelled cells in the injured spinal 
cord  was  higher  than  that  in  the  sham-operated  spinal  cord  this  did  not  prove 
statistically significant (p=0.432, Mann Whitney Test).
Table  7.1.  Quantification of double labelling with BrdU and HuC/D in cytospin 
preparations 48 hours after injury at E ll
No. of 
samples
Total 
BrdU+ve 
cells counted
Total double­
labelled cells
% total 
BrdU+ve cells 
which co­
expressed 
HuCD
Average % 
double-labelled 
cells in group 
(±SEM)
Sham 9 2455 16 0.65 0.65 (±0.195)
Injured 4 800 10 1.25 1.65 (±0.89)
254Fig. 7.14. Analysis of neurogenesis in spinal cord cytospin preparations 48 
hours after injury at E ll. A)-E) Immunostaining for HuC/D (red) and BrdU 
(green) in cytospin preparations taken from injured (A and B) or sham-operated 
(C-E)  spinal  cords  48  hours  after  injury  at  Ell.  Double-labelled  cells  were 
observed in both sham-operated and injured samples (arrows). Scale bars =  16 
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7.2.6.  Analysis of neurogenesis in the chick spinal cord at 4 days after injury at Ell
The results of the experiments described above had unexpectedly revealed the presence 
of apparent neurogenesis in sham-operated spinal cords. However despite the use of the 
cytospin preparation,  there were still  some difficulties  in identifying double labelling 
with  HuC/D  and  BrdU.  The  non-nuclear labelling  of HuC/D  made  if difficult to be 
absolutely certain a cell was labelled with both markers. Consequently, it was decided 
that analysis of neurogenesis with the nuclear marker NeuN might improve confidence 
in these findings. Since NeuN is expressed later than HuC/D, in order to use NeuN as a 
marker  for  neurogenesis,  spinal  cords  were  collected  4  days  after injury.  BrdU  was 
administered daily from El 1 to result in cumulative labelling and prevent dilution of the 
BrdU signal in dividing cells. Confocal analysis was used to assess double labelling of 
BrdU and NeuN in 30pm spinal cord sections of injured and sham-operated embryos. 
As shown in Fig. 7.15 and Fig. 7.16, cells double labelled with NeuN and BrdU were 
found in both injured and sham-operated embryos. In total, 4 double-labelled cells were 
identified out of 7 sections taken from 4 embryos in the injured spinal cord whereas in 
the sham-operated spinal cord a total of 10 double-labelled cells were identified out of 9 
sections  examined  from  6  embryos.  In  order  to  confirm  these  results,  cytospin 
preparations of dissociated spinal cord cells 4 days after injury and BrdU labelling were 
also stained for BrdU and NeuN.  Again, as  shown in Fig.  7.17, double-labelled cells 
were found in both injured and sham-operated samples. BrdU labelling was observed to 
be lower in these samples and an average of only 61 BrdU positive cells were counted 
per sample. Because the sample numbers were very low it was not possible to carry out 
statistical  analysis  on  these  data;  however  there  did  not  appear  to  be  a  significant 
difference  in  the  percentage  of double-labelled  cells  between  the  injured  and  sham- 
operated cords (Table 7.2). It was notable that the percentage of double-labelled cells
Fig. 7.15. (next page) Analysis of neurogenesis in the sham-operated spinal cord 4 
days after BrdU labelling at E ll. Confocal images of immunostaining for NeuN (red) 
and  BrdU  (green)  in  30  pm  transverse  sections  of  spinal  cord  4  days  after  BrdU 
labelling at El 1. The central panel of each images shows a single confocal scan in the x- 
y plane taken from a stack of confocal images. Side panels to the right and bottom show 
cross sectional view in the x-z and y-z planes through the stack in the places indicated 
by the dashed white lines. Double labelled cells are indicated by arrows. Inset pictures 
show high magnification view of the double-labelled cells. Scale bars = 40 pm
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BrdU mergedFig. 7.16. (previous page) Analysis of neurogenesis in the injured spinal cord 4 
days after injury at E ll. Confocal images of immunostaining for NeuN (red) and 
BrdU  (green) in 30  pm transverse  sections of spinal  cord 4  days  after injury  and 
BrdU labelling at Ell. The central panel  of each images shows a single confocal 
scan in the x-y plane taken from a stack of confocal images. Side panels to the right 
and bottom show cross sectional view in the x-z and y-z planes through the stack in 
the places indicated by the dashed white lines. Double labelled cells are indicated 
by arrows. Inset pictures show high magnification view of the double-labelled cells. 
Scale bars = 40 pm
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Fig.  7.17.  Analysis  of neurogenesis in spinal cord cytospin  preparations 4 
days  after  injury  at  E ll.  A)-D)  Immunostaining  for NeuN  (red)  and  BrdU 
(green) in cytospin preparations taken from injured (A) or sham-operated (B-D) 
spinal cords 4 days after injury at El 1. Double-labelled cells were observed in 
both sham-operated and injured samples (arrows). Scale bars = 16 pm.
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much lower in the cytospin preparations assessed at 4 days after injury. This may have 
been a result of a greater loss  of neurons in the preparation of a cytospin from these 
older embryos.
Table  7.2.  Quantification  of double-labelling  with  BrdU  and  NeuN  in  cytospin 
preparations 4 days after injury at E ll
No. of 
samples
Total 
BrdU+ve 
cells counted
Total double­
labelled cells
% total 
BrdU+ve cells 
which co­
expressed 
NeuN
Average % 
double-labelled 
cells in group 
(±SEM)
Sham 2 1833 2 0.109 0.11 (±0.08)
Injured 2 1833 1 0.555 0.07 (±0.05)
7.2.7.  Analysis of proliferation after injury in the regenerating chick spinal cord
The  results  described  above  revealed  unexpectedly  that  neurogenesis  is  not  only 
observed in the injured spinal cord, but is also present in the normal spinal cord at Ell. 
These results, however, did not confirm whether this process is up-regulated after injury 
at this stage. In order to investigate further how the spinal cord responds to injury, it was 
important to determine whether there is an increase in overall proliferation following an 
injury. Sections located approximately 300 pm caudal or rostral to the injury site were 
stained  for BrdU.  Two  confocal  images,  one  of each  half of a transverse  section of 
spinal cord, were used for image analysis. Using image analysis software, each section 
was  divided into  three regions;  the ependymal region consisting of a pseudostratified 
layer of cells around the central canal, the grey matter and the white matter (Fig. 7.1.D). 
The number of BrdU positive cells was counted in each region and expressed relative to 
the  total  area of that region.  Sections  from a total  of 4 injured  and  6  sham-operated 
spinal cords were measured, with up to two sections (one caudal and one rostral) taken 
from  each  embryo.  As  shown  in  Fig.  7.18,  there  was  a  significant  increase  in  the 
number of BrdU positive cells in the grey matter of the spinal cord 24 hours after injury, 
but no up-regulation of proliferation in the ependymal region or the white matter. This 
further supports the hypothesis that neurogenesis might increase after injury at El 1.
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Fig.  7.18.  Analysis  of proliferation  in  the  injured  chick  spinal  cord  by 
BrdU  labelling.  BrdU  positive  cells  were  counted  in  three  spinal  cord 
regions  in  transverse  sections  300  pm  from  the  injury  site,  24  hours  after 
injury and labelling with BrdU at Ell.  Data shows mean cell count/ pm2 ± 
SEM  in  sham  and  injured  embryos.  There  was  a  statistically  significant 
increase in proliferation in the grey matter. * p= 0.033 for grey matter p=0.83 
for ependyma  and p=0.394  for white matter  (Mann Whitney Test)
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7.2.8.  Analysis of neurogenesis in the E15 chick spinal cord
As described above,  neurogenesis in the chick spinal cord may continue at low levels 
beyond  the  expected  developmental  stage,  possibly  contributing  to  the  regenerative 
capacity of the E ll spinal cord. Since a subsequent reduction in this process might play 
a  role  in  the  loss  of  regenerative  capacity,  it  was  necessary  to  determine  whether 
neurogenesis  takes  place  in  the  E15  chick  spinal  cord.  BrdU  was  administered daily 
from E15 and spinal cords were collected at 24 hours and 4 days after labelling began. 
Confocal analysis of sections stained for BrdU and HuC/D or NeuN was carried out as 
before to assess spinal cord cells for double labelling of BrdU with neuronal markers. In 
a  total  of  7  different  embryos  no  double-labelled  cells  were  observed  (Fig  7.19), 
suggesting that significant neurogenesis does not take place after El5 in the chick spinal 
cord.
7.3. Discussion
Evidence  for  the  contribution  of neurogenesis  to  spinal  cord  regeneration  has  been 
obtained only for lower vertebrate species. Following the discovery of stem cells in the 
adult mammalian  CNS,  stimulation of endogenous progenitor cell populations is one 
option that is being considered as a therapeutic strategy for spinal cord injury. For this 
reason, it was of interest to determine the extent to which the loss of these capabilities 
might contribute to reduced regenerative capacity in the embryonic chick. In Chapter 6, 
an increase in the expression and phosphorylation of doublecortin was observed at Ell, 
which might reflect increased levels of neurogenesis.  In order to test this hypothesis, 
this study aimed to investigate neurogenesis in the injured chick spinal cord.
Fig.  7.19.  (next  page)  Analysis  of neurogenesis  in  the  E15  chick spinal  cord.  A)
Confocal  images  of immunostaining  for HuC/D  (red)  and BrdU  (green)  in  a 30  pm 
transverse  section  of spinal  cord  24 hours  after BrdU labelling  at El5.  B) Confocal 
images  of immunostaining  for NeuN  (red)  and  BrdU  (green)  in  a  30  pm transverse 
section  of spinal  cord  4  days  after BrdU  labelling  at E15  The central panel  of each 
image  shows  a  single  confocal  scan  in  the x-y plane taken from a stack of confocal 
images. Side panels to the right and bottom show cross sectional view in the x-z and y-z 
planes through the stack in the places indicated by the dashed white lines. The arrows 
indicate potentially double-labelled cells which were eliminated from the analysis using 
this technique, Scale bars = 50 pm (same magnification in all pictures)
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7.3.1. Assessing proliferation in the chick spinal cord
A  number  of different  techniques  exist  for the  detection  of cell  proliferation.  These 
include antibodies  against proteins expressed during specific phases of the cell cycle, 
such as PCNA and phosphorylated histone-3 (H3), DNA incorporation of BrdU or 3H- 
thymidine and retroviral labelling with proteins such as green fluorescent protein (GFP). 
In this  study,  cell proliferation was detected by labelling DNA in dividing cells with 
BrdU.  This  method  labels  all  cells  that  synthesise  DNA  during  the  period  in  which 
BrdU is available in the egg. Once incorporated, BrdU will remain present in the DNA 
of the  cell  throughout  subsequent  rounds  of division  and,  ultimately,  differentiation. 
Unlike  3H-thymidine, which is detected by autoradiography, BrdU can be detected by 
immunohistochemistry,  allowing  cells  to  be  double  labelled  with  specific  cell-type 
markers (Gratzner  1982). These factors were important for this study since they allow 
the detection of cells  which have divided,  incorporating BrdU and differentiated into 
neurons  at  a  later  time  point.  In  contrast,  markers  such  as  PCNA  and  H3  are  only 
expressed for a relatively limited time during division, which would hinder such double­
labelling analysis. The use of BrdU rather than 3H-thymidine also avoids the need to use 
radioactive  isotopes  and  is  a  more  efficient  method  of labelling  cells  than retroviral 
labelling. As the results of the current study show, it was possible using this technique 
to label proliferating cells at all developmental stages tested.
In  this  chapter,  BrdU  labelling  revealed  that  there  is  a  high  level  of  ongoing 
proliferation in the chick spinal cord at both E ll and E l5. Cells which were positive for 
BrdU were detected throughout the spinal cord; between E ll and E l5 there was a trend 
towards increased labelling in the white matter and reduced labelling in the grey matter, 
which fits with the transition between neurogenesis and astrocyte and oligodendrocyte 
development.
7.3.2. Timing of the expression of transitin and 3CB2 in the developing chick spinal 
cord
In this chapter,  the expression of transitin and 3CB2 was investigated, providing new 
information on the timing of the expression of these markers in the chick spinal cord. In 
a number of species, nestin has been used as a marker of neural precursor or stem cells,
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although  it  has  also  been  shown  that  nestin  is  expressed  by  reactive  astrocytes 
(Dahlstrand et al.  1995; Lendahl et al.  1990; Reynolds  and Weiss  1992; Weiss et al. 
1996). At present, no chick homologue of nestin has been identified; however a member 
of the same family of intermediate filament proteins, transitin, has been shown to share 
45%  homology  to  nestin  in  the  a-helical  core  domain,  and  to  share  a  similar 
developmental expression pattern (Cole and Lee 1997; Lee and Cole 2000; Napier et al. 
1999; Yuan et al.  1997). The results of the present study confirmed and extended these 
previously reported patterns of transitin expression in the developing chick spinal cord 
and showed that, by E ll, most expression has become restricted to the dorsal midline 
with  only  low  levels  of  expression  persisting  in  radial  fibres  to  relatively  late 
developmental  stages  (at  least  E l6).  Similarly,  staining  with  the  radial  glial  marker 
3CB2, showed that the pattern of radial glial expression in the chick spinal cord matches 
that  observed  in  other  species  (McMahon  and  McDermott  2002).  Again  expression 
became restricted mainly to the dorsal midline at late stages, and only very low-level 
expression persisted in radial fibres. Both transitin and 3CB2 have been reported to be 
expressed in radial glia, and radial glia have been suggested to act as neural precursors 
during  development.  This  expression  therefore indicates  that radial  glial cells,  which 
might potentially give rise to new neurons are mostly down-regulated by E ll, although 
the persistence of low-level staining might be associated with radial glial that would go 
on to transform into astrocytes.
7.3.3.  Changes in the expression of neural precursors and radial glia in the chick 
spinal cord after injury
Initial  experiments  showed  that  there  are  high  levels  of ongoing  proliferation  in  the 
spinal cord at El 1. Under normal circumstances at this stage, it was presumed that most 
of these cells would become astrocytes or oligodendrocytes as the developmental period 
of neurogenesis  has  been  reported  to  be  over by  E9  (Fujita  1964).  It  was  therefore 
important to determine whether, in response to injury, any of the dividing cells might 
adopt a phenotypic fate which is untypical for this stage of development and become 
neuronal, in order to replace neurons lost in the injury. This was suggested by the results 
of Chapter  6 ,  in  which the early  neuronal marker doublecortin was  shown to be up- 
regulated after injury.
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In this chapter it was shown that transitin is also Up-regulated after injury at E ll. This is 
in  agreement with  a number of studies which have demonstrated an up-regulation of 
nestin expression after spinal cord injury (Namiki and Tator 1999; Shibuya et al. 2002). 
It has been suggested that the up-regulation of nestin may represent an increase in the 
number of neural precursor cells and may subsequently contribute to the production of 
glial cells and the formation of a glial scar (Frisen et al.  1995). However, a glial scar has 
not  been  observed  in  the  developing  chick  spinal  cord  and,  at  the  stages  being 
examined,  the spinal cord is too immature for this up-regulation to represent reactive 
astrocytes.  Alternatively,  transitin  expression  might  represent  an  up-regulation  or 
activation  of  radial  glial  or  other  multipotential  progenitor  cells  that  could  help  to 
replenish lost neurons after injury.
The up-regulation of transitin observed after injury at E ll might therefore represent an 
up-regulation in the formation of radial glial cells or the conversion of another cell type 
to  a  radial  glia  phenotype.  A  marker  of radial  glial,  3CB2,  has  been  demonstrated 
previously to be up-regulated after spinal cord injury in the rat (Shibuya et al.  2003) . 
However, no up-regulation of 3CB2 expression was observed after injury at El 1 or E15. 
The discrepancy between these results and those reported previously might be explained 
by  experimental  differences;  in  the  current study,  3CB2  expression was  measured at 
twenty-four hours after injury wheras in the rat spinal cord 3CB2 was first up-regulated 
at  1  week after injury.  It is  therefore possible that  such  an up-regulation might have 
been missed in the present study. The up-regulation of transitin but not 3CB2 observed 
in the current study might also be a reflection of heterogeneity of the radial glial cell 
population. It has been shown previously that different subtypes of radial glia may be 
destined towards different fates (Hartfuss et al. 2001; Kriegstein and Gotz 2003). On the 
other  hand,  up-regulation  of  transitin  expression  may  have  occurred  in  radial  glia, 
already present in the spinal cord, although the staining patterns observed in the current 
study would suggest that any such population of cells would be very small. This was 
partly addressed by double-labelling for BrdU and transitin, which indicated that some, 
but  not  all,  of the  transitin  expression  might  be  found  in  cells  which  have  recently 
divided,  although  it  was  difficult  to  assess  the  correlation  between  the  filamentous 
staining of transitin and the nuclear BrdU staining.
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7.3.4.  Assessing neurogenesis in the chick spinal cord
While  the up-regulation of transitin and doublecortin  at E ll  may be indicative of an 
increase  in  the  numbers  or activity  of neural  stem cells  it remained unclear to  what 
extent this might lead to the generation of mature neurons in the injured spinal cord. It 
was  therefore  necessary  to  develop  a  technique  to  visualise  the  new-born  neurons 
directly.  This  issue  was  addressed  by  double  staining  for  both  BrdU  incorporation, 
beginning at the time of injury,  and neuronal phenotypic markers, HuC/D and NeuN. 
These  markers  were  chosen  from  several  available  because  it  was  hoped  that  their 
localisation  in  the  cell  body  (HuC/D)  and  the  nucleus  (NeuN)  would  simplify  the 
identification of double-labelled cells. In contrast, the early neuronal markers p3-tubulin 
and  doublecortin  were rejected from this  study  as  their extensive  labelling of axonal 
tracts  in  addition  to  the  cell  body  severely  hampered  the  ability  to  determine 
conclusively whether a particular cell was double labelled.
In the present study double labelling with BrdU and HuC/D or NeuN was demonstrated 
by two different methods:  three-dimensional confocal analysis of spinal cord sections 
and  cytospin  preparation  of  dissociated  spinal  cord  cells.  These  two  different 
approaches  to  investigating  double  labelling  were  employed  in  order  to  reduce  the 
possibility  of falsely  identifying  cells  as  double  labelled.  Confocal  analysis  of thick 
sections provided the advantage of allowing the analysis of large numbers of cells and 
the visualisation of each potentially double-labelled cell from three dimensions, as well 
as providing positional information about the localisation of any double-labelled cells. 
The cytospin preparation provides better single-cell resolution of double-labelled cells 
but removes all positional information and may alter the morphology of the cells being 
studied. Both methods are time-consuming; however it was felt that this type of in-depth 
analysis  was  required  in  order  to  be  fully  confident  of the  results  obtained.  Many 
double-labelling  studies in the past have relied on analysis of sections by fluorescent 
microscopy alone. However the experience gained during the current work suggests that 
it is easy to obtain false positive identification of double-labelling by this method as it is 
difficult to distinguish a single cell labelled with both markers from two cells closely 
positioned to one another, each labelled with only one marker.
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7.3.5.  Ongoing neurogenesis in the E ll chick spinal cord
One of the most interesting findings of these investigations was that neurogenesis in the 
chick spinal cord appears to still be ongoing at El 1, albeit at a relatively low level. This 
is  further  supported  by  the  findings  of the  previous  chapter,  in  which  expression  of 
doublecortin, which has been proposed to be a marker of neurogenesis, was shown to be 
relatively high at this stage. It has been believed previously that all neurogenesis in the 
spinal  cord ends  several  days  before  this  time point.  However,  in reality, there have 
been very few studies examining the question of the timing of the end of the neurogenic 
period in the chick. Many more studies have tended to focus more on the initiation of 
neurogenesis. One study which has attempted to comprehensively investigate this issue 
used  3H-thymidine  to  label  cells  undergoing  division  at  specific  time  points  during 
development  (Fujita  1964).  As  with  BrdU  labelling  in  the  chick,  this  results  in  a 
cumulative labelling  and all cells dividing  after the administration are labelled, while 
those  which  have  already  undergone  their terminal  differentiation remain unlabelled. 
Using this technique, it was shown that the last day at which cells which subsequently 
became neuronal could be labelled was at E9 in the cervical spinal cord and E8 in the 
lumbar spinal cord (Fujita 1964). There may be a number of reasons for the conflicting 
findings  of the  current  study  and  this  previous  report.  For  example,  the  methods  of 
identifying neurons  were different,  with the older study relying on the distribution of 
cells  at  various  time  points  during  development,  rather  than  labelling  with  neuronal 
markers as in the current experiments. Importantly, as shown in the present study, the 
numbers of double-labelled cells that are found represent a fairly low proportion of the 
total  number of cells  in the  spinal cord.  In the study by Fujita, very low numbers of 
embryos  were  studied  (for  example,  only  two  embryos  were  labelled  at  E ll  and 
examined after hatching) and relatively thin microtome sections were examined. Use of 
the confocal microscope which could visualise all cells in a 30pm section, has allowed 
the  examination  of many  more  cells  in the current study,  making  it more likely that 
these  relatively  rare  double-labelled  cells  would  be  identified.  Double  labelling  was 
confirmed  using  four  different  experimental  protocols  and  a  total  of  33  embryos 
(including  both  sham-operated  and  injured  samples):  confocal  analysis  of BrdU  and 
neuronal markers at 24 hours and 4 days after injury, and cytospin preparations taken at 
48 hours and 4 days after injury. This variety of different approaches all produced the
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same results, adding to confidence in the conclusion that neurogenesis takes place in the 
E ll chick spinal cord.
Having stated that the number of cells undergoing neurogenesis at this stage is relatively 
low  it  is  important  to  consider  whether  this  level  of  ongoing  neurogenesis  is  of 
biological  relevance,  and  in  particular  whether  it  may  make  a  contribution  to  the 
regenerative capacity of the embryonic chick spinal cord at E ll. From the numbers of 
double-labelled cells counted in this study it is suggested that around 2 double-labelled 
cells might be identified in one 30|im section of spinal cord, giving a total of 6 6 double­
labelled cells  per millimetre length of spinal cord.  It is possible that the true number 
would be higher than this,  since the stringent criteria used to identify double-labelled 
cells in this study are likely to underestimate the extent of neurogenesis.  It remains to 
be  determined  whether  this  proportion  of newly  bom  neuronal  cells  does  make  an 
important  contribution  to  the  repair  process  after  spinal  cord  injury.  However  the 
existence of ongoing neurogenesis does  suggest that the E ll  chick spinal cord is less 
mature  than  previously  thought  and  that  the  regenerative  process  might  involve  the 
replacement  of  lost  cells  from  endogenous  progenitors  in  addition  to  axonal 
regeneration.
This study also raises the issue of when neurogenesis does end in the chick spinal cord. 
Due to the cumulative labelling strategy it is not possible to know at what time point 
after labelling  began the double-labelled cells  were actually bom.  As  shown in these 
results, no double-labelled cells were observed in the chick spinal cord after labelling at 
E l5,  suggesting  that by  this  stage,  neurogenesis  is complete.  A more comprehensive 
study,  involving  BrdU  labelling  at  successive  stages  between  E ll  and  E15  could 
provide an answer to this question.
7.3.6.  Is neurogenesis up-regulated after injury at Ell?
As  outlined  above,  the  results  of  this  investigation  revealed  double-labelled  cells, 
indicating  neurogenesis,  present in the injured spinal  cord and also,  unexpectedly, in 
sham-operated spinal cords. The original assumption was that no double-labelled cells 
would be found in the sham-operated spinal cords and so any double labelling in the
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injured  spinal  cord  would  therefore  represent  an  up-regulation  of neurogenesis  after 
injury. Therefore, the primary purpose of the study was not to quantify the number of 
double-labelled  cells.  Consequently,  the  number  of  samples  that  there  was  time  to 
collect and analyse was insufficient for a thorough quantitative analysis of neurogenesis. 
This was made more difficult by the low levels of neurogenesis observed -  an average 
of only 2 cells per section were double labelled. However, in light of the identification 
of new-born cells in the normal post-El 1 spinal cord, attempts were made to determine 
whether  this  process  is  up-regulated  in  the  injured  spinal  cord.  In  support  of  the 
suggestion  that  neurogenesis  might  increase  after  injury,  a  significant  increase  in 
proliferation in the grey matter was observed at 24 hours after injury, which could be 
indicative of an increase in the birth of neuronal precursors, although it is not possible to 
know  whether this increase might,  in fact, indicate an increase in the proliferation of 
glial  progenitors.  Furthermore,  as  shown  in  Chapter  6,  the  microtubule  protein, 
doublecortin,  which  is  expressed in early post-mitotic  neurons,  was  shown to be up- 
regulated after injury at El 1, as was transitin, a putative marker of neural precursors.  In 
spinal cord sections, the number of cells double-labelled with BrdU and HuC/D at 24 
hours  after  injury  was  greater  in  the  injured  samples  examined  than  in  the  sham- 
operated spinal cords. This might therefore represent an up-regulation of neurogenesis 
in the injured spinal cord. However, when examining the frequency of double labelling 
between BrdU and NeuN at 4 days after injury the situation was reversed, with larger 
numbers  of double-labelled cells being identified in the sham-operated samples. This 
might represent an increase in cell death in the injured spinal cord. Unfortunately, the 
numbers obtained were insufficient for statistical comparison.
The cytospin preparation represented an opportunity to carry out cell counting in order 
to  investigate  this  further.  The number of double-labelled cells  was compared to the 
total number of BrdU labelled cells for two reasons. Firstly, due to the fact that nuclear 
dyes do not appear to work correctly after BrdU administration, it was difficult to obtain 
a measure of total cell numbers and secondly, this method was also expected to take into 
account any possible variation in BrdU up-take between embryos.  Using both HuC/D 
and NeuN as neuronal markers, it was found that there was no significant difference in 
the frequency with which double-labelled cells were found in the injured spinal cord in 
comparison  to  the  sham-operated  spinal  cords.  Again,  the  sample  numbers  were 
relatively  low  and  there  was  a  large  degree  of variability  within  each  experimental
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group,  suggesting that a small increase in neurogenesis would not be detected by this 
method.
Overall,  these  results  do  not  provide  sufficient  evidence  of  an  up-regulation  of 
neurogenesis after injury at E ll in the chick spinal cord. However, it would be of great 
interest to carry out a more quantifiable comparison of double labelling in the injured 
and sham-operated spinal cord. This would require much larger sample numbers, which 
is no trivial given the low survival rates, particularly at 4 days after injury for analysis 
with NeuN, and variability in the up-take of BrdU which means that around half of the 
embryos do not become labelled.
7.3.7.  Conclusions
In  this  chapter,  the  potential  contribution  of  proliferation  and  neurogenesis  to  the 
regenerative capacity of the E ll  chick spinal cord has been considered. A number of 
difficulties  and precautions  necessary  when using BrdU labelling in conjunction with 
neuronal  markers  have  been  identified.  The  findings  of  these  investigations  have 
demonstrated  for  the  first  time  that,  in  the  E ll  chick  spinal  cord,  proliferation  and 
neurogenesis  are ongoing processes,  whereas neurogenesis appears to be complete by 
E15.  The  regeneration-competent chick  spinal cord  is  therefore  less  mature than has 
previously  been  expected  which  may  contribute  to  its  favourable response  to  injury. 
There  appears  to  be  a  correlation  between  the  end  of  neurogenesis,  which  was 
demonstrated to occur somewhere between E ll  and E l5, and the loss of regenerative 
capacity.  An increase in proliferation in the spinal cord grey matter, together with an 
increase  in  transitin  and  doublecortin  expression,  may  indicate  an  up-regulation  of 
neurogenesis after injury at El 1, although further work will be required to examine this 
quantitatively.
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8.1. Background
The  chick  spinal  cord  undergoes  a  dramatic  loss  of regenerative  capacity  at  a  key 
transitional stage of embryonic development, around E l3. This model system therefore 
provides  an  opportunity  to  examine  both  the  processes  involved  in  spinal  cord 
regeneration  and those that are involved in preventing such regeneration,  in the same 
species. The embryonic chick represents a system that shares features both with highly 
regeneration-competent lower vertebrates and with mammalian species. Understanding 
the factors which govern changes in regenerative capacity in the embryonic chick may 
provide insights into why the adult mammalian spinal cord is incapable of regeneration 
after injury, and may therefore suggest strategies to improve the outlook for spinal cord 
injury patients.
The majority of previous studies, both in the chick and in other regeneration competent 
and  incompetent  species  have  tended  to  focus  on  promoting  axonal  re-growth  as  a 
central  issue.  These studies have shown that strategies which down regulate or block 
inhibitory  signalling  from  a  range  of  myelin  and  glial-scar  derived  molecules  may 
improve axonal re-generation. Indeed, in the chick, delaying myelination of the spinal 
cord  has  been  shown  to  extend  the  regeneration-competent  period  (Keirstead  et  al. 
1992;  Keirstead et al.  1997; Keirstead et al.  1995). Axonal regeneration could also be 
enhanced by strategies which boost the intrinsic capacity of CNS neurons to regenerate 
and  also  by  the  use  of factors  which  directly  drive  and  encourage  axonal  extension. 
However, although the re-growth of axonal tracts is clearly an essential component of 
any  functional recovery  after disruption of such tracts, it is likely that a multitude of 
different  factors  contribute  to  the  determination  of  regenerative  capacity.  Future 
therapeutic strategies will almost certainly have to deal with more than one aspect of the 
response to injury in the non-regenerating spinal cord in order to achieve success.
It is apparent that the success or failure of regeneration will be influenced by the degree 
of cell loss -  that is, the number of viable cells which remain in the spinal cord in order 
to re-grow  their axons or receive and respond to restored synaptic connections.  It is 
important to consider that spinal cord injury results in the disruption, and often complete
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destruction of the cells which make up of local neuronal circuits, in addition to the long 
axonal tracts which once passed through the lesion site. Restoring function to these local 
circuits cannot therefore be achieved by axonal re-growth alone. Furthermore, cell loss 
contributes to the failure of axon regeneration through the generation of cavities within 
the cord that act as a barrier to growth. Given that some degree of cell loss is inevitable 
after  an  injury,  two  factors  may  affect  this  parameter:  protective  mechanisms  that 
minimise  the  extent  of cell  death,  and  cellular replacement  mechanisms  which  may 
compensate for those cells lost. The extent to which these mechanisms contribute to the 
success of regeneration in the embryonic chick pre-El3 has not been fully determined 
and was therefore the focus of this thesis. The overall objective of the project was to 
increase our knowledge about whether a decrease in the number of viable cells in the 
spinal cord, as a result of increased cell death or deficient recruitment and proliferation 
of replacement cells, contributes to the decreased regenerative capacity observed after 
E l3 in the chick spinal cord, and to identify underlying mechanisms which contribute to 
this change.
8.2.  Factors contributing to cell death in the non-regenerating chick spinal cord
8.2.1.  Reduced  haemorrhage  after injury  correlates  with  reduced apoptosis and 
tissue damage
Which factors govern the extent of cell loss after spinal cord injury? Secondary injury 
mechanisms play a well-established role in expanding the damage which occurs in the 
mammalian  spinal  cord  after  injury.  In  mammals,  a  progression  of  vascular  and 
biochemical  events  and  cellular  responses,  including  haemorrhage,  ischemia  and 
inflammation,  ultimately  results  in  axonal  damage,  apoptotic  cell  death  and  the 
formation of fluid-filled cavities within the cord (Profyris et al. 2004; Hausmann 2003). 
Many  of these  responses  occur identically  in  the E15  chick  spinal  cord  after injury, 
suggesting  that  this  model  provides  an  accurate  representation  of a non-regenerating 
system similar to the adult mammal.  Previous studies in our laboratory, together with 
results presented in this thesis have demonstrated that there is a dramatic change in the 
response of the spinal cord to trauma between E ll  and E l5, in terms of the degree of 
tissue  damage,  haemorrhage  and  apoptotic  cell  death  occurring  after injury  (O'Neill 
2002; Whalley et al. 2006).  The correlation between the extent of haemorrhage within
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the cord and the subsequent apoptotic response was particularly notable, suggesting that 
a causal relationship might exist between these two factors. The extent of haemorrhage 
is related to the vascularisation of the spinal cord, which increases dramatically between 
E ll and E l5 (O’Neill 2002; Whalley et al. 2006). These observations have been further 
supported by  additional previous work which demonstrated that artificially enhancing 
the  haemorrhagic  response to injury  at E ll  by diazepam administration resulted in a 
massively  expanded  apoptotic  response  (O'Neill  2002;  Whalley  et al.  2006).  In  this 
thesis the results of the converse experimental approach, the pharmacological reduction 
of haemorrhage  by  administration  of a haemostatic  compound,  have  been  presented. 
The results of this study support the previous findings, providing further evidence for a 
causal  relationship  between  the  presence  of  blood  in  the  spinal  cord  after  injury, 
apoptosis and cavitation. It is not possible to determine from these experiments whether 
increased haemorrhage and apoptosis is the sole or even the main factor underlying loss 
of regeneration in the chick spinal cord. More long-term studies, investigating whether 
treatment with desmopressin results in improved functional outcome, would be required 
to answer this question. It may well be the case that the presence of inhibitory factors 
preventing axonal re-growth, or the requirement for a supply of replacement cells would 
additionally  have  to  be  addressed  to  restore  function  completely.  Nevertheless,  a 
reduction in apoptosis and subsequent cavitation certainly reduces the degree of axonal 
reconstitution that would be required and would help to provide a more axon-friendly 
environment  for  such  re-growth.  Neuroprotective  mechanisms  or  the  absence  of 
apoptotic  stimuli  might  therefore  make  a  significant  contribution  to  the  successful 
regeneration of the E ll spinal cord.
The combination of these results with previous work suggests that haemorrhage may be 
a  key  secondary  injury  mechanism  which  results  in  apoptotic  cell  death  and  that 
strategies for reducing haemorrhage could provide neuroprotection in non-regenerating 
systems  such  as the post-El3  chick or the adult mammal.  Haemorrhage is one of the 
earliest events to occur after injury and it could therefore prove difficult to find ways to 
reduce  or  block  haemorrhage  within  a  realistic  therapeutic  timeframe.  Nevertheless, 
since  haemorrhage continues  to expand over a period of hours  after the initial insult 
there might still be room for a reduction in the overall impact of this event. The delay 
between the onset of haemorrhage and the first signs of apoptosis (around 8 hours in the 
chick)  does,  however,  indicate that understanding the downstream factors  which link
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these  two  phenomena  might  suggest  ways  in  which  to  minimise  the  impact  of 
haemorrhage.  Therefore,  the main focus of this half of the project was to investigate 
further the underlying mechanisms that might link haemorrhage to apoptosis.
8.2.2.  Caspase-dependent mechanisms are involved in apoptosis after spinal cord 
injury in the E15 chick.
A  preliminary  study  presented  in  this  thesis,  together  with  a  subsequent  study  by 
Steeves and colleagues, indicate that caspase-inhibition can reduce apoptosis following 
injury  in the chick spinal  cord,  suggesting that caspase-dependent mechanisms are at 
least partially  involved  in  this  response  and  that inhibition  of caspase  activity  might 
reduce  the  secondary  injury  response  (McBride  et  al.  2003).  However,  caspase 
activation  represents  a  relatively  late  step  in  the  progress  of  apoptosis  and  direct 
inhibition of caspases might act too far down these pathways to save cells from damage. 
It might be of greater use for therapeutic purposes to identify factors acting upstream of 
caspases,  which  are responsible  for triggering the  apoptotic  response.  Given the link 
between haemorrhage and apoptosis at least some of these factors are likely to be either 
blood-borne, or activated or induced by factors carried in the blood. Although a wide 
range  of different factors  and cell types could fit this description, the serine protease 
family of coagulation factors can be considered among the candidates for this role.
8.2.3. Thrombin is unlikely to be involved in the apoptotic response to spinal cord 
injury in the chick
The serine protease thrombin has been linked by a number of different in vivo and in 
vitro studies to affect cell survival and cell toxicity (Donovan et al.  1997; Junge et al. 
2003;  Lee  et  al.  1997;  Masada  et  al.  2000;  Nishino  et  al.  1993;  Pike  et  al.  1996; 
Smirnova et al.  1998; Smith-Swintosky et al.  1995; Striggow et al. 2000; Turgeon et al. 
1999;  Vaughan  et  al.  1995;  Xue  and  Del  Bigio  2001).  Thrombin  is  endogenously 
expressed in the central nervous system, as are its receptor, PAR-1 and cognate serpins, 
such as PN-1, suggesting that thrombin has a function in the normal spinal cord (Choi et 
al.  1990; Deschepper et al.  1991; Dihanich et al.  1991; Weinstein et al.  1995). In chick 
spinal  motomeuron  cultures,  thrombin  activation  of  the  PAR-1  receptor  has  been 
demonstrated  to  cause  apoptotic  cell  death  by  caspase-dependent  mechanisms
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(Smirnova  et  al.  1998;  Turgeon  et  al.  1999;  Turgeon  et  al.  1998).  Furthermore, 
increased  thrombin  expression  and  activity  has  been  demonstrated  in the  injured rat 
spinal  cord  (Citron  et  al.  2000b).  Thrombin  was  therefore  an  obvious  candidate  for 
initial investigations into serine protease function in the injured chick spinal cord.
There are several possible mechanisms by which thrombin could be linked to apoptosis 
in  response  to  haemorrhage,  and  thereby  linked  to  the  developmental  loss  of 
regeneration:  the precursor prothrombin, present in the spinal cord, might be activated 
by blood-borne factors entering the spinal cord after injury; or alternatively thrombin, 
entering the nervous tissue at high quantities, might trigger apoptosis, either directly or 
via  activation  of  another  factor.  In  these  cases,  the  presence  of larger  quantities  of 
blood, and hence larger amounts of thrombin or thrombin-activators, would explain the 
differential response of the E l5 spinal cord compared to the E ll  spinal cord, in which 
haemorrhage  is  reduced.  It  is  also  worth  considering  however,  that  the  response  of 
spinal cord cells to thrombin might be regulated developmentally, with the El 1  spinal 
cord  being  more  resistant  to  thrombin-induced  apoptosis.  Indeed  a  change  in  the 
susceptibility  of spinal cord cell  to apoptosis  with development was  suggested in the 
current work by  the increased sensitivity to low  serum conditions in E15  spinal cord 
slice  cultures  compared to E ll.  Finally,  although unrelated to haemorrhage it is also 
possible that endogenous prothrombin gene expression might be induced in the spinal 
cord  in  response  to  injury,  as  was  observed  in  the  rat  spinal  cord,  presumably  to  a 
greater extent in the E l5 spinal cord than the E ll  spinal cord. These possibilities were 
therefore  all  considered  in  this  study.  The results  of this  study indicated firstly that 
prothrombin expression in the normal spinal cord is similar at E ll and El5. The results 
also show that neither the expression nor activity of thrombin is increased after injury in 
the non-regenerating chick spinal cord.  While these experiments were not exhaustive, 
with  only  two  time-points  tested  and  limitations  associated  with  sample  sizes,  these 
results suggest that thrombin is not significantly activated or induced endogenously in 
response  to  injury,  in  contrast  to  the  studies  in  the  adult  rat  (Citron  et  al.  2000b). 
Whether this is due to species- or developmental age-related differences, or a difference 
in the techniques used is unknown. Furthermore, experiments conducted in organotypic 
cultures suggest that exogenous thrombin does not readily cause apoptosis in the chick 
spinal cord and that there is no developmental regulation of the response to thrombin 
with developmental age, in contrast to the change in response to low serum conditions.
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It was however, not possible to rule out the possibility that a second blood-borne factor 
is required in addition to thrombin to trigger apoptosis.
Interestingly,  several  of the  results  pointed  towards  the  potential  involvement  of an 
alternative serine protease in the response to injury at E l5. A large increase in overall 
protease  activity,  as  indicated  by  non-specific  cleavage  of  a  chromogenic  substrate, 
suggests that up-regulation of serine proteases other than thrombin may occur. In further 
support of these findings,  the relatively non-specific serine protease inhibitor PPACK 
provided slight, though non-significant, protection against apoptosis in the slice culture 
system.  A number of other serine proteases, including the plasminogen activators tPA 
and urokinase, have also been linked to nervous system damage (Abe et al.  2003; del 
Zoppo  1998; Figueroa et al.  1998; Flavin et al.  2000; Kataoka et al.  2000; Masos and 
Miskin  1997;  Melchor et al.  2003).  Of the  plasminogen  activators  only  urokinase  is 
expressed in the chick CNS. Although the results of this study suggest that endogenous 
urokinase  expression  is  not  regulated  by  injury,  it  would  be  of  great  interest  to 
investigate changes in the activity of this protease after injury.
This study has also highlighted the difficulties associate with investigating changes in 
individual genes or proteins in a complex scenario such as spinal cord injury. With a 
multitude of possible factors to choose from, these results have demonstrated that even 
with  reasonable  grounds  for  the  choice,  it  may  not  be  possible  to  select  the  most 
interesting and important factor.  With the availability of multi-gene and multi-protein 
analysis  techniques  now  expanding  to  include  species  such  as  the  chick,  a  good 
approach for the future would be to examine a number of different factors at one time, 
allowing a more exhaustive analysis.
8.3.  The identification of neurogenesis in the regenerating chick spinal cord
While the first part of this study concentrated on the apoptotic response as a potential 
similarity between the post-El3 spinal cord and other non-regenerating systems such as 
the adult mammal, in the second half of the study the focus moved to the investigation 
of responses  in  the  E ll  spinal  cord  which  are  potentially  similar  to  those  of other 
regeneration-competent  systems.  In  lower  vertebrates,  proliferation  and  neurogenesis 
have been demonstrated to occur after spinal cord injury and may make an important
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contribution  to  the  regenerative  response  (Zhang  et  al.  2000;  Benraiss  et  al.  1999; 
Anderson  et  al.  1994).  In  contrast,  in  the  adult  mammal,  although  the  presence  of 
endogenous  stem  cells  within  the  spinal  cord  has  been  demonstrated,  there  is  no 
evidence that these cells are effectively recruited in response to injury (Mothe and Tator 
2005; Namiki and Tator 1999; Takahashi et al. 2003; Yamamoto et al. 2001). The lack 
of the ability to recruit replacement cells for those lost during trauma may therefore be a 
feature of non-regenerating systems. However, the contribution of such mechanisms to 
the regenerative ability of the chick spinal cord had not previously been investigated, 
with the majority of studies in this model focusing on axonal regeneration.
8.3.1.  Doublecortin is regulated in response to injury in the E ll chick spinal cord
Studies  into  the  activity  and  identity  of precursor  cells  and  neurogenesis  are  made 
difficult due to the lack of available markers to distinguish one cell type from another. 
This is further complicated in the chick, by the absence of some of the classical neural 
precursor markers  such as nestin.  One molecule which has risen to prominence over 
recent  years  is  doublecortin,  a  microtubule  associated  protein  linked  to  cortical 
migration  (Bai et al.  2003;  des Portes et al.  1998; Francis et al.  1999; Gleeson et al. 
1999).  A  number  of  studies  have  used  doublecortin  as  a  marker  of  neurogenesis, 
exploiting the fact that this protein, unlike many neuron-specific proteins, is expressed 
only transiently during neuronal development (Couillard-Despres et al. 2005; Nacher et 
al.  2001; Rao M.S. and Shetty A.K. 2004). While this approach has been demonstrated 
successfully in the adult rodent brain, the expression and regulation of doublecortin in 
the  chick  spinal  cord  was  unknown.  I  therefore  set  out  to  determine  firstly  whether 
doublecortin could be used as a neurogenic marker. The expression of doublecortin in 
the developing chick spinal cord was investigated, revealing high levels of expression 
throughout  development  (Fig  8.1).  Although  these  results  demonstrated  that 
doublecortin would not be a useful marker of neurogenesis, because of the persistence 
of expression throughout development, the investigation of doublecortin expression did 
indicate some interesting differences between the El 1 and the E15 spinal cord and point 
to a potential role for doublecortin after injury (Fig 8.1). Doublecortin protein was both 
present at higher levels and more highly phosphorylated at E ll  in comparison to El5. 
Furthermore,  in  response  to  injury  at  E ll  but  not  E15,  an  increase  in  doublecortin 
mRNA and protein levels occurred together with even greater levels of phosphorylation.
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This suggests that phosphorylated doublecortin may be a hallmark of less mature neural 
development, a notion which is supported by the expression of this form of the protein 
in  neuroblastoma cells.  The return  to  a more phosphorylated  state  after injury  might 
therefore  be  indicative  of  a  recapitulation  of  developmental  processes  such  as 
neurogenesis.  Phosphorylation  of doublecortin  has  been  demonstrated  to  regulate  its 
binding to microtubules,  and hence phosphorylation may reduce microtubule stability 
(Schaar et al.  2004;  Tanaka et al.  2004).  Such  a mechanism might be involved in a 
range of different cellular functions, including but not restricted to neurogenesis, many 
of  which  might  be  expected  to  contribute  to  the  response  to  injury.  For  example, 
increased doublecortin levels might reflect an increase in axonal growth activity, which 
might be triggered by the injury. Alternatively, some in vitro studies have indicated that 
doublecortin might be neuroprotective against certain forms of toxic stimuli and it can 
be  hypothesised  that  the  increase  in  doublecortin  expression  acts  to  protect  the  E ll 
spinal  cord  from  cell  death-inducing  factors.  It  is  therefore  of interest  to  determine 
which, if any, of these hypotheses are true.
8.3.2.  Expression of transitin and 3CB2 in the developing chick spinal cord
In addition to doublecortin, several other potential neural markers were investigated in 
this thesis, providing new information on their expression patterns during normal spinal 
cord development in the chick. Although expression of the nestin homologue, transitin 
has previously been investigated in the chick brain, information on its expression in the 
spinal  cord,  particularly  at  late  stages  was  sparse.  Similarly,  the  radial  glial  antigen 
3CB2  has  been  extensively  investigated  at  early  developmental  stages  in  the  chick 
spinal  cord  and  in  the  adult  chick  brain.  This  thesis  therefore  adds  to  what  was 
previously  known  about  the  timing  of the  down-regulation  of these  markers  at later 
stages of spinal cord development (Fig 8.1). Both transitin and 3CB2 were demonstrated 
to  be  expressed  throughout  development,  becoming  restricted  to  the  midline  of the 
spinal cord after the end of neurogenesis.  Only low level expression was observed in 
radial  fibres  at  all  developmental  stages  tested,  suggesting  that by  these  stages  most 
radial glia have been down-regulated. However, the presence of a small population of 
radial glia that persist in the spinal cord provided the possibility, supported in part by 
the  findings  with  doublecortin,  that these  cells  could be activated  or up-regulated  to 
participate in neuronal replacement after injury.
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8.3.3.  Neurogenesis is ongoing in the chick spinal cord at E ll
Does  the  increase  in  phosphorylated  doublecortin  represent  a  recapitulation  of 
neurogenesis after injury? The results of the present study show that, as in most species 
tested, there is an increase in cell proliferation in the E ll  spinal cord after injury. This 
occurred exclusively in the grey matter,  which could point to an up-regulation in the 
proliferative  activity  of neural precursors.  This concept was  further supported by the 
increased expression of transitin (Fig 8.1), a chick protein which has been suggested to 
be  similar to  mammalian  nestin,  and is  expressed in neural precursor and radial glia 
(Lee  and  Cole  2000;  McCabe  et  al.  1992;  Cole  and  Lee  1997).  However  both 
proliferation and nestin up-regulation have been  shown to occur in both regeneration 
competent  and  incompetent  species  and  are  unlikely,  therefore,  to  be  important  for 
regeneration (Mothe and Tator 2005;  Namiki  and Tator  1999; Takahashi et al.  2003; 
Yamamoto  et al.  2001;  Benraiss  et al.  1999).  It was  therefore essential to determine 
whether this proliferation is followed by the production of new neurons, which is more 
likely to be a determining characteristic of regeneration-competency.
In the current  study  a thorough double-labelling approach was taken to identify cells 
which  began  proliferating  at  or  after  the  time  of  injury  and  then  subsequently 
differentiated  to  form  neurons.  Unexpectedly,  this  analysis  revealed  the  presence  of 
cells  undergoing  neurogenesis  at  stages  much  later than  was  expected in the  normal 
chick spinal cord, confirmed by two separate approaches. This finding is supported by 
the persistent expression of doublecortin which was also noted in the chick spinal cord 
at these stages.  In order to provide an indication of the end of the neurogenic period, 
identical  analysis  was carried out in the E l5  spinal cord and no double-labelled cells 
were  found,  revealing  that neurogenesis  is  complete  at  some point between E ll  and 
E l5. This is in contrast to previous estimates of the end of neurogenesis occurring by E9 
at the latest (Fujita  1964).  Therefore,  although neurogenesis was also observed after 
injury at E ll, it is not possible to know from these results whether this process is up- 
regulated  in  response  to  injury.  In  the  future,  more  quantitative  experiments  will  be 
required  to  determine  whether  this  is  the  case.  It  seems  likely,  however,  that  the 
existence  of ongoing  neurogenesis  in the  spinal cord could in itself contribute to the 
regenerative response.  These results suggest that the spinal cord is fairly immature at 
this  time-point,  which  may  make  it  simpler  to  recapitulate  developmental  processes
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required  for regeneration.  Additionally,  a  spinal  cord which is  still  in the process of 
generating  neurons  may  be  more permissive for neuronal development and plasticity 
and axonal growth. In support of this, the end of neurogenesis, between E ll  and E15, 
corresponds  well  with  the  loss  of regenerative  capacity.  Table  8.1  summarises  the 
evidence  which  this  study  has  provided  that  neurogenesis  might  play  a  role  in 
determining the regenerative capacity of the chick spinal cord.
Table 8.1 Summary of the evidence for a contribution of neurogenesis to
regenerative capacity in the embryonic chick spinal cord
E ll E15
Ongoing neurogenesis Yes No
Up-regulation of transitin expression Yes No
Up-regulation of doublecortin 
expression
Yes No
Up-regulation of proliferation in grey 
matter
Yes
Up-regulation of neurogenesis Unknown Unknown
8.4.  Conclusions
This thesis aimed to provide some preliminary answers to the question of why the Ell 
chick spinal cord is able to regenerate, in contrast both to the E15 chick spinal cord and 
to  the  adult  mammal.  As  outlined  in  the  introduction  to  this  thesis  it  is  possible  to 
hypothetically  devise  a  set  of  conditions  which  must  be  met  for  spinal  cord 
regeneration,  meaning  functional  recovery,  to  occur  (Fig  1.6).  These  can  be broadly 
divided into  1) a requirement for sufficient numbers of viable cells to be present within 
the spinal cord, and  2) the ability of these cells to re-grow and thus restore functional 
axonal tracts and synaptic contacts. In this thesis I have investigated principally which 
factors may contribute to the first of these requirements. The project has dealt with two 
different, but related aspects of the early response to injury -  mechanisms which result 
in cell death and those which result in cell replacement. Figure 8.2 summarises the new 
information which has been gained by this study, together with aspects which remain to 
be addressed and new questions which these findings have raised.
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Overall, this study suggests that both increased cell death and reduced cell replacement 
may make a contribution to the loss of regenerative capacity in the chick. The results 
provide additional support for a causal relationship between haemorrhage and apoptosis 
and have given insights into possible factors linking these two phenomena, suggesting 
that  thrombin  is  not  of key  importance  but  that  other  serine  proteases  might be  of 
greater interest. Future work will need to determine exactly which factors are involved 
in this link and both microarray-based approaches and the organotypic culture system 
devised in  this  thesis  may contribute to this  work.  The  second part of this  study has 
indicated for the first time that ongoing neurogenesis takes place in the spinal cord at 
E ll, which might contribute to the regenerative capacity at this stage. Further work will 
be required to investigate whether this process is up-regulated in response to injury and 
furthermore whether the newly generated neurons make a significant contribution to the 
functional  recovery.  It should also be noted that cell death and cell replacement are 
interrelated  -  that  is,  cellular  replacement  alone  would  be  ineffective  if  the  newly 
generated  cells  themselves  die.  Likewise,  although  neuroprotection  may  account for 
some of the ability to regenerate, cell death was observed at both developmental stages 
examined,  suggesting  that  some requirement for cellular replacement may  always be 
necessary. This relationship would also need to be taken into account when designing 
clinical  strategies to  alter these responses in the adult mammal and a combination of 
neuroprotective  and  cellular  replacements  strategies  should  be  considered.  In 
conclusion,  the  chick  spinal  cord  has  been  demonstrated  to  be  capable  of revealing 
much  information  about  the  factors  that  determine  the  extent  to  which  the  central 
nervous  system  can  regenerate.  This  study  has  opened  up  a  number  of interesting 
avenues for future research. For example these results could be followed up by further 
investigation of the potential role of serine proteases such as urokinase in the apoptotic 
response  to  injury  at  E15.  Further  exploration  of  the  potential  functional  role  of 
doublecortin up-regulation and phosphorylation in the regenerative response on the Ell 
spinal cord could also be carried out. In particular, it would be of interest to investigate 
the potentially neuroprotective function of this protein.
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Al.  The  effect  of  roscovitine  on  SH-SY5Y  cells.  SH-SY5Y  human 
neuroblastoma  cells  were  grown  on  plastic  and  incubated  with  the  Cdk5 
inhibitor, roscovitine. Images show typical phase-contrast images of the cells 
after  24  hours  incubation.  A)  control  culture,  incubated  with  an  equivalent 
amount  of DMSO  B)  10  pM roscovitine,  C) 20  pM roscovitine.  Treatment 
with the Cdk5 inhibitor resulted in signs of cell death such as cell rounding and 
detachment Scale bars =100 pm.
285A2. The effect of different apoptotic agents on SH-SY5Y ceils. SH-SY5Y 
human neuroblastoma cells were grown on glass coverslips and incubated 
with  various  concentrations  of  thrombin,  rotenone  or  nocodazole  to 
determine the threshold dose required to cause signs of cell death . Images 
show typical phase-contrast images of the cells after 6 hours incubation. For 
each  treatment  the  pictures  from  left  to  right  show  1)  control  2)  sub- 
threshold dose and 3) above threshold dose. A) thrombin B) rotenone and C) 
nocodazole Scale bars =100 pm
286A3. Identification of apoptotic cells with ethidium bromide, acridine orange 
and JC-1. A)-B) Apoptotic cells identified by their condensed chromatin after 
staining  with  acridine  orange  (A),  which  stains  chromatin  in  all  cells  and 
ethidium bromide  (B),  which stains chromatin in dead cells.  Arrows indicate 
two cells, still living, which show evidence of condensed chromatin. Arrowhead 
shows  one  cell  which  is  dead  and  shows  evidence  of apoptosis.  C)  Phase- 
contrast image of the cells shown in A and B.  D) JC-1  staining of SH-SY5Y 
cells  treated  with  roscovitine.  Cells  with  normal  mitochondrial  membrane 
potential accumulate JC-1  in the mitochondria in aggregates which produce red 
fluorescence  (arrow  in  high  magnification  view).  Cells  with  loss  of 
mitochondrial  membrane  potential  do  not  accumulate JC-1  and  exhibit  only 
green fluorescence in the cytoplasm. D’) Phase contrast image of cells shown in 
D.  Scale bars = 50 pm3001
mOD
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Appendix Fig. 4. Treatment of SH-SY5Y cells with doublecortin antisense 
oligodeoxynucleotides. SH-SY5Y human neuroblastoma cells were grown in 
a 96 well plate and incubated with various concentrations of low dose (A) or 
high dose (B)  sense  or antisense oligodeoxynucleotides against doublecortin 
for  three  days.  Graphs  show  results  of an  ELISA  using  anti-doublecortin 
antibody to measure doublecortin protein levels. No consistent knockdown of 
doublecortin with antisense treatment could be observed.
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